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Abstract
Abstract
DNA damage may lead to mutations and loss of genome integrity. Lesions 
encountered during replication cause the replication machinery to stall and, 
unless repaired or bypassed, can result in lethality of the cell. The DNA 
polymerase processivity clamp, PCNA (proliferating cell nuclear antigen), 
mediates either mutagenic damage bypass or error-free damage avoidance 
through its post-translational modification states. Mono-ubiquitylated PCNA 
stimulates the activity of translesion DNA polymerases, while poly- 
ubiquitylation of PCNA is a pre-requisite for error-free damage avoidance by a 
yet unknown mechanism. Recent findings in the laboratory suggested that 
Replication Protein A (RPA), an essential single-stranded (ss) DNA-binding 
protein, is required for induction of PCNA ubiquitylation upon DNA damage. 
Consequently, the aim of my thesis was to gain further insight into the 
mechanism by which RPA is involved in the up-stream signals that activate 
PCNA modification.
The Rad 18 protein from Saccharomyces cerevisiae (S. cerevisiae) is the 
ubiquitin ligase (E3) responsible for PCNA mono-ubiquitylation. The 
interactions of Rad 18 with DNA and RPA, and the effects of this interaction on 
Rad 18 binding to ssDNA, were studied in detail.
Recombinant Rad 18 was purified as a complex with its ubiquitin-conjugating 
enzyme, Rad6. Their stable association and ubiquitin conjugation activity was 
verified. Furthermore, basal levels of PCNA ubiquitylation were reconstituted 
in vitro. Yeast Rad18 was reported by others to bind preferentially to ssDNA 
over dsDNA. The intrinsic ssDNA-binding activity of the recombinant Rad 18 
protein was confirmed by pull-down assays using biotinylated 
oligonucleotides. Importantly, Rad 18 is able to bind to ssDNA and to other 
ssDNA-containing structures, but also to forked-DNA consisting entirely of 
double-stranded (ds) DNA regions. Rad 18 binding to DNA was demonstrated 
to be dependent on the ionic strength of the buffer. At low salt concentrations 
Rad18 was found to stably associate with ssDNA. At moderate to high salt 
concentrations, including in ionic strength conditions that could be considered
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physiological, Rad18 did not bind to ssDNA. Interestingly, binding to ssDNA at 
low ionic strength confers a stable association of Rad 18 with the DNA for 
subsequent high ionic strength conditions. Taken together, these findings 
suggest that Rad 18 binds to ssDNA at low salt concentrations with low 
affinity. Thereafter, a slow conformational change leads to an increased 
binding affinity that renders the ssDNA-bound Rad 18 stable association with 
the ssDNA in high salt concentrations. Furthermore, these findings argue 
against the speculation that Rad 18 can bind to sites of DNA damage in vivo 
by itself.
In vitro experiments further demonstrated that the yeast Rad18-Rad6 complex 
interacts physically with RPA. The findings in this work support a mechanism 
through which both proteins bind directly to RPA. Further analysis of 
recombinant RPA subunits revealed that both Rfa2 and the DNA-binding 
domain of Rfa1 contribute independently to the specific interactions with the 
complex. Interestingly, the association between the Rad18-Rad6 complex and 
the DNA-binding domain of Rfa1 is stimulated by the presence of ssDNA. 
Furthermore, at physiological ionic strength, RPA recruits the Rad18-Rad6 
complex to ssDNA. These findings support a model by which RPA-coated 
ssDNA recruits Rad18 to sites of DNA damage. Thus, ssDNA-bound RPA 
may provide the up-stream signal for the activation of the DNA damage 
tolerance pathway and for PCNA ubiquitylation. Although this has yet to be 
clarified, most likely the interactions of Rad 18 with both RPA and DNA 
contribute to its localisation to stalled replication forks in vivo.
Although the SAP domain of human Rad 18 was reported to be both 
necessary and sufficient for its interactions with DNA, the results obtained in 
this work suggest that this function may not be conserved in yeast. 
Nevertheless, this domain is essential for the in vivo function of yeast Rad18. 
Although its effect may be indirect, the SAP domain appears to contribute to 
the correct conformation of the Rad 18 protein and to facilitate the interaction 
of the E3 with PCNA, thereby allowing the ubiquitylation of the clamp.
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Chapter One: Introduction
1 Introduction
The first aim of this introduction is to describe general concepts regarding DNA- 
binding proteins. The parameters affecting the binding of proteins to DNA and 
relevant DNA-binding domains will be presented. Special attention will be given 
to RPA and to the ssDNA-binding protein family to which it belongs. Next, the 
problem of DNA damage will be introduced together with the mechanisms 
through which cells sense and deal with it. Emphasis will be placed on the 
mechanisms operating during DNA replication. In addition, the involvement of 
RPA and Rad18 in the different DNA repair and damage bypass pathways will 
be delineated. As Rad 18 belongs to the ubiquitin system, the mechanisms of 
ubiquitin conjugation and the biological importance of post-translational 
modification of proteins by ubiquitin will be presented. Finally, the RAD6 
pathway to which the RAD18 gene belongs will be described in detail.
1.1 Parameters Affecting DNA-Protein Interactions
DNA, the carrier of the genetic information of the cell, is a highly reactive 
molecule (Friedberg et al., 1995). All biological processes involving the DNA 
require the activity of DNA-binding proteins. Through their binding, these 
proteins execute essential manipulations upon the DNA, facilitating DNA 
replication, transcription, repair and recombination (Lilley, 1995).
1.1.1 Chemical Bonds Participating in DNA-Protein 
Interactions
The binding of a protein to DNA involves a network of electrostatic and 
hydrophobic interactions that create a stable DNA-protein interface (Lilley, 
1995). The most important electrostatic interactions are the hydrogen bonds, in 
which nitrogen or oxygen atoms of one binding partner contact a hydrogen 
atom of another. These are mediated via direct contacts between the side- 
chains of the protein’s amino acids (aa) or its amide groups and the DNA sugar- 
phosphate backbone. Many DNA-binding proteins form hydrogen bonds with 
the donor and acceptor atoms along the edges of the minor and the major
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grooves of the DNA (Dickerson and Chiu, 1997). Importantly, the DNA base 
sequence influences its curvature as well as the specific spatial localisation of 
these donor and acceptor atoms. Thus, some proteins are able to recognise 
specific DNA sequences through their interactions (Dickerson and Chiu, 1997). 
Hydrophobic interactions between proteins and DNA include the base stacking 
interactions, in which aromatic side-chain residues of the proteins and the 
aromatic ring(s) of the DNA bases participate in van der Waals interactions 
(Seeman e ta l., 1976).
1.1.2 Buffer Conditions Can Affect DNA-Protein 
Interactions
1.1.2.1 The Effects of the Solvent
Naturally, DNA-protein complexes exist in aqueous solutions. Ordered water 
molecules, which exist at their binding interface and are isolated from the bulk 
of the solvent, can often mediate the hydrogen bonds between the protein and 
the DNA (Lilley, 1995). In addition, these water molecules may fill gaps between 
the surfaces of the two binding partners, contributing to their compatibility. 
Buried surfaces within DNA-protein complexes may also contribute to their 
stability (Lilley, 1995). On the one hand, such buried surfaces can form between 
hydrophilic faces of the protein and the DNA. In this case, dissociation of water 
molecules could be entropically favourable and the electrostatic contacts 
between the molecules will be enhanced. On the other hand, non-polar 
residues of the protein could intercalate between the DNA bases, forming a 
hydrophobic buried surface while excluding the solvent molecules, and thus 
enhancing the interactions within the complex (Seeman et al., 1976; Lilley, 
1995).
1.1.2.2 The Effects of Ions
The ionic environment can significantly affect DNA-protein interactions. When 
the two macromolecules bind, new electrostatic bonds are established (Record 
et al., 1985). Electrolyte ions, previously required for the structural stability of
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the individual macromolecules, are often displaced or redistributed in favour of 
the new interactions. In theory, a release of cations or anions from the interface 
of the DNA or the protein, respectively, can promote the association of the 
complex (Leirmo et al., 1987). Thus, even small changes to an in vitro ionic 
environment might result in significant effects to the interactions between DNA 
and proteins (Record et at., 1985). Correspondingly, the thermodynamics and 
the kinetics of enzymatic reactions involving DNA-protein interactions are often 
highly dependent on the salt concentrations in the buffer (Leirmo etal., 1987).
The effects of ions on DNA-protein interactions can be divided into specific or 
non-specific effects. Specific ion effects are derived from binding sites for a 
specific ion on one or both of the macromolecules (Griep and McHenry, 1989). 
These ions can have a direct effect on the function of the protein. In contrast, 
non-specific ion effects can be regarded as the effects of the buffer ionic 
strength on the complex formation. However, empirical experiments have 
revealed that the identity and the charge of ions can specifically promote or 
disrupt DNA-protein interactions. The Hofmeister series is a useful ranking of 
anions reflecting their effects on protein solubility, which is in accordance with 
their ability to be displaced from the protein’s interface (Griep and McHenry, 
1989). Similarly, recent studies provided an empirical ranking of anions that 
contributed to DNA-protein interactions. The order of these anions was as 
follows: glutamate > fluoride > acetate > chloride > bromide = nitrate > iodide > 
hypochloride (Griep and McHenry, 1989).
1.1.3 Structural Aspects Affecting DNA-Protein 
Interactions
Conformational changes of both the DNA and the protein are often important for 
the complex formation (Lilley, 1995). Double-helical DNA is flexible and can 
have, in principle, two types of movement. One is a twisting motion, in which a 
base pair rotates around its local helical axis relative to its neighbouring bases. 
The other is a bending movement, which results in a deviation from the straight 
helical axis of the DNA backbone. Perhaps the most striking conformational 
change that dsDNA undergoes is the packaging into chromatin by histones as
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approximately 2 m of dsDNA is contained within a nucleus of 20 diameter 
(Rocha and Verreault, 2008). This is achieved through several layers of DNA 
coiling, with the first one being the wrapping of 147 base pairs (bp) of DNA 
around a nucleosome. ssDNA can also undergo significant conformational 
changes. For example, in the case of Escherichia coli (E.coli) single-stranded 
DNA-binding protein (SSB), ssDNA can be wrapped around a SSB oligomer, 
resulting in a compacted filament structure (Krauss etal., 1981).
Conformational changes of a protein, induced by its binding to DNA, may 
involve a significant rearrangement of the protein structure. These structural 
alterations confer improved stability and reduce the free-energy state of the 
protein by enhancing the interactions between the two macromolecules (Lilley,
1995). In addition, these conformational changes can regulate the catalytic 
activity and the specificity of the DNA-binding protein. For example, 
conformational changes may facilitate an enzymatic modification of the DNA, if 
during the transition state of the reaction specific DNA bases are brought into 
the catalytic centre of the protein. Alternatively, if reactive atoms within the 
protein re-orientate upon its binding to the DNA, its catalytic activity toward a 
third molecule can be enhanced (Lilley, 1995). Conformational changes 
following DNA-protein binding may also result in a cooperative behaviour. For 
example, DNA binding by one protein monomer may enhance the binding of a 
second monomer through favourable protein-protein interactions (Lilley, 1995). 
Examples for cooperative binding can be found during ssDNA-protein filament 
formation of several single-stranded DNA-binding proteins (Lohman et al., 
1986) (see 1.3).
1.2 DNA-Binding Domains
In most cases, DNA-binding proteins interact with the DNA via conserved 
structural domains. These domains modulate the protein’s binding specificity 
and selectivity toward different DNA structures (Lilley, 1995). In addition, 
conformational changes within these domains can regulate the protein’s affinity 
for the DNA. Often, a single domain is sufficient and necessary for the DNA- 
binding activity of a protein, but sometimes multiple DNA-binding domains may
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act together (Lilley, 1995). Three DNA-binding domains relevant to this thesis 
are introduced below.
1.2.1 The OB Fold
The OB (oligonucleotide / oligosaccharide binding) fold, first described in 1993, 
was identified in five different proteins able to bind either to oligonucleotides or 
to oligosaccharides (Murzin, 1993). These proteins, a tRNA synthetase from 
yeast, a nuclease from staphylococcus and three bacterial cytotoxins, did not 
share sequence homology or similar functions. However, common structural 
determinants and key residues that contribute to the formation of the fold were 
found. The OB fold consists of five p-strands that coil together to form a closed 
p-barrel (Theobald et al., 2003). This barrel is often capped by an a-helix  
located between the third and fourth p-strands. The conserved ligand-binding 
interface is centred on p-strands p2 and p3, with additional contributions from 
the C-terminal regions of strands p1 and p5 (see Figure 1.1). Further important 
binding residues are located in the loops sticking outwards from the p-barrel 
axis. These loops, marked as L in Figure 1.1, are variable in sequence, length 
and conformation. As a consequence, they contribute to significantly different 
ligand-binding sites and to variations in the fold length, ranging between 70 and 
150 amino acids. A representative of the canonical structure of an OB fold, 
derived from the yeast Asp-tRNA synthetase, is shown in Figure 1.1 (Murzin, 
1993; Theobald eta!., 2003).
The type and the positioning of the ligand depend on the architecture and the 
topology of the OB fold rather than on its sequence. Therefore, the OB fold is 
considered a structure-related binding site (Murzin, 1993). The nucleic acid- 
binding super-family is the largest within the OB folds and representatives 
containing this motif participate in almost any process involving the 
manipulation of either ssDNA or RNA (Theobald et al., 2003). According to the 
current understanding, OB-fold-containing proteins can be divided into three 
categories with respect to their functional recognition: (a) proteins that bind 
nucleic acids without apparent specificity; (b) proteins that bind to sequence- 
specific single-stranded regions of nucleic acids; and (c) proteins that interact
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with non-helical structured nucleic acids. Different OB-fold-containing proteins 
may undergo either a dramatic conformational change or only subtle shifts upon 
binding to nucleic acids. In addition, the OB fold is a modular domain, often 
involved in the protein’s oligomerisation on the DNA (Theobald et al., 2003). 
Since its identification, the OB fold was also found to be involved in protein- 
protein interactions, and it is now referred to as an oligo-binding fold 
(Bochkareva et al., 2001).
An OB-fold-containing protein, which is relevant to this thesis, is the hetero- 
trimeric Replication Protein A from S. cerevisiae, hence referred to as yRPA. 
This protein contains six OB folds, some of which are involved in ssDNA- 
binding, protein-protein interactions or both. As RPA binds with little or no 
sequence specificity to ssDNA, it belongs to the first category of nucleic acid- 
binding OB-fold-containing proteins described above. RPA and its OB folds are 
described in detail in paragraph 1.3.2 below. Chapters 5 and 6 of this thesis 
present the importance of the OB folds of RPA in its interaction with Rad 18, in 
the absence and in the presence of ssDNA, respectively.
Figure 1.1 -  The canonical OB-fold domain
The OB-fold from Asp-tRNA synthetase is shown as a representative of the ideal OB- 
fold domain. From the N-terminus to the C-terminus, strand 01 is shown in red, 02 in 
orange, 03 in yellow, the helix between 03 and 04 in green, 04 in blue, and 05 in violet. 
The conserved ligand-binding interface is centred on 0-strands 02 and 03, with 
additional contributions from the C-terminal regions of strands 01 and 05. An a-helix, 
which is found in some, but not in all OB-fold containing proteins, is shown in white at 
the top of the figure, just N-terminal to strand 01. Variable loops (L) between strands 
are indicated in black text. This figure was adapted from Theobald et al. (2003).
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1.2.2 The Zinc Fingers
Zinc-binding repeats were first identified in the Xenopus laevis transcription 
factor IIIA (Miller etal., 1985). This motif was found to be extremely abundant in 
eukaryotic proteins and is now regarded as a ‘classical’ Zinc Finger (ZnF). 
Since then, additional types of zinc binding domains were identified in many 
proteins, and they are all regarded as Zinc Fingers (ZnFs) (Rubin et al., 2000). 
The yeast genome is estimated to encode 500 proteins containing ZnFs. These 
proteins are diverse with regard to their sequences, structures and functions. 
Reducing conditions in the environment, which favoured protein folding around 
a zinc atom, could be evolutionary accountable for the versatility and 
abundance of ZnF-containing proteins (Mackay and Crossley, 1998).
Proteins bind to zinc as a cofactor for their catalytic activity or as a structural 
component important for their stability. The latter is characteristic for ZnFs, as 
the zinc atom does not normally participate directly in the function of the protein 
(Krishna et al., 2003; Gamsjaeger et al., 2007). Although at first ZnFs were 
thought to only bind to nucleic acids (DNA or RNA), today they are implicated in 
binding of lipids, in protein-protein interactions and in ubiquitin conjugation. 
Hence, ZnF-containing proteins participate in a range of cellular processes: 
DNA replication and repair, protein translation and programmed cell death 
(Krishna etal., 2003; Gamsjaeger etal., 2007).
Different protein families in a particular ZnF fold group (see below) may have 
distinct protein / DNA interaction modes, contributing even more to the diversity 
among the ZnF-containing proteins. However, some common features can be 
found (Gamsjaeger et al., 2007). First, ZnFs undergo very little, if any 
conformational changes upon recognition of their binding partners. This could 
be due to the stability of the domain structure, maintained by coordinative 
bonds with the zinc atom. Second, ZnFs tend to mediate modular protein- 
protein interactions. They can either promote oligomerisation of their respective 
proteins or tandem ZnFs participate in the binding of the same substrate. Third, 
although ZnFs mediate moderate to weak protein-protein interactions, these
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have been proven to be highly specific and their importance in regulation of 
cellular process is evident (Gamsjaeger etal., 2007).
Structural analysis of ZnF-containing proteins revealed eight distinct classes of 
ZnF folds (see Table 1-1), comprising of total of 32 protein families (Krishna et 
al., 2003). Two of them, fold group 1 (C2H2-like Finger) and fold group 3 
(Treble Clef Finger), which are relevant to this thesis, are described below.
1.2.2.1 C2H2-like Finger (Fold Group 1, see Table 1-1)
This fold group contains ZnFs in which a left-handed ppa-unit is formed by a p- 
hairpin followed by an a-helix (Krishna et al., 2003). Two zinc ligands are 
donated by a conserved turn at the end of the p-hairpin (zinc kunckle) and the 
other two originate from the C-terminal end of the a-helix. The C2H2-like finger 
structure is stabilised by the coordinated binding of a single zinc atom. This fold 
group consists of two families, of which one, the C2H2 finger family (also known 
as the ‘classical’ ZnF), has relevance to this thesis. This fold consists of 28 to 
30 amino acids with two conserved cysteine residues followed by two 
conserved histidine residues at a specific spacing (Krishna et al., 2003). 
However, substitutions of one or both histidines to cysteines can also occur. 
Usually, members of the C2H2 finger family interact with the major groove of 
the DNA via their a-helix. Some were reported to be involved in a simultaneous 
binding to both a specific DNA sequence and a protein, but these interactions 
occur via different recognition surfaces (Gamsjaeger et al., 2007). Others were 
found to participate solely in protein-protein interactions.
A C2H2-like finger-containing protein with relevance to this thesis is the Rad 18 
protein from S. cerevisiae, hence referred to as yRad18. It contains a ZnF of the 
C2H2-like finger family with a C2HC pattern between amino acids 188 and 210. 
This motif was suggested to participate in DNA-protein or protein-protein 
interactions of yRad18 (see paragraph 1.7.3 for more details). In addition, yRPA 
contains a ZnF of the C2H2-like finger family with a C4 pattern (Cys4-type) 
between amino acids 486 and 508 of its largest subunit, Rfa1. This motif seems 
to be important for ssDNA-binding and recognition of damaged DNA (see 
paragraph 1.3.2 for more details).
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Table 1-1
Table 1-1: Eight ZnF fold groups based on the structural properties 
around the zinc-binding site
The ligands that chelate zinc (coloured orange) are shown as ball-and-stick. The 
helices are coloured cyan. The zinc knuckle connecting the two strands of the p-hairpin 
is shown in red. The primary p-strands adjacent to the knuckle are coloured in purple 
and other strands in yellow. Loops are shown in light green. Other parts of the 
structure, which do not belong to the zinc-binding region of the structure, are shown in 
grey. A brief description of the ligand placement within each fold group is given. This 
table was adapted from Krishna et al. (2003).
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1.2.2.2 Treble Clef Finger (Fold Group 3 -  see Table 1-1)
Proteins that contain treble clef fingers are diverse and often do not have any 
sequence homology nor functional similarity (Krishna et al., 2003). The core 
structure of the treble clef motif consists of a p-hairpin at the N-terminus and an 
a-helix at the C-terminus. The zinc knuckle donates two ligands whereas the N- 
terminal turn of the helix contribute the other two. In most cases, a loop and a p- 
hairpin are present between the N-terminal p-hairpin and the C-terminal a-helix. 
Sometimes, a helix or a pair of helices is present instead. These secondary 
structural elements vary in length and in conformation, contributing to the 
diversity of the core motif (Krishna et al., 2003). Hence, this group can be 
divided into ten protein families of which the RING finger-like family is relevant 
to this thesis. Typically, the RING (really interesting new gene) finger is 40 to 60 
amino acids long and consists of a set of histidine and cysteine residues with a 
characteristics spacing, allowing the coordination of two zinc ions in a cross- 
brace structure (Pickart, 2001). This domain was found to be involved in 
protein-protein interactions in the context of ubiquitin ligase activity, bringing 
together an E2 ubiquitin-conjugating enzyme and a specific substrate 
(Gamsjaeger etal., 2007).
The yRad18 protein contains a RING domain, of a C3HC4 pattern, between 
amino acids 28 and 62, which is essential for its ubiquitin ligase activity (see 
paragraph 1.7.3 for more details). Chapter 3 of this thesis deals with the 
catalytic activity of yRad 18 in vitro.
1.2.3 The SAP Domain
Using bioinformatics tools Aravind and Koonin (2000) identified a novel and 
statistically significant conserved putative DNA-binding motif, consisting of 35 
amino acids. They named this motif SAP, after three proteins that contained it: 
SAF-A/B (scaffold attachment factor A or B), Acinus and PIAS1 (protein inhibitor 
of activated signal transducer and activator of transcription 1). The identified 
consensus sequence was predicted to have a helix-extended loop-helix 
structure, as shown in Figure 1.2. Independently, biochemical studies of human 
SAF-A protein revealed a 45 amino acid region, which was necessary and
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sufficient for binding to scaffold attachment regions (SAR), AT-rich DNA 
elements found in eukaryotes (Kipp et al., 2000). The authors described a 31 
amino acid motif within this region, which they found by database search to be 
conserved in additional eukaryotic but not prokaryotic proteins, and termed it a 
SAF-Box. As it turned out, this was the same domain described by Aravind and 
Koonin (2000). The three early-identified SAP-containing proteins, mentioned 
previously, have been reported to play different roles involving DNA. Both SAF- 
A and Acinus are implicated in apoptosis (Gohring et al., 1997; Sahara et al., 
1999). The SAF-A protein is cleaved at its SAP domain during apoptosis and, 
as a result, loses its SAR-binding ability, which is important for the proper 
nuclear architecture of the cell (Gohring et al., 1997). In contrast, Acinus is 
activated by caspase-3 cleavage and its SAP domain is required for chromatin 
condensation during apoptosis (Sahara et al., 1999). The third SAP-containing 
protein, PIAS1, is implicated in regulation of the tumour suppressor protein, p53 
(Okubo et al., 2004). It belongs to a family of proteins, all containing the SAP 
domain, which are E3 small ubiquitin-related modifier (SUMO) ligases. The 
mammalian members of this family, encoded by four genes, include the PIAS1, 
PIASx (PIAS2), PIAS3 and PIASy (PIAS4) genes whereas in S. cerevlsiae there 
are only two PIAS family members, encoded by SIZ1 and SIZ2. Although the 
PIAS proteins were first identified as interacting partners of transcription factors, 
it is now clear that their activity extends to modulation of other cellular 
processes via their SUMO ligase activity (Palvimo, 2007).
The number of eukaryotic proteins identified to contain a SAP domain is 
increasing. Among them, there are proteins involved in DNA repair. One 
example is Ku70, which is important for DNA double-strand break (DSB) 
recognition and repair via the non-homologous end joining pathway (Walker et 
al., 2001). In addition, and most relevant for this thesis, Rad18, the ubiquitin 
ligase involved in the DNA damage tolerance pathways, also contains a SAP 
domain (Nakajima etal., 2006). Furthermore, this domain is found in all RAD18 
sequences cloned thus far from various eukaryotic organisms (Notenboom et 
al., 2007), suggesting an important role for this domain in the function of Rad18.
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Figure 1.2 -  Sequence alignment of SAP motives from different genes and 
organisms
The alignment is shown along with a schematic representation of the predicted 
secondary structure (two amphipatic helices). The colouring is according to the 90%  
consensus that includes h (hydrophobic) or I (aliphatic) residues shaded yellow 
(YFWLIVMA); s (small) residues coloured green (SAGTVPNHD); p (polar) residues 
coloured purple (STQNEDRKH); and b (bulky) residues shaded grey (KREQW FYLMI). 
The species abbreviations are: At, Arabidopsis thaliana\ Ce, Caenorhabditis elegans; 
Dm, Drosophila melanogaster, Gg, Gallus gallus] Hs, Homo sapiens; Sc, 
Saccharomyces cerevisiae, Sp, Schizosaccharomyces pombe; and Zm, Zea mays. 
This figure was taken from Aravind and Koonin (2000).
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Some of the SAP-containing proteins harbour this motif as their sole DNA- 
binding element, while others have additional DNA-binding determinants. In 
most of these proteins, the SAP domain is believed to be involved directly in 
DNA-binding. Although Aravind and Koonin (2000) have suggested a few 
common features for the SAP motif, the variability among the SAP-containing 
proteins imply that it might have different binding specificities toward DNA 
depending on the protein. According to Kipp et al. (2000), the SAP domain of 
human SAF-A protein preferentially binds to SAR DNA over non-SAR DNA. 
Similarly, the SAP domain of the SUMO ligase PIAS1 was found to bind to AT- 
rich dsDNA sequences (Okubo et al., 2004). In contrast, the Ku70 protein 
recognises dsDNA ends and binds to them with high affinity independent of the 
DNA sequence (Lehman et al., 2008), whereas the SAP domain found in the 
human Rad 18 (hRad18) ubiquitin ligase preferentially binds to ssDNA or to 
forked-DNA structures (Notenboom etal., 2007; Tsuji etal., 2008).
Since its first identification as a putative DNA-binding motif, additional or 
alternative roles are emerging for the SAP domain. According to Okubo et al. 
(2004), the SAP domain of the PIAS1 protein plays a dual role in binding to 
DNA and to its substrate, p53. Another example for a dual role of the SAP 
domain was found in PIASxa, an isoform of the PIASx protein. Its SAP domain 
was identified to be important for binding to AT-rich DNA elements but also to 
Fli1 (Friend leukaemia integration-1), an EST (E26 transformation specific) 
transcription factor (van den Akker et al., 2005). Their interaction results in 
sequestering Fli1 into a transcriptional inactivated complex and preventing its 
activity. In addition, the SAP domain of the yeast E3 SUMO ligase Siz1 was 
suggested to contribute to its selectivity toward some of its substrates as well as 
to its nuclear localisation (Reindle etal., 2006). Nonetheless, it was not formally 
shown whether the latter is due to its interaction with the DNA or due to 
structural overlap of the SAP domain with its nuclear localisation signal. Recent 
findings in my lab suggest that Siz1 binds to dsDNA via its SAP domain (Parker 
et al., in revision).
As discussed above, the SAP domains from different proteins have diverse 
DNA-binding specificities. Therefore, it is not surprising that structural
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information, obtained for various SAP-containing proteins, reveals differing 
DNA-binding modes as well as variations in the proposed domain size (Devany 
et al., 2008). With regard to the SAP domain of hRad18, a few important 
residues in the extended loop were identified by mutational analysis 
(Notenboom et al., 2007). As these residues were similar to the residues in the 
P IA S I’s SAP domain that were implicated in DNA-binding (Okubo etal., 2004), 
the authors suggested that these two proteins might have a similar DNA-binding 
mode (Notenboom etal., 2007).
The yRad18 protein contains a putative SAP domain between amino acids 278 
and 312. Insights regarding the contribution of yRad18’s SAP domain to its 
interactions and catalytic activity and its homology to the hRad18 SAP domain 
are presented in Chapter 7 of this thesis.
1.3 Single-stranded DNA-Bindinq Proteins
Among the various DNA-binding proteins that exist, of particular relevance to 
this thesis is the single-stranded DNA-binding protein (SSB) family, to which 
RPA belongs. Single-stranded DNA-binding proteins (SSBs) are present in all 
organisms and they are essential for viability (Kur et al., 2005). These proteins 
bind to ssDNA with high affinity, most of them with little or no sequence 
specificity. In addition, they are implicated in all biological processes involving 
DNA in the cell: replication, repair and recombination (Kur et al., 2005). During 
these processes, the DNA undergoes multiple conversions between double­
stranded and single-stranded forms. Under physiological condition, ssDNA is 
energetically unfavourable. Therefore, SSBs are required for maintaining its 
conformation and for preventing interstrand and intrastrand re-annealing 
(Bochkarev and Bochkareva, 2004). Furthermore, through their binding, SSBs 
protect ssDNA against nuclease attack or undesired chemical modification and 
prevent the formation of secondary structures (Kur et al., 2005). Moreover, their 
binding and activity can facilitate the recognition of ssDNA by other enzymes, 
whose activity may be essential.
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The proteins within the SSB family have high sequence variability and can be 
found in different oligomeric states (Kur et al., 2005). Depending on the 
organism, SSBs are homo-dimers, hetero-trimers or homo-tetramers. For 
example, Deinococcus Thermus SSB is a homo-dimer, the eukaryotic 
Replication Protein A is a hetero-trimer and the Escherichia coli (E. coli) SSB is 
a homo-tetramer. In addition, the same protein might change its oligomeric 
state upon ssDNA-binding, as is the case of the E. coli SSB protein. Alterations 
to its ssDNA-binding mode result in changes to its oligomeric state (Lohman 
and Ferrari, 1994) (see 1.3.1 below). Nevertheless, SSBs share biochemical 
and structural characteristics, and there is evidence for their evolutionary 
conservation (Kur et al., 2005). One common element is a conserved domain, 
the OB fold, which was discussed in detail in paragraph 1.2.1. Another common 
trait is an obligatory oligomerisation upon ssDNA-binding, when four DNA- 
binding OB folds are brought together (Kur et al., 2005). The ssDNA-binding 
properties of SSBs are defined by several parameters. The length of the ssDNA 
that directly interacts with a protein is known as the interaction site, whereas 
the length of the ssDNA that is covered when the protein is bound is considered 
to be the occluded binding site (Wold, 1997). The equilibrium binding constant 
for a single protein molecule binding to the interaction site is termed the 
intrinsic binding constant, while cooperativity is a unitless parameter 
representing the affinity differences between a protein binding in isolation 
versus in proximity to a previously bound protein. Each set of these parameters 
represents a binding mode under specific conditions.
Two SSBs that were used in this thesis, the E. coli SSB protein and yRPA, are 
described below.
1.3.1 The Single-Stranded Binding Protein
The E. coli single-stranded binding (SSB) protein forms a stable homo-tetramer 
in solution, consisting of four 18.8 kDa monomers (Weiner etal., 1975). It binds 
to ssDNA with high affinity through its four OB folds (one per monomer), and it 
is essential for DNA metabolism in bacteria (Lohman and Ferrari, 1994).
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In the presence of ssDNA SSB has two binding modes, which result in different 
occluded binding sites. The first one involves only two subunits out of four 
contacting the ssDNA, with an occluded site size of ~ 35 nucleotides and high 
binding cooperativity (also referred to as an “unlimited” cooperativity) (Lohman 
and Overman, 1985; Lohman and Ferrari, 1994). The second binding mode 
involves all four subunits contacting the ssDNA, with an occluded site size of ~ 
65 nucleotides and low binding cooperativity (limited to formation of octamers). 
These binding modes are affected principally by salt concentration but also by 
other factors, such as salt type, temperature, pH and concentration of the SSB 
protein (Bujalowski etal., 1988). As mentioned earlier, various studies based on 
electron microscopy, nuclease digestion and oligonucleotide-binding 
stiochiometry revealed that, at least in the high site-size binding mode, the 
ssDNA can be wrapped around the SSB tetramer (Krauss et al., 1981; Lohman 
and Ferrari, 1994). The effects of salt on ssDNA-SSB interactions are complex, 
even in a single binding mode. This complexity is due to the uptake and release 
of both cations and anions during the binding reaction (Overman et al., 1988), 
and these, in turn, are also affected by pH and temperature.
1.3.2 Replication Protein A
Replication protein A (RPA) is an abundant SSB protein, conserved in all 
eukaryotes (Wold, 1997). It binds to ssDNA with very high affinity and to dsDNA 
and RNA to a much lesser extent (Kim et al., 1992; Wold, 1997; Sibenaller et 
al., 1998). Initially, it was isolated from human cell extracts as an essential 
component for DNA replication in vitro by the large T antigen simian virus 40 
(SV40) (Fairman and Stillman, 1988; Wold and Kelly, 1988). Later, RPA was 
discovered in yeast as an essential protein for cell survival, and was suggested 
to play important roles in DNA recombination and repair (Heyer etal., 1990; Brill 
and Stillman, 1991).
As mentioned earlier, RPA exists as a hetero-trimeric complex. Human RPA, 
referred to as hRPA, consists of subunits RPA70, RPA32 and RPA14, 
according to their molecular weights (Wold, 1997). RPA from S. cerevisiae 
consists of subunits Rfa1, Rfa2 and Rfa3 according to the genes that encode
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them, RFA1, RFA2 and RFA3. The molecular weight of the RPA subunits 
slightly varies across species and yRPA subunits are 69, 36 and 13 kDa, 
respectively (Brill and Stillman, 1989). The yRPA and the hRPA are highly 
homologous to each other, the overall structure of yRPA was found to be very 
similar to that of hRPA, and the proteins have similar ssDNA-binding affinities 
(Kim et a l, 1992; Park et a l, 2005). Nevertheless, there are some structural 
differences that may account for differences in protein-protein interactions found 
between the two species (Park etal., 2005). For example, yRPA cannot support 
SV40 DNA replication in vitro due to its lack of interaction with the large T 
antigen.
The assembly of the RPA complex is mediated by direct interactions between 
Rfa1 and Rfa2 and between Rfa2 and Rfa3 (Lin et al., 1996), and the RPA 
complex appears to be very stable in vitro. Current knowledge indicates that 
RPA is not tightly bound to chromatin throughout the cell cycle, and that a large 
portion of the RPA molecules can be also found in the cytoplasm (Wold, 1997). 
The findings in Davies et al. (2008) support this notion. Nevertheless, RPA was 
shown to associate with replication origins following treatment with hydroxyurea 
(HU) (Tanaka and Nasmyth, 1998) and (Daigaku and Ulrich -  unpublished data) 
and to localise to DNA replication (Adachi and Laemmli, 1992) and repair foci 
(Sakamoto e ta l,  2001).
1.3.2.1 Rfa1
Rfa1 can be divided into three functional domains: an N-terminal domain 
(approximately aa 1 -  170), a central DNA-binding domain (approximately aa 
170 -  450) and a C-terminal domain (approximately aa 450 -  621) (Wold, 1997) 
(see Figure 1.3).
The N-terminal part of yRfal contains an OB fold (OB-F). This region was 
shown to be important for replication and recombination, as point mutations in 
this domain are either lethal or result in defects in these processes (Longhese 
et al., 1994; Firmenich et al., 1995). In addition, the N-terminal domain of 
hRpa70 was reported to bind to p53 (Dutta et a l, 1993), to the nucleosome
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remodelling complex FACT (facilitates chromatin transcription) (VanDemark et 
a l, 2006) and to the N-terminal region of ATRIP (ATR-interacting protein) (Ball 
et a l, 2007). Hence, it is mainly considered to be important for protein-protein 
interactions (Braun e ta l,  1997).
In the centre of Rfa1 lie tandem OB folds (OB-A and OB-B) that bind to ssDNA 
with high affinity (Gomes and Wold, 1996) and thus are considered to be the 
principal ssDNA-binding domain of RPA. This is consistent with the finding that 
mutations in OB-A or -B either reduce or abolish the in vitro replication activity 
of RPA (Wold, 1997). Additionally, there are a few reports on the importance of 
this region in RPA interactions with other proteins (i.e. transcription factors, 
Bloom and Werner helicases, SV40 T antigen, XPA (xeroderma pigmentosa 
group A) protein and Rad51 recombinase), reviewed in Wold (1997) and in 
Fanning et al. (2006).
The C-terminal part of Rfa1 contains an OB fold (OB-C), harbouring a 
conserved putative Cys4-type ZnF. This ZnF is important for ssDNA-binding 
(Brill and Bastin-Shanower, 1998) and it was implicated in recognition of DNA 
damage (Lao et a l, 2000). In addition, the C-terminal part of Rfa1 was 
demonstrated to be both necessary and sufficient for formation of the RPA 
complex via its interaction with Rfa2 (Lin etal., 1996).
1.3.2.2 Rfa2
Rfa2 consists of three functional domains: a small N-terminal domain (aa 1 -  
40), which undergoes a cell-cycle and DNA damage dependent 
phosphorylation, a central domain (aa 40 -  170) important for interactions with 
Rfa3 as well as with ssDNA, and a C-terminal domain (aa 170 -  273), which is 
required for interactions of Rfa2 with other proteins (Wold, 1997) (see Figure 
1.3).
There are at least seven possible phosphorylated sites within the N-terminal 
domain of Rfa2, and a number of different kinases were proposed to modify it 
(Fanning et al., 2006). Cyclin-dependent kinases (Cdk) phosphorylate Rfa2 in
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mitotic cells, thereby reducing its interaction with DNA polymerase a-primase. 
DNA-PK (DNA-dependent protein kinase), ATM (ataxia-telangiectasia mutated) 
and ATR (ataxia-telangiectasia mutated- and Rad3-related) kinases were 
suggested to be involved in Rfa2 phosphorylation in response to DNA damage, 
but the phosphorylation sites as well as the in vivo kinetics of Rfa2 modification 
differ depending on the type of damage. So far, the consequences of Rfa2 
phosphorylation are not entirely understood.
The middle part of Rfa2 consists of an OB fold (OB-D), which was 
demonstrated to bind ssDNA with weak-affinity in the context of the full complex 
(Bastin-Shanower and Brill, 2001). Rfa2 was reported to interact with XPA 
protein, Rad52 and uracil-DNA glycosylase reviewed in Wold (1997). All of 
these interactions are weak but specific and occur via a common surface of 
Rfa2 C-terminus (Fanning etal., 2006).
1.3.2.3 Rfa3
Rfa3 contains a single OB fold (OB-E), spanning its entire 122 amino acids (see 
Figure 1.3). This domain was suggested to be important for the trimerisation 
and the conformational stability of the RPA complex (Fanning et al., 2006). 
According to (Bastin-Shanower and Brill, 2001), so far there is no evidence 
supporting a role of Rfa3 in ssDNA-binding.
1.3.2.4 Interactions of RPA with DNA
As mentioned earlier, RPA interacts preferentially with ssDNA, with an intrinsic 
binding constant between 109 and 1011 M '\ depending on the experimental 
conditions (Kim et al., 1992; Wold, 1997; Sibenaller etal., 1998). In addition, it 
binds to ssDNA with a defined 5’ to 3’ polarity (Wold, 1997). It has a slight 
binding preference towards pyrimidine-rich sequences compared to purine-rich 
DNA sequences (Kim et al., 1992). These findings hold true for both the yeast 
and human RPA proteins (Kim et al., 1992). RPA was found to have different 
ssDNA-binding modes depending on the salt concentration with variation to the 
occluded binding site (Kumaran et al., 2006). Under physiological conditions,
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hRPA bound to 30 nucleotides (nt), whereas under other conditions an 
occluded site of 8 to 10 nt was evident (Kim et al., 1992; Blackwell and 
Borowiec, 1994). The latter was confirmed by the crystal structure of the 
hRPA70 DNA-binding domain bound to ssDNA (Bochkarev et al., 1997) (see 
Figure 1.4). The findings regarding yRPA were at first ambiguous (Alani et al., 
1992), but it appears that its occluded binding site ranges between 18 to 28 
depending on the salt concentration (Sugiyama et al., 1997; Kumaran et al., 
2006). The binding cooperativity of hRPA was found to be low compared to 
other SSBs (Kim et al., 1992). Initially, yRPA was reported to have very high 
binding cooperativity by one publication (Alani et al., 1992), but a few others 
discovered only low or moderate cooperativity (Sugiyama etal., 1997; Kumaran 
et al., 2006).
Upon binding to ssDNA, both hRPA and yRPA undergo significant 
conformational changes (Bochkareva et al., 2001; Park et al., 2005). These 
involve both RPA70 and RPA32 and result in modulation of RPA activity. This 
regulation affects RPA as a substrate, i.e. ssDNA-bound RPA becomes a better 
substrate for phosphorylation (Blackwell et al., 1996), but this can also affect its 
interactions with other proteins (Bochkareva et al., 2001; Davies et al., 2008). 
As mentioned previously, although there are six OB folds in the RPA complex, 
only four of them seem to be directly involved in binding to ssDNA. The current 
accepted model suggests that these folds act in a sequential mode. OB-A and 
OB-B contact the ssDNA first, then OB-C is engaged in the binding, and finally 
OB-D comes into play (Philipova et al., 1996). This sequential binding results in 
different ssDNA-binding modes of RPA, with different lengths of occluded 
binding site.
In addition to its high affinity for ssDNA, RPA can bind to dsDNA and promote 
unwinding of the duplex strands (Lao etal., 1999). The suggested model is that 
the disruption of the duplex is followed by RPA binding to the exposed ssDNA, 
thus driving the unwinding reaction forward by enhanced ssDNA stability. In 
addition, RPA can recognise and bind to damaged DNA and consequently has 
an important role in DNA repair (Lao etal., 2000). This will be further discussed 
in paragraph 1.4.2.
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1.3.2.5 Interactions of RPA with Proteins
To date, RPA has been found to interact with many proteins. These can be 
divided into three main groups: proteins involved in DNA replication, proteins 
involved in DNA repair and recombination and a third miscellaneous group 
(Wold, 1997). The data from various RPA-protein interaction studies indicate 
that RPA70 and RPA32 subunits are the major contributors to these 
interactions (and accordingly Rfa1 and Rfa2 in yeast) (Wold, 1997).
One example from the first group is the primase subunit of DNA polymerase 
alpha, which interacts with hRPA (Dornreiter et al., 1992). This interaction was 
suggested to be important for the initiation and the elongation steps of DNA 
replication, and is conserved in S. cerevisiae (Smith etal., 2000).
Other examples within this group are viral proteins, such as the large T antigen 
from SV40 (Dornreiter et al., 1992), the viral initiator from Epstein-Barr virus 
EBNA1 (Epstein-Barr nuclear antigen-1) protein (Zhang etal., 1998) and the E1 
protein (Loo and Melendy, 2004) from bovine papilloma virus, which interact 
with hRPA. However, these interactions might be species-specific, suggesting a 
functional difference between human and yeast RPA (Park etal., 2005).
Examples from the second group extend to proteins from the nucleotide 
excision repair, XPA protein (He et al., 1995; Matsuda et al., 1995), XPG  
(xeroderma pigmentosa group G) protein (He et al., 1995; Matsunaga et al.,
1996), and ERCC1/XPF (excision repair cross-complementation group 1 / 
xeroderma pigmentosa group F) nuclease (Matsunaga et al., 1996) as well as 
with the DSB repair proteins, Rad52 (Hays et al., 1998) and Rad51 (Stauffer 
and Chazin, 2004). In addition, RPA was found to be involved in the activation 
of the replication checkpoint through the recruitment of the ATR-ATRIP (ATR- 
interacting protein) complex (Zou and Elledge, 2003). In the same publication, 
this role was also confirmed in yeast as ssDNA-bound yRPA recruited the 
equivalent Mec1-Ddc2 complex. Similarly, the clamp loader Rad17-Rfc2-5 
interacted with RPA, thereby recruiting the DNA repair clamp Rad9 complex 
(also known as the 9-1-1 complex) and activating the checkpoint response (Zou
et al., 2003). The function of RPA in DNA repair and recombination as well as in
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the activation of the replication checkpoint will be further discussed in 
paragraphs 1.4 and 1.5.
The third group of proteins that interact with RPA includes transcriptional 
activators such as Gal4 (He et al., 1993), VP16 (virion phosphoprotein 16) (He 
et al., 1993; Li and Botchan, 1993) as well as the tumour suppressor p53 (Dutta 
etal., 1993; Li and Botchan, 1993). The latter interaction was shown to mediate 
ATR-dependent p53 phosphorylation (Tibbetts et al., 1999), and was suggested 
to coordinate between DNA repair and the p53-dependent checkpoint control in 
response to DNA damage (Abramova etal., 1997).
The mechanistic aspects of the interactions of RPA with proteins and ssDNA 
are complex and diverse. On the one hand, RPA may ‘trade places’ on the DNA 
with other proteins (Fanning et al., 2006). This applies, for example, to Rad51 
recombinase filament formation during DSB repair via homologous 
recombination. In addition, this is suggested to occur in DNA replication, repair 
and recombination pathways when several RPA binding partners may compete 
for their association with ssDNA-bound RPA, in a hand-off mechanism. This 
successive exchange of binding partners could rely on a gradual increase in the 
affinities of the incoming proteins. Alternatively, it could depend on the ability of 
the incoming proteins to modulate RPA binding to the ssDNA. On the other 
hand, ssDNA-bound RPA may stimulate the binding of other proteins to the 
DNA, such as in the cases of ATRIP-ATR or Rad17, mentioned previously (Zou 
and Elledge, 2003; Zou et al., 2003). Similarly, also the function of other 
proteins may stimulate RPA binding to ssDNA, as in the case of the Werner and 
Bloom helicases (Fanning et al., 2006). In turn, RPA binding to the newly 
exposed ssDNA enhances the unwinding activity of these helicases.
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Figure 1.3 -  Schematic representation of yRPA subunits and their OB domains
The RPA complex from S. cerevisiae consists of three subunits, Rfa1, Rfa2 and Rfa3. Rfa1 contains the principal ssDNA-binding domain 
(OB-A and OB-B). In addition, OB-C harbours the ZnF motif and contributes to ssDNA and to RPA trimerisation. The N-terminal part of 
Rfa1 contains OB-F, which is important for protein-protein interactions. Rfa2 can be phosphorylated on its N-terminus. The central OB-D  
domain can bind weakly to ssDNA and is important for the trimerisation of RPA. The C-terminal part of Rfa2 participates in protein- 
protein interactions. Rfa3 consists of OB-E, which was shown to be important for the trimerisation of the RPA complex. This figure was 
adapted from Phillipova et al. (1996).
i
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Figure 1.4 -  The crystal structure of hRPA70 DNA-binding domain bound 
to ssDNA
The DNA-binding domain of hRPA70 (aa 181 -  422), shown in green, was crystalized 
with a 8 bp long ssDNA (the backbone is shown in brown and the bases are marked in 
blue). Three nucleotides are contained within each OB fold and the space between 
them is bridged by two nucleotides. The position of these nucleotides is maintained by 
an extensive network of hydrogen bonds with RPA as well as stacking interactions 
between phenylalanine residues of RPA and the DNA bases. Although the structure of 
the tri-nucleotide bound by each fold is almost identical and the overall structure of the 
two folds is very similar, the protein / DNA contacts for each fold are considerably 
different, and the OB fold-A makes much more extensive contact with the DNA than 
OB fold-B. This figure was taken from Bochkarev et al. (1997).
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1.4 The DNA Damage Response
1.4.1 DNA Damage and Its Sources
Throughout evolution, DNA was chosen over RNA to carry the genetic 
information and to pass it on to the next generation most likely due to its relative 
stability. However, this does not mean that it is at all inert. On the contrary, the 
DNA is constantly exposed to damage either by spontaneous sources occurring 
during DNA metabolism or by exogenous sources originating from the 
environment (Friedberg et al., 1995; Hoeijmakers, 2001). The DNA damaging 
agents that were used in this thesis to test the sensitivity of different yeast 
strains will be described in detail, whereas others will be only briefly mentioned.
1.4.1.1 Endogenous Damage
Endogenous DNA damage originates from the inner environment within cells as 
well as from the cellular metabolic processes (Friedberg et al., 1995; Jackson 
and Loeb, 2001). The DNA can be depurinated by water, resulting in the 
formation of abasic sites, also know as apurinic /  apyrimidinic (AP) sites, due to 
base loss (Jackson and Loeb, 2001). Deamination of DNA bases, and 
particularly deamination of cytosines, is an example for a spontaneous loss of 
functional groups. This can result in base transversion during replication 
(Jackson and Loeb, 2001). In addition, cellular metabolism of oxygen can give 
rise to reactive oxygen species, leading to oxidative base damage (Friedberg et 
al., 1995). Also, base misincorporation by DNA polymerases during replication 
may lead to mutations (Jackson and Loeb, 2001).
1.4.1.2 Physical Sources of DNA Damage
Physical sources of DNA damage are ultraviolet (UV) light or ionising radiation 
(IR). UV is a component of the sunlight and can lead to the formation of 
covalent bonds between two adjacent pyrimidine bases, also known as cis, syn 
cyclobutane pyrimidine dimers (CPDs), or pyrimidine (6-4) pyrimidone 
photoproducts (PP), bulky lesions occurring on cytosine 3’ to a pyrimidine base 
(Setlow, 1966; van Hoffen et al., 1995). These lesions result in the distortion of
- 4 9 -
Chapter One: Introduction
the dsDNA helix. The most commonly used form of UV light in biological 
research is the UVC wavelength (254 nm) (Friedberg et a i, 1995). Ionising 
radiation originating from either natural or man-made sources can cause 
various type of base damage. In addition, it can cause single-strand or double­
strand breaks in the DNA (Veatch and Okada, 1969), which may be the most 
dangerous types of damage as potentially they can lead to discontinuity in the 
DNA (Branzei and Foiani, 2005).
1.4.1.3 Chemical Sources of DNA Damage
Exposure to DNA damaging agents can result in chemical alteration of the 
DNA. Alkylating agents, such as methyl-methane sulfonate (MMS), can 
covalently insert alkyl groups into DNA bases (Ludlum et a /., 1964). Unless 
repaired, this modification may interfere with DNA replication, as the pairing of 
the alkylated nucleotide with the correct nucleotide on the complementary 
strand is compromised (Hakem, 2008). Consequently, this may result in base 
misincorporation and DNA point mutations. Alternatively, alkylating agents, 
such as nitrogen mustards, but also other types of cross-linking agents, can 
catalyse protein-DNA cross-links, introduce monoadducts or cross-links into the 
same DNA strand (intrastrand cross-links) or covalently link two DNA strands 
(interstrand cross-links or ICLs) (Lawley et a i, 1969; McHugh etal., 2001). The 
latter may prevent DNA unwinding necessary for replication and transcription. 
Other chemical agents, such as 4-nitroquinoline 1-oxide (4NQO), lead to bulky 
adducts in the DNA, inducing predominantly base substitutions or frame shift 
mutations during DNA replication (Ong etal., 1975).
1.4.2 The DNA Damage Response throughout the Cell Cycle
DNA damage can interfere with the basic processes of DNA metabolism, such 
as DNA replication and transcription. Hence, DNA damage may have 
detrimental effects on cell proliferation and survival (Friedberg, 2003; Branzei 
and Foiani, 2008). In order to reverse or remove DNA damage and maintain 
their genomic stability, living organisms have developed an array of DNA repair 
mechanisms (Friedberg, 2003). In response to DNA damage, an orchested
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action of sensors, transducers and effectors, employ the appropriate DNA repair 
pathway and coordinate this with ongoing cellular physiology (Harper and 
Elledge, 2007). These coordinated processes are termed the DNA damage 
response (DDR). Many forms of cancer are linked to defects in the DDR, 
delineating its importance in maintenance of genomic stability. Below, the 
different DNA repair mechanisms are briefly outlined and the contribution of 
RPA activity in each pathway is highlighted. The DNA damage response during 
DNA replication is the most relevant to this thesis. Therefore, a dedicated 
paragraph follows below (1.5).
The different mechanisms of DNA repair can be regarded as a set of tools, 
which cells can employ to deal with DNA damage. Which tool is used and 
when, depends on the type of the DNA lesion and on the cell cycle phase it is 
encountered (Branzei and Foiani, 2008).
1.4.2.1 Direct Damage Reversal
The direct reversal of DNA damage by lesion-specific enzymes is thought to be 
active throughout the cell cycle (Branzei and Foiani, 2008). Some types of base 
alkylation, such as the O6 alkyl-adduct of guanine or methylation of adenine and 
cytosine (1-methyladenine and 3-methylcytosine) can be directly reversed by 
methyltransferases or DNA dioxygenases, respectively (Sedgwick et al., 2007). 
In many organisms, excluding humans, CPDs or pyrimidine (6-4) pyrimidone 
PP, the major lesions produced by UV irradiation, can be reversed by 
photolyases, enzymes activated by blue light (de Lima-Bessa et al., 2008; 
Goosen and Moolenaar, 2008).
1.4.2.2 Single-Strand Damage Repair (BER, NER, MMR)
Repair of single-strand damage can occur by the base excision repair (BER) or
by the nucleotide excision repair (NER) pathways while the mismatch repair
(MMR) pathway removes DNA mismatches. BER can replace single DNA
bases that were damaged by oxidation, alkylation or deamination. In addition, it
processes AP sites and single-stranded breaks (Wilson and Bohr, 2007). NER
can replace several damaged bases and is responsible to deal with a large
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variety of backbone distorting DNA lesions, induced by UV or mutagenic 
chemicals, including intrastrand or interstrand cross-links and bulky adducts 
(Prakash and Prakash, 2000). Both pathways proceed by recognition and 
excision of the damaged base(s) followed by DNA synthesis to fill in the ssDNA 
gaps (Prakash and Prakash, 2000; Wilson and Bohr, 2007). In vitro 
reconstitution of eukaryotic BER requires a minimum of four core enzymes 
(Wilson and Bohr, 2007), whereas for NER, more than 30 proteins are needed 
(Prakash and Prakash, 2000). Although both repair pathways operate 
throughout the cell cycle, NER is especially important during G1 phase when it 
contributes to the repair of lesions prior to DNA replication (Branzei and Foiani, 
2008).
In BER, RPA was reported to interact with several DNA glycosylases, enzymes 
that initiate damaged-base recognition and cleavage (Fan and Wilson, 2005). 
This interaction is thought to mainly contribute to the long-patch BER sub­
pathway, in which a longer repair tract is generated (2-13 bases) (Fortini et al.,
2003). In addition, RPA appears to be a negative regulator for the undesired 
cleavage of single-stranded AP sites by APE1 (apurinic / apyrimidinic 
endonuclease 1) (Fan etal., 2006), the central AP endonuclease in mammalian 
cells, which coordinates most of the BER reactions (Fortini etal., 2003). Both in 
yeast and mammalian cells, RPA plays a central role in the global genome NER 
sub-pathway. It contributes to lesion recognition via its ZnF (Stigger etal., 1998) 
and through its association with Rad 14 (or XPA in mammalian cells) (He et al., 
1995; Matsuda etal., 1995). Following the bidirectional unwinding of the dsDNA 
at the site of the lesion by Rad3 and Rad25 helicases (or their respective 
human homologues, XPD and XPB) (Sung et al., 1996), RPA stabilises the 
bubble structure that is formed. Human RPA is thought to recruit XPG (He et al., 
1995) and ERCC1/XPF nucleases (Matsunaga et al., 1996) for the subsequent 
incisions (Davies etal., 1995; Habraken etal., 1995; Park etal., 1995). Finally, 
RPA is required for the gap-filling step in coordination with RFC (replication 
factor C), PCNA (proliferating cell nuclear antigen) and DNA polymerase e (or 6) 
(Aboussekhra etal., 1995).
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As previously mentioned, mismatch repair (MMR) does not deal with DNA 
damage per se, but rather recognises base substitutions or small insertions and 
deletions (IDLs). These mismatches are removed by excision and the ssDNA 
gaps are filled (Harfe and Jinks-Robertson, 2000; Kunkel and Erie, 2005). MMR 
acts predominantly during S phase to replace base mispairing during replication 
(Branzei and Foiani, 2008). In addition, MMR plays important roles in 
homologous recombination (Harfe and Jinks-Robertson, 2000) and in other 
DNA metabolic pathways (Li, 2008). RPA seems to be involved in all steps of 
MMR: it enhances the strand-specific excision, stabilises the ssDNA gap that is 
formed and facilitates re-synthesis of DNA (Ramilo et al., 2002; Dzantiev et al., 
2004; Zhang et al., 2005b). In addition, RPA phosphorylation may regulate the 
contribution of RPA to MMR (Guo et al., 2006b). Unphosphorylated RPA 
stimulates the strand-specific cleavage more efficiently, whereas 
phosphorylated RPA facilitates MMR-associated DNA re-synthesis more 
effectively (Guo etal., 2006b).
1.4.2.3 Double-Strand Break Repair (HRR, NHEJ)
The common feature of the BER, NER and MMR pathways is that, after 
removing the damage, they all use the genetic information from the undamaged 
DNA strand to complete the repair. However, what happens if both DNA strands 
are damaged? Double strand breaks result in the discontinuity of the DNA helix 
and thus are often regarded as the most cytotoxic types of DNA damage 
(Branzei and Foiani, 2008). They can be repaired by the homologous 
recombination repair (HRR) or by the non-homologous end joining (NHEJ) 
pathways (Barzel and Kupiec, 2008). While the former uses the genetic 
information of the homologous sister chromatids to repair the break and avoid 
mutations, the latter ligates the DNA ends in an error-prone manner. Non- 
homologous end joining is used mainly during G1 phase, whereas homologous 
recombination is principally important during S phase to mediate replication fork 
restart or during G2-M phase when sister chromatids are in close proximity and 
held by cohesion (Branzei and Foiani, 2008).
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Processing of DSBs by homologous recombination involves the resection of the 
DNA ends exposing 3’ ssDNA ends (Barzel and Kupiec, 2008). RPA is required 
for their protection and stabilisation preceding the binding of the Rad51 
recombinase, which is needed for the strand invasion step. In yeast, Rad52 
mediates the exchange between RPA and Rad51 on ssDNA, and both proteins 
have been reported to bind to RPA (Hays et al., 1998; Stauffer and Chazin, 
2004). In vitro, both yeast and human RPA have been reported to stimulate the 
yeast or human Rad52 protein, respectively, during the strand-annealing step 
(Sugiyama etal., 1998; Mcllwraith and West, 2008).
1.4.2.4 DNA Damage Bypass
In addition to DNA repair pathways, cells have DNA damage bypass 
mechanisms, which operate during S phase to ensure the completion of DNA 
replication, even in the presence of DNA damage (Branzei and Foiani, 2008). 
These include the break-induced replication (BIR) and the DNA damage 
tolerance pathways, which are described in detail below (see paragraphs 1.5.4 
and 1.7). In brief, both pathways bypass DNA damage encountered during 
replication. The BIR pathway deals specifically with single-strand breaks while 
the DNA damage tolerance pathway can bypass various types of single­
stranded lesions. The latter pathway can occur via one of two mechanisms: 
bypass of lesions via translesion synthesis (TLS), mediated by specialised DNA 
polymerases, or via damage avoidance (1.5.4.2 and 1.7).
1.4.2.5 Interstrand Cross-Link (ICL) Repair
If both DNA strands are cross-linked together, cells have to employ several
pathways in a coordinated manner to repair the lesion and restore the ability to
separate the DNA strands (McHugh et al., 2001). Studies in yeast have
revealed that the mechanism, by which ICLs are repaired, is cell cycle
dependent. For example, if a replication fork meets an ICL during S phase, it
may collapse (see 1.5.2), leading to the formation of a DSB. The DSBs that
arise from such an encounter may be produced by the NER endonucleases or
by additional overlapping endonucleases (McHugh et al., 2000). The source of
the DSBs can be either dual strand incisions or single-strand breaks that are
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converted to DSBs during replication. The homologous recombination repair 
pathway can, in principle, repair these DSB intermediates. However, in 
stationary phase haploid yeast cells lacking homologous chromosomes, the 
processing of ICLs is different. Initial incisions on one strand by the NER 
proteins allow the cross-link region to become ‘unhooked’. Pol£, a specialised 
lesion bypass (translesion) DNA polymerase (see 1.7.6), is suggested to fill in 
the exposed ssDNA gap (McHugh et al., 2000). Subsequently, a second NER- 
mediated incision on the other strand can remove the cross-link, and the 
remaining nick is sealed. The evidence obtained from yeast cells in G1 phase is 
consistent with this model (Sarkar etal., 2006). In addition, Pold was suggested 
to act up-stream to Pol£, probably in attempt to fill in the gap. Subsequent 
PCNA mono-ubiquitylation was demonstrated to be required for Pol£ 
recruitment for lesion bypass and repair of the ICLs (Sarkar et al., 2006). In 
human cells, the repair pathways for ICLs are less understood, but it appears 
that they mainly occur in S phase (McHugh et al., 2001) and involve a 
combination of NER, HRR and TLS (Wang, 2007). Consistently, studies with 
plasmids, either containing site-specific ICL or treated with cross-linking agents, 
suggest that ICLs repair and homologous recombination repair may be 
localised to the nuclear matrix in human cells (Atanassov etal., 2005; Mladenov 
etal., 2006).
1.5 Maintenance of Genomic Stability during 
Replication
DNA replication, the process by which the cell duplicates its genetic code, has
to be accurate and highly processive, and occur only once per cell cycle
(Branzei and Foiani, 2007). It is carried out by the replisome, a multi-enzyme-
DNA complex (McGlynn and Lloyd, 2002). In brief, the core of the replisome
contains two replicative DNA polymerases, e and 6, which are responsible for
the synthesis of the leading and the lagging strand, respectively (Baker and
Bell, 1998). Together with accessory proteins, the sliding clamp PCNA and
RFC, the sliding clamp-loader, they maintain their processivity (Baker and Bell,
1998). Ahead of the advancing polymerases, a hexameric helicase, MCM2-7
(minichromosome maintenance), unwinds the parental dsDNA. For the
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discontinuous lagging strand synthesis, the DNA polymerase a-primase 
complex is responsible to synthesize the Okazaki fragments (Baker and Bell, 
1998). In addition, replication fork progression is controlled by many other 
proteins that contribute to the stability of the forks and to problem solving, in 
case that they encounter roadblocks, such as DNA damage (Branzei and 
Foiani, 2005). The intimate link between DNA replication and repair can be 
derived from the crucial involvement of RPA and PCNA in both processes 
(Andreassen et a i, 2006).
1.5.1 Sensing DNA Damage during Replication
In order to sense DNA damage or replication stress, cells have evolved sensor 
proteins. These can activate checkpoint signalling networks that are responsible 
to decide whether to permit progression of the cell cycle or to arrest it, allowing 
DNA repair or apoptosis to take place (Shechter et al., 2004). Activation of the 
checkpoint response by DNA damage leads to a cascade of phosphorylation 
events, mediated by two major kinases, ATM and ATR. These two proteins 
regulate two distinct but interconnected pathways, which consist of many 
feedback loops, and thus are not linear signalling pathways (Petrini and 
Stracker, 2003; Shechter et al., 2004). The ATM kinase is mainly activated by 
DSBs, either generated by exogenous sources, such as IR or by intrinsic 
sources, such as recombination during meiosis (Kurz and Lees-Miller, 2004). 
The ATR kinase can be activated by a range of DNA damaging agents, UV, and 
also upon DNA replication stress caused by HU or aphidicolin. Additionally, 
ATR plays a role in maintaining the activation of the ATM pathway (Shechter et 
al., 2004). S. cerevisiae has two genes MEC1 and TEL1 that encode proteins 
with homology to ATM. However, complementation studies indicated that ATR 
is the functional homologue of Mec1 protein whereas ATM seems to be 
functionally more similar to Te ll protein (Bentley et al., 1996), although the 
latter was found to be more restricted to functions related to telomere 
metabolism (Craven et al., 2002). How is DNA damage sensed by the ATR  
pathway? One of the leading hypotheses suggests that a common DNA 
intermediate generated either directly by DNA damage or as a result of initial 
DNA damage processing, results in the activation of the ATR pathway
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(Cimprich, 2007). This activation could be mediated through the binding of ATR 
itself or other component(s) of the pathway to that aberrant DNA structure. 
Recent studies proposed a common mechanism for checkpoint activation 
during S phase. Apparently, various types of DNA damaging agents cause the 
functional uncoupling of the DNA polymerase from the MCM helicase thus 
exposing ssDNA stretch which is quickly coated by RPA (Byun et al., 2005). As 
ssDNA-bound RPA was shown to stimulate the recruitment of ATRIP-ATR in 
vitro (Zou and Elledge, 2003), this could provide, in principle, a mechanistic 
explanation for the activation of the kinase. In addition, the same authors have 
shown that this recruitment is conserved in yeast. Similarly, RPA and ATRIP are 
also required for the Rad 17-dependent loading of the 9-1-1 complex onto a 
DNA template (Zou et al., 2003). This complex, composed of the Rad9, Radi 
and Hus1 proteins, is a ring shape protein that resembles PCNA (the 
homologues in S. cerevisiae are named Rad9, Rad 17 and Mec3, respectively). 
The clamp loader Rad17-Rfc2-5 (termed Rad24-Rfc2-5 in S. cerevisiae) 
actively loads it to sites of DNA damage, thereby facilitating ATR-mediated 
phosphorylation and the activation of the checkpoint (Parrilla-Castellar et al.,
2004). In addition, the 9-1-1 complex is suggested to play roles in DSB repair, 
translesion synthesis and up-regulation of gene expression in response to 
damage (Fu etal., 2008).
1.5.2 Mechanisms of Replication Fork Stalling and Collapse
DNA replication is the moment in which the cell is most vulnerable to DNA 
damage as it might challenge the progression, stability or restart of replication 
forks through several mechanisms, as shown in Figure 1.5 (Branzei and Foiani, 
2005; Lambert et al., 2007). Firstly, certain types of DNA lesions encountered 
during S phase might lead to the uncoupling of the replisome and the helicase 
(Branzei and Foiani, 2005). Such lesions could be, for example, abasic sites, 
alkylated bases or bulky intrastrand adducts, which prevent the base pairing 
within the DNA polymerase, but allow the movement of the helicase (Byun et 
al., 2005; Lambert and Carr, 2005). Furthermore, exposure to aphidicolin, an 
inhibitor of DNA polymerases, or to hydroxyurea, which causes nucleotides 
depletion by inhibition of ribonucleotide reductase, will lead to replication stress
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by a similar uncoupling mechanism (Tercero and Diffley, 2001; Shechter et al.,
2004). As a consequence, ssDNA regions will be exposed, thereby activating 
the replication checkpoint via the ATR kinase (1.5.1).
Secondly, DNA damage on the leading strand can result in the uncoupling of its 
synthesis from that of the lagging strand (Branzei and Foiani, 2005). This may 
happen, for example, in case of ssDNA nick on the leading strand. During 
replication, this nick will be converted to a one-ended DSB, resulting in a 
discontinuity in the nascent strand (McHugh et al., 2000; Aguilera and Gomez- 
Gonzalez, 2008). Uncoupling of strand synthesis will result in ssDNA exposure 
of the leading strand, and thus to the activation of the replication checkpoint 
(Branzei and Foiani, 2005). A nick, located on the lagging strand, may result in 
a similar but parallel scenario in which the uncoupling between the strands 
leads to ssDNA exposure on the lagging strand. Alternatively, uncoupling of 
strand synthesis may be avoided by re-priming of the replication fork 
downstream of the block (Aguilera and Gomez-Gonzalez, 2008).
Thirdly, interstrand or protein-DNA cross-links can block the helicase movement 
and inhibit DNA unwinding, thus preventing the progression of the replication 
fork (Branzei and Foiani, 2005). In this case, the whole replisome will be stalled, 
and the replication checkpoint will not be activated. However, ICLs do cause a 
cell cycle arrest, suggesting that fork processing is required for checkpoint 
activation.
By definition, a stalled fork is regarded as one where the replisome is still 
bound, whereas in a collapsed fork the replisome has already dissociated and 
no longer protects the nascent ends of the DNA (Lambert and Carr, 2005). 
Resumption of DNA replication from a stabilised stalled replication fork is 
termed fork restart. By a similar notion, re-association of the replisome with a 
collapsed fork is referred to as fork restart. The contribution of the replication 
checkpoint to replication fork stabilisation will be delineated in the next 
paragraph.
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Figure 1.5 -  Stalling of replication forks
(a) Replication forks encountering genomic pausing sites or lesions on the template 
may stall, accumulating checkpoint signals represented by long stretches of ssDNA 
coated by RPA that result from (b) uncoupling between the replisome and the 
replicative helicase or (c) uncoupling of leading and lagging strand synthesis; (d) 
checkpoint activation does not occur when the replication block prevents helicase 
progression. The red and blue circles indicate the leading and the lagging strand DNA 
polymerases, respectively; the green circle, the RPA complex; and the triangle, the 
helicase. This figure was taken from Branzei and Foiani (2005).
- 5 9 -
Chapter One: Introduction
1.5.3 Stabilisation of Stalled Forks by the Replication 
Checkpoint
There are several lines of evidence implicating the ATR kinase in the regulation 
of DNA replication, some reviewed in Shechter et al. (2004). Firstly, in response 
to DNA damage or replication stress, ATR specifically inhibits late origin firing 
via modulations of the S phase kinases, Cdk2/Cyclin E and Cdc7/Dbf4. 
Secondly, ATR activation leads to p53 phosphorylation and thereby to inhibition 
of Cdk and PCNA functions via p 2 iwaf1/c,p1. Thirdly, the ATR kinase was 
suggested to phosphorylate the MCM helicase subunits, thereby inhibiting 
replication fork progression directly. Fourthly, activation of the ATR pathway 
outside of S phase is not robust (Ward et al., 2004). And finally, as convincingly 
demonstrated in S. cerevisiae, under replication stress or damage conditions, 
Mec1 kinase phosphorylates its downstream target, Rad53 protein, and thereby 
protects replication forks from collapse (Lopes et al., 2001; Tercero and Diffley, 
2001). Additional phosphorylation targets in S. cerevisiae that were suggested 
to contribute to fork stabilisation are Mrc1, Csm3 and Tof1 proteins, which 
under normal conditions are considered to be non-essential components of the 
replisome (Branzei and Foiani, 2007; Lambert et al., 2007). These processes 
are referred to as the DNA replication checkpoint.
Taken together, the replication checkpoint plays an important role in 
stabilisation of stalled replication forks by preventing the dissociation of the 
replisome (Lambert et al., 2007). Hence, DNA replication can efficiently restart 
after the problem is resolved. However, under some circumstances the 
replisome may dissociate, leading to the collapse of the replication fork 
(Lambert et al., 2007). In the latter case, forks converging from adjacent 
replicons may complete the replication (McGlynn and Lloyd, 2002). However, if 
the fork collapses in regions lacking converging forks, or if it is converted to a 
DSB, then recombination mechanisms may be needed to either protect the 
DNA ends or to actively restore replication (McGlynn and Lloyd, 2002; Lambert 
etal., 2007).
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1.5.4 Mechanisms of Replication Fork Restart
As explained in the previous paragraphs, both DNA damage and replication 
stress may cause stalling or collapsing of the replication fork, thus leading to 
DNA replication arrest (Shechter et al., 2004). Unless this arrest is overcome 
and DNA replication is restarted and completed, the cell may die (McGlynn and 
Lloyd, 2002). As mentioned in paragraph 1.4.2.4, cells use DNA recombination 
as well as DNA damage tolerance mechanisms to coordinate the progression of 
DNA replication in the presence of damage (Branzei and Foiani, 2007). The 
Rad18 protein, which is the focus of this thesis, mediates the DNA damage 
tolerance mechanisms. These are briefly covered here (paragraph 1.5.4.2) and 
also described in depth in paragraph 1.7.
1.5.4.1 Recombination-Mediated Replication Restart
Replication-associated DNA breaks pose a significant challenge to the 
progression of replication forks and may result in fork collapse (Lambert et al., 
2007). As previously mentioned, if the replication fork encounters a single- 
strand break, it is converted to a one-ended DSB (McHugh etal., 2000; Aguilera 
and Gomez-Gonzalez, 2008). Subsequently, DNA synthesis can be restarted by 
homologous recombination or by break-induced replication (BIR) (McEachern 
and Haber, 2006). It appears that there are at least two BIR sub-pathways in S. 
cerevisiae: one is Rad51-dependent and requires about 100 bp of homology 
whereas the other is Rad52- and Rad50-dependent and can occur with shorter 
regions of homology (McEachern and Haber, 2006). To date, three possible 
models were suggested for the mechanism of BIR. The common initiation of all 
three models involves a strand invasion step that creates a D-loop intermediate, 
which consists of a joint hetero-duplex DNA molecule. The first model suggests 
that DNA synthesis occurs via primer extension in parallel to the migration of 
the D-loop down the template. Subsequently, the newly synthesised single­
strand can be filled in. The second model hypothesised that the D-loop is 
converted into a complete unidirectional replication fork that migrates until the 
end of the template chromosome. As a result, a single Holliday junction is 
formed which can be resolved by cleavage and re-ligation events resulting in a 
crossover dsDNA product. According to the third model, branch migration
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enzymes act on the D-loop so that both leading and lagging strands are 
displaced at the same time, resulting in conservative DNA synthesis.
In general, recombination seems to predominantly act at collapsed forks rather 
than at stalled forks (Lambert et al., 2007), although this observation may not 
apply to every organism. The rationale for this may be that it is preferential for 
the cell to overcome replication-associated damage by DNA damage tolerance 
mechanisms instead of by recombination.
1.5.4.2 DNA Damage Tolerance Mechanisms
DNA damage tolerance mechanisms, do not remove DNA lesions, but enable 
the restart of stalled replication forks and the completion of replication by 
damage bypass (Ulrich, 2005). As mentioned earlier, damage bypass can occur 
in two distinct ways. Specialised DNA translesion synthesis (TLS) polymerases, 
can replace the replicative polymerases to allow bypass of DNA lesions. Due to 
low fidelity of these polymerases, this process may be error-prone (Prakash et 
al., 2005; Ulrich, 2005). Hence, although TLS promotes cell survival, it can lead 
to undesirable mutations. Alternatively, DNA damage can be avoided during 
replication in an error-free bypass as the newly synthesised sister chromatid 
serves as the new template for the continuation of replication (Ulrich, 2007; 
Yang and Woodgate, 2007). In eukaryotes, the RAD6 pathway to which RAD18 
belongs, mediates both of the DNA damage tolerance mechanisms via protein 
ubiquitylation. Thus, before presenting the RAD6 pathway in detail (1.7), a brief 
introduction of the ubiquitin system is provided (1.6).
1.6 The llbiauitin System
Ubiquitin is a 76 amino acid protein, conserved in all eukaryotes, which serves 
as a post-translational modifier of proteins. Through its conjugation, the 
function, localisation and destiny of the target protein may be modulated or 
altered. The Rad18 protein is an E3 ubiquitin ligase, and Chapters 3 and 7 of 
my thesis deal with its catalytic activity. Therefore, the mechanism of ubiquitin 
conjugation, the different types of poly-ubiquitin chains and the consequences 
that protein ubiquitylation may have, are introduced below.
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1.6.1 The Mechanism of Ubiquitin Conjugation
Ubiquitin conjugation occurs between the C-terminus of ubiquitin (glycine 76) 
and an e-amino group of a lysine residue of a substrate via a sequential three- 
step mechanism (Pickart, 2001; Passmore and Barford, 2004). First, the 
ubiquitin is activated in an ATP-dependent manner by an E1 ubiquitin-activating 
enzyme. A cysteine in the catalytic domain of this enzyme forms a thioester 
bond with G76 of ubiquitin. Second, the thioester bond is transferred onto the 
active-site cysteine residue of an E2 ubiquitin-conjugating enzyme. Third, by the 
assistance of an E3 ubiquitin ligase enzyme, an isopeptide bond is formed 
between ubiquitin and a substrate lysine residue. If this cascade of events is 
repeated, a poly-ubiquitin chain can be formed, where the ubiquitn moieties are 
covalently linked to each other via one of the lysine residues of ubiquitin. In 
some occasions, this requires the activity of yet another enzyme, termed E4 
(Hoppe, 2005).
Most organisms have only one E1 enzyme, which initiates all ubiquitylation 
reactions (Pickart, 2001). In its fully loaded state it carries two activated 
ubiquitin molecules, one as a thioester and the second as an adenylate 
intermediate. Usually, there are a few different E2 enzymes, which each 
cooperates with multiple E3s. The catalytic core of the E2 enzymes contains a 
conserved cysteine residue essential for their activity. The many E3 enzymes in 
each organism provide the specificity for the substrates. Currently, two principal 
types of E3s were identified, according to the nature of their catalytic domain: 
the HECT (homologous to E6-associated protein C-terminus) domain E3s and 
the RING domain E3s (Pickart, 2001; Passmore and Barford, 2004). As the 
Rad18 protein belongs to the latter class, the RING domain is the most relevant 
to this thesis. Its structure and characteristics were already described in detailed 
in paragraph 1.2.2.2. In short, the RING domain coordinates the binding of two 
zinc atoms forming a stable scaffold. The RING E3s are believed to bridge 
between the specific substrate and the E2 enzyme for subsequent ubiquitylation 
(Pickart, 2001).
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1.6.2 Different Types of Ubiquitin Modifications
There are various types of ubiquitin modifications. If only one ubiquitin moiety is 
conjugated onto a specific lysine of a substrate, the substrate has become 
mono-ubiquitylated. Alternatively, a few lysines of the same substrate may be 
mono-ubiquitylated, and this is often regarded in the literature as multi- 
ubiquitylation. Importantly, ubiquitin has seven different lysine residues. 
Through them, it can also form poly-ubiquitin chains of variable length and 
linkage, resulting in protein poly-ubiquitylation (Passmore and Barford, 2004). 
The specificity of the poly-ubiquitin chain linkage is important as it confers a 
specific structure, and thereby can result in different outcomes for the modified 
protein (Passmore and Barford, 2004; Pickart and Fushman, 2004; Harper and 
Schulman, 2006).
1.6.3 Consequences of Ubiquitin Modifications
In accordance with the variety of ubiquitin modifications, their consequences 
can be very diverse. Moreover, the knowledge regarding their contribution to 
the regulation of cellular processes is continuously growing (Pickart and 
Fushman, 2004). Mono-ubiquitylation of proteins was reported to have different 
outcomes. For example, mono-ubiquitylation of some plasma membrane 
proteins has been implicated in their intracellular vesicle trafficking and re­
localisation, while for others endocytosis is followed by their degradation in the 
lysosome (Pickart and Fushman, 2004; Ulrich, 2005). In addition, mono- 
ubiquitylation of histones was shown to regulate chromatin structure and 
influence transcription locally, whereas mono-ubiquitylation of DNA repair 
factors such as the Fanconi anemia FANCD2 protein or PCNA was found to 
modulate their protein-protein interactions and thereby their function (Wang, 
2007) (see also 1.7.6).
Poly-ubiquitylation of proteins via lysine 48 of ubiquitin is largely involved in 
targeting proteins to degradation via the 26S proteasome (Ulrich, 2002; Pickart 
and Fushman, 2004). The implications of protein degradation range from the 
regulation of protein levels to the recycling of misfolded proteins (Ulrich, 2002). 
More relevant to this thesis are the K63-poly-ubiquitin chains, which were
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reported to have a more extended structure compared to the K48-linked poly- 
ubiquitin chains (Varadan et al., 2004). These non-canonical chains were 
shown to be involved in intracellular trafficking, in the inflammatory response, in 
ribosome biogenesis and in DNA damage bypass (Ulrich, 2005) (see also 
1.7.7). Additional linkages of ubiquitin-ubiquitin chains exist, however their 
consequences are less understood (Pickart and Fushman, 2004). In addition to 
the structurally diverse ubiquitin chains that can be formed, each ubiquitin 
moiety has multiple protein-interaction surfaces (Harper and Schulman, 2006). 
These can be recognised by distinct downstream components that contain 
ubiquitin-binding domains, hence regulating protein-protein interactions and 
protein functions (see 1.7.6).
In addition to ubiquitin, there are ubiquitin-like modifiers, which have similar 
conjugation machineries but confer other consequences. The small ubiquitin- 
like modifier (SUMO) shares similar three-dimensional structure with ubiquitin 
(Geiss-Friedlander and Melchior, 2007). Protein sumoylation is thought to 
mainly modulate protein-protein interactions, and there is increasing evidence 
suggesting that the roles of sumoylation may be as diverse as ubiquitylation.
1.7 The RAD6 Pathway
Historically, genetic screens for yeast strains sensitive toward UV irradiation 
resulted in the isolation of several mutants (Cox and Parry, 1968). 
Subsequently, these mutants were placed into three separate epistasis groups 
(Friedberg et al., 1995). The RAD3 group, which consists of genes responsible 
for the nucleotide excision repair; the RAD52 group, whose members are 
involved in repair of DSBs by homologous recombination; and the RAD6 group 
(Lawrence and Christensen, 1976) that consists of genes, which when mutated 
conferred also sensitivity to various chemical agents (Prakash, 1975).
In S. cerevisiae, the RAD6 pathway was sub-divided into three epistasis groups 
according to their sensitivity and damage-induced mutagenesis (Ulrich, 2005). 
Both RAD6 and RAD18  genes control all three sub-pathways. The RAD6 gene 
encodes a ubiquitin-conjugating enzyme (E2) and the RAD18 gene encodes a
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ubiquitin ligase enzyme (E3) (Jentsch etal., 1987; Hoege etal., 2002; Garg and 
Burgers, 2005). Two of the three sub-pathways contain genes encoding TLS 
polymerases. The first sub-pathway is an error-prone pathway involving REV3, 
REV7  and REV1 genes, encoding two subunits of DNA polymerase £ (PoK;) 
and Rev1, respectively (Ulrich, 2005). When these genes are mutated, DNA 
damage-induced mutation rates are reduced. The second sub-pathway is an 
error-free pathway involving RAD30, which encodes DNA polymerase q (Polq), 
a fairly accurate polymerase for bypass of CPD lesions induced by UV 
(Johnson et al., 1999; Washington et al., 2000). The third sub-pathway is 
damage avoidance (DA), which bypasses DNA damage in an error-free 
mechanism. It contains the RAD5, UBC13 and MMS2 genes, encoding a 
ubiquitin ligase enzyme (E3) and two ubiquitin conjugating enzymes (E2s), 
which act together as a hetero-dimer (Ulrich and Jentsch, 2000; Torres-Ramos 
et al., 2002; Ulrich, 2005). The epistatic hierarchy of the RAD6 pathway is 
illustrated in Figure 1.6, and a summary of the biochemical activities of the 
proteins, involved in this pathway, is shown in Table 1-2.
In 2002, the proliferating cell nuclear antigen (PCNA) from S. cerevisiae, an 
essential processivity factor for DNA polymerases, was identified as a substrate 
for the RAD6 pathway (Hoege et al., 2002). In response to DNA damage, 
members of the RAD6 pathway attach either mono-ubiquitin or poly-ubiquitin 
chain on PCNA (Hoege etal., 2002; Stelter and Ulrich, 2003; Kannouche etal.,
2004). These modifications were found to serve as a molecular switch to decide 
between the TLS or DA sub-pathways.
RAD6
i
RAD18 
/  |  \
R E V 3 /R E V 7  RAD30 RAD5
REV1 ,
U B C 13 /M M S 2
TLS TLS DA
(error-prone) (± error-free) (error-free)
Figure 1.6 -  The RAD6 pathway in S. 
c e re v is ia e
Arrows indicate the genetic relationships 
between the members of the RAD6  
pathway, as determined from the 
sensitivities of the respective mutants 
towards DNA-damaging agents. Two 
pathways of translesion synthesis (TLS), 
mediated by different damage-tolerant DNA  
polymerases, act independently of the 
error-free damage-avoidance (DA) system. 
This figure was taken from Ulrich (2005).
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Table 1-2: Members of the RAD6 pathway in S. cerevisiae
Abbreviations used: TLS -  translesion synthesis (error-prone); DA -  damage  
avoidance (error-free); PC N A  -  proliferating cell nuclear antigen. This table was taken 
from Ulrich (2005).
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1.7.1 Consequences of PCNA Modifications
In S. cerevisiae, the POL30 gene encodes PCNA (Moldovan et ai., 2007). 
PCNA belongs to the DNA sliding clamp family and is essential for DNA 
replication. It is a homo-trimer with a ring-like structure, which encircles the DNA 
and is able to slide on it freely. Each PCNA monomer consists of two globular 
domains linked by an interdomain connecting loop. The three monomers bind to 
each other in a head-to-tail arrangement, with an inner surface composed of 
positively charged a-helices and an outer surface composed of p-sheets. Thus, 
the PCNA ring has a pseudo-hexameric symmetry. Its stable association with 
the DNA requires an ATP-dependent loading by the clamp loader, RFC, which 
specifically loads PCNA onto 3 ’ ssDNA-dsDNA junctions. Until now, more than 
50 proteins were reported to interact with PCNA. Most of them do so via a 
conserved motif, termed PCNA interacting peptide (PIP), which contacts the 
interdomain loop on PCNA. Although this implies a competition between many 
PCNA interacting partners, it is theoretically possible that different proteins can 
bind to PCNA simultaneously, via its three identical monomers
In S. cerevisiae, PCNA is either mono-ubiquitylated or poly-ubiquitylated in 
response to DNA damage by the RAD6 pathway (Hoege et al., 2002). These 
modifications occur on a specific lysine, K164, which is conserved in all 
eukaryotes. The latter modification was shown to be K63-linked poly-ubiquitin 
chain, and according to genetic analysis it is implicated in rescue from damage 
sensitivity via the error-free RAD6 sub-pathway (Hoege et al., 2002). The 
former modification was demonstrated to be physiologically relevant and to 
mediate the translesion synthesis sub-pathways (Stelter and Ulrich, 2003). This 
was also confirmed biochemically, when mono-ubiquitylated PCNA was 
reported to stimulate both Polq and Rev1 bypass of abasic sites (Garg and 
Burgers, 2005). PCNA ubiquitylation is conserved in higher eukaryotes and 
mammalian Polq was discovered to have enhanced affinity toward mono- 
ubiquitylated PCNA (Kannouche et al., 2004; Watanabe et al., 2004). In 
mammalian cells, PCNA mono-ubiquitylation can be reversed by the de- 
conjugating activity of Usp1 (Huang et al., 2006). In yeast, although de- 
ubiquitylation of PCNA is clearly observed (Papouli et al., 2005), no specific
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isopeptidase has been identified up to date. Although mono-ubiquitylation of 
PCNA seems to be the predominant modification in mammalian cells, poly- 
ubiquitylated PCNA was recently detected as well (Motegi et al., 2006; Unk et 
al., 2008). It has yet to be determined what are the up-stream signals that 
choose which PCNA modification will occur, and hence which DNA damage 
tolerance pathway will be activated. Nevertheless, PCNA ubiquitylation provide 
a tight regulation to limit the DNA damage tolerance mechanisms to situations 
when they are needed, such as the restart of a stalled replication fork, and to 
maintain the correct balance between cell survival and genomic stability (Ulrich, 
2007).
In S. cerevisiae, PCNA was found to be sumoylated in an S phase dependent 
manner by the E2 SUMO-conjugating enzyme, Ubc9, and its E3 SUMO ligase 
partner Siz1 (Hoege et al., 2002; Stelter and Ulrich, 2003). Interestingly, the 
same residue that was targeted for ubiquitylation, K164, was shown to be 
sumoylated (Hoege et al., 2002). Additionally, another residue K127, which is 
located on the interdomain loop of PCNA within a sumoylation conserved motif, 
was demonstrated to be sumoylated, but to a lesser extent. In contrast to initial 
beliefs, conjugation of SUMO-SUMO chains was also observed on PCNA 
(Windecker and Ulrich, 2008). Furthermore, although both SUMO and ubiquitin 
target the same residue on PCNA, no competition between these modifications 
was observed (Papouli et al., 2005). PCNA sumoylation was shown to recruit 
the DNA helicase Srs2 to replication forks during S phase (Papouli et al., 2005; 
Pfander etal., 2005). This helicase was demonstrated to inhibit Rad51 filament 
formation in vitro (Krejci et al., 2003). Therefore, Srs2 recruitment is suggested 
to inhibit unscheduled Rad51-dependent recombination events, thereby 
allowing the DNA damage tolerance mechanisms to take place instead. These 
findings provided an explanation for the genetic interaction between Srs2 and 
members of the RAD6 pathway, as deletion of the SRS2 gene suppressed the 
DNA damage sensitivity of the RAD6 pathway mutants in a RAD52-/RAD51- 
dependent manner (Papouli et al., 2005; Pfander et al., 2005). So far, PCNA 
sumoylation seems to be limited to budding yeast and frog (Leach and Michael, 
2005). In Figure 1.7 the different modification of yeast PCNA and their 
consequences for DNA damage tolerance and recombination are shown.
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Figure 1.7 -  Coordination of replication and DNA damage tolerance by PCNA modifications
The scheme shows how the modified forms of PCNA elicit distinct transactions at a replication fork. Whereas unmodified PCNA (ring symbol) 
acts as a processivity factor for replicative polymerases (Pol6), DNA-damaging agents cause lesions (red star symbols) that block the 
progression of DNA replication. In response to replication fork stalling, PCNA is mono-ubiquitylated and poly-ubiquitylated at K164. Mono- 
ubiquitylation activates translesion synthesis by a damage-tolerant polymerase (Polri), whereas poly-ubiquitylation, involving K63 linkage, is a 
pre-requisite for an error-free damage avoidance pathway. Independent of DNA damage, PCNA is sumoylated during S phase at K164 and to 
a minor extent at K127, leading to the recruitment of the helicase Srs2 to the site of replication. Srs2 inhibits the formation of the 
recombinogenic Rad51 filament, thereby facilitating ubiquitin-dependent DNA damage tolerance upon replication fork stalling. This figure was 
taken from Ulrich (2005b).
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1.7.2 The Rad6 Protein
The RAD6 gene from S. cerevisiae encodes yRad6, an E2 ubiquitin-conjugating 
enzyme of 19.7 kDa (Jentsch et ai., 1987). It contains a catalytically conserved 
cysteine residue, cysteine 88, which when mutated to alanine, results in a rad6 
deletion phenotype (Sung et al., 1990). This phenotype includes sensitivity to 
UV irradiation (Cox and Parry, 1968) as well as to other DNA damaging agents 
(Prakash, 1975), an increase in spontaneous mutagenesis rates and loss of 
UV-induced mutagenesis (Lawrence and Christensen, 1976; Lawrence, 2007). 
The yRad6 protein was found to interact genetically and biochemically with 
yRad18, an E3 ubiquitin ligase, and together mediate the DNA damage 
tolerance mechanisms via PCNA ubiquitylation (Cassier-Chauvat and Fabre, 
1991; Bailly et al., 1997a; Bailly et al., 1997b; Hoege et al., 2002). Their 
interaction is mediated via two amphipathic a-helices on yRad6 (Bailly et al., 
1997b). Based on sequence conservation, two human homologues of the yeast 
RAD6 gene have been identified, HHR6A  and HHR6B  (Koken et al., 1991). 
Both were able to complement the DNA damage sensitivity of the rad6 deletion 
yeast strain, suggesting that they may be functionally redundant to each other 
(Koken etal., 1991). In addition, their activity with regard to hRad18 binding and 
to the activation of the DNA damage tolerance mechanisms was found to be 
conserved (Xin etal., 2000).
The yRad6 protein interacts with two more E3 ubiquitin ligase enzymes, Brel 
and Ubr1, with which it is involved in a number of other processes unrelated to 
DNA damage tolerance. These include histone H2B ubiquitylation, sporulation, 
telomere silencing, and protein degradation via the N-end rule (Broomfield et 
al., 2001).
1.7.3 The Rad18 Protein
The RAD18 gene from S. cerevisiae was isolated by complementation of the
UV sensitivity of rad 18 mutants, and was reported to encode a protein of 55.2
kDa (Jones et al., 1988; Fabre et al., 1989). The rad18 deletion strain was
found to have a similar defect in UV-induced mutagenesis as the rad6 mutant
(Cassier-Chauvat and Fabre, 1991), suggesting that RAD18 and RAD6 genes
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are epistatic to each other. Later on, their physical interaction was 
demonstrated by co-immunoprecipitation experiments (Bailly et al., 1994) and 
by biochemical analysis of truncated constructs (Bailly et al., 1997b). A region 
between amino acid 371 and 410 of yRad18 was found to be sufficient for its 
interaction with the E2 (Bailly et al., 1997b). In 1997, the yRad18 protein was 
purified as a hetero-dimer with yRad6 from yeast cells harbouring an over­
expression cassette for both genes (Bailly et al., 1997a). The complex was 
found to have ubiquitin conjugating and ATP hydrolytic activities. The latter 
activity was thought to originate from a Walker type A motif ‘GKS’ found in 
yRad18. However, it was considerably weaker in comparison to other known 
ATPases and may not be an intrinsic activity of yRad18 (Parker and Ulrich -  
unpublished results). In addition, the complex was able to bind to DNA with 
preference to ssDNA over dsDNA. As the Rad6 protein does not contain any 
DNA-binding domains and cannot bind DNA on its own (Bailly et al., 1994), the 
authors hypothesised that the DNA-binding activity originates from the Rad18 
protein. Furthermore, they speculated that Rad18 recruits Rad6 to DNA 
damage sites, and thereby mediate DNA damage tolerance. Consistently, 
yRad18 contains three putative DNA-binding domains: a RING domain, which is 
essential for its ubiquitin ligase activity (aa 28 -  65), a classical ZnF motif (aa 
188 -  210) with homology to the UBZ domain of Polri (Bienko et al., 2005), and 
a SAP domain (aa 278 -  312). A schematic representation of the structural 
domains of yRad18 is shown in Figure 1.8.
In accordance with genetic evidence, yRad18 and yRad5 proteins were found 
to interact with each other and to self-associate (Ulrich and Jentsch, 2000). A 
few years later, PCNA was identified as the substrate for yRad18-yRad6 -  
mediated ubiquitylation by genetic analysis and immunoprecipitation assays 
from MMS treated yeast cells (Hoege et al., 2002). Consistently, yRad18 and 
PCNA have been shown to interact by two-hybrid analysis. In addition, yRad18 
was found to interact with yUbc9, the E2-like enzyme responsible for PCNA 
sumoylation, suggesting crosstalk between PCNA modifications in yeast.
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Figure 1.8 -  Schematic representation of yRad18 structural domains
Rad18 from S. cerevisiae harbours a RING domain (aa 28-65), with C3HC4 structure, a ZnF (aa 188-210), with C2H2 structure, a SAP 
domain (aa 278-312) and a region sufficient for Rad6 binding (aa 371-410).
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Based on sequence homology, the human RAD18 gene was cloned (Tateishi et 
al., 2000; Xin et al., 2000). Apart from lacking the Walker type A motif, it was 
found to harbour homologous structural domains to its yeast counterpart. It 
bound to either hRad6A or hRad6B proteins (Tateishi et al., 2000; Xin et al., 
2000) and together they were able to ubiquitylate PCNA in vitro (Watanabe et 
al., 2004). However, hRad18 did not complement the rad18 deletion yeast 
strain with regard to its sensitivity toward DNA damage.
Recently, two publications have provided evidence regarding its DNA-binding 
properties. According to Notenboom et al. (2007), hRad18 showed preference 
toward ssDNA over dsDNA, but still could bind to both DNA structures. 
Moreover, the SAP domain of hRad18 was found to be sufficient for these 
interactions. Consistently, Tsuji et al. (2008) found that long ssDNA 
oligonucleotides, but also forked DNA structures, were the preferred substrate 
for hRad18 binding, and that the SAP domain was essential for its interaction 
with the DNA. Accordingly, human Rad 18 was suggested to be able to bind to 
stalled replication forks. In agreement with these in vitro results, Nakajima et al.
(2006) demonstrated that in human cells, the SAP domain of Rad 18 contributes 
to its localisation to stalled replication forks along with Polr].
The contribution of the classical ZnF motif of hRad18 for DNA-binding is still 
controversial. Nakajima et al. (2006) found this domain is important for the 
formation of replication-independent damage-induced foci in human cells, 
suggesting that it may contribute to DNA-binding. However, Notenboom et al.
(2007) reported that the ZnF domain of hRad18 was not able to bind to DNA by 
itself, but instead it bound to ubiquitin. Hence, the authours suggested that it 
functions as an ubiquitin-binding domain rather than a DNA-binding domain. In 
agreement with this latter publication, Bish and Myers (2007) showed that a ZnF 
construct of human Rad18 binds to K48-linked-poly-ubiquitin chains in vitro and 
reported its homology to ubiquitin-binding domains (type UBZ) from other 
proteins.
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1.7.4 The Rad5 Protein
The RAD5 gene encodes yRad5, a 134 kDa protein, with homology to helicases 
and chromatin remodelling factors of the SWI2 / SNF2 family (Johnson et al., 
1992). In addition to the seven helicase-like domains it contains a Walker B 
type ATPase motif, a C3HC4 RING domain and a leucine zipper motif (Johnson 
et al., 1992; Ulrich and Jentsch, 2000). Furthermore, its N-terminus consists of 
an HIRAN (HIP116 & Rad5 protein N-terminal) domain, predicted to be a DNA- 
binding domain (Iyer etal., 2006).
The yRad5 protein was shown to physically interact with yRad18 and yUbc13 
proteins (Ulrich and Jentsch, 2000; Ulrich, 2003). Through these interactions, it 
was suggested to mediate the association of the yRad18-yRad6 and the 
yUbc13-yMms2 hetero-dimers on damaged chromatin and coordinate their 
activity (Ulrich and Jentsch, 2000). Accordingly, yRad5 was found to interact 
with PCNA and regulate its poly-ubiquitylation in a RING-dependent E3 ligase 
manner (Hoege et al., 2002). The yRad5 protein has an ssDNA-dependent 
ATPase activity (Johnson et al., 1994). This was demonstrated to be important 
for a MRX (Mre11, Rad50 and Xrs2) complex-mediated DSB repair (Chen et al.,
2005). In correlation with its in vitro ssDNA-binding (Johnson et al., 1994), it 
was shown to bind to 3-resected ssDNA ends following a site-directed DSB in 
vivo (Chen et al., 2005). Recently, it was shown that the ATPase activity of 
yRad5 is stimulated by a range of DNA structures (Blastyak et al., 2007). In 
addition, yRad5 was able to specifically unwind a replication fork-like structure 
with homologous arms in vitro, suggesting that it could be implicated in 
replication fork reversal in vivo, and thus facilitate the DNA damage avoidance 
pathway (Blastyak etal., 2007).
Due to lack of sequence homology in higher eukaryotes, it was not clear 
whether a RAD5 yeast homologue existed. Recently, two functional 
homologues were identified in humans, SHPRH (the protein name originates 
from the initials of the domains it contains: SNF2, (linker-) Histone, PHD finger, 
RING domain and Helicase domain) and HLTF (helicase-like transcription 
factor), and their importance in PCNA poly-ubiquitylation was demonstrated 
(Motegi etal., 2006; Unk etal., 2008).
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1.7.5 The Ubc13 and Mms2 Proteins
The UBC13 gene encodes yllbc13, an E2 ubiquitin-conjugating protein (Brusky 
et al., 2000). The MMS2 gene encodes yMms2, an evolutionary related E2 
enzyme that lacks an active cysteine residue in its catalytic domain (Broomfield 
et al., 1998). Both genes were found to be components of the error-free sub­
pathway of the RAD6 pathway (Brusky et al., 2000). Together, yllbc13 and 
yMms2 form a complex that promotes the assembly of K63-linked ubiquitin 
chains in vitro, which were also shown to be required for the error-free DA sub­
pathway (Hofmann and Pickart, 1999). As mentioned before, the yeast Ubc13- 
Mms2 hetero-dimer associates with chromatin in response to DNA damage and 
co-localises with yRad5 (Ulrich and Jentsch, 2000). In addition, its ability to form 
K63-linked ubiquitin chains in vitro is stimulated by Rad5 (Parker and Ulrich -  
unpublished results). Mammalian homologues were identified by sequence 
similarity and their enzymatic activity was shown to be conserved (Franko et al., 
2001; McKenna et al., 2001; Ashley et al., 2002).
1.7.6 DNA Translesion Synthesis
Replication-blocking lesions may be overcome by the DNA synthesis activity of 
DNA translesion synthesis (TLS) polymerases (Ulrich, 2004). The active site of 
these specialised polymerases can accommodate damaged bases, as it is 
more open than the active site of replicative polymerases, which have sterical 
constraints for the correct structure of a Watson-Crick base pair (Yang and 
Woodgate, 2007). Therefore, this enables them to replicate over DNA lesions. 
However, the nature of their active sites, combined with the lack of proofreading 
activity, results in reduced fidelity of the TLS polymerases. In fact, due to their 
error-prone activity, the TLS polymerases are considered the major contributors 
to damage-induced mutagenesis (Ulrich, 2004). Hence, their activity must be 
highly regulated, and their reduced processivity results in their ability to 
incorporate only a few nucleotides at a time before dissociating from the DNA 
(Yang and Woodgate, 2007).
Most of the TLS polymerases, relevant to the RAD6 pathway, belong to the Y- 
family of polymerases (Ohmori et al., 2001). They differ from each other in the
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accuracy by which they process different lesions (Prakash et al., 2005). In 
addition to palm, thumb and finger domains found in all classical polymerases, 
the Y-family have a forth domain termed the ‘little finger’ or PAD (polymerase- 
associated domain) (Yang and Woodgate, 2007). In yeast there are two Y- 
family enzymes, which are also found in humans. Polq, encoded by the RAD30 
gene (or POLH in humans), can bypass UV-induced lesions with great accuracy 
(Johnson etal., 1999; Washington etal., 2000). Mutations in this gene may lead 
to the Xeroderma Pigmentosum Variant (XPV) syndrome (Lehmann, 2006b). 
This disease illustrates the importance of Polri in maintenance of genomic 
stability in humans, as XPV patients suffer from high predisposition to skin 
cancer. Rev1 protein, encoded by the REV1 gene (or REV1L in humans), is a 
deoxycytidyl transferase, which incorporates a dC across a lesion (Nelson etal., 
1996). Normally Rev1 cooperates with Pol£ in lesion bypass (see below). In 
mammalian cells there are two additional Y-family TLS polymerases: P o Ik  and 
Poll. The former is efficient in bypass of benzo[a]pyrene-guanine adducts (Ogi 
etal., 2002). The latter was found to associate with damage induced PCNA foci 
(Kakar et al., 2008), similar to the other Y-family TLS polymerases (Kannouche 
etal., 2004; Watanabe etal., 2004; Guo etal., 2006a; Guo etal., 2008).
Both in yeast and humans, Pol?, encoded by the REV3 and REV7  genes, 
belongs to the B-family of polymerases and therefore resembles to the 
replicative polymerases (Prakash et al., 2005). It is not so efficient in lesion 
bypass, but instead it harbours the ability to extend the primer termini beyond a 
DNA lesion. Thus, the current view is that many lesions may require the activity 
of two TLS polymerases, one to incorporate a nucleotide opposite a lesion, and 
the second one (Pol£) to perform the subsequent extension step (Prakash etal.,
2005).
As mentioned earlier, in response to DNA damage, PCNA is mono-ubiquitylated 
in a Rad18-Rad6-dependent manner both in yeast and in mammalian cells 
(Hoege et al., 2002; Kannouche et al., 2004; Watanabe et al., 2004), and this 
modification was shown to activate translesion DNA synthesis in yeast by 
genetic analysis (Stelter and Ulrich, 2003). But how can this modification induce 
the polymerase switch from the replicative polymerases to the translesion
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synthesis ones? Human Pohri, Poll and P o Ik  were demonstrated to physically 
interact with PCNA in vitro via their PIP domain, however their interactions may 
be weak (Lehmann, 2006b). Yeast and mammalian Rev1 was demonstrated to 
interact with PCNA via its BRCT domains (Guo et al., 2006a). In addition, 
human Polq was shown to preferentially interact with mono-ubiquitylated PCNA 
(Kannouche et al., 2004; Watanabe et al., 2004). Interestingly, all of these 
translesion polymerases contain ubiquitin-binding domains, which can 
potentially confer enhanced affinity of the polymerase to mono-ubiquitynated 
PCNA (Bienko etal., 2005; Lehmann, 2006b). This hypothesis was verified with 
yeast Polri (Parker etal., 2007), yeast and vertebrate Rev1 (Guo et al., 2006a; 
Wood et al., 2007) and verterbrate P ok (Guo et al., 2008). Furthermore, as 
mentioned before, both Polq and Rev1 were stimulated for abasic site bypass 
by mono-ubiquitylated PCNA in vitro (Garg and Burgers, 2005).
Currently, there are different models for the mechanistic aspects of the 
polymerase switch. On the one hand, mono-ubiquitylated PCNA can actively 
recruit TLS polymerases by their enhanced interaction (Ulrich, 2004). On the 
other hand, this modification may disrupt the binding of the replicative 
polymerases and facilitate the access for the TLS ones in a passive mode 
(Ulrich, 2004). Alternatively, PCNA modification may just switch between ‘on’ 
and ‘off modes of DNA polymerases, which are already associated with PCNA, 
in a manner referred to as the Tool belt’ model (Pages and Fuchs, 2002).
In addition to their role in replication restart, which is restricted to S phase, TLS 
polymerases may have additional roles. As mentioned earlier (1.4.2.5), Pol£ 
activity, induced by PCNA ubiquitylation, was demonstrated to be involved in 
ICL repair in G1 phase, suggesting a more general role of PCNA modification 
depending on the lesion encountered (Sarkar et al., 2006). Moreover, Polq was 
shown to participate in somatic hyper-mutation and / or class switching in the 
immune system as well as in homologous recombination, while Pok was shown 
to be involved in the filling-in steps of NER (Lehmann, 2006a).
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1.7.7 DNA Damage Avoidance
As mentioned before, the DNA damage avoidance (DA) is an error-free bypass 
of DNA damage (Ulrich, 2005). Although the mechanism by which it operates is 
not entirely understood, it is believed to occur in situations when the synthesis 
between the leading and the lagging strand is uncoupled (Branzei and Foiani, 
2007). As the synthesis on one of the strands continues, the synthesis on the 
other strand can be resumed as well if a template-switch occurs, and the newly 
synthesised sister chromatid strand is used for bypassing the lesion (Ulrich,
2005). This is supported by genetic experiments with plasmids containing 
single-stranded specific lesions, which demonstrated a Rad52-independent 
gene conversion event (Zhang and Lawrence, 2005a). One of the models 
suggests that the template switch involves the regression of the replication fork, 
forming a chicken foot-like structure, in which the two nascent DNA strands are 
paired (Ulrich, 2007). Recently, in vitro evidence was obtained in support of this 
model. Firstly, yeast Rad5 was shown to have a structure-specific helicase 
activity toward replication fork-like structure, suggesting that it could be involved 
in replication fork regression in vivo (Blastyak etal., 2007). Secondly, a chicken 
foot-like structure was observed in checkpoint deficient cells by electron 
microscopy studies (Sogo et al., 2002). Although, in principle, this observation 
supports the formation of this DNA structure, Muzi-Falconi et al. (2003) argues 
that it may only occur under pathological conditions.
As previously mentioned, the signal for the activation of the DNA damage 
avoidance is the conjugation of a K63-linked poly-ubiquitin chain on K164 of 
PCNA. Apparently, this is a two-step reaction (Parker and Ulrich -  unpublished 
results). First, PCNA is mono-ubiquitylated by Rad6-Rad18 in a rate-limiting 
step. Subsequently, Rad5 together with Mms2 and Ubc13 mediate PCNA poly- 
ubiquitylation. However, whether the ubiquitin moieties are added in a 
sequential mode or an entire pre-formed chain is conjugated, is not entirely 
clear. The mechanism by which PCNA poly-ubiquitylation promotes DNA 
damage avoidance has yet to be discovered. However, speculative models 
suggest that it is either important for the recruitment of essential factors, similar 
to the way PCNA mono-ubiquitylation promotes TLS, or for the dissociation of 
others (Moldovan etal., 2007).
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1.7.8 The Timing of the DNA Damage Tolerance 
Mechanisms
Historically, post-replicative repair was defined as the activity that cells use to fill 
in damage-induced single-stranded gaps without removal of the DNA lesions 
(Broomfield etal., 2001). This definition originated from the observation that the 
newly synthesised DNA from UV-irradiated E. coli strain deficient in NER had a 
lower molecular weight than that of the untreated controls (Rupp and Howard- 
Flanders, 1968). This observation was explained by the existence of ssDNA 
gaps opposed to UV-induced lesions. As further incubation of the DNA with the 
irradiated cells resulted eventually in its conversion into a higher molecular 
weight, the ssDNA gaps seemed to be filled in after the completion of 
replication. Thus, this model suggested that the damage is repaired ‘behind’ the 
replication fork (Lehmann and Fuchs, 2006).
Following the discovery of TLS polymerases, the assumption that such ssDNA 
gaps could be left within the leading strand was disfavoured. An alternative 
model suggested that these gaps were bypassed at the replication fork by a 
polymerase switch model (Lehmann and Fuchs, 2006) (see 1.7.6). In contrast, 
the possibility that ssDNA could be left on the lagging strand, which in its nature 
is discontinuous, was accepted. However, recent evidence obtained by electron 
microscopy experiments with S. cerevisiae NER deficient UV-irradiated cells, 
suggests that ssDNA regions can form behind the replication fork on both 
strands (Lopes etal., 2006). This finding holds true also in NER and TLS double 
mutants. In addition, 2D-gels revealed that replication forks are able to progress 
in the presence of UV-induced lesions, even in the TLS-deficient strains. These 
findings suggest that the ssDNA gaps are left behind the fork to be dealt with 
later (Lopes et al., 2006). Consequently, this publication raised the awareness 
of the initial model, and controversy regarding the tempo-spatial characteristics 
of the DNA damage tolerance mechanism, still persists in the field (Lehmann 
and Fuchs, 2006).
- 8 0 -
Chapter One: Introduction
1.8 Aims of this Thesis
In this thesis, I present my studies of the Rad18-Rad6 complex from S. 
cerevisiae and the analysis of its activity in vitro. Recent findings in my lab 
revealed the up-stream signals leading to the activation of DNA damage 
tolerance in vivo (Davies et a/., 2008). RPA was implicated in PCNA  
ubiquitylation and Rad18 was found to be a limiting factor for this modification of 
the clamp. Consequently, my aims were to gain further insights into the 
molecular mechanism of these up-stream events. To this end, I have 
investigated the relationships between the Rad18-Rad6 complex, RPA and 
DNA.
Chapter 3 describes the purification process of the Rad18-Rad6 complex and 
the analysis of its catalytic activity. PCNA ubiquitylation is reconstituted in vitro 
and Rad18 is found to be auto-ubiquitylated. Rad 18 ubiquitylation is observed 
also in vivo, both in yeast cells and in recombinant baculovirus infected insect 
cells. Chapter 4 describes the interactions between the Rad18-Rad6 complex 
and DNA. These interactions are mediated directly via Rad 18, whereas Rad6 
cannot bind to the DNA on its own. The effects of salt concentration, salt type 
and different DNA structures are analysed. Chapter 5 describes the interactions 
between the Rad18-Rad6 complex and RPA. The E3-E2 complex binds directly 
and independently to Rfa2 or to the DNA-binding domain of Rfa1. Chapter 6 
describes the interactions between the Rad18-Rad6 complex, RPA and ssDNA. 
The interaction between the DNA-binding domain of Rfa1 and Rad 18 is 
stimulated in the presence of ssDNA. Under conditions of high ionic strength, 
RPA recruits the Rad18-Rad6 complex to ssDNA. Finally, in Chapter 7, the role 
of the SAP domain of yeast Rad 18 is analysed in vivo and in vitro.
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2 Materials and Methods
2.1 Enzymes and Reagents
2.1.1 Enzymes and Proteins
Table 2-1
Enzyme Source
Zymolyase (20T) AMS Biotechnology
Ubiquitin activating enzyme (yeast E1) and 
ubiquitin mutants
BostonBiochem
Restriction enzymes, T4 polynucleotide kinase and 
Terminal transferase
New England Biolabs 
(NEB)
Benzonase Novagen
Single-stranded DNA-binding protein (SSB) Promega
Recombinant His-tagged ubiquitin (human) Sigma
Recombinant ubiquitin (yeast) Generated in the lab
Table 2-1: A list of the enzymes that were used.
2.1.2 Antibodies
Table 2-2
Monoclonal Antibody Source Dilution used
anti-ubiquitin (P4D1) Cell Signalling 
Technology
1:5000
anti-yeast 3-phosphoglycerate 
kinase (PGK)
Molecular Probes 1:10,000
anti-VSV-G Roche 1:3000
anti-GST (B-14) Santa Cruz Biotechnology 1:3000
anti-His (clone HIS-1) Sigma 1:3000
anti-PCNA (5E6, 3B9, 4A10) Generated by CR-UK 1:3000 of each
Table 2-2: A list of the primary monoclonal antibodies that were used.
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Table 2-3
Polyclonal Antibody Source Dilution used
anti-ubiquitin Sigma 1:5000
anti-PCNA (affinity purified) Generated in the lab 1:5000
anti-Rad6 Generated in the lab 1:5000
anti-yRfal A kind gift from Steve Brill 1:10,000
anti-Rad18 (DH1 and DH2 
rabbit terminal bleeds)
See 2.11 for details
anti-Rad18 (mouse 1,2 and 4 
terminal bleeds)
See 2.11 for details
Table 2-3: A list of the primary polyclonal antibodies that were used. 
Table 2-4
Secondary Antibody Source Dilution used
HRP-conjugated anti-mouse DakoCytomation 1:5000
HRP-conjugated anti-rabbit DakoCytomation 1:10,000
anti-rabbit y chain specific 
peroxidase conjugated (clone 
RG-96)
Sigma 1:2000
Table 2-4: A list of the secondary antibodies that were used.
2.1.3 Chemicals and Reagents
All chemicals (analytical reagent grade) were purchased from Sigma, BDH 
Chemicals or Fisher Scientific unless stated otherwise. Other materials were 
obtained as listed below.
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Table 2-5
Chemicals and Reagents Source
Ammonium persulfate (APS), Bromophenol blue, 
30% Acrylamide/Bis solution (37.5:1 Acrylamide: 
N , N’-methylene-bis-acrylamide electrophoresis 
purity reagent), Affi-Gel Blue Gel, Hydroxyapatite 
BioGel HTP Gel (HAP) and Standard Mw for gel 
filtration
Bio-Rad
NP-40 Calbiochem
Amino acids for yeast media Duchefa Biochimie
Activated CH-sepharose 4B beads, Glutathione 
sepharose 4 fast flow, HiTrap phenyl HP, HiTrap 
Q HP, HiTrap Heparin HP column, MonoQ (HR  
5/5), Superose 6 PC 3.2/30 and Superdex200 
10/300 GL
GE Healthcare
Agarose, Cellfectin, M13 reverse primer, 20X  
MOPS buffer, Pre-cast NuPage 4-12%  gels, 10X 
reducing agent and 4X NuPage sample buffer
Invitrogen
Dithiothreitol (DTT) Melford
Isopropyl-p-D-thiogalactopyranoside (IPTG) MP Biomedicals
20%  (w/v) sodium dodecyl sulfate (SDS) National Diagnostics
10X T4 polynucleotide kinase buffer, 10X C0 CI2, 
Buffers for restriction enzymes, Lambda DNA, 
100 bp DNA Ladder, 1 kb DNA Ladder
New England Biolabs 
(NEB)
X-Gal, peqGOLD protein marker and pre-stained 
peqGOLD protein marker IV
peqlab
Western lightning chemiluminescence reagent 
plus and radiolabelled reagents
Perkin Elmer
Ni-NTA agarose QIAGEN
Complete EDTA-free protease inhibitor, Protein 
G-agarose
Roche
Instant skimmed milk powder Sainsbury’s basics
Ethidium Bromide (10 mg/mL) Seven Biotech
Table 2-5: A list of the additional chemicals and reagents that were used.
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2.2 Media and Solutions
Unless stated otherwise, ultra-pure Millipore water was used in all media and 
solutions.
2.2.1 Media for Bacterial Cells
Luria Broth (LB) medium, Terrific Broth (TB) medium and SOC medium as well 
as LB agar were prepared by Cancer Research UK London Research Institute 
(LRI) Central Services.
All antibiotics were purchased from Sigma with the exception of Gentamicin 
(Invitrogen), prepared as 1000-fold stock solutions and stored at -20°C. The 
antibiotics were used for resistance selection of bacterial cells in media or agar 
plates.
Table 2-6
Antibiotic 1000X Stock concentration 
(mg/mL)
Solvent
Ampicillin 100 Water, sterilized by filtration
Chloramphenicol 34 Ethanol
Kanamycin 50 Water, sterilized by filtration
Tetracyclin 10 Water, sterilized by filtration
Gentamicin 7 Water, sterilized by filtration
Spectinomycin 100 Water, sterilized by filtration
Table 2-6: A list of the antibiotic stock solutions.
2.2.2 Media for Yeast Cells
Yeast Peptone (YP) medium, Yeast Peptone Glucose (YPD) medium, 20%  
(w/v) glycerol, YPD agar and 4% (w/v) bacto agar were prepared by Cancer 
Research UK LRI Central Services.
Dropout Powder stock was prepared by overnight mixing of 2 g p- 
aminobenzoic acid and 20 g of each: alanine, arginine, asparagine, aspartic
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acid, cysteine, glutamine, glutamic acid, glycine, inositol, isoleucine, lysine, 
methionine, phenylalanine, proline, serine, threonine, tyrosine and valine. 
Synthetic Complete (SC) powder stocks were prepared by overnight mixing 
of 36.7 g dropout powder, 4 g leucine, 2 g histidine, 2 g tryptophane, 2 g uracil 
and 0.5 g adenine. (For each specific stock, the appropriate amino acid was not 
included).
Synthetic Complete (SC) medium 2.5X stock was prepared as followed: 5 g 
of Synthetic Complete powder stock, 4.25 g Difco Yeast Nitrogen Base (without 
amino acids and ammonium sulfate) and 12.5 g ammonium sulfate were 
dissolved in 1 L water and stirred for 30 min. The medium was divided into 5 
aliquots of 200 mL each and autoclaved.
In order to prepare SC medium for yeast growth, 200 mL of 2.5X SC stock 
were mixed with 250 mL sterile distilled water and 50 mL of 20% (w/v) glucose 
solution (resulting in 2% (w/v) final concentration of glucose).
Selective SC plates, lacking the appropriate amino acids, were prepared by 
melting 250 mL of 4% (w/v) bacto agar and mixing it with 200 mL 2.5X SC 
specific stock and 50 mL 20% (w/v) glucose. The mix was poured into Petri 
dishes and allowed to solidify.
2.5X YP stock: 50 g bacto peptone and 25 g bacto yeast extract were 
dissolved in 1 L of water and stirred for 30 min. The medium was divided into 5 
aliquots of 200 mL each and autoclaved.
20% (w/v) Galactose stock: 20 g of galactose were dissolved in warm water 
up to a final volume of 100 mL and autoclaved.
20% (v/v) Glycerol stock: 20 mL of glycerol were diluted with water up to a 
final volume of 100 mL and autoclaved.
In order to prepare YP medium for yeast growth, 2.5X YP stock was diluted 
with sterile distilled water and a carbon source (glucose / glycerol / galactose) 
was added to a final concentration of 2% (w/v).
YP + Galactose agar plates: 250 mL of 4% (w/v) bacto agar were melted and 
mixed with 200 mL 2.5X YP stock and 50 mL of 20% (w/v) galactose. The mix 
was poured into Petri dishes and allowed to solidify.
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2.2.3 Media for Insect Cells
Insect Cell medium was prepared by Cancer Research UK LRI Central 
Services and consisted of Grace’s medium (without insect haemolymph) 
supplemented with 3.3 g/L lactalbumin hydrolysate and 3.3 g/L yeastolate 
(Invitrogen), 10% (v/v) heat inactivated fetal calf serum (Sigma), 100 pg/mL 
streptomycin and 100 u/mL penicillin.
2.2.4 Buffers and Solutions
Standard solutions of 0.5 M EDTA, 1 M Tris-HCI (pH 7.5 or 8), Tris-EDTA (TE) 
pH 8, 1 M MgCb, 5 M NaCI, Phosphate Buffered Saline (PBS) and Tris Borate 
EDTA (TBE) were prepared by Cancer Research UK LRI Central Services.
2.2.4.1 Buffers for Molecular Biology Methods for E. coli
Tbfl solution: 30 mM potassium acetate, 100 mM rubidium chloride, 10 mM 
calcium chloride, 50 mM manganese chloride, 15% (v/v) glycerol. The pH of the 
solution was adjusted to 5.8 with dilute acetic acid. The solution was autoclaved 
prior to use.
Tbfll solution: 10 mM MOPS, 75 mM calcium chloride, 10 mM rubidium 
chloride, 15% (v/v) glycerol. The pH of the solution was adjusted to 6.5 with 
dilute NaOH. The solution was autoclaved prior to use.
X-Gal stock solution: X-Gal was dissolved at 100 mg/mL in DMSO.
IPTG stock solution: IPTG was dissolved at 200 mg/mL in water and sterilized 
by filtration through a 0.2 ^m filter (Millipore).
2.2.4.2 Buffers for Molecular Biology Methods for Yeast Cells
LiT buffer: 100 mM lithium acetate and 10 mM Tris-HCI, pH 7.4. The solution 
was autoclaved prior to use.
LiT I PEG buffer: 100 g PEG (3350) was dissolved in 100 mL of LiT buffer. The 
solution was autoclaved prior to use.
ST DNA stock solution: Herring sperm DNA (Sigma D6898) was dissolved in 
TE buffer at 10 mg/mL and sheared by sonication to obtain homogenous
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solution (Branson sonifier). Three subsequent extraction steps with phenol, 
phenol/chlorophorm and chloroform were used to purify the DNA, followed by a 
sodium acetate / ethanol precipitation procedure (Sambrook et al., 1989). Prior 
to use, the solution was incubated at 95°C for 5 min.
Zymolyase solution: 50\iL of 20 mg/mL Zymolyase (20T) stock solution and 
50 p,L of 1 M DTT stock solution were mixed with 900 \iL sterile water (The final 
concentrations were 1 mg/mL Zymolase and 50 mM DTT). The solution was 
prepared fresh prior to an immediate use.
NaOH / p-ME: 1.85 M NaOH and 7.5% (v/v) p-ME. The solution was prepared 
fresh prior to an immediate use.
55% (w/v) TCA: 55 g TCA were dissolved in water up to 100 mL final volume.
HU buffer: 8 M urea, 5% (w/v) SDS, 200 mM Tris-HCI, pH 6.8, 1 mM EDTA, 
0.1% (w/v) bromophenol blue and 1.5% (w/v) DTT (added fresh).
2.2.4.3 Buffers for General Manipulation of DNA
50X TAE: 2 M Tris base, 2 M glacial acetic acid and 50 mM EDTA.
6X DNA Loading buffer: 50% (w/v) sucrose and 0.1% (w/v) bromophenol blue 
dissolved in TE and filtered through a 0.45 ^m filter (Millipore).
2.2.4.4 Buffers for General Manipulation of Proteins
5X Laemmli Sample buffer: 250 mM Tris-HCI, pH 6.8, 500 mM DTT, 10%  
(w/v) SDS, 0.1% (w/v) bromophenol blue and 10% (v/v) glycerol.
5X Laemmli Running buffer: 125 mM Tris base, 1.25 M glycine and 0.5%  
(w/v) SDS.
Coomassie Blue Staining solution: 2.5 g brilliant blue R (Sigma), 45% (v/v) 
methanol, 45% distilled water and 10% (v/v) glacial acetic acid. The solution 
was filtered prior to use.
De-staining solution: 45%  (v/v) methanol, 45%  distilled water and 10% (v/v) 
glacial acetic acid.
Gel Drying solution: 20%  (v/v) methanol and 3% (v/v) glycerol in water. 
Tris-HCI, pH 10.4 or pH, 9.4: Tris base was dissolved in water to a final 
concentration of 1 M. The pH was adjusted using HCI solution.
Blotting buffer I: 300 mM Tris-HCI, pH 10.4 and 15% (v/v) methanol.
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Blotting buffer II: 30 mM Tris-HCI, pH 10.4 and 15% (v/v) methanol.
Blotting buffer III: 25 mM Tris-HCI, pH 9.4, 40 mM 6-aminocaproic acid and 
15% (v/v) methanol.
PBST: 1X PBS + 0.1% (w/v) Tween 20.
Blocking solution: 5% milk powder dissolved in PBST.
Stripping buffer: 100 mM Tris-HCI, pH 7.5, 10 mM EDTA and 0.5% (w/v) SDS. 
140 pL of 100% (v/v) p-ME were added fresh to 20 mL stripping buffer per 
membrane.
2.2.4.5 Buffers for Protein Purifications
HI buffer: 30 mM HEPES-KOH, pH 7.8, 0.25 mM EDTA, 0.25% (w/v) myo­
inositol and 0.01% (v/v) NP-40.
GF RPA buffer: 30 mM HEPES-KOH, pH 7.8, 0.25 mM EDTA, 200 mM KCI, 
10% (v/v) glycerol and 1 mM DTT (added fresh).
RFA1 Washing buffer: 50 mM Tris-HCI, pH 7.5 and 25 mM NaCI.
RFA1 Elution buffer: 50 mM Tris-HCI, pH 7.5, 25 mM NaCI, 10 mM reduced 
glutathione and 10% (v/v) glycerol. The solution was freshly prepared prior to 
use.
RFA Dialysis buffer: 50 mM Tris-HCI, pH 7.5, 25 mM NaCI, 10% (v/v) glycerol 
and 1 mM DTT (added fresh).
RFA2 Lysis buffer: 25 mM Tris-HCI, pH 7.5, 250 mM NaCI, 1 mM EDTA and 1 
mM DTT (added fresh).
RFA2 Washing buffer: 25 mM Tris-HCI, pH 7.5, 500 mM NaCI, 1 mM EDTA  
and 1 mM DTT (added fresh).
RFA2 Elution buffer: 50 mM Tris-HCI, pH 8, 500 mM NaCI, 1 mM EDTA, 10 
mM reduced glutathione, 10% (v/v) glycerol and 1 mM DTT (added fresh).
RAD6 Lysis buffer: 20 mM HEPES-NaOH, pH 8, 500 mM NaCI and 1 mM 
EDTA, pH 8.
RAD6 Dialysis buffer: 50 mM Tris-HCI, pH 7.5, 150 mM NaCI, 10% glycerol 
and 0.5 mM DTT (added fresh).
PCNA Lysis buffer: 50 mM sodium phosphate, pH 8, 250 mM NaCI, 10% (w/v) 
sucrose, 5 mM imidazole and 1 mM p-ME (added fresh).
PCNA Washing buffer I: 50 mM sodium phosphate, pH 8, 500 mM NaCI and 
10 mM imidazole.
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PCNA Washing buffer II: 50 mM sodium phosphate, pH 8, 500 mM NaCI, 20 
mM imidazole and 10% glycerol.
PCNA Dialysis buffer: 25 mM Tris-HCI, pH 7.5, 50 mM NaCI, 1 mM EDTA and 
10% (v/v) glycerol.
Buffer A: 6 M guanidine hydrochloride, 100 mM sodium phosphate, pH 8, and 
10 mM Tris-HCI, pH 8.
Buffer C: 8 M urea, 100 mM sodium phosphate, pH 6.3, and 10 mM Tris-HCI, 
pH 6.3.
Hypotonic buffer: 50 mM Tris-HCI, pH 8, 10 mM KCI, 1.5 mM MgCI2 and 20 
mM sodium phosphate, pH 8.
RAD 18 Washing buffer I: 30 mM HEPES-NaOH, pH 7.4, 0.3 M NaCI, 10 mM 
imidazole and 1 mM p-ME (added fresh).
RAD18 Washing buffer II: 30 mM HEPES-NaOH, pH 7.4, 0.3 M NaCI, 20 mM 
imidazole and 1 mM p-ME (added fresh).
RAD18 Washing buffer III: 30 mM HEPES-NaOH, pH 7.4, 0.3 M NaCI, 20 mM 
imidazole, 100 pM ZnCI2, 10% (v/v) glycerol and 1 mM p-ME (added fresh). 
RAD18 Elution buffer: 30 mM HEPES-NaOH, pH 7.4, 0.3 M NaCI, 250 mM 
imidazole, 100 pM ZnCI2, 10% (v/v) glycerol and 1 mM p-ME (added fresh). 
RAD18 Dialysis buffer: 30 mM HEPES-NaOH, pH 7.4, 150 mM NaCI, 100 pM 
ZnCb, 10% (v/v) glycerol and 1 mM p-ME (added fresh).
QIAGEN buffer A: 100 mM NaH2P 0 4, 10 mM Tris base and 6 M guanidine 
hydrochloride. The final pH was adjusted to pH 8 with NaOH. The buffer was 
prepared fresh prior to use.
QIAGEN buffer C: 100 mM NaH2P0 4 , 10 mM Tris base and 8 M urea. The final 
pH was adjusted to pH 6.3 with HCI. The buffer was prepared fresh prior to use. 
QIAGEN buffer D: 100 mM NaH2P 0 4, 10 mM Tris base and 8 M urea. The final 
pH was adjusted to pH 5.9 with HCI. The buffer was prepared fresh prior to use. 
QIAGEN buffer E: 100 mM NaH2P 0 4, 10 mM Tris base and 8 M urea. The final 
pH was adjusted to pH 4.5 with HCI. The buffer was prepared fresh prior to use.
2.2.4.6 Buffers for Interaction Studies and Enzymatic Assays 
Annealing buffer: 25 mM Tris-HCI, pH 7.5, 50 mM NaCI and 5 mM MgCI2.
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PD Low-Salt Binding buffer: 25 mM HEPES-NaOH, pH 7.5, 15 mM KCI, 1 
mM EDTA and 0.05% Triton X-100. 0.5 mM DTT and 100 ng/mL BSA were 
added fresh prior to the experiment.
PD Low-Salt Binding (“- KCI”) buffer: 25 mM HEPES-NaOH, pH 7.5, 1 mM 
EDTA and 0.05% Triton X-100. 0.5 mM DTT and 100 ng/mL BSA were added 
fresh prior to the experiment.
PD High-Salt Binding buffer: 25 mM HEPES-NaOH, pH 7.5, 15 mM KCI, 1 
mM EDTA, 0.05% Triton X-100 and 250 mM NaCI. 0.5 mM DTT and 100 ng/mL 
BSA were added fresh prior to the experiment.
COIP Binding buffer: 50 mM Tris-HCI, pH 7.5, 250 mM KCI, 20% (v/v) glycerol 
and 1% (v/v) NP-40.
COIP Washing buffer: 50 mM Tris-HCI, pH 7.5, 250 mM NaCI and 20% (v/v) 
glycerol.
GST-PD Binding buffer: 50 mM Tris-HCI (pH 7.5), 50 mM NaCI, 1 mM EDTA 
and 0.05%  triton X-100.
Coupled-PD Binding buffer: 50 mM Tris-HCI, pH 7.5, 100 mM NaCI, 5 mM 
MgCb and 0.05 % Triton-X100.
Coupled-PD Washing buffer: 50 mM Tris-HCI, pH 7.5, 250 mM NaCI and 0.05 
% Triton-X100.
Ubiquitylation buffer: 50 mM HEPES-NaOH, pH 6, 100 mM NaCI, 10 mM 
MgCb, 5 mM ATP and 0.1 mM DTT. 5X stock was prepared, divided to aliquots 
and kept at -80°C for a few months. Aliquots were thawed and diluted prior to 
use.
2,3 Plasmids
Table 2-7
Number Name Use
81 pAD-1 Two Hybrid
82 pGBT9 Two Hybrid
110 pGBT -RAD18 Two Hybrid
111 pGAD-RAD18 Two Hybrid
308 YEplac181 Expression in yeast
349 jpTYB-RAD6 Expression in E. coli
386 Ylplac211 Expression in yeast
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387 Ylp211-GAL Expression in yeast
464 Ylp211-GAL-RAD18 Expression in yeast
617 pGAD-POL30 Two-Hybrid
618 pGBT -POL30 Two-Hybrid
637 pQE -POL30 Expression in E. coli
821 YEp181 -C U P I-^ U B I Expression in yeast
860 pETDuet-1
Expression in E. coli (2 target 
genes)
878 pQE-POL30(K164R) Expression in E. coli
879 pQE-POL30(K127/164R) Expression in E. coli
1128 p11d-sctRPA Expression in E. coli
1185 pGBT -RFA1 Two-hybrid
1190 pGBT-RFA 7(1 -563) Two-hybrid
1191 pGBT-RFA1(1-452) Two-hybrid
1192 pGBT-RFA1(1-317) Two-hybrid
1193 pGBT-RFA1(1-116) Two-hybrid
1194 pGBD-RFA 1(79-621) Two-hybrid
1195 pGBD-RFA 1(320-621) Two-hybrid
1196 pGBD-RFA 1(454-621) Two-hybrid
1199 pGBD-RFA 1(167-452) Two-hybrid
1200 pGBD-RFA 1(167-407) Two-hybrid
1201 pGBD-RFA 1(266-446) Two-hybrid
1265 pGAD-RAD18(1 -192) Two-hybrid
1266 pGBT-RAD18(1-192) Two-hybrid
1269 pGAD-RAD 18-SAPA{279-312A) Two-hybrid
1270 pGAD-RAD18-SAP*(G299A/R301 A/M304A) Two-hybrid
1271 pGBT-RAD18-SAPA(279-312A) Two-hybrid
1272 pGBT-RAD18-SAP*(G299A/R301A/M304A) Two-hybrid
1273 Ylp211-P18-RAD18-SAPA(279-312A) Expression in yeast
1274
Ylp211-P18-RAD18-
SAP*(G299A/R301A/M304A) Expression in yeast
1275 pFastBac-HTc- VSV-RAD 18- SAPA(279-312A) Bacmid cloning
1276
pFastBac-HTc- \/S\/-RAD 18- 
SAP*(G299A/R301 A/M304A) Bacmid cloning
1317 pGEX-yRFA1(181-422) Expression in E. coli
1502 pGEX-yRFA2 Expression in E. coli
Table 2-7: A list of all plasmids used in this thesis that were constructed 
by others or commercially available.
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Table 2-8
No. Name Construction Use
861
pETDuet-
RAD6(2)
PCR (oHU538/oHU539) from pAS-RAD6 (#102) 
cloned BamHI/Kpnl into pETDuet-1 (Bglll/Kpnl)
Expression in 
E. coli
862
pETDuet-His- 
RAD18(1)- 
RAD6(2)
PCR (OHU536/OHU057) from pGAD-RAD18 
(#111) cloned BamHI/Pstl into pETDuet- 
RAD6(2)
Expression in 
E. coli
863
pETDuet-
RAD18(2)
PCR (OHU536/OHU537) from pGAD-RAD18 
(#111) cloned Bglll/Kpnl into pETDuet-1 
(BamHI/Kpnl)
Expression in
E. coli
864
pETDuet -His- 
RAD6(1)- 
RAD18(2)
PCR (OHU538/OHU055) from pAS-RAD6 (#102) 
cloned BamHI/Pstl into pETDuet-RAD 18(2)
Expression in 
E. coli
865 pUC118-PhoA
“p4xH cassette” (#240, Helle’s PhD) cloned 
EcoRI/BamHI into pUC118 (#001) Cloning
866
pUC118-PhoA- 
Duet
Synthetic linker (oHU543/oHU544) was filled in 
with Klenow; cloned Xbal/Hindlll into pUC118- 
PhoA Cloning
867
pUC118-PhoA- 
Duet-His-RAD6
His-RAD6 from pETDuet-His-RAD6(1)-RAD 18(2) 
(Ncol/Pstl) cloned into pUC118-PhoA-Duet
Expression in
E. coli
868
pUC118-PhoA- 
Duet -His-RAD6- 
RAD18
RAD18 from pETDuet-His-RAD6(1)-RAD 18(2) 
(BamHI/Pstl) cloned into pUC118-PhoA-Duet- 
His-RAD6 (Bglll/Nsil)
Expression in 
E. coli
869
pUC118-PhoA- 
Duet-His-RAD18
His-RAD18 from pETDuet-His-RAD18(1)- 
RAD6(2) (Ncol/Pstl) cloned into pUC118-PhoA- 
Duet
Expression in 
E. coli
870
pUC118-PhoA- 
Duet -His-RAD 18- 
RAD6
RAD6 from pETDuet-His-RAD18(1)-RAD6(2) 
(BamHI/Pstl) cloned into pUC118-PhoA-Duet- 
His-RAD18 (Bglll/Nsil)
Expression in 
E. coli
871
YEp195-ADH-
His-RAD18
His-RAD18 from Ylp211 -P18-His6-RAD18 
(#505) (BamHI/Hindlll) cloned into YEp-ADH- 
His-Rad5 (#487) (replacing His-RAD5)
Expression in 
yeast
873
pQE-
POL30(K127R)
POL30(K127R) from Ylp128-P30- 
POL30(K127R) (#708) (BamHI/Pstl) cloned into 
pQE-32 (#152)
Expression in 
E. coli
1144
Ylp128-ADH-
RAD6
RAD6 from YEp195-ADH-RAD6 (#461) 
(EcoRI/Pstl) cloned into Ylplac128 (#66)
Expression in 
yeast
1146
pFastBac-HTc- 
VSV-RAD18
VSV-RAD18 from Ylp211 -P18-VSV-RAD18 
(#403) (BamHI/Pstl) cloned into pFastBac-HTc 
(#476)
Bacmid
cloning
Table 2-8: A list of all plasmids that were constructed for this thesis.
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2.4 DNA Oligonucleotides
Most oligonucletides were purchased from SIGMA. Biotinylated 
oligonucleotides for DNA-binding assays were purchased from Operon. Table 
10-1 in the appendix contains the sequences of all the oligonucleotides that 
were used in this thesis.
Table 2-9
Substrate Oligonucleotides
ssDNA XOI 5' [BiodT] GGACATCTTTGCCCACCTGCAGGTTCACCC 3'
dsDNA X01 5' [BiodT] GGACATCTTTGCCCACCTGCAGGTTCACCC 3' XOIc 3' CrGCGACGGCTTAAGATGGTCACGGAACGATCCTGTAGAAACGGGTGGACGTCCAAGTGGG 5’
Splayed
Duplex
XOI 5’ [BiodT] GGACATCTTTGCCCACCTGCAGGTTCACCC 3' 
X04 3’ GAACG GTACCTCGACAGATCTCCTAGGCTGATAGCTA 5'
5’-Flap X01 5’ [BiodT] GAAT T GGACATCTTTGCCCACCTGCAGGTTCACCC 3’ X02.1/2 3‘ CCTGTAGAAACGGGTGGACGTCCAAGTGGGT 5’ 
X04 3’ TGCGACGGCTTAAGATGGTCACGGAACGATGTACCTCGACAGATCTCCTAGGCTGATAGCTA 5
3’-Flap XOI 5’ [BiodT] GGACATCTTTGCCCACCTGCAGGTTCACCC 3’ X03.1/2 5’ CATGGAGCTGTCTAGAGGATCCGACTATCGA 3' 
X04 3’ TT AAGAT GGT CACGGAAC GTACCTCGACAGATCTCCTAGGCTGATAGCTA 5
dsFork 
*  <
XOI 5' [BiodT] GGACATCTTTGCCCACCTGCAGGTTCACCC 3' 
X02.1/2 3’ CCTGTAGAAACGGGTGGACGTCCAAGTGGGT 5‘ 
X03.1/2 5' CAT GGAGCT GTCTAGAGGAT CCG AC TAT CGA 3' 
X04 3' 3CTTAAGATGGTCACGGAACG GT ACCTCGAC AGAT CT CCT AGGCT GAT AGCTA 5
Table 2-9: A schematic representation of the DNA structures that were 
used.
Complementary DNA strands in the substrates and their corresponding sequences are 
highlighted with the same colour. Note that all structures share oligonucleotide X 0 1 . 
Black and red asterisks indicate the biotin and the 32P label, respectively, on each DNA  
structure. For additional details on each oligonucleotide that was used to generate the 
structures, refer to Table 10-1.
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2.5 Strains
2.5.1 Escherichia coli Strains
E. coli Top10 chemically competent cells were used for the propagation of most 
vectors and for DNA cloning. E. coli SURE chemically competent cells were 
used to propagate the vector harbouring yeast RFA*\, RFA2 and RFA3 genes 
(p11d-sctRPA, number 1128). E. coli DHIOBac electro-competent cells were 
used to generate recombinant baculovirus DNA as described in paragraph 
2.8.1. E. coli electro-competent or chemically competent cells (see paragraph 
2.12 for details): BL21-CodonPlus (DE3)-RIL. ER2655, Rosetta-gami B (DE3) 
pLysS and Codon2+ were used for protein expression.
Table 2-10
Name Source Genotype
Top10 Invitrogen F" mcrA A(mrr-hsdRMS-mcrBC) O80/acZAM15 
A/acX74 recA1 araA\39 A(ara-leu)7697 galU 
galK rpsL (StrR) endA1 nupG
SURE Stratagene e14- (McrA-) D(mcrCB-hsdSMR-mrr)171 
endA1 supE44 thi-1 gyrA96 relA1 lac recB 
recJ sbcC umuC::Tn5 (Kanr) uvrC [F' proAB 
lacFZDMW Tn10 (Tetr)]
DHIOBac Invitrogen F" mcrA A(mrr-/?sc/RMS-mcrBC) 
4>80/acZAM15 A/acX74 recA1 endAI araD139 
A(ara, leu)7697 ga/U ga/K X~ rpsL nupG 
/pMON 14272 / pMON7124
BL21-CodonPlus
(DE3J-RIL
Stratagene E. coli B F" ompT hsdS(rB~ me") dcm+ Tetr gal 
A(DE3) endA Hte [argil ileYleuWCamr]
ER2655 NEB F  lamda' fhuA2 [Ion] ompTlacZ:: T7 genel 
gal sulA 11 D (mcrC-mrr) 114::IS10 R(mcr 
73::miniTn10- TetS)2 R(zgb-210::Tn10) 
(TetS) endA 1 [dcm]
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Rosetta-gami B 
(DE3) pLysS
Novagen F” ompT hsdSB (rB mB ) gal dcm lacY1 ahpC 
(DE3) gor522::Tn10 trxB pLysSRARE (C am R, 
KanR, TetR)
Codon** Dale
Wigley
The strain was originally obtained from Steve 
Sandler (Kim et al., 1998), and modified by 
removing the Chloramphenicol resistance 
gene allowing selection of helper plasmid by 
using only Spectinomycin.
Table 2-10: A list of all E. coli strains that were used and their genotypes.
2.5.2 Yeast Strains
All yeast strains used in this thesis, except for the strains used in the two-hybrid 
analysis (2.13.4), were derivatives of the haploid form of the wild-type DF5 
strain (his3-A200 Ieu2-3,112 Iys2-801 trp1-1 ura3-52) (Finley et al., 1987), and 
were constructed as indicated below. All yeast strains used in the two-hybrid 
analysis (2.13.4) were derivatives of the yeast strain PJ69-4a (MATa trp1-901 
Ieu2-3,112 ura3-52 his3-200 gal4& galQOA LYS2::GAL1-HIS3 GAL2-ADE2 
met2::GAL7-lacZ) (James et al., 1996). These strains were constructed by co­
transformation of different vectors harboring the open reading frames of RFA1, 
RAD 18 and POL30 genes fused either to the GAL4 activation (AD) or the DNA- 
binding (BD) domains (see Table 2-7 for detailed plasmid list used in the two- 
hybrid assays).
Table 2-11
Strain Name Strain
Number
Genotype and Source Features and 
Use
DF5 a 2 MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52
(Finley etal., 1987).
WT
DF5 a 3 MATa, his3- 200, leu 2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52
(Finley etal., 1987).
WT
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rad18::W a 142 MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, rad18::TRP1 
(Ulrich and Jentsch, 2000)
UV sensitivity; 
Parental strain for 
construction
rad18::Wa 162
MATa, his3- 200, leu2-3,2- 
112, lys2-801, trp1-1(am), 
ura3-52, rad18::TRP1 
(Ulrich and Jentsch, 2000)
UV sensitivity; 
Parental strain for 
construction and 
used as control in 
2.13.1 and 2.13.2
PJ69-4A 195 MATa, trp1-901 leu2-3, 112 
ura3-52 his3-200 gal4A 
gal80A L YS2::GAL 1-HIS3 
GAL2-ADE2 met2::GAL7- 
lacZ)
(James etal., 1996)
Two-hybrid 
analysis (2.13.4); 
Parental strain for 
construction
rad18+ Ylp211- 
P18
MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, rad18::TRP1, 
Ylp211-P18::URA3
Constructed by 
integrative vector 
(no. 386) 
linearised by Stul; 
Used in 2.13.1, 
and 2.13.2.
rad18+Ylp211-
GAL
MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, rad18::TRP1, 
Ylp211-GAL::URA3
Constructed by 
integrative vector 
(no. 387) 
linearised by Stul; 
Used in 2.13.1, 
and 2.13.2.
rad 18 + Ylp128- 
ADH-RAD6 + 
YEp195-ADH- 
HisRAD18
MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, rad18::TRP1,
Yip 128-ADH-RAD6::LEU2, 
YEp 1 95-ADH-HIsRAD 18
Constructed by 
episomal vector 
(no. 1472); Used 
for protein 
purification
RAD18IAtl ATCC 201388: MATa, 
his3A1, leu2A0, met15A0, 
ura3A0, RAD18tap::HIS3 
(YSC 1178-7499523)
Purchased from 
Open biosystems; 
Used for protein 
purification
RAD6,ap ATCC 201388: MATa, 
his3A1, leu2A0, met15A0, 
ura3A0, RAD6tap::HIS3 
(YSC 1178-7500441)
Purchased from 
Open biosystems; 
Used for protein 
purification
W T+ YEp181- 
CUP1-HISUBI
MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, YEp181-CUP1- 
HisUBI::LEU2
Constructed by 
episomal vector 
(no. 821); Used in 
2.17.1
RAD1EP*a +
YEp181-CUP1-
H'SUBI
MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, RAD186ha::TRP1, 
YEp181-CUP1- 
HisUBI::LEU2
Constructed by 
episomal vector 
(no. 821); Used in 
2.17.1
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RAD1#*1a + 
YEp181
MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, RAD18?ha::TRP1, 
YEplac181::LEU2
Constructed by 
episomal vector 
(no. 308); Used in 
2.17.1
rad6 RADIS'*1* +
YEp181-CUP1-
HisUBI
MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, RAD18?ha::TRP1 , 
rad6::HIS3, YEp181-CUP1- 
HisUBI::LEU2
Constructed by 
episomal vector 
(no. 821); Used in 
2.17.1
RAD1&*1* 205 MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, RAD18sha::TRP1
Analysis of post- 
translational 
modifications of 
Rad 18; Parental 
strain for 
construction
rad 18 + Ylp128- 
ADH-RAD6
1472 MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, rad18::TRP1,
Yip 128-ADH-RAD6::LEU2
Constructed by 
integrative vector 
(no. 1144) 
linearised by Clal; 
Used for strain 
construction
rad18+Ylp211-
P18-rad18(SAPA)
1858 MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, rad18::TRP1, 
Ylp211-P18- 
RAD18( SAPA)::URA3
Constructed by 
integrative vector 
(no. 1273) 
linearised by Stul; 
Used in 2.13.1, 
and 2.13.2.
rad18+ Ylp211- 
P18-rad 18( SAP*)
1859 MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, rad18::TRP1, 
Ylp211-P18- 
RAD18( SAP*)::URA3
Constructed by 
integrative vector 
(no. 1274) 
linearised by Stul; 
Used in 2.13.1, 
and 2.13.2.
rad6 RAD18^ a 1867 MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, RAD186ha::TRP1, 
rad6::HIS3
Analysis of post- 
translational 
modifications of 
Rad 18;
Parental strain for 
construction
WT + Ylp211- 
GAL-RAD18
2058 MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, Ylp211-GAL- 
RAD18::URA3
RAD 18 over­
expression; Used 
in 2.13.2 
and.2.13.3
rad18 + Ylp211- 
GAL-rad18(SAP*)
2059 MATa, his3- 200, leu2-3,2- 
112, Iys2-801, trp1-1(am), 
ura3-52, rad18::TRP1, 
Y!p211-GAL- 
RAD 18( SAP*)::URA3
rad18(SAP*) over­
expression; Used 
in 2.13.2 
and.2.13.3
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rad18 + Ylp211- 2060 MATa, his3- 200, leu2-3,2- rad18(SAPA)
GAL-rad18(SAPA) 112, Iys2-801, trp1-1(am), over-expression;
ura3-52, rad18::TRP1, Used in 2.13.2
Ylp211-GAL- and.2.13.3
RAD18(SAPA)::URA3
Table 2-11: A list of all yeast strains that were used and their genotypes.
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2.6 Molecular Biology Methods for E. coli
2.6.1 Preparation of E. coli Competent Cells
2.6.1.1 Electro-competent Cells
A fresh overnight culture was used to inoculate 1 L of LB medium (1/100). The 
culture was grown at 37°C, with shaking at 250 RPM , up to an O.D.eoo of 0.5 to 
0.8. The cells were chilled on ice for 15-30 min and then harvested by 
centrifugation at 4000g, 4°C, in a SLA-3000 rotor, for 15 min. The supernatant 
was removed, and the pellet was re-suspended in a total of 1 L of ice-cold 
sterile water. The cells were harvested by centrifugation at 4000g, 4°C, in SLA- 
3000 rotor, for 15 min, and the supernatant was removed as before. Then, the 
pellet was re-suspended in a total of 0.5 L of ice-cold sterile water, and 
harvested as described before. The pellet was re-suspended again in 20 mL of 
sterile ice-cold 10% (v/v) glycerol, centrifuged as before and the supernatant 
was removed as before. Finally, the cells were re-suspended in 2-3 mL of sterile 
ice-cold 10% (v/v) glycerol to obtain around 1 X 1010 cells/mL. The competent 
cells were then dispensed into 100 \iL aliquots on ice and stored at -80°C.
2.6.1.2 Chemically Competent Cells
A fresh overnight culture was used to inoculate 1 L of LB medium (1/100). The 
culture was grown at 37°C, with shaking at 250 RPM, up to an O .D .600 of 0.5 to 
0.8. The cells were chilled on ice for 15-30 min and then harvested by 
centrifugation at 4000g, 4°C, in a SLA-3000 rotor, for 15 min. The supernatant 
was removed, and the cells were re-suspended in 400 mL Tfbl solution (0.4 of 
original volume). The cell suspension was incubated on ice for 15 min, then the 
cells were harvested and the supernatant was removed as before. The pellet 
was re-suspended in 40 mL Tfbll (0.04 of original volume) and incubated on ice 
for additional 15 min. Typically, the resulting concentration of cells was -  2 X  
109 cells/mL. Finally, the competent cells were dispensed into 100 \iL aliquots 
on ice and stored at -80°C.
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2.6.2 Transformation of E. coli
2.6.2.1 Electroporation Method
Aliquots of electro-competent cells were thawed on ice for 10 min (1 aliquot was 
used per 1 or 2 transformation reactions -  see 2.6.1.1). In parallel, a 0.2 cm 
sterile cuvette (Cell Projects) was placed on ice to cool. The DNA was mixed 
with the cells and incubated on ice for 30 min. The Pulse Controller (Bio-Rad) 
was set to 200 Q and the Gene Pulser apparatus (Bio-Rad) was set to 25 p,FD 
and 2.5 kV. The cells were transferred to the cold cuvette and the cuvette was 
placed in the safety chamber slide against the electrodes. One pulse was 
performed to achieve electroporation and the cells were immediately re­
suspended in 1 mL of SOC medium. Then, the cells were incubated at 37°C, 
with shaking at 250 RPM, for 1 h. Finally, about 1/10 of the transformation 
reaction (if re-transformation) or all of it (if cloning) was plated on LB agar plates 
with selective antibiotics and incubated overnight at 37°C.
2.6.2.2 Heat-shock Method
Aliquots of chemically competent cells were thawed on ice for 10 min (1 aliquot 
was used per 1 or 2 transformation reactions -  see 2.6.1.2). The DNA was 
mixed with the cells and incubated on ice for 30 min. Then, the cells were 
incubated at 42°C for 1.5 min, immediately placed back on ice and re­
suspended with 1 mL of SOC medium. If ampicillin was the appropriate 
selective antibiotic, the cells were spun down, 900 \iL of the supernatant was 
removed and the rest was used to re-suspend the cells and plate them on LB 
agar plates supplemented with ampicillin. Otherwise, cells were incubated at 
37°C, with shaking at 250 RPM, for 1 h. Then, about 1/10 of the transformation 
reaction (if re-transformation) or all of it (if cloning) was plated on LB agar plates 
with selective antibiotics and incubated overnight at 37°C.
2.6.3 Isolation of Plasmid DNA
A few isolated E. coli colonies were used to inoculate 3 mL of LB medium each,
containing the appropriate selection antibiotics. The cultures were grown at
37°C, with shaking at 250 RPM, for 16 h, and subsequently used for plasmid
-101  -
Chapter Two: Materials and Methods
isolation. The procedure was carried out using the QIAprep Spin Miniprep kit 
(Q IAGEN) according to the manufacturer’s instructions. Plasmid concentration 
was quantified using the Nanodrop (ND-1000 spectrophotometer; Labtech 
International).
2.7 Molecular Biology Methods for Yeast Cells
2.7.1 Transformation of Yeast Cells by the LiOAc/PEG 
Method
A yeast culture was grown to logarithmic phase (O.D.eoo =1-2) in YPD or in 
selective medium at 30°C. The cells were harvested by centrifugation at 3000  
RPM, room temperature, for 5 min in rotor A-4-81 (Eppendorf) (~ 1800g). The 
supernatant was removed; Approximately 9 X 107 cells were re-suspended in 
100 pL LiT buffer per transformation reaction and transferred to a 
microcentrifuge tube. ST DNA stock solution was incubated for 5 min at 95°C. 
100 pg ST DNA was pre-mixed with approximately 1-2 pg of DNA (either 
episomal plasmid or linearised integrative plasmid) and then added to the cell 
suspension. Subsequently, 500 pL of LiT / PEG buffer were added to each 
transformation reaction, the cells were immediately mixed by vortex for 3-5 s, 
and incubated for 15-30 min on a rotating wheel at room temperature. Then, 50 
pL of DMSO were added per transformation reaction and the cells were 
incubated at 42°C for 10-15 min followed by centrifugation at 800g for 1 min. 
The supernatant was quickly removed with a pipette, and the cells were re­
suspended in 100 pL sterile water. Finally, the cells were plated on selective 
media plates lacking the appropriate amino acids and incubated for 2-3 days at 
30°C.
2.7.2 Colony PCR
A Zymolyase solution was freshly prepared, and 50 pL were dispensed per 
PCR tube. Single isolated colonies were picked into each tube (the less 
material used the better) and incubated at room temperature for 10 min. The 
lysed cells were pelleted by centrifugation at maximal speed for 2 min in a
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butterfly centrifuge (Roth). The supernatant was aspirated using a pump. The 
tubes were briefly centrifuged again to ensure that all of the supernatant was 
removed. The pellets were then dried at 95°C for 5 min, re-suspended in a PCR  
reaction mix and subjected to PCR amplification.
2.7.3 Preparation of Total Cell Extracts from Yeast Cells
A yeast culture was grown to logarithmic phase (O.D.eoo =1-2) in Y P D  or in 
selective medium at 30°C. About 2 O.D.eoo of cells were transferred to a 2 mL 
microcentrifuge tube and harvested by centrifugation at 800g, room 
temperature, for 3 min. The supernatant was discarded and the cells were 
either frozen or processed immediately. The pellet was re-suspended in 500 \iL 
of sterile water. Then, 75 pL of freshly made NaOH / p -M E  solution was added, 
the cells were mixed by vortex and incubated on ice for 15 min. Subsequently, 
75 \iL of 55 % (w/v) TCA solution were added, the cells were mixed by vortex 
and incubated on ice for additional 10 min. As a result, the protein contents of 
the cells were precipitated. Total protein was harvested by centrifugation at 
16100g, 4°C, for 10 min. The supernatant was removed with a pipette; the 
pellets were centrifuged again at 16,000g, 4°C, for 2 min and the supernatant 
was removed as before. Finally, the pellets were re-suspended in 40 jaL of HU 
buffer and incubated at 65°C for 15 min. If necessary, the pH of the samples 
was adjusted by addition of 1-2 pL Tris-HCI buffer, pH 10.4.
2.8 Molecular Biology Methods of Baculovirus and 
Insect Cells
2.8.1 Baculovirus Production
DHIOBac electro-competent cells were transformed with -  1 ng pFastBac-HTc- 
VSV-RAD18 , pFastBac-HTc-VSV-RAD18-SAPA(279-Z 12A) or pFastBac-HTc- 
VSV-RADf8-SAP*(G 299A/R301A/M 304A) plasmid DNA as described in 
paragraph 2.6.2.1, except that the transformed cells were incubated at 37°C 
with vigorous shaking for 4 h before plating. Recombinant baculovirus shuttle 
vectors (bacmid) were generated based on a site-specific transposition of the
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expression cassettes (Luckow et al., 1993). The transformation reactions were 
plated on LB agar plates containing kanamycin, gentamicin and tetracycline as 
well as 40 pL of X-Gal stock solution and 4 pL of IPTG stock solution that were 
spread on top of the plates and allowed to dry at 37°C for 4 h (Sambrook et al., 
1989). The plates were incubated at 37°C for 48 h. Successful transposition 
resulted in white colonies (due to the disruption of the lacZ gene in the bacmid 
DNA). The resulting colonies were re-streaked on new plates containing 
kanamycin, gentamicin, tetracycline, X-Gal and IPTG as described above. After 
an overnight incubation at 37°C, isolated white colonies were picked, inoculated 
with shaking in LB medium overnight and the bacmid DNA was extracted 
according to the method described in the Bac-to-Bac Baculovirus Expression 
System user manual (Invitrogen). In order to verify the recombination of VSV- 
RAD18  gene into the bacmid DNA, PCR amplification was performed using one 
primer annealing to the bacmid DNA (M13 reverse) and the other to the 5 ’ of 
the RAD18  gene (oHU 536). Positive clones gave rise to a PCR product of ~ 
1900 bp.
2.8.2 Transfection of Insect Cells
Typically, Spodoptera frugiperda Sf9 cells were used for transfection and 
amplification of the virus, but either High Five of Sf9 cells were used for the 
protein production.
Sf9 cells were transfected with recombinant bacmid DNA [harbouring 
h,sVSVRAD18 WT, (SAPA) or (SAP*)] using the Cellfectin reagent according to 
the Bac-to-Bac Baculovirus Expression System user manual (Invitrogen) in 6- 
well plates. The P1 virus stock was harvested after 5 days of incubation at 
27°C. Following centrifugation at 1000 RPM for 5 min in rotor TY.JS (J_6B 
Beckman Centrifuge), the supernatant was collected, dispensed into aliquots 
and frozen at -80°C (protected from light). The P1 titer was assumed to be ~ 4-7 
X 10® pfu/mL.
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2.8.3 Amplification of Baculovirus
Approximately 2 X 107 Sf9 cells were plated per 175 mm flask containing 40 mL 
of Insect Cell medium (5 X 105 cells/mL, >97% viability). The cells were allowed 
to settle at 27°C for 1 h and then P1 baculovirus stocks, harbouring different 
constructs, were amplified as described below to obtain P2 stocks. An 
estimated 0.1 pfu/cell was used per P1 viral stock, but the optimal volumes for 
virus amplification were tested empirically.
P2 viral stocks of HlsVSVRAD18 W T  or (SAPA) were obtained by infecting Sf9 
cells with 300 pL of the respective P1 stock followed by incubation at 27°C for 7 
days.
P2 viral stock of HisVSVRAD18 (SAP*) was obtained by infecting Sf9 cells with 
500 pL of the P1 stock followed by incubation at 27°C for 7 days.
P3 viral stock of RAD6  was obtained by 2 subsequent amplifications. A P1 
viral stock of RAD6, constructed by Dr. Helle Ulrich, was amplified by infecting 1 
X 106 Sf9 cells (at 1 X 106 cells/mL) with 100 pL followed by incubation at 27°C 
for 4 days. The resulting P2 viral stock had an estimated titer of 4 X 108 pfu/mL.
5 pL of it were then used to infect 2 X 107 Sf9 cells, followed by incubation at 
27°C for 6 days.
All P2 and P3 baculovirus stocks were stored at 4°C, protected from light, and 
were subsequently used for protein production and purification.
2.9 General Methods for DNA Manipulation
2.9.1 Determination of DNA Concentration
DNA concentrations were determined by measuring the absorbance at 260 nm. 
Plasmid DNA concentration was usually measured using the Nanodrop (ND- 
1000 spectrophotometer; Labtech International). Oligonucleotide concentration 
was measured using a quartz cuvette (GE Healthcare) in an Ultraspec 3100 pro 
spectophotometer (GE Healthcare). Calculations were based on the estimation
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that a solution of 33 ng/mL ssDNA or 50 ng/mL dsDNA results in an 
absorbance of 1 at 260 nm (A26o)-
2.9.2 DNA Standards
Lambda DNA was digested with Pstl to generate a ladder. Commercial DNA 
markers, such as 100 bp and 1 kb DNA Ladders, were used as well.
2.9.3 Agarose Gel Electrophoresis
Agarose gels contained 0.8-2% (w/v) agarose in TAE or TBE buffers, 
depending on the size of the DNA fragment that was analysed. DNA samples 
were supplemented with 1/5 their volume of 6X DNA Loading buffer and run in 
TAE or TBE buffer, respectively, at 100 V  or at 75 V  (6 or 4.5 V/cm) in a 
Jencons Scientific horizontal gel electrophoresis apparatus.
2.9.4 Visualization of DNA by Ethidium Bromide Staining
0.5 pg/mL ethidium bromide was incorporated into the agarose gel before it was 
allowed to set. DNA bands were visualized by exposing the gel to UV light at 
254 nm in a BioDocJt UV transilluminator (UVP).
2.9.5 Native PAGE
Native polyacrylamide gels contained 8-12% polyacrylamide, 1X TBE, 0.1%  
(w/v) APS and 0.1%  (v/v) TEMED. Sample buffer consisting of 40% (w/v) 
sucrose and 0.25%  (w/v) bromophenol blue was added in 1/5 volume ratio to 
the samples. Native gels were either prepared using the Cambridge gel 
apparatus or the Bio-Rad mini protean gel system and were run at 200 V or at 
60 V, respectively, in 1X TBE buffer for a few hours either at room temperature 
or at 4°C, depending on the experiment. The gels were exposed to an 
Amersham hyperfilm ECL (GE Healthcare) to allow excision of appropriate 32P- 
labelled DNA. Alternatively, the gels were dried onto a 3 mm filter paper 
(Whatman), and 32P-labelled DNA was detected by autoradioagraphy or by 
phosphorimager analysis (see paragraphs 2.9.6 and 2.9.7).
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2.9.6 Autoradiography
Dried polyacrylamide gels were exposed to Amersham hyperfilm ECL (GE  
Healthcare) for different times (from a few min to a few days), depending on the 
intensity of the labelling, and developed using an automatic X-Ray film 
processor (model JP-33; Jungwon Precision Industry).
2.9.7 Phosphorimager Analysis
Dried polyacrylamide gels were exposed to Amersham Bioscience phosphor 
screens for 5-16 h. The screens were analysed either on a Storm 
Phosphorimager (model 840) or on a Typhoon Trio (GE Healthcare) using an 
ImageQuant software.
2.10 General Methods of Protein Manipulation
2.10.1 Determination of Protein Concentration
2.10.1.1 Absorbance at 280 nm
The absorbance at 280 nm was measured either by the Nanodrop (ND-1000  
spectrophotometer; Labtech International) or in a quarz cuvette (GE  
Healthcare) in an Ultraspec 3100 pro spectophotometer (GE Healthcare). The 
extinction coefficient (e) was calculated for each protein, using the following 
formula:
e [M X cm]'1= 5700 X (number of Tryptophane residues) + 1300 X (number 
of Tyrosine residues)
The protein concentration was calculated using the Beer-Lambert law: 
Concentration [M] = Absorbance I  e [M 1 X cm’1] X path length [cm]
2.10.1.2 Comparison by Coomassie Staining
Different dilutions of the analysed protein sample were prepared alongside with 
samples of known BSA concentrations. Then, protein samples were subjected 
to SDS-PAGE followed by Coomassie staining. The gel was imaged using 
Fujifilm LAS-3000 and the intensity of the stained bands was evaluated using
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the AIDA software (Raytest Isotopenmessgeraete). A BSA standard curve was 
plotted and further used to estimate the protein concentration.
2.10.1.3 Bradford Method
The Bradford method (Bradford, 1976) was used with the Bio-Rad protein assay 
according to the manufacturer’s instructions. The absorbance at 595 nm was 
measured in Biophotometer (Eppendorf) using a plastic cuvette and compared 
to a standard curve obtained with known BSA concentrations.
2.10.2 Molecular Weight Standards
peqGOLD Protein-Marker and peqGOLD Protein-Marker IV (Pre-stained) were 
used for Coomassie staining and Western blotting.
In order to determine the molecular weights of proteins using gel filtration, a mix 
of known proteins (Mw standard for gel filtration -  Bio-Rad) was used to create 
a standard curve.
2.10.3 SDS-PAGE
Either pre-cast NuPage 4-12%  gels were used or Tris-Glycine-SDS- 
polyacrylamide gels were prepared according to the Laemmli protocol 
(Laemmli, 1970) in a Bio-Rad mini protean gel system.
For pre-cast gels, the protein samples were supplemented with NuPage sample 
buffer containing a reducing agent and incubated at 70°C for 10 min. Gels were 
run in 1X MOPS buffer at constant 150 V for 1.5 h.
Tris-Glycine-SDS-polyacrylamide resolving gels typically contained 8-15%  
polyacrylamide whereas stacking gels contained 5% polyacrylamide. Gel 
solutions and running buffers were prepared according to the protocols 
described in Sambrook et al. (1989). Protein samples were supplemented with 
sample loading buffer (either Laemmli Sample buffer or HU buffer), followed by 
incubation at 95°C for 5 min or incubation at 65°C for 15 min, respectively. Gels 
were run at constant 150 V  for 1 h in 1X Laemmli Running buffer.
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2.10.4 Coomassie Blue Staining
Following SDS-PAGE, gels were soaked in Coomassie Blue Staining solution 
for a few hours up to overnight. Stained gels were de-stained with several 
washes in De-staining solution, briefly washed in distilled water and incubated 
overnight with Gel Drying solution. Subsequently, gels were dried on 3 mm 
Whatman paper covered with Saran (Dow) in a GelAir Dryer (Bio-Rad).
2.10.5 Western Blotting
Protein samples were subjected to SDS-PAGE as described in paragraph 
2.10.3 and transferred onto a PVDF membrane (Millipore). Prior to transfer, the 
PVDF membrane was activated with methanol, soaked in water for 2 min and 
then soaked in Blotting buffer II for at least 20 min. 6 layers of Whatman gel 
blotting paper (Schleicher and Schuell), cut to membrane size, were used as 
follows. 2 layers were soaked in Blotting buffer I and placed onto the anode 
plate of a semi-dry blotter apparatus (Roth). Next, 1 layer, soaked in Blotting 
buffer II, was overlaid. On top of these 3 layers, the PVDF membrane was 
placed, followed by the gel, which was briefly washed in buffer II. Finally, 3 
layers of Whatman gel blotting paper, soaked in Blotting buffer III, were laid on 
top, and the whole stack was covered by the cathode plate. The transfer 
conditions were at constant 40 A (for the Bio-Rad mini protean gels) or at 55 A 
(for the pre-cast gels (Invitrogen)) for 1.5 h (25 V  was set as the maximal 
voltage allowed). After the transfer, the membranes were incubated in Blocking 
solution at room temperature for 30 min, followed by an overnight incubation at 
4°C with a primary antibody (Table 2-2 and Table 2-3), which was diluted in the 
Blocking solution. Three consecutive washes with PBST solution, each of 10 
min, were carried out. Then, the appropriate secondary antibody (Table 2-4) 
was diluted in the Blocking solution, and the membranes were incubated at 
room temperature for 1 h. Three additional consecutive PBST washes were 
performed as before, followed by the application of the Western lightning 
chemiluminescence reagent plus according to the manufacturer’s instructions. 
The membranes were exposed to Amersham hyperfilm ECL (GE Healthcare) 
for 5 s up to 2 h (depending on the intensity of the signal), which was developed
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using an automatic X-Ray film processor (model JP-33; Jungwon Precision 
Industry).
If re-blotting was required, membranes were incubated with Stripping buffer at 
50°C for 30 min and then washed three times with PBST for 10 min each. Then, 
the membranes were blocked and probed with a different primary antibody as 
described above.
2.11 Generation of Antibodies against Rad18
Recombinant yeast H,sVSVRad18 was purified under denaturing conditions from 
High Five insect cells (see paragraph 2.12.6.2). After determination of protein 
concentration by measuring the absorbance at 280 nm, the denatured protein 
was dialysed against PBS, resulting in the formation of a white precipitate. This 
suspension was further used to raise antibodies against yeast Rad 18.
2.11.1.1 Anti-Rad18 Mouse Polyclonal Serum
Four -  1 mg/mL aliquots (1 mL each) of denatured Rad18 protein were 
prepared in PBS and used to immunise four mice by the Cancer Research UK - 
Monoclonal Antibody Facility (project number Ccs 444). Mice test bleeds were 
analysed by Western blotting on total cell extracts prepared from yeast and on 
purified H,sVSVRad18. Spleen tissue was removed from the mice and hybridoma 
cells were generated from single antibody producing cells. Unfortunately, all 
positive hybridomas, subjected to scale-up production, proved to lose antibody 
expression. As a consequence, I diluted the polyclonal serum of each mouse to 
a final concentration of 50% (v/v) glycerol and used it for Rad18 detection. The 
terminal bleed of mouse 4 gave the best results in Western blots (used at 
1:1500 dilution in blocking solution and could be re-used several times). The 
terminal bleeds of mice 1 and 2 were somewhat less sensitive (used at 1:1000 
dilution in blocking solution) whereas mouse 3 terminal bleed showed a strong 
non-specific background and therefore was not used.
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2.11.1.2 Anti-Rad 18 Rabbit Polyclonal Serum
Six aliquots of denatured Rad18 protein were prepared in PBS (200 [ig for the 
first aliquot, 100 pg for 5 aliquots) and used by Harlan Sera-Lab Ltd. to 
immunise two rabbits. Test bleeds were analysed by Western blotting against 
total cell extracts prepared from yeast and purified H,sVSVRad18. The terminal 
bleeds, designated as DH1 and DH2 from rabbits 1 and 2 respectively, were 
used as a stock antibody. Aliquots of the bleeds were diluted with glycerol to a 
final concentration of 50% (v/v) and kept at -20°C. As the DH1 terminal bleed 
gave slightly better results, it was preferred for Rad18 detection.
Detection of Rad18 in total cell extracts prepared from yeast:
Membranes were first blocked with 3% milk in PBST for 30 min at room 
temperature. DH1 terminal bleed stock was diluted at 1:10,000 in 0.3% milk in 
PBST and incubated at 4°C overnight. Following three consecutive washes in 
PBST, each for 10 min, membranes were incubated with HRP-conjugated anti­
rabbit antibody diluted at 1:10,000 in 0.3%  milk in PBST at room temperature 
for 1 h. Membranes were then washed and developed as described in 
paragraph 2.10.5.
Detection of purified HisVSVRad18 in pull-down experiments containing 
RPA:
Unfortunately, DH1 total bleed was found to cross-react with yeast RPA. To 
solve this problem, the cross-reactivity activity was depleted from the bleed by 
incubation of the diluted antibody (1:5000 in 3% milk in PBST) for 4 h at room 
temperature with a Protran nitrocellulose transfer membrane (Schleicher and 
Schuell BioScience) onto which purified RPA was spotted (2.3 X 10'10 mol RPA 
per 2.4 \iL of DH1 bleed). The depletion procedure was repeated twice and 
diluted antibodies were stored at -80°C and re-used several times.
2.12 Protein Purification
2.12.1 Purification of Yeast Replication Protein A (RPA)
Yeast RFA1 , RFA2  and RFA3  gene expression was induced and the RPA
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complex was purified based on Henricksen etal. (1994).
Electro-competent BL21-CodonPlus (DE3)-RIL E. coli cells were transformed 
with an RPA expression vector (no. 1128), harbouring the yeast RFA1 , RFA2 
and RFA3 genes, by electroporation and plated on LB agar plates 
supplemented with ampicillin and chloramphenicol. After an overnight 
incubation at 37°C, a single colony was used to inoculate 1 L of TB medium 
containing ampicillin and chloramphenicol. The culture was incubated at 37°C 
overnight without shaking, and then placed on a shaker at 250 RPM until 
O.D.eoo reached 0.6. Induction was carried out by adding 0.3 mM IPTG to the 
culture and subsequently incubating at 37°C for 2 h. Cells were harvested by 
centrifugation at 4,250g, 4°C, for 20 min in a SLA-3000 rotor, and then re­
suspended in cold HI buffer (5 mL of HI buffer per 1 L of culture). The re­
suspended cells were quickly frozen in liquid nitrogen and kept at -80°C  
overnight. Prior to lysis, cells were thawed on ice and supplemented with fresh 
1 mM PMSF, 1 mM DTT and 1 tablet of Complete protease inhibitor per 50 mL 
of buffer. The cells were disrupted by sonication (Branson sonifier) using 5 short 
bursts of 10 s at 40% output, followed by incubation on ice for 1 min. The lysate 
was further homogenized by passing through a Stansted homogenizer (model 
TC5-612W -332) at 70 MPa at 4°C. Soluble lysate was obtained by 
centrifugation at 45,000g, 4°C, for 20 min in a SS-34 rotor. The supernatant was 
further cleared by centrifugation at 100,000g, 4°C, for 30 min using a 70Ti rotor 
(Beckman), then quickly frozen in liquid nitrogen and kept at -80°C overnight. 
Four chromatographic steps were used to purify RPA: Affi-Gel Blue column 
(Bio-Rad), HAP column (Bio-Rad), MonoQ column (HR 5/5; GE Healthcare) and 
gel filtration (Superdex200 10/300 GL; GE Healthcare). The lysate was thawed 
and the protein concentration was estimated by the Bio-Rad protein assay 
according to the manufacturer’s instructions, using BSA as a standard. 
Accordingly, the lysate was applied at approximately 8 mg protein per mL of 
resin by gravity flow to an Affi-Gel Blue column, which was pre-equilibrated in HI 
buffer containing 50 mM KCI. The column was then connected to a BioLogic 
pump (Bio-Rad) and sequentially washed at 2 mL/min flow rate with 3 column 
volumes of each: HI buffer containing either 50 mM KCI, 0.8 M KCI, 0.5 NaSCN  
or 1.5 M NaSCN. RPA was eluted in the 1.5 M NaSCN wash and the protein 
concentration was estimated using the Bio-Rad protein assay as described
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before. The peak of the protein was pooled and applied directly to a HAP 
column, pre-equilibrated with HI buffer containing 50 mM KCI. A ratio of 5 mg 
protein per mL of resin was used and the loading was carried out by gravity 
flow. The column was connected to a BioLogic pump (Bio-Rad) and washed at 
a flow rate of 6 mL/min (the fastest flow-rate possible) with 3 column volumes of 
each: HI buffer, HI buffer containing 80 mM potassium phosphate or HI buffer 
containing 500 mM potassium phosphate. Wash samples were analysed by 
SDS-PAGE followed by Coomassie staining. RPA was found to elute mainly in 
the fractions of the HI buffer containing 80 mM potassium phosphate. Those 
fractions were combined, and the protein content was determined by the Bio- 
Rad protein assay as before. The pooled fractions were diluted 2-fold with HI 
buffer to reduce the ionic strength, and applied to a MonoQ column that was 
equilibrated with HI buffer containing 50 mM KCI. Up to 8 mg protein was 
loaded onto this column in one run. The column was washed with HI buffer 
containing 50 mM KCI followed by a wash with HI buffer containing 100 mM 
KCI, until a stable UV trace was obtained. Then, a gradient was developed 
between HI buffer containing 200 mM KCI or 400 mM KCI, with RPA eluting 
around 300 mM KCI. The flow rate used with this column was 1 mL/min and 
500 \iL fractions were collected. Elution fractions were supplemented to final 
10% (v/v) glycerol concentration and samples were analysed by SDS-PAGE  
followed by Coomassie staining. Accordingly, peak fractions were pooled and 
run on a Superdex200 10/300 GL gel filtration column at a flow rate of 0.4 
mL/min in GF RPA buffer. The protein purity was assessed to be ~ 91%. The 
final yield was approximately 3 mg of RPA complex from 12 L of culture.
2.12.2 Purification of GSTRfa1 (DNA-Binding Domain)
Chemically competent BL21-CodonPlus (DE3J-RIL E. coli cells were 
transformed by heat shock method with a plasmid harbouring the DNA-binding 
domain of the yeast R FA 1(182-421) gene fused to GST on its N-terminus (no. 
1317). Transformed cells were plated on LB agar plates containing ampicillin. 
After incubation at 37°C overnight, several colonies were tested for RFA 1 (182- 
421) expression on a small scale, using 3 mL cultures, inducing expression with 
addition of IPTG up to 0.5 mM final concentration and incubating the cells at 
18°C overnight. A single colony that was identified to show good expression
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levels in the small-scale experiment was used to inoculate 400 mL of LB 
medium containing ampicillin. The culture was incubated at 37°C overnight 
without shaking. Then, it was incubated with shaking at 250 RPM at 37°C for a 
few hours, until the absorbance at 600 nm reached 0.6. IPTG was added to the 
culture to a final concentration of 0.5 mM, and induction of protein expression 
was carried out at 18°C overnight. Cells were harvested by centrifugation at 
4250g, 4°C, in a SLA-3000 rotor and re-suspended in PBS. Prior to lysis, 
Complete protease inhibitor was added (1 tablet per 50 mL of suspension). 
Cells were passed through a Stansted homogenizer (model TC5-612W -332) at 
70 MPa at 4°C. Then, the lysate was sonicated using 5 short bursts of 10 s at 
40%  output, followed by incubation for 1 min on ice (Branson sonifier). Crude 
lysate was centrifuged at 20,000 RPM, 4°C, in a SS-34 rotor. The lysate was 
further cleared by centrifugation at 40,000 RPM, 4°C, for 30 min, in a 45Ti rotor 
(Beckman). Glutathione sepharose 4 Fast Flow beads (GE Healthcare) were 
washed 3 times in PBS (1 mL column bed volume). The supernatant from the 
ultracentrifugation step was added to those beads and incubated at 4°C for 1 h 
on a rotating platform. Then, the resin was poured into a 10 mL polypropylene 
column (Pierce) and allowed to settle. The column was washed by gravity flow 
with 5 column volumes of PBS followed by 5 column volumes of RFA1 Washing 
buffer. Then the column was transferred to room temperature for a few min. 
GSTRfa1 (182-421) was eluted from the column by re-suspending the beads with 
RFA1 Elution buffer. Elution fractions were analysed using SDS-PAGE followed 
by Coomassie staining. Fractions containing GSTRfa1 (182-421) were pooled 
and dialysed against RFA Dialysis buffer, using Spectra/Por molecularporous 
membrane tubing (Cutoff 3.5 kDa; SpectrumLabs). The protein sample was 
concentrated by a viva-spin concentrator (Cutoff 3 kDa; Vivascience). The purity 
of the protein preparation was assessed to be around 70% and the final yield 
was 0.3 mg.
2.12.3 Purification of GSTRfa2
Chemically competent Codon2+ E. coli cells were transformed by heat shock 
method with a plasmid, harbouring the yeast RFA2 gene fused to GST on its N- 
terminus (Table 2-7), and plated on LB agar plates containing ampicillin and 
spectinomycin. After an overnight incubation at 37°C, a single colony was used
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to inoculate 10 mL of LB medium supplemented with ampicillin and 
spectinomycin and grown at 37°C overnight. This culture was then used to 
inoculate a 4 L culture that was grown up to an absorbance of 0.6 at 600 nm. 
Subsequently, GST-RFA2 expression was induced by addition of IPTG to a 
final concentration of 0.5 mM and an overnight incubation at 18°C with shaking 
at 250 RPM. The cells were harvested by centrifugation at 4250g, 4°C, in a 
SLA-3000 rotor and re-suspended in RFA2 Lysis buffer. Complete protease 
inhibitor was added (1 tablet per 50 mL of suspension) before the cells were 
homogenized by passing through a Stansted homogenizer (model TC5-612W - 
332) at 70 MPa at 4°C. The lysate was cleared by centrifugation at 45,000g, 
4°C, for 20 min in a SS-34 rotor. The supernatant was further centrifuged at 
100,000g, 4°C, for 30 min using a 45Ti rotor (Beckman). Glutathione sepharose 
4 Fast Flow (GE Healthcare) (5 mL bed volume) was packed under pressure 
and equilibrated with at least 10 column volumes of RFA2 Lysis buffer. The 
supernatant resulting from the ultracentrifugation step was loaded onto the 
column by gravity flow. The column was sequentially washed with 3 column 
volumes of RFA2 Lysis buffer, and then with RFA2 Washing buffer at 2 mL/min 
until a stable UV absorbance was obtained. The column was transferred to 
room temperature for a few min. Then, GSTRfa2 was eluted by re-suspending 
the beads in a RFA2 Elution buffer. Elution fractions were analysed by SDS- 
PAGE followed by Coomassie staining, and fractions containing GSTRfa2 were 
pooled. The protein was dialysed against RFA Dialysis buffer, using 
Spectra/Por molecularporous membrane tubing (Cutoff 3.5 kDa; 
SpectrumLabs). The protein was concentrated using a viva-spin concentrator 
(Cutoff 10 kDa; Vivascience). The purity of the protein was estimated to be 90%  
and the final yield was approximately 130 mg.
2.12.4 Purification of Rad6
Chemically competent ER2655 E. coli cells were transformed by heat shock 
method with plasmid pTYB-RAD6 (no. 349), harbouring the yeast RAD6 gene 
fused to a bi-functional tag (intein and chitin binding domain) on its N-terminus, 
and plated on LB agar plates containing ampicillin. After incubation at 37°C 
overnight, a single colony was used to inoculate 3 mL of LB medium 
supplemented with ampicillin and grown at 37°C overnight. This culture was
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then used to inoculate a 2 L culture that was grown up to an absorbance of 0.6 
at 600 nm. RAD6  expression was induced by addition of 0.5 mM IPTG followed 
by incubation at 15°C for 18 h, with shaking at 250 RPM. The cells were 
harvested by centrifugation at 4250g 4°C in a SLA-3000 rotor and re-suspended 
in RAD6 Lysis buffer. Prior to lysis, 1 mM PMSF was added. The cells were 
sonicated by 5 bursts of 10 s each, followed by incubation for 1 min on ice 
(Branson sonifier). The lysate was cleared by centrifugation at 45,000g, 4°C, for 
30 min in a SS-34 rotor. To assess the protein expression levels and its 
solubility after lysis, samples were taken during various steps, boiled in 1X 
Laemmli Sample buffer without D TT. and analysed by SDS-PAGE followed by 
Coomassie staining. The cleared supernatant was added to 15 mL chitin beads 
(New England Biolabs) that were pre-equilibrated in more than 10 column 
volumes of RAD6 Lysis buffer. The beads were incubated on a rotating platform 
at 4°C for 1 h, transferred to a column (Bio-Rad) and allowed to settle. The 
column was then connected to a BioLogic pump (Bio-Rad). It was washed with 
10 column volumes of RAD6 Lysis buffer at 2 mL/min followed by a quick flush 
with 3 column volumes of RAD6 Lysis buffer containing 50 mM DTT. 
Subsequently, the column was closed, transferred to room temperature and 
incubated overnight to promote the self-cleavage reaction of the chitin-bound 
intein tag. Elution of Rad6 was carried out with RAD6 Lysis buffer and the 
elution fractions were subjected to SDS-PAGE and analysed by Coomassie 
staining. Column fractions containing Rad6 were pooled (~ 20 mL) and 
concentrated by amicon ultra device (Millipore) of 10 kDa cutoff up to 2 mL, 
according to the manufacturer’s instructions. The concentrated sample was 
dialysed at 4°C against RAD6 Dialysis buffer. The purity of the protein was 
estimated to be 90% and the final yield was approximately ~ 3.8 mg.
2.12.5 Purification of HIsPCNA WT and HisPCNA Mutants
The purification procedure was based on Biswas et al. (1995).
Electro-competent Rosetta-gami B (DE3) pLysS E. coli cells were transformed 
by electroporation method with a plasmid, harbouring a copy of the yeast 
POL30 gene (either W T  or point mutation - pQE30-POL30  (no. 637) / pQE32- 
POL30 (K127R) (no. 873) / pQE32-POL30 (K164R) (no. 878) / pQE32-POL30  
(K127/164R) (no. 879)), and plated on LB agar plates containing ampicillin and
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chloramphenicol. After incubation at 37°C overnight, a single colony was used 
to inoculate 3 mL of LB medium supplemented with ampicillin and 
chloramphenicol and grown at 37°C overnight. This culture was used to 
inoculate a 2 L culture that was grown up to an absorbance of 0.6 at 600 nm. 
Subsequently, POL30  expression was induced by addition of IPTG to a final 
concentration of 1 mM, followed by incubation at 37°C for 4 h, with shaking at 
250 RPM. The cells were harvested by centrifugation at 4250g, 4°C, in a SLA- 
3000 rotor and re-suspended in PCNA Lysis buffer. Immediately before lysis, 1 
tablet of Complete protease inhibitor was added per 50 mL of suspension. The 
cells were incubated at 37°C for 5 min and then placed back on ice. The cells 
were disrupted by passage through a French Press at 750 psi. The crude lysate 
was centrifuged at 45,000g, 4°C, in a SS-34 rotor for 20 min. The supernatant 
was collected and kept on ice. The pellet was re-suspended with PCNA Lysis 
buffer and was further disrupted by 3 bursts of 10 second sonication each 
followed by incubation for 1 minute on ice (Branson sonifier). Following 
centrifugation at 30,000g, 4°C, in a SS-34 rotor for 20 min, the supernatants 
were combined. NaCI and imidazole concentrations were adjusted to 500 mM 
and 10 mM, respectively, and the supernatant was added to 3 mL column 
volume of Ni-NTA agarose (QIAGEN) beads that were pre-equilibrated with 
PCNA Washing buffer I. The beads were incubated on a rotating platform at 
4°C for 1 h, then poured into a column (Bio-Rad) and allowed to settle. The 
column was washed with PCNA Washing buffer I, until the UV absorbance 
returned to its basal level. Subsequently, the column was washed with 5 column 
volumes of PCNA Washing buffer II. To elute the protein, a 15 mL gradient was 
developed up to an imidazole concentration of 250 mM. Column fractions were 
collected and analysed by SDS-PAGE followed by Coomassie staining. 
Fractions containing PCNA were pooled and dialysed against PCNA Dialysis 
buffer. The estimated purity of the proteins was 90-95%. The final yields from a 
2 L culture were as follows: ~ 142.8 mg for H|SPCNA {WT), ~ 37.8 mg for 
Hi8PCNA (K164R), ~ 18.3 mg for Hi8PCNA (K127R) and -  32.7 mg for Hi8PCNA  
(K127/164R).
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2.12.6 Purification of Yeast Hl,vsvRad18-Rad6 from 
insect Cells
2.12.6.1 Purification under Native Conditions
The purification procedure was based on Cai et al. (1996). Either High Five or 
Sf9 (Invitrogen) insect cells were used. Cells were plated in Insect Cell medium 
in 175 mm flasks and allowed to adhere to the surface at 27°C for 1 h. A 
monolayer (2 X 107 cells per flask) of about 80% confluency was infected 
simultaneously with recombinant viruses that produce either H,sVSVRAD18 or 
RAD6 (the optimal ratio of virus stocks was tested empirically each time and 
was dependent on the respective P2 stocks). The same protocol was used for 
the purification of HlsVSVRad18 (SAP*) and HisVSVRad18 (SAPA) mutants. After 
infection, cells were incubated at 27°C for 48 h. The cells were collected by 
gentle tapping and harvested by centrifugation at 1000 RPM, 4°C, in rotor 
TY.JS (J_6B Beckman Centrifuge) for 20 min. The supernatant was discarded; 
the cells were washed in cold PBS and harvested as described before. The 
pellet was re-suspended in two volumes of hypotonic buffer and supplemented 
with protease inhibitors: 0.5 mM PMSF, 0.2 ng/mL aprotinin, 0.2 ng/mL 
leupeptin and 1 tablet of Complete protease inhibitor. Subsequently, the cells 
were lysed with 20 strokes of a Dounce homogenizer (Wheaton) on ice. The 
lysate was centrifuged at 2400g, 4°C, for 30 min. The supernatant was 
subjected to ultracentrifugation at 43,500g, 4°C, for 30 min, resulting in a 
soluble cytoplasmic fraction that was used for subsequent purification steps. In 
parallel, the nuclear pellet, derived from the low-speed centrifugation step, was 
re-suspended in two volumes of hypotonic buffer without KCI. The NaCI 
concentration was adjusted to 0.42 M, protease inhibitors were added as 
before, and the nuclear mix was incubated on a rotating platform at 4°C for 30 
min. Following this incubation, the mix was subjected to ultracentrifugation at 
43,500g, 4°C, for 30 min, resulting in a soluble nuclear fraction that was used 
for subsequent purification steps. Both the soluble cytoplasmic fraction and the 
soluble nuclear fraction were adjusted to 0.3 M NaCI and 10 mM imidazole, and 
passed through 0.45 pm filters (Millipore). Each filtrate was incubated 
separately with Ni-NTA agarose beads (QIAGEN) that were pre-equilibrated in 
the corresponding buffer (with imidazole) at 4°C for 2 h. Approximately 35 of
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beads were used per 2 X  107 infected insect cells for each fraction. The beads 
were poured into two separate polypropylene columns (Pierce), allowed to 
settle and drained by gravity. The columns were washed manually with 5-10 
column volumes each of RAD 18 Washing buffer I, II and III, subsequently. The 
columns were incubated with RAD18 Elution buffer for a few min and then 
eluted. This was repeated several times. Elution fractions were collected and 
analysed by SDS-PAGE and Coomassie staining. Column fractions containing 
Rad 18 and Rad6 were pooled and dialysed in 3.5 kDa cutoff dialysis tubing 
(Spectra/Por molecularporous membrane tubing; SpectrumLabs) against 
RAD 18 Dialysis buffer. The sample was concentrated using a 3 kDa cutoff 
vivaspin concentrator (Vivascience) and the protein concentration was 
determined by Coomassie staining comparison to a BSA standard curve. 
Starting from 1.2 X 109 Sf9 cells, the typical protein yield was ~ 1 mg for 
H,sVSVRad18 purified from cytoplasmic fraction. Using 2 X 108 Sf9 cells, the 
protein yield was approximately 0.1 mg for HlsVSVRad18 (SAPA) and 0.01 mg for 
HlsVSVRad18 (SAP*) from the cytoplasmic fraction. The typical purity was around 
70-80% . Mock purification was carried out from insect cells infected with 
baculovirus harbouring only RAD6.
2.12.6.2 Purification under Denaturing Conditions
Purification of Rad18 under denaturing conditions was based on the 
QiAexpressionist handbook (QIAGEN). Pellets obtained from the
ultracentrifugation steps described in 2.12.6.1 were combined and re­
suspended in QIAGEN buffer A. The suspension was disrupted by 4 bursts of 
10 s (Branson sonifier) each followed by incubation for 1 min on ice. Then, the 
suspension was incubated on a rotating platform for 30 min at room 
temperature and centrifuged at maximal speed for an additional 30 min in a F- 
34-6-38 rotor (Eppendorf). The supernatant was filtered through a 0.45 nm filter 
(Millipore) and added to Ni-NTA beads (QIAGEN) that were pre-washed in 
QIAGEN buffer A. The beads were incubated for 2 h at room temperature, 
transferred to a column (Bio-Rad), allowed to settle and the column was drained 
by gravity. The beads were then washed twice with 8 column volumes of 
QIAGEN buffer C. Subsequently, the beads were eluted four times with 1 
column volume of Q IAGEN buffer D and four times with 1 column volume of
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QIAGEN buffer E. The elution fractions of the column were subjected to SDS- 
PAGE and were analysed by Coomassie staining. Column fractions containing 
Rad18 were pooled and used for antibody production as described in paragraph 
2 .11.
2.13 Yeast Genetics
2.13.1 UV Sensitivity Streak Assay
The relevant yeast strains were grown in YPD medium to logarithmic phase. 
Equal numbers of cells (typically 1.5 - 3.5 X 105 cells) were streaked out onto 
YPD plates and subjected to a gradient of UV irradiation (0-3 min, 1.67 Jm'2s'1) 
as described in Ulrich (2001).
2.13.2 Sensitivity Spot Assay
The relevant yeast strains were constructed by transformation of a rad 18 
deletion strain with an integrative plasmid harbouring RAD18 (WT), RAD18 
(SAP*) or RAD18  (SAPA) under the control of either the RAD18  or the GAL1 
promoter (Table 2-7 and Table 2-11). Transformed cells were re-streaked, and 
the presence of the RAD18  alleles was confirmed by colony PCR. To ensure 
protein expression, total cell extracts were prepared and analysed by SDS- 
PAGE followed by Western blotting. Isolated colonies were inoculated in YPD  
for overnight incubation at 30°C. Yeast strains harbouring the GAL1 promoter 
for RAD18  over-expression were induced as described in paragraph 2.13.3. 
Overnight cultures were then diluted in YPD or YP + GAL, as appropriate, and 
were grown for 2 generations up to a logarithmic phase. The absorbance at 600 
nm was measured, and the cells were diluted with sterile water to a final O.D.eoo 
= 0.2. Additional three 10-fold serial dilutions were prepared, and 3.5 \xL of each 
dilution was spotted onto plates containing DNA damaging agents 
(approximately 1.4 X  104, 1.4 X 103, 140 and 14 cells / drop, respectively). 
Preparation of plates:
MMS (100%  stock) or 4NQ O  (dissolved in DMSO), both purchased from Sigma, 
were added to the melted agar at appropriate concentrations. Plates were
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poured, allowed to settle on a straight surface and then dried for at least 4 h in a 
DNA/RNA UV-cleaner cabinet (Alpha laboratories).
2.13.3 Induction of RAD18 Over-Expression
Yeast strains harbouring RAD18 (W T), RAD18 (SAP*) or RAD18 (SAPA) under 
control of the GAL1 promoter (Table 2-11) were re-streaked onto selective 
medium plates lacking uracil to ensure the correct integration of the expression 
cassette and even growth conditions. Single colonies were inoculated in YPD  
for overnight incubation at 30°C. The O .D .600 of the cultures was measured and 
the cells were diluted in YP + 2% glycerol at O.D.eoo = 0.4. The cells were 
incubated at 30°C for approximately 8 h. The O .D .600 was measured (~ O .D .600 
= 1-1.5), the cells were diluted into either YPD (for suppression of expression) 
or YP + 2% galactose (for over-expression), and the cultures were incubated at 
30°C overnight. In the morning, overnight cultures were diluted in YPD or YP + 
GAL, as appropriate, and were grown for 2 generations up to a logarithmic 
phase. Subsequently, these cultures were used for total cell extract 
preparations or for sensitivity spot assays.
2.13.4 Two-Hybrid Analysis
Different constructs of the open reading frames of RFA1, RAD18 and POL30  
fused either to the GAL4 activation (AD) or to the DNA-binding domain (BD) 
were co-transformed into the yeast strain PJ69-4A (James et al., 1996) 
(according to 2.7.1, except that 0.3 -  0.5 pg per plasmid DNA were used per 
transformation). Transformed cells were selected by growth on selective 
medium lacking leucine and tryptophane (-LW). Five representative colonies 
per transformation were combined in 500 pL of sterile water, followed by an 
additional 5-fold dilution in sterile water. 3.5 pL of each dilution was plated on 
selective medium plates lacking different sets of amino acids. Positive 
interactions were scored by growth on plates lacking leucine, tryptophane and 
histidine (-HLW ) whereas stronger interactions were detected on plates also 
lacking adenine (-AHLW). Selective plates lacking leucine and tryptophane (- 
LW) were used as a positive control for growth.
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2.14 Enzymatic Assays
2.14.1 In vitro Ubiquitylation Assays
A complete ubiquitylation reaction (8 pL) contained 112.5 nM yeast E1, 65 pM 
ubiquitin, 3 pM H,SPCNA and different concentrations of the purified H,sVSVRad18- 
Rad6 complex. The samples were incubated in Ubiquitylation buffer at 30°C for 
various times (30 min to 4 h). The reactions were stopped by addition of one 
volume of HU buffer, followed by 15 min incubation at 65°C. The samples were 
subjected to SDS-PAGE and analysed by Western blotting.
2.14.2 Radiolabelling of Oligonucleotides
Either 5’- or 3 ’-biotinylated oligonucleotides were purchased from Operon. The 
dried pellet was re-suspended in TE, pH 8, to a final concentration of 1 mM, and 
subjected to a radiolabelling reaction as described in 2.14.2.1 or in 2.14.2.2., as 
appropriate. Non-modified oligonucleotides, typically purchased from SIGMA, 
were re-suspended in TE, pH 8, to a final concentration of 100 pM, and 
subjected to a radiolabelling reaction similar to that described in 2.14.2.1.
2.14.2.1 5’-32P-End Labelling of Oligonucleotides
Approximately 3 nmol of each 3’-biotinylated oligo-dT (Table 10-1) were used 
per labelling reaction. The reaction mix consisted of 1X NEB T4 polynucleotide 
kinase buffer, 20 pCi of [y-32P] ATP and 20 units of T4 polynucleotide kinase 
enzyme, in a final volume of 50 pL. Following incubation at 37°C for 30 min, the 
reaction was stopped by addition of EDTA to a final concentration of 50 mM and 
incubation at 65°C for 15 min.
2.14.2.2 3’-32P-End Labelling of Oligonucleotides
Approximately 7 nmol of 5 ’-biotinylated X O I oligo (Table 2-9 and Table 10-1) 
were used in each labelling reaction. The 50 pL reaction mix contained 1X of 
NEB buffer 4, 0.25 mM of C0 CI2, 50 pCi of [a-32P] dATP or dCTP and 40 units 
of Terminal transferase enzyme. After incubation at 37°C for 30 min, the
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reaction was terminated by addition of EDTA to a final concentration of 50 mM 
and incubation at 70°C for 10 min.
2.15 Preparation of DNA Substrates and Protein - DNA 
Interaction Assays
2.15.1 Removal of Unincorporated Nucleotides
5’- or 3 ’-radiolabelled oligonucleotides (from paragraph 2.14.2) were separated 
from an excess of the radioactive nucleotide using ProbeQuant G-50 micro 
columns (GE Healthcare) according to the manufacturer’s protocol. As the 
radiolabelling of the oligos was for tracing purposes only, the efficiency of 
labelling was not assessed.
2.15.2 Preparation of DNA Substrates
Approximately 1 nmol of 3 ’-radiolabelled X O I oligonucleotide were used per 
annealing reaction. Different combinations of unlabelled nucleotides were used 
in a 3-fold excess to generate the different DNA structures (Table 2-9) in 
Annealing buffer. Annealing reactions were heated in a water bath at 95°C for 5 
min and then allowed to slowly cool overnight.
2.15.3 Gel Purification of Oligonucleotides and DNA 
Substrates
Radiolabelled oligonucleotides or annealed DNA substrates were purified on 
12% native polyacrylamide gels at 200 V, 4°C, for 2-3 h. The gel was exposed 
to an Amersham hyperfilm ECL (GE Healthcare) for a few min, and the 
appropriate DNA bands were excised from the gel. The bands were cut to small 
pieces, and soaked in 900 \iL 0.5X TBE overnight. The gel particles were spun 
down, the supernatant was transferred to a clean tube and the gel particles 
were further washed with 300 pL 0.5X TBE. To assess the elution efficiency, 
radioactive counts were measured using the liquid scintillation analyzer 
(Packard).
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2.15.4 Protein - DNA Interaction Assays
2.15.4.1 Gel Shift Assays
Approximately 0.5 pmol of radiolabelled oligonucleotide were used per 10 pL 
reaction. The DNA was incubated with various concentrations of the respective 
proteins at 4°C or 30°C for 15 min up to 1 h and then subjected to native gel 
electrophoresis followed by phosphorimager analysis.
2.15.4.2 Pull-Down Assays with Biotinylated DNA
2.15.4.2.1 Binding DNA Structures to Streptavidin Beads
Streptavidin beads (ImmunoPure, Pierce) were washed 3 times in 0.5X TBE 
buffer. Equal amounts of radioactive counts per DNA structure were incubated 
with streptavidin beads. The radioactive counts of the input sample and the 
unbound DNA were compared to assess how much DNA was bound to the 
beads. In general, approximately 5-10 pmol DNA were bound per 15 pL aliquots 
of beads. After washing 3 times in 0.5X TBE beads were either used 
immediately or stored at 4°C for subsequent pull-down experiments as 
described in paragraph 2.15.4.2.3.
2.15.4.2.2 Binding ssDNA to Streptavidin Beads
Streptavidin beads (ImmunoPure, Pierce) were washed 3 times in PBS with 1 
mM EDTA. Unlabelled biotinylated oligonucleotides were immobilized on the 
beads for 1 h at room temperature. The absorbance at 260 nm for both the 
input sample and the unbound DNA was compared to assess how much DNA 
was bound to the beads. Typically and unless stated otherwise, 5 pmol DNA 
was bound per 15 pL aliquots of beads. After washing 3 times in PBS with 1 
mM EDTA beads were either used immediately or stored at 4°C for subsequent 
pull-down experiments as described in paragraph 2.15.4.2.3.
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2.15.4.2.3 DNA-Bound Streptavidin Pull-Down Assays
DNA-bound streptavidin beads, prepared as described in 2.15.4.2.1 or in 
2.15.4.2.2, were washed three times in PD Binding buffer (Low- or High-Salt 
according to the experiment). 15 pL of beads were incubated with 5 pmol 
H,sVSVRad18 for 1 h at 4°C (100 pL). Alternatively, prior to Rad18 addition, 
increasing amounts of purified yeast RPA or bacterial SSB (Promega) (2.4, 8 
and 24 pmol) were incubated with the beads for 30 min at 4°C (300 pL), 
followed by a brief wash in PD Binding buffer (Low- or High-Salt according to 
the experiment - 500 pL each wash). After incubation with H,sVSVRad18, the 
beads were washed three times with 500 pL of High-Salt Binding buffer and 
twice with the same buffer without BSA. Bound material was eluted with 20 pL 
of 2X NuPage sample buffer containing a reducing agent and incubated at 70°C  
for 10 min. The samples were then analysed by SDS-PAGE (NuPage 4-12%  
Bis-Tris Gel -  Invitrogen) followed by Western blotting.
2.16 Protein - Protein Interaction Assays
2.16.1 Co-immunoprecipitation of Rad6 with HlsVSVRad18
Approximately 5 pmol of HlsVSVRad18 were diluted into 100 pL COIP Binding 
buffer. The input was pre-cleared with 60 pL of protein-G agarose beads 
(Roche) at 4°C for 1 h. A 1/10 dilution of anti-Rad18 DH1 terminal bleed (from 
the 50%  (v/v) glycerol stock) was prepared in PBS and centrifuged at maximal 
speed for 2 min. 5 pL of the antibody’s supernatant were added to the cleared 
input and incubated at 4°C for 2.5 h. After centrifugation for 1 min at maximal 
speed, the supernatant was mixed with 20 pL of washed protein-G agarose 
beads at 4°C for 1 h. After four washes in COIP Binding buffer, the beads were 
washed once in COIP Washing buffer. The samples were eluted with 20 pL of 
2X NuPage sample buffer containing a reducing agent, incubated at 70°C for 10 
min and subjected to SDS-PAGE (NuPage 4-12%  Bis-Tris Gel -  Invitrogen). 
Western blotting against Rad 18 and Rad6 was carried out as follows: Rad 18 
was detected by terminal bleed of mouse 4 as described in paragraph 2.11.1.1.
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Rad6 was detected by anti-Rad6 antibody (1:3000) followed by incubation with 
anti-rabbit y chain specific peroxidase conjugated antibody (1:2000).
2.16.2 Glutathione Pull-Down Assays
2.16.2.1 In the Absence of ssDNA
Approximately 0.5 nmol of GST, GSTRfa1 (182-421) or GSTRfa2 were 
immobilized on 20 pL of glutathione sepharose 4 Fast Flow (GE Healthcare) in 
GST-PD Binding buffer for 30 min at 4°C. The beads were briefly washed with 
500 pL GST-PD Binding buffer. 10 pmol HlsVSVRad18 were added in the same 
buffer containing 100 pg/mL BSA and incubated at 4°C for 1 h. Then, the beads 
were washed 3 times with 500 pL of GST-PD Binding buffer containing BSA 
and twice more with the same buffer without BSA. Finally, the bound material 
was eluted with 20 pL of 2X NuPage sample buffer containing a reducing agent, 
incubated at 70°C for 10 min and subjected to SDS-PAGE (NuPage 4-12%  Bis- 
Tris Gel -  Invitrogen) followed by Coomassie staining or Western blotting.
2.16.2.2 In the Presence of ssDNA
Approximately 0.5 nmol of GST or GSTRfa1 (182-421) were incubated with oligo- 
dT of different lengths (10, 16, 35) at either 1:1 ratio or 1:5 excess of oligo for 
45 min at 4°C in GST-PD Binding buffer. Each sample was then incubated with 
20 pL of glutathione sepharose 4 Fast Flow (GE Healthcare) at 4°C for 1.5 h. 
Subsequently, the beads were washed once with 500 pL GST-PD Binding 
buffer containing 100 pg/mL BSA. 10 pmol H,sVSVRad18 were added and the 
pull-down reactions were carried out as described in paragraph 2.16.2.1.
2.16.3 Protein-Derivatised Sepharose Pull-down Assays
2.16.3.1 Coupling Proteins to CH-Sepharose Beads
Yeast RPA (2.12.1), BSA or SSB were covalently coupled to CH-sepharose 4B 
beads (GE Healthcare) at 2.5 pg/pL according to the manufacturer’s 
instructions.
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2.16.3.2 Protein-Derivatised Sepharose Pull-Down Assays
Protein-derivatised sepharose beads (2.16.3.1) were used for pull-down 
reactions (15 pL of beads per reaction). Approximately 5 pmol of recombinant 
Rad6, HlsVSVRad18 and H|SPCNA were added to the beads and incubated in 
Coupled-PD Binding buffer, supplemented with 2.5 u benzonase (Novagen), at 
4°C for 1 h. The beads were washed 5 times with Coupled-PD Washing buffer. 
Bound material was eluted with 20 pL of 2X NuPage loading buffer containing a 
reducing agent, incubated at 70°C for 10 min and analysed by SDS-PAGE  
followed by Western blotting.
2.17 Analysis of Post-Translational Modifications of 
Proteins
2.17.1 Ni-NTA Pull-Down Assays from Yeast Extracts
under Denaturing Conditions
Yeast strains harbouring the gene of interest fused to a His-tag were grown in 
adequate conditions to allow the expression of the His-tagged protein. 
Overnight cultures were diluted in adequate medium and subsequently were 
grown for 2 generations up to O .D .600 = 1-2. When appropriate, cells were 
treated with DNA damaging agents for 60-90 min. Approximately 70-100  
O.D.eoo of cells were harvested per strain by centrifugation at 1800g for 5 min in 
50 ml_ falcon tubes at room temperature. Cells were re-suspended in 5 mL of 
ice-cold sterile water. 800 pL of freshly prepared NaOH / p-ME solution were 
added, the tubes were mixed by vortex and the cells were incubated on ice for 
20 min. Then, 800 pL of 55% (w/v) TCA were added, the tubes were mixed by 
vortex and incubated on ice for additional 20 min. Tubes were centrifuged at 
8000 RPM at 4°C for 20 min in a F-34-6-38 rotor (Eppendorf). The supernatant 
was removed by aspiration and the pellet was centrifuged at the same 
conditions for additional 2 min, and the supernatant was aspirated as before. 
The pellet was then re-suspend in 1.5 mL of buffer A and allowed to rotate at 
room temperature for 1 h (or until the pellet was completely dissolved). 
Subsequently, the solution was transferred to a microcentrifuge tube and 
centrifuged at maximal speed for 15 min at room temperature. The supernatant
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was then used for the following Ni-NTA pull-down procedure. Ni-NTA agarose 
beads (QIAGEN) were washed 3 times in 1 mL of buffer A followed by short 
centrifugations of 5 s at 5000 RPM. 20 pL of beads (40 pL of 50% slurry) were 
used per pull-down reaction. The cell extract was added to the beads along with
22.5 pL 1M imidazole and 22.5 pL 10% (v/v) Tween 20, resulting in final 
concentrations of 15 mM and 0.15%  (v/v), respectively. The tubes were left to 
mix overnight on a rotating wheel at room temperature. The beads were 
harvested by a brief centrifugation of 5 s at 5000 RPM, and most of the 
supernatant was carefully removed with a pipette. The rest of the supernatant 
was then removed by a 25 pL Hamilton syringe. The beads were washed twice 
with buffer A supplemented with 0.05%  (v/v) Tween 20. Then, 3 times with 
buffer C, supplemented with 0.05%  (v/v) Tween 20. Finally, the beads were 
eluted in 20-40 pL of 2X NuPage loading buffer containing a reducing agent, 
incubated at 70°C for 10 min and analysed by SDS-PAGE followed by Western 
blotting.
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3 Results I: Purification and Catalytic Activity of 
Rad18
3.1 Introduction
My initial goal was to gain insights into the in vitro activity of the Rad18 protein 
from S. cerevisiae, especially with relevance to PCNA mono-ubiquitylation. 
Based on Bailly et al. (1997), I intended to purify yeast Rad 18 in a complex with 
Rad6. My first approach was to purify these proteins recombinantly from E. coli. 
Two different cloning strategies were used. One strategy was based on the 
pETDuet-1 expression vector that facilitated the cloning of two open reading 
frames. This vector was used to generate two constructs harbouring both 
RAD18  and RAD6 genes with one or the other fused to an N-terminal His tag. 
The other strategy was based on a bi-cistronic RAD6-RAD18 construct where 
the two genes were connected by a linker with a ribosomal entry site. This insert 
was cloned into a pUC118 expression vector under the control of the phoA 
promoter. This promoter allows a gradual increase in gene expression following 
phosphate starvation conditions and was previously used by Ulrich et al. (1995) 
for the successful production of antibodies. Following various optimisation 
experiments, the best expression conditions were obtained for the phoA 
HisRAD18-RAD6  construct and the proteins were purified using Ni-NTA affinity 
chromatography based on Biswas et al. (1995). Although the protein 
preparation exhibited ubiquitin-conjugating activity, this was not specific for 
PCNA. Moreover, two of the prominent protein bands in the preparation 
corresponding in size to yRad18, were identified as metabolic bacterial proteins 
by mass spectrometry analysis. As a result, I recognised the necessity to 
explore alternative expression systems.
Even though a purification of yeast protein from its native organism would seem 
the obvious choice, the relatively low expression levels of the RAD18 gene has 
posed a significant challenge. In order to obtain constitutive over-expression of 
the Rad 18 and the Rad6 proteins, a yeast strain was constructed to harbour 
both the RAD6 and the RAD18  genes under the control of the ADH1 promoter. 
Nonetheless, the Rad18 protein, which was fused to an N-terminal His-tag, was
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only detected by Western blot analysis. Following a preliminary attempt to purify 
Rad18 by Ni-NTA affinity chromatography, which resulted in poor yield, this 
approach was abandoned.
Another strategy was to use yeast strains harbouring either the RAD6 or the 
RAD18  genes fused to a C-terminus TAP tag (these strains were obtained from 
Open biosystems). This strategy was shown to be useful for native purification 
of low abundance protein complexes (Puig et al., 2001). A few purification 
attempts were carried out. Essentially, Rad6-TAP was isolated and identified by 
mass-spectrometry. However, none of the prominent bands that co-purified with 
Rad6 and corresponded in size to the yRad18 protein were identified as such. 
Subsequently, this approach was not pursued.
In parallel to the trials described above, insect cells were tested as an 
alternative expression system. Baculovirus harbouring a copy of the yeast 
HisVSVr AD18  gene was constructed and used to infect insect cells. 
Consequently, high expression levels of RAD18  were observed in whole cell 
extracts of baculovirus-infected insect cells, thus providing a promising source 
for protein production.
3.2 Results
3.2.1 Co-infection with HisVSVRAD18 and RAD6 
Baculoviruses Improves Solubility of Rad18
As previously mentioned, insect cells (either High Five or Sf9), infected with a 
baculovirus harbouring a copy of yeast HisVSVRAD18, proved to express high 
levels of RAD18. However, initial experiments revealed that the protein was 
mostly insoluble (Figure 3.1 A). To overcome this, different methods for cell lysis 
were analysed. Cell lysis was carried out using either Dounce homogenizer 
alone, a combination of Dounce homogenizer and sonication, or gentler 
extraction using a hypo-osmotic buffer followed by addition of a detergent. 
Moreover, Tris-HCI, HEPES or sodium phosphate buffers were tried combined 
with detergents (N P-40 or triton X-100) and with osmolytes (sucrose or 
glycerol).
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Bailly et al. (1997a) were only able to purify Rad18 from yeast cells when it was 
associated in a complex with Rad6. This suggests that Rad6 contributes to 
Rad18’s proper conformation. To test if this observation also applied to yeast 
Rad 18 produced in insect cells, the cells were co-infected with a baculovirus 
harbouring a copy of the yeast RAD6  gene. As shown in Figure 3.1B, the levels 
of Rad18 protein in whole cell extracts were similar when the cells were infected 
either with HisVSVRAD18  virus alone or with both HisVSVRAD18 and RAD6 viruses. 
However, following cell fractionation and ultracentrifugation of the cytoplasmic 
and nuclear fractions, an increased amount of soluble Rad 18 could be detected 
by Western blot analysis in the extracts of cells that were co-infected.
The optimised protocol for cell lysis and subsequent manipulation prior to 
Rad 18 purification was based on Cai et al. (1996) and it is described in detail in 
paragraph 2.12.6.1. In brief, 48 h co-infected insect cells were lysed with a 
Dounce homogenizer, and the cellular extract was fractionated into nuclei and 
cytoplasm by two centrifugation steps: low speed centrifugation followed by an 
ultracentrifugation. To prevent carry-over of any insoluble Rad18, the 
cytoplasmic fraction was subjected to an ultracentrifugation step after its 
isolation. Both fractions were used in subsequent steps separately.
3.2.2 Purification of the H,sVSVRad18-Rad6 Complex from 
Bacuiovirus-lnfected Insect Cells
The HlsVSVRad18-Rad6 complex was partially purified under native conditions by 
Ni-NTA affinity chromatography as described in paragraph 2.12.6.1. 
Modifications to the purification protocol, which was based on Cai et al. (1996), 
involved the use of HEPES buffer instead of Tris-HCI. In addition, 100 pM ZnCb 
were included in the RAD 18 Washing III, Elution and Dialysis buffers, following 
a suggestion in Mackereth et al. (2000) that including ZnCfe in the purification 
steps could improve the conformational stability of zinc binding proteins. Elution 
fractions that contained both Rad 18 and Rad6 were pooled and either 
subjected to further purification steps as described later in paragraph 3.2.4 or 
dialysed, concentrated and quantified as described in paragraph 2.12.6.1. As 
shown in Figure 3.2A and Figure 3.2B, both H®vsvRad18 and Rad6 proteins can
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be detected by Coomassie staining and by Western blot analysis. In addition, 
the identity of the prominent band in the protein preparation, which 
corresponded in size to yeast HlsVSVRad18, was verified by mass spectrometry, 
as was the band corresponding in size to yeast Rad6. The purity of the 
H,sVsvRad18 protein was estimated to be 80%. For control purposes, the same 
purification procedure was carried out on insect cells that were only infected 
with RAD6  baculovirus. As shown in Figure 3.2C and Figure 3.2D, the mock 
preparation contained a small amount of Rad6, but no Rad18.
3.2.3 Rad6 Co-purifies with H,sVSVRad18
3.2.3.1 Gel Filtration
The purified complex from paragraph 3.2.2 was subjected to further qualitative 
analysis by gel filtration, using a Superdex 6 PC 3.2/30 column (GE  
Healthcare). The fractions obtained from this column were subjected to SDS- 
PAGE and analysed by Western blot. As shown in Figure 3.3A, (fractions 27- 
31), Rad6 was found to co-elute with Rad18, verifying that they form a complex. 
However, free Rad6 was also found (fractions 34-39), suggesting either that the 
complex is partially unstable or that an excess of Rad6 had bound non- 
specifically to the Ni-NTA affinity column during purification. Using a mix of 
standard proteins, the complex size was estimated to be around 450 kDa. 
Assuming a stoichiometric ratio of 1:1 between Rad18 and Rad6 obtained 
from yeast (Bailly et al., 1997a), a complex formation of six Rad18-Rad6 hetero­
dimers could theoretically fit to this approximated molecular weight. However, 
using gel filtration analysis to estimate the size of a complex can be quite 
inaccurate, as the elution profile is affected by the proteins’ shape. Moreover, 
according to Notenboom et al. (2007), mammalian Rad18-Rad6 complex was 
found to form a dimer of hetero-dimers.
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Figure 3.1 -  Solubility of HisVSVRAD18 produced in baculovirus-infected 
insect cells
A. A Coomassie-stained gel of total cell extracts obtained from either non-infected or 
HisVSVRAD18  baculovirus-infected High Five insect cells. The cells were lysed by 
sonication in Tris-HCI buffer containing NP-40 (Total). Note that yeast HwVSVRAD18 was 
over-expressed. The cell extracts were subjected to centrifugation; The supernatant 
and the pellet material were compared.
B. Western blot analysis of total cell extracts derived from High Five insect cells 
infected either with HisVSVRA D 18  virus alone or in combination with RAD6 virus. Cell 
extracts were prepared using the optimised protocol and the supernatants of 
cytoplasmic (Cyt.) and nuclear (Nuc.) fractions obtained after an ultracentrifugation 
step were analysed. Anti-VSV antibody was used for HlsVSVRad18 detection and anti- 
Rad6 antibody was used for Rad6 detection.
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3.2.3.2 Co-lmmunoprecipitation
In order to verify that Rad6, detected in the protein preparation, was indeed 
associated with Rad 18 in a stable complex, a co-immunoprecipitation 
experiment was carried out. The partially purified Ni-NTA eluate, used as an 
input, was incubated either with the anti-Rad18 or with the anti-HA antibodies. 
The immunoprecipitated samples were eluted, subjected to SDS-PAGE and 
analysed by Western blotting. As shown in Figure 3.3B, Rad18 was 
immunoprecipitated by the anti-Rad18 antibody but not by the anti-HA antibody. 
Consistently, Rad6 was found to co-immunoprecipitate with Rad18.
3.2.4 Attempts to Improve the Purity of the HisVSVRad18-Rad6 
Complex
Since a nuclease contamination was detected in the protein preparation 
obtained after the Ni-NTA affinity column, I have attempted to improve the purity 
of the H,sVSVRad18-Rad6 complex by subsequent chromatographic steps.
3.2.4.1 Cation Exchange Column
The protein sample was diluted at a ratio of 1:1 with RAD18 Dialysis buffer 
without NaCI, in order to adjust the starting NaCI concentration to 150 mM, and 
loaded onto a HiTrap Q HP column (GE Healthcare). After washing the column 
with RAD18 Dialysis buffer (containing 150 mM NaCI), a gradient was 
developed between 200 mM NaCI and 500 mM NaCI. The H,sVsVRad18-Rad6 
complex was found to elute in a discrete peak around 300 mM NaCI. However, 
the resulting purified complex still exhibited significant nuclease activity and the 
overall purity did not seem to be significantly improved.
3.2.4.2 Hydrophobic Phenyl Sepharose Chromatography
Hydrophobic phenyl sepharose chromatography requires the application of a 
sample in a high ionic strength buffer, to enhance the hydrophobic interactions 
between the proteins and the column. Consequently, the protein sample was 
adjusted to 1.5 M NaCI, loaded onto a HiTrap phenyl HP column (GE
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Healthcare) and the column was washed with RAD18 Dialysis buffer containing
1.5 M NaCI. Two linear gradients were applied to elute the column. First, the 
NaCI concentration was gradually reduced to 200 mM NaCI. Thereafter, it was 
gradually reduced down to 0 mM NaCI. H,sVSVRad18 was found to elute as a 
discrete peak around 200 mM NaCI. However, Rad6 did not bind to the column 
and was detected in the column’s flow through. Unfortunately, this resulted in 
the precipitation of the HlsVSVRad18 protein in subsequent steps. Similar results 
were obtained when ammonium sulfate was used instead of NaCI.
3.2.4.3 Heparin Column
Heparin is a naturally occurring glycosaminoglycan. The purification method 
using Heparin columns is based on the affinity of different proteins for heparin. 
It is often used for the purification of DNA-binding proteins, as it is negatively 
charged and can mimic the charge of the DNA. The protein sample was 
dialysed in RAD18 Dialysis buffer at 4°C overnight as described in 2.12.6.1. The 
sample was loaded onto the HiTrap Heparin HP column (GE Healthcare) and 
the column was washed with RAD18 Dialysis buffer. To elute the column, a two- 
step linear gradient was applied. The gradient was developed between 150 mM 
NaCI and 500 mM NaCI followed by a second gradient between 500 mM NaCI 
and 1 M NaCI. The HlsVsVRad18-Rad6 complex was found to elute in two peaks 
around 500 mM and 600 mM NaCI. However, the overall purity did not seem to 
improve much and the nuclease activity still persisted in the protein preparation.
Additional attempts to improve the purity of the H,sVSVRad18-Rad6 complex were 
not pursued.
- 1 3 5 -
Chapter Three: Results I
A.
P
Coomassie 35 *
Hl3VSVRad18
Rad6
B. j f
a P&
anti-VSV
anti-Rad6 i m m
rtavsvRadie
Rad6
C.
Eluate
55 -
Coomassie 45
35
25 -
15-
-  "^RadlS
-  Rad6
D.
anti-VSV
anti-Rad6
Eluate
i i
A®+
_ _ -J - HlsVSVRadl8 
Rad6
Figure 3.2 -  Partial purification of the yeast H,sVSVRad18-Rad6 complex 
from baculovirus-infected insect cells
A. Analysis of the input and the eluate obtained after Ni-NTA affinity chromatography 
by Coomassie staining.
B. Analysis of the input and the eluate obtained after Ni-NTA affinity chromatography 
by Western blotting. Whole cell extract from non-infected cells was used as a negative 
control. Hl#vsvRad18 was detected by anti-VSV antibody and Rad6 was detected by 
anti-Rad6 antibody.
C. Comparison by Coomassie staining between the mock eluate, obtained from RAD6 
baculovirus-infected insect cells, and the purified ^^RadlS-RadG complex, obtained 
from RAD6 and HisVSVR A D18  baculoviruses-infected insect cells.
D. Comparison by Western blot analysis between the mock eluate, obtained from 
RAD6 baculovirus-infected insect cells, and the purified H,sVSVRad18-Rad6 complex, 
obtained from R AD6  and H,sVSVRAD18 baculoviruses-infected insect cells. H“vsvRad18 
was detected by anti-VSV antibody and Rad6 was detected by anti-Rad6 antibody.
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Figure 3.3 -  Rad6 associates with HlsVSVRad18 in a complex
A. Analysis by gel filtration of the H®vsvRad18-Rad6 complex, obtained from the Ni-NTA 
affinity column. The column fractions were separated on SDS-PAGE and analysed by 
Western blot. HlsVSVRad18 was detected by anti-VSV antibody and Rad6 was detected 
by anti-Rad6 antibody. Arrows indicate the molecular weights of the standard proteins 
used as a control.
B. The H®vsvRad18-Rad6 complex, obtained from the Ni-NTA affinity column, was 
subjected to immunoprecipitation either with anti-Rad18 (polyclonal DH1 rabbit serum) 
or with anti-HA (polyclonal) antibodies. Western blot analysis was performed using 
anti-Rad18 antibody (polyclonal mouse 4 serum) for Rad18 detection, and anti-Rad6 
antibody followed by anti-rabbit y chain-specific peroxidase-conjugated antibody, for 
Rad6 detection.
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3.2.5 Rad18 is Auto-ubiquitylated
3.2.5.1 Yeast hisVSVRad18 is Ubiquitylated in Insect Cells
As described in paragraph 3.2.1, the purification procedure of yeast 
HlsVsvRacj18-Rad6 complex from baculovirus-infected insect cells involved the 
fractionation of the cellular extract into nuclei and cytoplasm followed by 
subsequent purification of the complex from both fractions. As shown in Figure 
3.4A (upper panel), the partially purified complexes derived from both fractions 
contained a band corresponding in size to yeast H,sVSVRad18 that was 
recognised by the anti-VSV antibody, as expected. Interestingly, an additional 
higher band was detected in the cytoplasmic fraction that was absent from the 
nuclear one. Accordingly, when the fractions were combined, this band 
appeared to become diluted (Figure 3.4A -  upper panel).
I postulated that this higher migrating band, recognised by the anti-VSV  
antibody, could represent a post-translational modified form of yeast 
H,sVSVRad18. Miyase et al. (2005) found that mammalian Rad18 existed in two 
species, an unmodified and a mono-ubiquitylated form, with the latter 
predominantly found in the cytoplasm. Accordingly, the size of this band 
corresponded to the size of a nuclei-derived HlsVSVRad18 protein conjugated to 
one ubiquitin moiety in vitro (Figure 3.5A and Figure 3.5B). This will be further 
discussed in paragraph 3.2.5.3 below. Thus, most probably, yeast H,sVSVRad18 
is mono-ubiquitylated in baculovirus-infected insect cells, and its modified form 
can be found in the cytoplasm.
As shown in Figure 3.4A (lower panel), the partially purified complexes derived 
from both fractions contained comparable levels of Rad6. Similarly to Rad 18, 
Rad6 was also modified, most probably by ubiquitin. However, differently from 
Rad18, the higher migrating band, corresponding to mono-ubiquitylated Rad6, 
could be detected in the complexes derived from both fractions, although it 
appeared weaker in the nuclei-derived one.
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3.2.5.2 Rad18 is Ubiquitylated in Yeast Cells
It was not clear whether ubiquitylation of yeast Rad 18 in baculovirus-infected 
insect cells was an artefact of the expression system or a physiologically 
relevant post-translational modification. Therefore, it was important to test if 
Rad 18 was also modified in yeast cells. To this end, either WT, RAD18?ha or 
rad6 RAD1SPha yeast strains were transformed with an episomal plasmid 
containing a His-tagged UBI gene under the control of the CUP1 promoter (no. 
821). As a negative control, the R A D 1 (fHA strain was transformed with an 
empty plasmid (no. 308). Following induction of HlsUBI over-expression with 
CuSC>4, the post-translational modifications of Rad 18 in the different strains 
were analysed by Ni-NTA pull-down assays under denaturing conditions. As 
shown in Figure 3.4B (lower panel -  anti-His antibody), the presence of 
H,8ubiquitin conjugates was verified in total cell extracts from strains harbouring 
the CUP1-h,sUBI construct. In addition, these conjugates were precipitated as a 
result of the Ni-NTA pull-down assay, confirming that the experiment was 
working properly. According to the loading control, equivalent amounts of cells 
were used from each strain for the preparation of cell extracts (Figure 3.4B -  
middle panel -  anti-PGK antibody). Correspondingly, similar Rad186HA levels 
were observed in total cell extracts derived from the rad6 RAD18?ha strain, 
harbouring the CUP1-H,SUBI construct, or from the RAD18?ha strain, harbouring 
the empty plasmid (Figure 3.4B -  upper panel -  anti-HA antibody). In contrast, 
the cell extract obtained from the R A D 1ffHA strain, harbouring the CUP1-HisUBI 
construct, appeared to contain somewhat higher Rad186HA levels as well as 
another band, probably corresponding to mono-ubiquitylated Rad186HA (Figure 
3.4B -  upper panel -  anti-HA antibody). The identity of this band as mono- 
ubiquitylated Rad186HA was further confirmed as it was precipitated by the Ni- 
NTA pull-down assay, together with another higher migrating band, probably 
corresponding to Rad186HA conjugated to two ubiquitin moieties. The results 
suggest that this pull-down experiment was useful for the identification of His- 
tagged ubiquitin-Rad186HA conjugates, as unmodified Rad186HA was not 
precipitated. As mentioned above, the strains harbouring the CUP1-HisUBI 
construct did not contain equal levels of the Rad186HA protein. Even though the 
rad6 R A D 1(fHA strain had less Rad18 compared with the RAD1E?ha strain, 
mono-ubiquitylated Rad186HA could be pulled-down from it, suggesting that
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under the tested conditions, the in vivo ubiquitylation of Rad18 does not depend 
on Rad6.
3.2.5.3 HisVSVRad18 is Auto-ubiquitylated In vitro
The ability of E3 ligases to become auto-ubiquitylated is often regarded as a 
hallmark of their catalytic activity in the absence of a substrate. Therefore, 
H,sVSVRad18-Rad6 complexes derived from the cytoplasmic or the nuclear 
fractions were assessed for their auto-ubiquitylation activity by in vitro 
ubiquitylation assays with the E1 activating enzyme and ubiquitin, but without 
PCNA. As shown in Figure 3.5A, the H,sVSVRad18 protein of both complexes 
was auto-ubiquitylated in the complete reactions, but not in those lacking the E1 
enzyme. These results indicate that the H,sVSVRad18 protein in both complexes 
is functional, and that its RING domain is properly folded. After 2 h of incubation 
at 30°C, the nuclei-derived HlsVSVRad18-Rad6 complex was conjugated to one 
ubiquitin moiety. This mono-ubiquitylated H,sVSVRad18 corresponded in size to 
the higher migrating band observed in the cytoplasm-derived HlsVSVRad18 
protein preparation. This result is consistent with the suggestion that the latter 
consists of both an unmodified and a mono-ubiquitylated form of HlsVSVRad18.
As shown in Figure 3.5B, the levels of ubiquitin-Rad18 conjugates increased 
with increased incubation time in the reactions containing the cytoplasm-derived 
H|8vsvRad18-Rad6 complex (Cyt.), as expected. However, the auto- 
ubiquitylation activity of the nuclei-derived HlsVSVRad18-Rad6 complex (Nuc.) 
was significantly reduced compared to that of the cytoplasm-derived complex 
(Cyt.). Since the Rad6 content in both complexes was similar (Figure 3.4A -  
lower panel), it is unlikely that this protein is responsible for the difference 
observed in the auto-ubiquitylation efficiency. Rather, it is more probable that 
this difference originates from a variation in Rad 18 between the two protein 
preparations. Possibly, mono-ubiquitylation of HlsVSVRad18, found in the 
cytoplasm-derived complex, could enhance its catalytic activity. Alternatively, 
the nuclei-derived protein preparation might contain a contaminant that limits 
the efficiency of the auto-ubiquitylation reaction.
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Figure 3.4 -  Rad18 is ubiquitylated in vivo
A. The yeast H,sVSVRad18 and Rad6 proteins are post-translationally modified in 
baculovirus-infected insect cells. Western blot analysis of partially purified HisVSVRad18- 
Rad6 complexes obtained from isolated cytoplasm (Cyt.) or nuclei (Nuc.). A 1:1 ratio 
mix of both complexes was loaded in the middle lane (Comb.). Rad 18 was detected by 
anti-VSV antibody and Rad6 was detected by anti-Rad6 antibody. Note that for Rad18 
analysis, the samples were separated on an 8% SDS-PAGE gel, whereas for Rad6 
analysis, the samples were separated on a 12% gel.
B. Rad18 is ubiquitylated in yeast cells. The WT, RAD18?ha or rad6 RAD18?ha yeast 
strains, harbouring the CUP1-HisUBI construct, or the RAD18?ha strain, harbouring an 
empty plasmid, were induced for Hl8L/B/ over-expression with 100 mM C u S 04. 
Hl8Ubiquitin conjugates were precipitated from the different strains by Ni-NTA pull-down 
assays under denaturing conditions. In parallel, total cell extracts were prepared as 
well. Samples were subjected to SDS-PAG E followed by Western blot analysis. 
H,sUbiquitin conjugates were detected with anti-ubiquitin antibody. PGK was used as a 
loading control and detected with anti-PGK antibody. Rad186HA was detected with anti- 
HA antibody (polyclonal).
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Figure 3.5 -  Hl,vsvRad18 is auto-ubiquitylated
A. Approximately 3 pM of H,,vsvRad18-Rad6 complexes, purified either from the 
cytoplasmic fraction (Cyt.) or from the nuclear fraction (Nuc.) of baculovirus-infected 
insect cells, were incubated in buffer containing 25 mM Tris-HCI, pH 7.5, 100 mM 
NaCI, 10 mM MgCI2, 5 mM DTT and 10 mM ATP at 30°C for 2 h. The complete 
ubiquitylation reaction contained 190 nM E1 enzyme and 39 ^M ubiquitin. Incomplete 
ubiquitylation reactions, lacking the E1 enzyme, were used as a negative control. The 
reactions were stopped; samples were subjected to SDS-PAGE and analysed by 
Western blotting. Hisv5vRad18 was detected by anti-VSV antibody.
B. Same as in A., but complete ubiquitylation reactions were incubated at 30°C for 0, 2 
and 3 h.
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3.2.6 The HisVSVRad18-Rad6 Complex Mono-ubiquitylates 
PCNA In vitro
3.2.6.1 Specificity of PCNA Mono-ubiquitylation
In order to test the catalytic function of the cytoplasm-derived H,sVSVRad18-Rad6 
complex, in vitro ubiquitylation assays were carried out in the presence of its 
biological relevant substrate, PCNA. As shown in Figure 3.6A, PCNA mono- 
ubiquitylation could be reconstituted in vitro. A band corresponding in size to 
mono-ubiquitylated H|SPCNA appeared after incubation of 4 h in the lane of the 
complete ubiquitylation reaction. This band was absent from lanes that 
contained incomplete reactions, lacking either the E1 enzyme, the HlsVSVRad18- 
Rad6 complex (E2 and E3 enzymes) or H|SPCNA. To further confirm the identity 
of this band, His-tagged ubiquitin was used instead of W T ubiquitin. As a 
consequence, a shift in the mobility of this band was observed, verifying that it 
corresponded to mono-ubiquitylated H,SPCNA.
In addition, the specificity of this reaction was assessed using the H,SPCNA  
(K164R) mutant instead of the W T protein. Indeed, as shown in Figure 3.6A, 
this mutant was not modified, suggesting that the purified H,sVSVRad18-Rad6 
complex retained its selectivity and specificity towards PCNA.
Nevertheless, the overall efficiency of PCNA ubiquitylation was fairly poor as a 
very small percentage of the substrate became modified. This suggests that the 
reaction was not performed under optimal conditions.
3.2.6.2 Optimisation of PCNA Mono-ubiquitylation
In order to improve the conditions for PCNA mono-ubiquitylation in vitro, various 
parameters were analysed for their effects on the reaction efficiency. These 
included variations to buffer composition, buffer pH and incubation times. In 
short, HEPES buffer was found to be favourable over Tris-HCI. In addition, 
moderately acidic buffer conditions (pH 6) seemed to enhance PCNA 
modification over basic conditions (pH 9). Initially, 5 mM of the reducing agent 
DTT were used in the reaction. Reducing the concentration of this agent to 0.1
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mM significantly contributed to PCNA ubiquitylation. Two different E1 enzymes, 
which were available in the lab, wheat E1 (purified in the lab) and yeast E1 
(purchased from Boston Biochem) were tested, and the latter provided better 
results. Moreover, different concentrations of ubiquitin, PCNA and the modifying 
enzymes were tested. Comparison of reactions containing either the nuclei- 
derived H,sVSVRad18-Rad6 complex or the cytoplasm-derived one revealed that 
the latter exhibits better PCNA mono-ubiquitylation efficiency. This result 
correlated with the findings for Rad18 auto-ubiquitylation (Figure 3.5B).
In contrast to parameters that had an effect on the reaction efficiency, addition 
of 100 nM ZnCfe to the reaction buffer did not make a significant difference. 
Furthermore, addition of DNA (ssDNA, dsDNA or dsFork DNA structures) to the 
reaction did not result in enhanced PCNA modification. As shown in Figure 
3.6B, by optimising the reaction parameters as mentioned above, the efficiency 
of PCNA mono-ubiquitylation by H,sVSVRad18-Rad6 complex was slightly 
improved (compare to Figure 3.6A).
However, as it later turned out, the conditions used for this reaction only 
allowed a basal level of PCNA modification by the Rad18-Rad6 complex. 
According to Garg and Burgers (2005), PCNA has to be loaded on DNA in order 
to obtain efficient PCNA mono-ubiquitylation. Nevertheless, under these 
optimised conditions of the basal reaction, the intensity of the band 
corresponding in size to mono-ubiquitylated PCNA increased with incubation 
time and with higher H,sVSVRad18-Rad6 concentrations (Figure 3.6B). Therefore, 
the ability of HisVSVRad18-Rad6 to perform its catalytic activity towards its 
biological identified substrate, as established by Hoege et al. (2002), was 
confirmed in our in vitro system.
Interestingly, the auto-ubiquitylation levels of cytoplasm-derived H,sVSVRad18 
were not altered in the presence or the absence of PCNA (Figure 3.6B -  upper 
panel), suggesting that these two ubiquitylation reactions are independent of 
each other.
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Figure 3.6 -  PCNA m ono-ubiquitylation can be reconstituted in vitro  by 
the HisVSVRad18-Rad6 complex
A. PCNA is specifically mono-ubiquitylated on K164 by the HlsVSVRad18-Rad6 complex 
in vitro. In vitro ubiquitylation assays were carried out using either W T or mutant 
HisPCNA (K164R) as substrate (3 pM). His-tagged ubiquitin replaced W T ubiquitin 
where indicated (65 pM). Approximately 1.5 pM H,sVSVRad18-Rad6 complex were used 
as indicated. E1 was used at 190 nM. Samples were incubated in a buffer containing 
25 mM Tris-HCI, pH 7.5, 100 mM NaCI, 10 mM MgCI2, 5 mM DTT and 10 mM ATP at 
30°C for 0 or 4 h. The reactions were stopped; samples were subjected to SDS-PAGE  
followed by Western blot analysis. PCNA was detected by anti-PCNA antibody 
(polyclonal).
B. PCNA mono-ubiquitylation was improved by modification of the reaction conditions. 
The complete reaction (8 pL) contained 65 pM ubiquitin, 112.5 nM E1, 3 pM PCNA and 
increasing concentrations of cytoplasm-derived H,#vsvRad18-Rad6 complex (0.75, 1.5 
or 3 pM). The proteins were incubated in Ubiquitylation buffer at 30°C for 0, 2 or 4 h. 
Reactions were analysed as in A. Hl#vsvRad18 was detected by anti-VSV antibody. 
PCNA was detected by anti-PCNA antibody (polyclonal).
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3.3.1 Purification of Rad18
After several unsuccessful attempts to over-express and purify yeast RAD18  
from E. coli or yeast, H‘sVSVRAD18  bacoluvirus-infected insect cells showed 
significant over-expression of the recombinant constructs in whole cell extracts. 
Therefore, this was considered the method of choice for Rad18 production. At 
first, Rad18 was found to be nearly insoluble. In order to solve this problem, the 
cells were co-infected with a baculovirus harbouring the RAD6 gene. This 
approach had two advantages. First, since Rad6 is the ubiquitin-conjugating 
enzyme that cooperates with Rad 18 to perform their enzymatic activity, co- 
expressing them as a complex meant that there was no need to add extra Rad6 
for subsequent experiments that involved studying the catalytic activity of 
Rad18. Second, as shown in Figure 3.1 B, the co-infection procedure improved 
Rad18’s solubility, probably because Rad6 contributes to the correct folding of 
Rad 18 (Bailly et al., 1997a). The solubility of Rad 18 was further improved by 
optimising the cell lysis and the subsequent purification conditions based on Cai 
eta l. (1996), as described in paragraphs 3.2.1 and 3.2.2.
Using Ni-NTA affinity chromatography, a partially purified yeast H,sVSVRAD18- 
Rad6 complex was obtained (Figure 3.2). Although the complex could be 
purified either from the cytoplasm or from the nuclei fractions, the protein 
preparation resulting from the former was found to be more active than the 
latter (Figure 3.5 and data not shown). Thus, the cytoplasm-derived 
H»vsvpac|^Q_Racj6 complex was used in all subsequent experiments described 
in Chapters 4-7.
According to the Coomassie staining, it seemed that there was an excess of 
Rad 18 compared to Rad6 in the protein preparation. However, since the 
Coomassie blue dye does not bind to all proteins with the same efficiency, it 
could be that the Rad6 protein does not stain as well as the Rad18 protein. 
Alternatively, Rad6 could have been partially lost during the purification 
procedure.
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The association of Rad 18 with Rad6 in a complex was verified by gel filtration 
(Figure 3.3A) as well as by co-immunoprecipitation (Figure 3.3B). Some of the 
gel filtration fractions contained free Rad6. As this was not a characteristic of all 
the protein preparations obtained in separate experiments, and since the mock 
purification, derived from RAD6 baculovirus-infected insect cells, contained a 
residual amount of Rad6 (Figure 3.2C and Figure 3.2D), it is likely that a small 
percentage of Rad6 had bound non-specifically to the Ni-NTA column. Another 
possibility is that the complex was partially unstable during the experiment, 
leading to the dissociation of the Rad 18 protein from Rad6 and its subsequent 
precipitation.
Additional attempts to further purify the HlsVSVRad18-Rad6 complex were carried 
out. Nevertheless, the Rad 18 protein was found to be sensitive to aggregation if 
separated from Rad6 during purification, as in the case of the phenyl sepharose 
column. In addition, although HlsVSVRad18 and Rad6 were found to co-elute 
following the cation exchange or the heparin columns, the nuclease 
contamination still persisted after these procedures. As a consequence, I have 
settled for the purification protocol described earlier (3.2.2). The nuclease 
contamination problem was bypassed using EDTA to inhibit the nuclease 
activity (Viadiu and Aggarwal, 1998) and the DNA-binding activity of Rad18 was 
studied by pull-down experiments followed by Western blot analysis that 
allowed the detection of a specific interaction between the Rad 18 protein and 
the DNA.
3.3.2 The Catalytic Activity of Rad18
3.3.2.1 Radi8 Auto-ubiquitylation
As shown in Figure 3.4A, the protein preparation of the yeast HlsVSVRad18-Rad6 
complex, derived from the cytoplasmic fraction of baculovirus-infected insect 
cells, contains both unmodified and mono-ubiquitylated HlsVSVRad18. This 
observation reproduces the findings of Miyase et al. (2005) for mammalian 
Rad 18. Furthermore, it suggests that similarly, the pool of yeast HlsVSVRad18- 
Rad6 complex in the cytoplasm is different from the pool of this complex in the
- 1 4 7 -
Chapter Three: Results I
nucleus of insect cells. Therefore, the complexes derived from both fractions 
were used separately.
Although I was able to verify that Rad 18 can be ubiquitylated in yeast cells 
(Figure 3.4B), the significance of this modification is still unclear. In mammalian 
cells, mono-ubiquitylated Rad 18 was predominantly found in the cytoplasm 
(Miyase et al., 2005). In addition, poly-ubiquitylated Rad 18 species were found 
to accumulate following a treatment with an inhibitor of the 26S proteasome
(Miyase et al., 2005). Based on these observations, Miyase et al. (2005)
concluded that ubiquitylation of mammalian Rad 18 regulates its localisation and 
thereby modulates its levels in the cell. Possibly, this explanation also holds 
true for the post-translational modification of yeast HlsVSVRad18 observed in 
baculovirus-infected insect cells. However, the ubiquitylation of Rad18 in yeast 
cells may have other physiologically relevant roles.
Indications that the mammalian and the yeast systems may be different from 
each other were obtained from Figure 3.4B. First, in contrast to mammalian 
cells, in which Rad18 poly-ubiquitylation was reported to depend on Rad6
(Miyase et al., 2005), deletion of the RAD6  gene in yeast cells did not
completely abolish Rad 18 ubiquitylation. Although Rad6 seems to contribute to 
Rad18 modification to some extent, another E2 may contribute as well. 
Alternatively, Rad18’s E3 ligase activity may be sufficient for its own 
modification. The finding that H,sVSVRad18-Rad6 is auto-ubiquitylated in vitro 
(Figure 3.5) supports this last explanation but cannot rule out the involvement of 
the Rad6 protein in Rad18’s modification. Second, although the total cell 
extracts were prepared from equivalent number of cells for all the tested yeast 
strains (Figure 3.4B), it appears that over-expression of Hlsubiquitin results in 
enhanced levels of Rad 18 compared to the same strain harbouring the empty 
plasmid. In contrast, deletion of the rad6 gene appears to reduce Rad18 levels 
(Figure 3.4B and data not shown). Although these observations should be 
confirmed with additional strains, it seems unlikely that Rad18 ubiquitylation in 
yeast leads to its degradation as was suggested for the mammalian Rad18 
protein (Miyase et al., 2005).
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A clue for the possible role of mono-ubiquitylation of yeast Rad 18 can come 
from the findings presented in Figure 3.5. Accordingly, the cytoplasm-derived 
H|svsvRad18-Rad6 complex that contains mono-ubiquitylated Rad18 is more 
active than the one derived form the nuclear fraction, with respect to both 
Rad18 auto-ubiquitylation and PCNA mono-ubiquitylation. Hence, it is possible 
that this modification of Rad18 enhances its catalytic activity. Mechanistically, 
the improved catalytic efficiency observed for mono-ubiquitylated Rad 18 could 
simply imply that conjugation of the first ubiquitin moiety onto Rad 18 is a rate- 
limiting step for the subsequent addition of ubiquitin moieties and the build-up of 
poly-ubiquitin chains on Rad 18. Furthermore, the conjugation of ubiquitin onto 
Rad18 may be a pre-requisite and a rate-limiting step for subsequent PCNA  
mono-ubiquitylation. Alternatively, Rad18 ubiquitylation could involve a change 
of the protein’s conformation that results in an improved E3 ligase activity. 
Accordingly, mono-ubiquitylation of Rad 18 in yeast cells might have a 
regulatory role for its function.
Whether Rad 18 auto-ubiquitylation is a side reaction or a relevant step in 
Rad18’s biological activity is yet to be determined. Nevertheless, preliminary 
experiments suggested that Rad 18 ubiquitylation in yeast cells is not dependent 
on DNA damage (data not shown), whereas PCNA ubiquitylation is specifically 
induced by DNA damage or replication arrest (Davies eta l., 2008). Therefore, it 
is plausible that these two modifications are independent processes. On one 
hand, the results presented in Figure 3.6B support this hypothesis, as 
H,sVSVRad18-Rad6 auto-ubiquitylation activity was similar in the presence or in 
the absence of PCNA. On the other hand, this observation does not contradict a 
model in which Rad18 auto-ubiquitylation is needed prior to PCNA modification.
3.3.2.2 PCNA Mono-ubiquitylation
As shown in Figure 3.6, PCNA mono-ubiquitylation was reconstituted in vitro 
using the partially purified yeast HlsVSVRad18-Rad6 complex. In addition, the 
specificity of the in vitro reaction for the physiological site of modification was 
verified using a PCNA mutant, K164R, which lacks the conserved ubiquitin 
attachment site (Figure 3.6A).
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The poor reaction efficiency for PCNA mono-ubiquitylation, observed in Figure 
3.6A, was slightly improved by optimisation of various reaction conditions 
(Figure 3.6B). However, Garg and Burgers (2005) argued that efficient mono- 
ubiquitylation of PCNA by yeast Rad 18 could only be obtained if PCNA was 
loaded on DNA. These results were different from the observations for the 
human counterpart, which was shown to readily mono-ubiquitylate PCNA in the 
absence of DNA (Watanabe et a /., 2004). Thus, the results obtained in Figure 
3.6 represent only a basal activity of HlsVSVRad18-Rad6 complex towards PCNA. 
Nonetheless, taking together the results presented in Figure 3.5 and in Figure
3.6, I can conclude that the purified HlsVSVRad18-Rad6 complex exhibits an E3 
ligase activity, and retains its selectivity and specificity toward PCNA. In 
addition, these results indicate that the domains essential for the catalytic 
activity of Rad 18 are folded properly.
In 2005, Garg and Burgers (2005) showed that mono-ubiquitylated yeast PCNA  
was able to stimulate Polq and Rev1 bypass of abasic sites. As a consequence 
of this publication, the focus of my thesis has shifted. Rather than focusing on 
the characterisation of PCNA mono-ubiquitylation by the Rad18-Rad6 complex, 
I decided to study other aspects of Rad18’s function in vitro. As will be 
discussed later, those aspects proved to be tightly connected to the up-stream 
signals that activate the DNA damage tolerance response via PCNA  
modification.
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4 Results II: Interactions of the Rad18-Rad6 
Complex and DNA
4.1 Introduction
Originally, the open reading frame of the RAD18 gene from S. cerevisiae was 
suggested to contain three potential nucleic acid binding domains with 
homology to ZnFs (Chanet e ta l., 1988; Jones et al., 1988; Bailly et al., 1997b). 
Two of these three domains form a RING domain, which nowadays is 
suggested to be responsible for the ubiquitin ligase activity of Rad18 (Ulrich and 
Jentsch, 2000), while the third domain is a classical ZnF domain. In addition, 
yRad18 contains a putative SAP domain that may contribute to its DNA-binding 
activity.
The ability of the Rad18 protein to bind ssDNA was initially determined by pull­
down experiments from yeast cell extracts using an ssDNA-agarose column. In 
addition, radiolabelled ssDNA was shown to bind to immunopurified Rad 18, 
transferred onto a nitrocellulose membrane (Bailly et al., 1994). Later, this was 
confirmed by filter binding assays with purified Rad18-Rad6 complex from S. 
cerevisiae (Bailly et al., 1997a). However, these filter binding experiments were 
performed at low salt concentration of 15 mM KCI using poly(dT) 
oligonucleotides that were, in average, 221 nt long. Most probably, these 
conditions do not represent the physiological conditions found inside yeast 
cells. Nonetheless, these findings led to the hypothesis that yeast Rad 18 could 
recognise and bind to ssDNA stretches resulting from DNA damage sites, thus 
mediating DNA damage bypass (Bailly etal., 1997a).
In order to gain additional insights regarding the DNA-binding properties of 
yeast Rad 18 and to compare its properties with those of the human protein 
(Nakajima et al., 2006; Notenboom et al., 2007; Tsuji et al., 2008), further 
characterisation of the interaction between Rad 18 and DNA was carried out.
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4.2.1 Rad18 Binding to ssDNA is Affected by NaCI
In order to test the ssDNA-binding properties of the purified H,sVSVRad18-Rad6 
complex described in Chapter 3, biotinylated oligonucleotides were immobilized 
onto streptavidin beads and used in pull-down experiments. The retention of the 
H'8Vs vR a d 1 8 - R a d 6  complex on ssDNA was detected by Western blot analysis.
In Bailly et al. (1997a), increasing sodium chloride (NaCI) concentrations were 
shown to displace Rad 18 from ssDNA by filter binding assays. At 100 mM NaCI, 
about 40%  of bound Rad18 was displaced whereas at 250 mM NaCI, more than 
95%  of bound Rad18 was displaced from the ssDNA. In order to test the effect 
of NaCI on the interaction between Rad18 and ssDNA in our system, 
HlsVSVRad18-Rad6 was incubated at a range of NaCI concentrations with an 
immobilized oligonucleotide. The ionic strength was kept constant in each of the 
samples throughout the experiment, including the washing steps. After elution, 
the samples were subjected to SDS-PAGE and analysed by Western blotting. 
As shown in Figure 4.1, the Rad18 signal gradually decreased as the NaCI 
concentration increased. However, some non-specific binding of Rad18 to the 
DNA-free streptavidin beads was also detected.
To avoid this background signal, the same experiment was repeated incubating 
the H,sVSVRad18-Rad6 complex and the ssDNA with the same binding buffers as 
in Figure 4.1 but using more stringent washing conditions. The PD High-Salt 
Binding buffer (250 mM NaCI) was used in the washing steps for all of the 
binding reactions and the samples were analysed as before. As shown in 
Figure 4.2, the background signal was now abolished, and only specific signals 
of Rad18 binding to ssDNA-bound streptavidin beads were detected. 
Surprisingly, even at these stringent washing conditions, a significant Rad 18 
signal was observed for the samples in which the initial binding buffer contained 
NaCI concentration equivalent to or lower than 50 mM. As before, the affinity of 
Rad 18 for ssDNA had decreased with the increase of NaCI concentration in the 
binding buffer (Figure 4.1).
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NaCI 0 mM 50 mM 100 mM 150 mM 250 mMi-------------------- n------------------ n------------------- n------------------- n-----------------1
input bound
i— — i-------------------------------------------------------------------------------------------- 1
ssDNA _ ~ + + - +  + -  + + - +  + -  + +
Hl8VSVlRad18 + □
Figure 4.1 -  Rad18 binding to ssDNA is affected by NaCI
The H*vsvRad18-Rad6 complex (5 or 25 pmol) was incubated with a 75mer of mixed 
sequence (no. 870; ~ 5 pmol) at 4°C for 1 hour in PD Low-Salt Binding buffer 
supplemented with different NaCI concentrations (0, 50, 100, 150 and 250 mM NaCI). 
Then, the beads were washed 3 times in respective binding buffers and twice with 
respective buffers with no BSA. After elution, the samples were subjected to SDS-PAGE  
followed by Western blotting. Rad 18 was detected with anti-Rad18 antibody (polyclonal 
mouse 4 serum). The rectangle in the label of the figure refers to the maximal amount of 
protein used, which in this case was 25 pmol.
NaCI
input
0 mM 50 mM 100 mM 150 mM--------------- n---------------------n-------------------- n------------------
bound
HisVSVRad18 □
anti-Rad18
Figure 4.2 -  Rad18 binding to ssDNA is stable even after stringent 
washing
The Hi# Rad18-Rad6 complex (5 or 25 pmol) was incubated with a 75mer of mixed 
sequence (no. 870; ~ 5 pmol) at 4°C  for 1 hour in PD Low-Salt Binding buffer 
supplemented with different NaCI concentrations (0, 50, 100, 150 and 250 mM NaCI). 
Then, the beads were washed 3 times with PD High-Salt Binding buffer and twice more 
with the same buffer with no BSA. After elution, the samples were subjected to SDS- 
PAGE followed by Western blotting. Rad18 was detected with anti-Rad18 antibody 
(polyclonal mouse 4 serum).
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4.2.2 Rad18 Binds Directly to ssDNA
It was essential to establish that the binding of Rad18 to ssDNA was specific in 
our system. To this end, the retention of recombinant yeast Rad6, which was 
never reported to bind DNA on its own and does not contain any known DNA- 
binding motifs (Bailly et al., 1994), was evaluated in parallel to that of the 
H'svsvRad18-Rad6 complex. Their binding to ssDNA was tested at low salt 
concentrations with PD Low-Salt Binding buffer containing 15 mM KCI but no 
NaCI. As shown in Figure 4.3, H,sVsVRad18 was able to bind to an immobilized 
oligonucleotide, but did not bind to the DNA-free streptavidin beads. In contrast, 
binding of the recombinant Rad6 either to the DNA-free or to the ssDNA-bound 
streptavidin beads was not detected. Nevertheless, when Rad6 was present in 
a complex with H,sVSVRad18, it was retained on the ssDNA-bound beads, 
indicating that it was brought to the DNA via Rad18. Note that in Figure 4.3 the 
recombinant Rad6, purified from E. coli, is slightly larger than the Rad6, purified 
as a complex with HlsVSVRad18 from insect cells, due to a few additional 
residues that were left after its N-terminal tag was cleaved (see 2.12.4).
4.2.3 Kinetics of the interaction between the Rad18-Rad6 
complex and ssDNA
According to Figure 4.2, HlsVSVRad18, retained on ssDNA at low salt 
concentrations, could be subjected to washing at high-salt concentrations 
without significant loss of binding. This finding suggested that the binding of 
H,sVsvRac| l8  to ssDNA at low ionic strength might confer an improved stability to 
their association during subsequent stringent washing steps. Therefore, the 
kinetic behaviour of Rad 18 binding to ssDNA was analysed. The HlsVSVRad18- 
Rad6 complex was incubated with an immobilized oligonucleotide for different 
periods of time under conditions of low salt concentration, followed by washing 
steps with high-salt buffer. As demonstrated in Figure 4.4, a slight signal, 
corresponding to Rad18 binding, could be already detected after 5 minutes of 
incubation. However, at 30 minutes of incubation and onwards, the amount of 
DNA-retained Rad18 did not change significantly, suggesting a stable 
association of H,sVSVRad18 with ssDNA. According to the anti-Rad6 antibody 
Western blot, the binding pattern of Rad6 correlated with that of Rad18.
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Rad6
" ^ R a d l S
ssDNA
anti-Radi 8 
anti-Rad6
input bound
1 1--------------------------------------------------
+ - + + + +
“ + - - + +
-  -  -  +  -  +
Figure 4.3 -  Rad 18 but not Rad6 binds directly to ssDNA
The HlsVSVRad18-Rad6 complex or the recombinant Rad6 protein shown in Figure 5.1 
were used. Approximately 5 pmol of each protein were incubated with a 75mer 
oligonucleotide of mixed sequence (no. 870; -  5 pmol) at 4°C for 1 hour in PD Low-Salt 
Binding buffer. The beads were washed 3 times in PD High-Salt Binding buffer and 
twice with the same buffer with no BSA. After elution, the samples were subjected to 
SDS-PAGE followed by Western blotting. Rad 18 was detected with anti-Rad18 
antibody (polyclonal mouse 4 serum) and Rad6 was detected with anti-Rad6 antibody.
input bound
Time (min.)
1
-  60 5 10 20
..— ~i
30 45 60
ssDNA -  -  + + + + + +
anti-Rad18 *
anti-Rad6 • _  —
Figure 4.4 -  Kinetics of the interaction between the Rad18-Rad6 complex 
and ssDNA
The Hi8VSVRad18-Rad6 complex (5 pmol) was incubated with a 75mer oligonucleotide of 
mixed sequence (no. 870; -  5 pmol) at 4°C for different time points, as indicated 
above, in PD Low-Salt Binding buffer (15 mM KCI). The beads were washed 3 times in 
PD High-Salt Binding buffer (15 mM KCI and 250 mM NaCI) and twice with the same 
buffer with no BSA. After elution, the samples were subjected to SDS-PAGE followed 
by Western blotting. Rad 18 was detected by anti-Rad18 antibody (polyclonal mouse 4 
serum) and Rad6 was detected by anti-Rad6 antibody.
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4.2.4 The Effect of Salt Type on Rad18’s Binding to ssDNA
As shown in Figure 4.2, Rad18’s binding to ssDNA was sensitive to NaCI 
concentration. However, not only salt concentration but also salt type can affect 
the binding of a protein to other proteins or to DNA. For instance, anion-specific 
effects could result from anions interacting at binding sites at the protein-water 
interface (Griep and McHenry, 1989) and interfere with the binding of Rad18 to 
ssDNA. Accordingly, in some cases, protein-DNA interactions were found to be 
less salt-sensitive to glutamate than to chloride (Paz-Elizur et a/., 1996). 
Following a study suggesting that glutamate is the major intracellular anion in E. 
coli (Richey et al., 1987) and another suggesting that acetate-based buffers are 
preferred for DNA helicases’ activity derived from yeast or human (Bachrati and 
Hickson, 2006), I decided to carry out DNA-binding experiments in buffers 
containing different salt types and concentrations.
H'sVsVRad18-Rad6 was incubated with an immobilized oligonucleotide at various 
conditions as described in the figure legend below (Figure 4.5). Following one- 
hour incubation at 4°C, the beads were washed in parallel with a buffer 
containing 250 mM of the corresponding salt type. After elution, samples were 
subjected to SDS-PAGE and analysed by Western blotting. As shown in Figure 
4.5A and Figure 4.5B, the affinity of Rad18 for ssDNA was reduced as salt 
concentration increased. However, for the glutamate salts as well as for the 
acetate salts this reduction was less pronounced at the intermediate salt 
concentration (100 mM).
As the experiment using potassium salts (Figure 4.5A), was done separately 
from the experiment using sodium salts (Figure 4.5B), the effect of all six salt 
types was tested in parallel using the same salt concentration (100 mM). As 
shown in Figure 4.5C, the positive effects of glutamate and acetate on the 
interactions between Rad18 and ssDNA, proposed by Figure 4.5A and Figure 
4.5B, were confirmed. Apparently, a change in the cationic salt composition 
(sodium versus potassium) did not have a significant effect on these 
interactions.
- 1 5 6 -
Chapter Four: Results II
A.
Potassium salt Chloride Glutamate Acetate
Salt concentration (mM)
T II
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II
15 100 250
1
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— + + + -  + + +
1
-  + + +
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• *- ■
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B.
Sodium salt Chloride Glutamate Acetate
Salt concentration (mM)
1 V!
15 100 250 15 100 250 15 100 250
control
I"
input
ii ii i i
bound
ssDNA -
r~ ii I + + + I + + +
... t 
— + + +
anti-Rad 18 £ -
-
C.
Anion type 
Cation type
ssDNA 
anti-Rad 18
Chloride Glutamate Acetate
Na K Na K Na K
input bound (100 mM salt)
F ig u re  4 .5  -  R a d 1 8  b in d in g  to  s s D N A  is less  s e n s itiv e  to  g lu ta m a te  o r  to  
a c e ta te  th a n  to  c h lo r id e  a n io n
A. The Hi#vsvRad18-Rad6 complex (5 pmol) was incubated with a 75mer 
oligonucleotide of mixed sequence (no. 870; -  5 pmol) at 4°C for 1 hour in PD Low-Salt 
Binding (“- KCI”) buffer with different concentrations of potassium salts as indicated 
(15, 100 and 250 mM of potassium chloride, potassium glutamate and potassium 
acetate). Beads were then washed 3 times in PD Low-Salt Binding (“- KCI”) buffer 
supplemented with 250 mM of the corresponding salt type and twice more in the same 
buffer with no BSA. The positive control sample was bound in PD Low-Salt Binding and 
was washed with PD High-Salt Binding buffer. After elution, the samples were 
subjected to SDS-PAG E followed by Western blotting. Rad18 was detected with anti- 
Rad 18 antibody (polyclonal mouse 4 serum).
B. Same as in A., but instead of potassium salts, sodium salts were used for binding as 
indicated (15, 100 and 250 mM of sodium chloride, sodium glutamate and sodium 
acetate). For washing, PD Low-Salt Binding (“- KCI”) buffer was supplemented with 
250 mM of the corresponding salt type.
C. Same as in A., but instead of different salt concentrations, Rad 18 was bound to the 
oligonucleotide in PD Low-Salt Binding (“- KCI”) containing 100 mM of different salt 
types as indicated. The beads were washed with PD Low-Salt Binding (“- KCI”) buffer 
that was supplemented with 250 mM of the corresponding salt type.
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4.2.5 Rad18 Binds to Different Lengths of ssDNA
Bailly et al. (1997a) found that the yRad18 protein bound to poly(dT) 
oligonucleotides and to M13 ssDNA of a mixed nucleotide sequence. When 
considering non-sequence specific ssDNA-binding properties of a protein, as in 
the case of Rad18, the DNA can be viewed as a series of overlapping binding 
sites, each equivalent in size to the protein’s binding site (Kim et al., 1992). To 
determine the minimal binding site of Rad 18, gel-purified biotinylated poly(dT) 
oligonucleotides, consisting of different lengths were pre-bound to streptavidin 
beads. 5 pmol of the H,sVSVRad18-Rad6 complex were incubated with 
approximately 5 pmol of each oligonucleotide per reaction. As shown in Figure
4.6, Rad 18 retention on ssDNA was enhanced on the longer oligonucleotides. A 
signal for Rad 18 binding to the oligonucleotides shorter than 35 bases or to the 
DNA-free beads was barely detected. This implies that the minimal binding site 
of Rad 18 to ssDNA is between 25 and 35 nt long, although this result may be 
influenced by the experimental set up (see 4.3.3.3 below).
4.2.6 The Rad18-Rad6 complex binds to different DNA 
structures
According to Bailly et al. (1997a), yRad18 was found to preferentially bind to 
ssDNA compared to dsDNA. However, their experiments did not address 
whether Rad18 could bind to other DNA structures. In addition, PCNA, Rad18’s 
substrate, is known to be required for processive replication and DNA repair 
events (Biswas et al., 1995), which are all processes involving dynamic 
changes in the DNA structure. Moreover, PCNA ubiquitylation was shown to 
require replication or repair intermediates in vivo (Sarkar et al., 2006; Davies et 
al., 2008) and efficient Rad 18-dependent PCNA ubiquitylation in vitro was 
obtained only when the PCNA was loaded on the DNA (Garg and Burgers, 
2005). Thus, it is conceivable that Rad 18 might encounter a variety of DNA 
structures in vivo. Therefore, it was important to assess the structure specificity 
of Rad 18 binding to DNA. To this end, different DNA structures were prepared 
(Table 2-9) and immobilized on streptavidin beads. Two different amounts of 
the HisVsVRad18-Rad6 complex were incubated with each DNA structure and the 
retention of Rad 18 was analysed in PD Low-Salt Binding buffer or in the same
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buffer supplemented with 100 mM NaCI. As shown in Figure 4.7, at both 
experimental conditions, Rad 18 bound to ssDNA as expected. In addition, it 
bound to the branched DNA structures. At the low salt concentration, Rad18 
retention to the 3-F lap  structure seemed somewhat better than its retention to 
the 5 ’-Flap structure or to the ssDNA. This small effect was reproducible. In 
addition, the signal obtained for Rad 18 binding to the Splayed Duplex structure 
was comparable to that obtained for the ssDNA. In contrast, at 100 mM NaCI, 
the overall retention of Rad18 to any DNA structure seemed reduced and 
visualisation of a clear signal required longer exposure of the blot (compare the 
signal intensity of the input sample as well as the background signal for 
Rad18’s retention to the DNA-free beads between the two experiments). At this 
salt concentration, Rad18 bound best to the Splayed Duplex structure, also in 
comparison to the ssDNA. What was apparent from both experiments was that 
the least preferred structure was the dsDNA. Surprisingly, despite the absence 
of ssDNA in the dsFork structure, Rad 18 bound it better compared to the 
dsDNA structure (see Figure 4.7 -  upper panel).
4.3 Discussion
4.3.1 Advantages and Disadvantage of the Experimental 
Methods
In order to characterise the binding properties of Rad18 to DNA, I used pull­
down experiments with biotinylated oligonucleotides bound to streptavidin 
beads. Although this method enabled me to study different aspects of Rad18 
interaction with DNA as will be discussed below, it had several disadvantages 
over other experimental methods, i.e. filter-binding assay or gel-shift assay. In 
contrast to the latter, where the binding molecules are analysed in solution, in 
pull-down experiments either the DNA or the protein has to be immobilized on 
beads, thus creating an artificial situation. In addition, as the protein is detected 
by Western blotting, this method is less sensitive by a few orders of magnitude 
compared to gel-shift assay or to filter-binding assay, in which the DNA is 
detected by radioactive labelling. Furthermore, due to the non-linear nature of 
the ECL reagent used to develop the Western blot, the results that were
obtained by the pull-down experiments could not be considered quantitative.
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input bound
i---------1 i----------------------------
dT length (b) -  -  15 25 35 45 60
ssDNA -  - + +  + + +
anti-Rad 18
F ig u re  4 .6  -  T h e  R a d 1 8 -R a d 6  c o m p le x  b in d s  to  d if fe re n t o lig o  d T  le n g th s
The HlsVSVRad18-Rad6 complex (5 pmol) was incubated with poly(dT) oligonucleotides 
consisting of different lengths (15mer, 25mer, 35mer, 45m er and 60mer; oligos 1184, 
1183, 1182, 1181 and 1180, respectively) at 4°C for 1 hour in PD Low-Salt Binding 
buffer. The beads were washed 3 times in PD High-Salt Binding buffer and twice more 
with the same buffer with no BSA. After elution, the samples were subjected to SDS- 
PAGE followed by Western blotting. Rad18 was detected with anti-Rad18 antibody 
(polyclonal mouse 4 serum).
input
i 1 r
bound
nt
DNA -  -
HisVSVRad18 + □
61 61 ---------ii-------- 31 ,3*
anti-Rad18
low salt
-15 mM KCI —-*
medium salt
15 mM KCI 
+ * —  <-»
100 mM NaCI
F ig u re  4 .7  -  T h e  R a d 1 8 -R a d 6  c o m p le x  b in d s  to  d iffe re n t D N A  s tru c tu re s
The Hi#vsvRad18-Rad6 complex (5 or 25 pmol) was incubated with approximately 5 pmol of 
each DNA structure (ssDNA, dsDNA, Splayed Duplex, 5 ’-Flap, 3 ’-Flap and dsFork) at 4°C  
for 1 hour in PD Low-Salt Binding buffer (low salt; 15 mM KCI) or with the same buffer 
supplemented with 100 mM NaCI (medium salt; 15 mM KCI + 100 mM NaCI). The beads 
were washed 3 times with PD High-Salt Binding buffer (15 mM KCI + 250 mM NaCI) and 
twice more with the same buffer with no BSA. After elution, the samples were subjected to 
SDS-PAGE followed by Western blotting. Rad 18 was detected with anti-Rad 18 antibody 
(polyclonal mouse 4 serum). Note that all of the DNA structures consist of a common 
61 mer oligonucleotide -  X 0 1  (no. 1055).
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Nevertheless, this method was chosen for the following reasons. Firstly, as the 
yeast H,sVSVRad18-Rad6 complex, isolated from insect cells, was only partially 
purified, it was important to determine that the ability to bind DNA was intrinsic 
to Rad18 and was not due to a contaminant in the protein preparation. 
Preliminary gel-shift experiments to test whether Rad 18 was able to cause 
mobility retardation of the DNA resulted in a poor shift (data not shown). 
Unfortunately, this shift was also observed while using a mock-purified 
preparation, suggesting that this activity did not originate from the Rad18 
protein. However, by performing pull-down experiments followed by Western 
blot analysis, a specific signal for Rad 18 binding to the DNA was detected. 
Secondly, the pull-down method allowed the use of stringent washing steps to 
test the stability of the association between the Rad 18 protein and the DNA. 
Lastly, this method had been successfully used in a number of studies (Zou and 
Elledge, 2003; Zou etal., 2003).
Until now, the only published biochemical study regarding the DNA-binding 
properties of yeast Rad18 was based on the filter-binding assay (Bailly et al., 
1997a). Although the kinetic parameters for ssDNA-Rad18 interaction were not 
calculated, Bailly et al. (1997a) convincingly showed a preference for yRad18 
binding to ssDNA over dsDNA. Recently, Notenboom et al. (2007) have 
confirmed a binding preference for ssDNA over dsDNA also for human Rad18 
by gel shift assays. In addition, using surface plasmon resonance analysis they 
were able to show that hRad18’s SAP domain but not the ZnF was sufficient for 
binding to both ssDNA and dsDNA, and calculate the corresponding apparent 
affinities. Surface plasmon resonance technique is a quantitative and sensitive 
method, allowing real-time interaction studies between an analyte and a 
surface-immobilized ligand, by measuring the change in the refractive index 
near the surface (Fivash et al., 1998). Therefore, this method allowed 
Notenboom et al. (2007) to identify important residues in the extended loop of 
the SAP domain, which when mutated resulted in reduced affinities for DNA.
To summarise, using pull-down experiments to study the interaction of Rad 18
and DNA, I observed qualitative changes in the affinity of Rad 18 for the DNA
under various experimental conditions (different incubation times -  see Figure
4.4; different salt concentrations or salt types used in the binding buffer -  see
-161 -
Chapter Four: Results II
Figure 4.2 and Figure 4.5). Furthermore, I was able to establish that the binding 
of Rad18 to the DNA was specific (Figure 4.3) and affected by the length of the 
ssDNA (Figure 4.6) or by the DNA structure (Figure 4.7). In most cases, when I 
analysed similar questions to those already addressed by Bailly et al. (1997a), 
similar results were obtained.
4.3.2 Experimental Conditions and Specificity of Binding
The buffer used in the biotinylated pull-down experiments contained the 
detergent NP-40 to avoid non-specific interactions between the proteins and the 
beads. In addition, the chelator EDTA was used to inhibit the contaminating 
nuclease activity observed in the H,sVSVRad18-Rad6 protein preparation. The 
binding reactions were performed at 4°C to ensure the stability of all the 
components during the binding.
As shown in Figure 4.3, Rad18 did not bind to the DNA-free beads. This 
supports the notion that the conditions used for the experiment resulted in a 
specific binding of Rad18 to the DNA. Moreover, Rad6 did not bind to the DNA 
on its own. Nonetheless, in the presence of Rad18, a significant percentage of 
Rad6 was pulled down, suggesting that when Rad6 is bound to Rad18 it can be 
brought to the DNA. This observation is consistent with previously published 
data (Bailly eta l., 1994; Bailly etal., 1997a).
4.3.3 DNA-Binding Properties of Rad18
4.3.3.1 Binding Affinity
According to paragraph 4.2.1, the amount of Rad18 retained on the DNA was 
reduced with increased NaCI concentration, suggesting that the NaCI in the 
binding buffer reduced the affinity of Rad18 for ssDNA. This is consistent with 
Bailly et al. (1997a), in which Rad 18 binding to the DNA was shown to be 
sensitive to increasing concentrations of salt. Noticeably, as shown in Figure 
4.2, once Rad 18 was bound to ssDNA at low salt concentration (15 mM KCI or 
15 mM KCI + 50 mM NaCI) even repeated washing steps at high salt 
concentration (up to 250 mM NaCI) did not result in a complete dissociation of
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Rad 18 from the DNA, whereas in the binding reactions with higher salt 
concentrations (100 mM up to 250 mM), Rad 18 binding to the DNA was no 
longer detected. These findings suggest that high NaCI concentrations can 
disrupt the association of Rad18 with DNA. However, once Rad18 binds to the 
DNA in low NaCI concentrations, it may undergo a conformational change that 
improves its resistance to the effects of NaCI.
Unfortunately, these results cannot directly predict the binding properties of 
Rad18 to DNA in vivo. It is plausible that yet unidentified post-translational 
modifications of Rad18 and / or interaction with other proteins could influence 
its affinity for ssDNA. In addition, local salt or protein concentrations might affect 
the binding of Rad18 to the DNA in vivo. Nonetheless, the ionic strength in 
yeast cells is most probably higher than 50 mM NaCI. Hence, Rad 18 might not 
be able to bind DNA under physiological conditions.
When comparing the effect that different salt types had on Rad18 binding to 
ssDNA (Figure 4.5), both glutamate and acetate seemed to relax Rad18 
sensitivity towards increasing salt concentrations in comparison to chloride. One 
explanation could be a differential effect that those anions have on the water 
molecules that mediate the hydrogen bonds between the protein and the DNA 
(Lilley, 1995). As mentioned in the introduction, the Hofmeister series is an 
empirical ranking of anions reflecting their effects on protein solubility and 
based on more recent studies, a similar ranking order of anions that enhance 
protein-DNA interactions was suggested to be: glutamate > fluoride > acetate > 
cloride > bromide = nitrate > iodide > hypochloride (Griep and McHenry, 1989). 
According to Figure 4.5, chloride ion seems to have a stronger disrupting effect 
on the interaction between Rad 18 and ssDNA than glutamate or acetate. 
Consequently, it is likely that Rad18 binding to the DNA behaves according to 
the Hofmeister series.
4.3.3.2 Binding Kinetics
As observed in Figure 4.4, the binding of Rad18 to ssDNA at low salt 
concentrations resulted in their stable association towards subsequent high-salt 
washing. Although the high-salt washing steps took almost one hour, the
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differences in the amount of bound Rad 18 between the short low-salt incubation 
times and the longer low-salt incubation times were noticeable. This suggests 
that the salt-resistant binding of Rad 18 to the DNA was not an immediate 
reaction but rather occurred gradually in a time scale of a few minutes. After 30 
minutes of incubation, maximal signals of Rad18 binding to ssDNA were 
obtained, and there was no apparent change to retained levels of Rad18 in the 
later time points. A possible explanation could be that the ssDNA-bound Rad18 
might undergo a slow conformational change that stabilises its binding to the 
ssDNA and reduces its dissociation rate. The results are consistent with this 
model as once this conformational change occurs, the stringent washing 
conditions do not lead to a significant loss of Rad18’s binding. An additional 
experiment should have been performed to test if the binding of Rad18 to 
ssDNA is rescued by using low-salt instead of high-salt washing steps after the 
short low-salt incubation times. This result would have argued in favour of the 
proposed model.
In parallel to Rad18 binding, Rad6 was also retained on the DNA through its 
interaction with Rad 18 and its binding kinetics correlated with those of Rad 18.
Bailly et al. (1997a) performed the only published experiment addressing the 
binding kinetics of full-length yRad18 to the DNA. After 10 min incubation with 
radiolabelled ssDNA, an excess of cold ssDNA was added at indicated time 
points. Already after less then 2 min incubation, the relative binding was 
reduced to 20%, suggesting a relatively fast off-rate. Unfortunately, their result 
cannot be directly compared to the result from Figure 4.4, as the latter reflected 
a time course of salt-resistant DNA-protein association and not an assay for the 
off-rate of pre-bound Rad18-ssDNA complex.
4.3.3.3 Minimal Binding Site
Until now, the minimal binding site of the Rad18-Rad6 complex to the DNA has 
not been determined. Derived from Figure 4.6, it can be estimated that the 
minimal binding site required for binding of the Rad18-Rad6 complex to the 
ssDNA is between 25 and 35 nucleotides. The estimation was used in 
subsequent experiments, as will be discussed later in Chapter 6 (Figure 6.2).
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Nevertheless, the minimal occluded site of proteins can vary between solution 
conditions and might depend on the approach used for analysis (Kumaran et 
al., 2006). In our system, the ssDNA is attached on one end to streptavidin 
beads, which may cause sterical hindrance for the binding of proteins. 
Therefore, the observed minimal binding site of 25-35 nt may be an over­
estimation of the actual one.
4.3.3.4 Structure Preference
Bailly et al. (1997a) and Notenboom et al. (2007) showed that yeast and human 
Rad18, respectively, have a preference for binding ssDNA over dsDNA. 
Consequently, my initial hypothesis was that the ssDNA would be the preferred 
structure in both tested salt conditions (Figure 4.7). In addition, if Rad18 could 
only bind to ssDNA, one should expect that the relative amount of bound Rad18 
would correspond to the relative length of ssDNA region in a particular DNA 
structure. Although the amount of bound Rad18 on ssDNA and on the Splayed 
Duplex structure at the low salt concentration is comparable, Rad18 binds 
somewhat better to the 3’-Flap. Moreover, at the higher salt concentration, the 
DNA structural preference of Rad 18 has slightly changed towards the Splayed 
Duplex, indicating that NaCI might influence the protein’s conformation and 
consequently, its binding preferences to different DNA structures. Additionally, 
the salt may influence the DNA structure. According to these in vitro results, it 
seems that Rad 18 can bind to DNA-branched structures. Consistently, Tsuji et 
al. (2008) have recently demonstrated that human Rad 18 binds preferentially to 
forked DNA structures and to long ssDNA, suggesting that potentially Rad 18 
could recognise similar DNA intermediates resulting from replication fork 
stalling.
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5 Results III: Interactions of the Rad18-Rad6 
Complex and RPA
5.1 Introduction
Until recently, the up-stream signals that lead to the activation of the RAD6 
pathway by PCNA ubiquitylation were not clear. As mentioned before, it was 
presumed that the ssDNA-binding ability of Rad 18 allowed it to directly 
recognise ssDNA stretches resulting from DNA damage sites, thus mediating 
DNA damage bypass (Bailly et al., 1997a). However, the results presented in 
Chapter 4 suggest that under physiological conditions, yeast Rad18 is not able 
to bind ssDNA on its own. In parallel, recent findings in the laboratory provided 
additional clues regarding the signals required for PCNA ubiquitylation. Firstly, 
analysis of the cell-cycle dependence of PCNA ubiquitylation revealed that this 
modification occurs in S phase in response to DNA damage, but not in G1 or 
G2 arrested cells (Davies et al., 2008, Figure 1A in Appendix). Subsequently, 
using a temperature-sensitive mutant of an essential kinase gene responsible 
for DNA replication initiation, cdc?As, active replication forks were shown to be 
required for PCNA ubiquitylation (Davies et al., 2008, Figure 2 in Appendix). In 
addition, as over-expression of Rad18 relaxed the conditions required for PCNA  
modification (Davies et al., 2008, Figure 1B in Appendix), it appears that under 
normal conditions, the E3 ligase is a limiting factor for PCNA ubiquitylation. 
Secondly, induction of PCNA modification correlated with treatment of DNA 
damaging agents that cause accumulation of ssDNA (Davies et al., 2008, 
Figure 3 in Appendix). As ssDNA bound to RPA was suggested to be the signal 
for activation of the replication checkpoint (Zou and Elledge, 2003; Zou et al., 
2003), the possible contribution of RPA to PCNA ubiquitylation was studied. 
Interestingly, when Rfa1, the largest subunit of the RPA complex, was depleted 
to about 5% by the use of a heat-inducible degradation signal (Dohmen et al., 
1994), PCNA ubiquitylation was abolished. However, at the same time, the S 
phase dependent PCNA sumoylation seemed to be unaffected (Davies et al., 
2008, Figure 4E in Appendix). Taken together, these results suggested that 
upon DNA damage, PCNA is ubiquitylated on stalled replication forks and that 
RPA is required for the induction of this modification. As Rad18 was found to be
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a limiting factor for PCNA ubiquitylation, RPA-bound ssDNA could be involved 
in the recruitment of Rad18 to stalled replication forks. To test this possibility, 
the interaction between Rad18 and RPA was studied. Co-immunoprecipitation 
experiments showed that RPA and Rad18 interacted in vivo with each other 
(Davies et al., 2008, Figure 5G in Appendix). Furthermore, by two-hybrid 
analysis, Rad18 (but not Rad5) was found to interact with two subunits of the 
RPA complex, Rfa1 and Rfa2 (Davies et al.t 2008, Figure 5A in Appendix). In 
order to gain additional insights into the mechanism of the interaction between 
Rad 18 and RPA, in vitro studies were carried out.
5.2 Results
5.2.1 Rad18 Interacts Directly with RPA
The recombinant yeast RPA complex was purified from E. coli, and as shown in 
Figure 5.1 (lane 3), it consists of three subunits: Rfa1, Rfa2 and Rfa3, with 
corresponding molecular weights of 69, 36 and 13 kDa, as expected. In order to 
test whether Rad 18 and RPA interact physically with each other, RPA was 
covalently coupled to CH-sepharose beads. Subsequently, pull-down 
experiments with the H,sVSVRad18-Rad6 complex in the presence of a non­
specific nuclease were performed. As shown in Figure 5.2, Rad18 was retained 
on the RPA- but not on the BSA-derivatised beads, suggesting that the two 
proteins interact physically with each other. To determine if Rad6 can bind to 
RPA directly or indirectly via its association with Rad 18, the recombinant Rad6 
protein and the H,sVSVRad18-Rad6 complex were assayed for interactions with 
RPA in a similar manner to that described above. H|SPCNA was used as a 
negative control since it was never reported to interact directly with RPA. As 
shown in Figure 5.1 (lanes 1 and 2), approximately 50 pmol of HlsVSVRad18- 
Rad6 complex had a comparable Coomassie staining to approximately 20 pmol 
of recombinant Rad6. 10% of these amounts were used as input for the 
experiment. As shown in Figure 5.3, Rad6 was able to interact with RPA either 
in the presence or in the absence of Rad18, suggesting that its interaction with 
RPA was direct. However, HisPCNA did not bind to RPA, indicating that the 
experimental conditions allowed only specific interactions with RPA, as in the 
case of the HisVSVRad18-Rad6 complex and the recombinant Rad6 protein.
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Coomassie
55 - 
45 - 
35 -
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1 2 5 64
Figure 5.1 -  Purified proteins used for interaction studies
The recombinant Rad6 protein (lane 1; 20 pmol) or the H®vsvRad18-Rad6 complex 
(lane 2; 50 pmol) were analysed by SDS-PAGE followed by Coomassie staining to 
ensure comparable amounts of Rad6. Approximately 3 pg of RPA (lane 3), GST (lane 
4), GSTRfa1 (182-421) (lane 5) or GSTRfa2 (lane 6) were visualised by Coomassie 
staining.
anti-Rad 18
Figure 5.2 -  HisVSVRad18 and RPA interact directly with each other via 
protein-protein interactions.
The His Rad18-Rad6 complex (5 pmol) was incubated in Coupled-PD Binding buffer, 
supplemented with 2.5 u benzonase, at 4°C for 1 h with either BSA- or RPA-derivatised 
beads. The beads were washed 5 times with Coupled-PD Washing buffer. After 
elution, the samples were subjected to SDS-PAGE followed by Western blotting. 
Rad 18 was detected with anti-Rad 18 antibody (polyclonal mouse 4 serum).
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Figure 5.3 -  Rad6 interacts with RPA in the presence or in the absence of 
Rad 18
Approximately 5 pmol of HisVSVRad18-Rad6 or HisPCNA or 2 pmol of Rad6 were 
incubated in Coupled-PD Binding buffer, supplemented with 2.5 u benzonase, at 4°C 
for 1 h with either BSA- or RPA-derivatised beads. The beads were washed 5 times 
with Coupled-PD Washing buffer. After elution, the samples were subjected to SDS- 
PAGE followed by Western blotting. Rad6 was detected with anti-Rad6 antibody and 
H»vsvR a c j1 g  a n c j h« p q n a  were detected with anti-His antibody.
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5.2.2 Mapping of Rad18-RPA Interaction
As mentioned before, Rad18 was shown to interact with Rfa1 and Rfa2 in the 
two-hybrid system (Davies et al., 2008, Figure 5A in Appendix). To further map 
these interactions, different truncations and mutations of the open reading 
frame of RAD18, RFA1 and RFA2 genes were analysed for their interaction by 
two-hybrid assays. The N-terminal region of Rad 18 (aa 1-192) including the 
RING domain was found to contribute most to the binding of both subunits, 
while the ZnF and the SAP domain were found to be irrelevant (Davies et a/., 
2008, Figure 5D in Appendix); (see also Figure 1.8). In addition, the C-terminus 
of Rad18 containing the region essential for Rad6 binding (Bailly et al., 1997b), 
was found to be dispensable for Rad18’s interactions with both Rfa1 and Rfa2 
(Davies et al., 2008, Figure 5D in Appendix); (see also Figure 1.8).
In parallel, amino acids 167-452 of Rfa1, which consist of the primary DNA- 
binding domain (OB folds A and B), were found to be sufficient for the 
interaction with Rad18 (Davies et al., 2008, Figure 5E in Appendix); (see also 
Figure 1.3). With regard to Rfa2, the interaction domain could not be further 
narrowed by two-hybrid due to auto-activation behaviour of its constructs in the 
assay.
In order to determine if Rfa2 or the DNA-binding domain of Rfa1 were able to 
directly interact with Rad18, in vitro pull-down assays were carried out.
GSTRfa1 (182-421), the primary DNA-binding domain of yRfal (Gomes and 
Wold, 1996; Bochkarev et al., 1997; Bochkarev et al., 1999; Walther et al., 
1999; Park et al., 2005), or GSTRfa2 were purified recombinantly from E. coli and 
visualised by Coomassie staining in Figure 5.1 lane 5 or lane 6, respectively. 
The interaction between the HlsVSVRad18-Rad6 complex and the GSTRfa1 (182- 
421) or the GSTRfa2 proteins was studied by pull-down experiments. As shown 
in Figure 5.4 and in Figure 5.5, the complex was able to bind to GSTRfa1 (182- 
421) or to GSTRfa2, respectively, but not to GST alone or to the protein-free 
glutathione sepharose beads.
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Figure 5.4 -  GSTRfa1 (182-421) is sufficient for Rad18 interaction
Approximately 0.5 nmol of GST or GSTRfa1 (182-421) were pre-immobilized on 
glutathione sepharose in GST-PD Binding buffer for 30 min at 4°C. After a brief wash 
with GST-PD Binding buffer, 10 pmol of H,sVSVRad18-Rad6 were added in the same 
buffer containing 100 ^ig/mL BSA and incubated at 4°C for 1 h. Then, the beads were 
washed 3 times with 500 of GST-PD Binding buffer containing BSA and twice more 
with the same buffer without BSA. After elution, the samples were subjected to SDS- 
PAGE followed by Coomassie staining or Western blotting. Rad 18 was detected with 
anti-Rad 18 antibody (polyclonal mouse 4 serum).
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Figure 5.5 -  GSTRfa2 is sufficient for Rad18 interaction
Approximately 0.5 nmol of G ST or GSTRfa2 were pre-immobilized on glutathione 
sepharose in G ST-PD  Binding buffer for 30 min at 4°C. After a brief wash with GST-PD  
Binding buffer, 10 pmol H,sVSVRad18-Rad6 were added in the same buffer containing 
100 ng/mL BSA and incubated at 4°C for 1 h. Then, the beads were washed 3 times 
with 500 [iL of G ST-PD  Binding buffer containing BSA and twice more with the same 
buffer without BSA. After elution, the samples were subjected to SDS-PAGE followed 
by Coomassie staining or Western blotting. Rad18 was detected with anti-Rad18 
antibody (polyclonal mouse 4 serum).
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5.3 Discussion
As shown in Figure 5.2, the HlsVSVRad18-Rad6 complex and RPA interact 
physically with each other. This is in agreement with the results obtained by the 
two-hybrid and by the co-immunoprecipitation assays performed in Davies et al. 
(2008). By including a non-specific nuclease in the pull-down experiment 
(Figure 5.2), I found that the interaction between HlsVSVRad18-Rad6 complex 
and RPA occurs via protein-protein interactions and is not mediated by DNA.
Similarly, Rad6 was found to directly interact with RPA, either in the presence or 
in the absence of Rad 18 (Figure 5.3). Unfortunately, as yRad18 cannot be 
purified on its own, I was unable to separate the contribution of the Rad6 
protein on the interaction between Rad18 and RPA. In principle, these results 
cannot exclude that Rad6 recruits Rad 18 to RPA, and that the interaction 
between the latter two proteins is indirect. However, as mentioned earlier, the 
C-terminal region of Rad18, which is required for Rad6 binding (Bailly et al., 
1997b), was dispensable for its interactions with Rfa1 and Rfa2 (Davies et al., 
2008, Figure 5D in Appendix). Therefore, this possibility seems unlikely. Taken 
together, these results indicate that both Rad 18 and Rad6, separately or as a 
complex, are able to directly interact with RPA. However, the contribution of 
each individual protein to this interaction is still unknown.
Since Rad6 is an ubiquitin-conjugating enzyme that cooperates with additional 
ubiquitin ligases, Brel (Hwang etal., 2003) and Ubr1 (Dohmen etal., 1991), the 
significance of the interaction between Rad6 and RPA could extend beyond the 
DNA damage tolerance pathway. In principle, this interaction could have 
additional consequences, such as for gene transcription via modulation of 
histone H2B ubiquitylation or for protein degradation of the N-end rule 
substrates, but this has yet to be determined.
Due to the essential roles of PCNA and RPA during replication, it is plausible 
that they are in the proximity of each other. Nevertheless, up to date there is no 
published evidence regarding their physical interaction. Consequently, H|SPCNA 
was included as a negative control in the pull-down with RPA-derivatised 
beads. As H,SPCNA bound neither to the BSA- nor to the RPA-derivatised
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beads, the identified interactions of RPA with either Rad 18 or Rad6 in this 
experiment are likely to be specific.
By means of the two-hybrid analysis in Davies et al. (2008), the interactions 
between the Rad 18 protein and the individual subunits of RPA were further 
mapped. Subsequently, pull-down assays with GSTRfa1 (182-421) verified the 
two-hybrid results and established that the DNA-binding domain of Rfa1 is 
sufficient for the interaction with Rad 18 (Figure 5.4). Similarly, pull-down assays 
with GSTRfa2 were consistent with the two-hybrid results and determined that 
this subunit was sufficient for the interaction with Rad18 (Figure 5.5). In 
addition, these experiments revealed that both Rfa1 and Rfa2 subunits 
contribute independently to the interaction with Rad 18. Accordingly, it is likely 
that Rad18’s affinity for the RPA complex is greater than its affinities for each 
one of the individual subunits.
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6 Results IV: Interactions of the Rad18-Rad6 
Complex, RPA and ssDNA
6.1 Introduction
As described in Chapter 5, yeast Rad 18 physically interacts with RPA. 
According to Chapter 4, and in agreement with previously published data (Bailly 
et al., 1997a), yeast Rad18 has intrinsic ssDNA-binding activity. Therefore, I 
was interested to test how the addition of ssDNA affects the interaction between 
Rad18 and RPA. In addition, since GSTRfa1 (182-421), the primary DNA-binding 
domain of Rfa1, was found to be sufficient for direct interaction with H,sVSVRad18 
(Figure 5.4), it was important to determine if this domain was able to bind to 
Rad 18 and to ssDNA simultaneously. This would provide essential insights 
regarding the nature of the interaction between Rad 18 and RPA.
6.2 Results
6.2.1.1 ssDNA Stimulates the Interaction between Rad18 and
the DNA-Binding Domain of Rfa1
A simplified system was chosen to test the effects that ssDNA had on Rad 18 
interaction with the DNA-binding domain of Rfa1. I followed an experimental 
set-up that only allowed the GSTRfa1 (182-421) protein to directly interact with 
ssDNA. The DNA-binding domain of human RPA70 (181-422), had been 
crystallized with an eight nt long ssDNA (Bochkarev et al., 1997); (see Figure 
1.4). A simulation of the solution structure of the DNA-binding domain of yeast 
Rfa1 bound to ssDNA suggested a similar positioning of the oligonucleotide 
(Park et al., 2005). As the minimal binding site required for Rad18-ssDNA 
interaction was estimated to be between 25 and 35 nucleotides (Figure 4.6), 
short oligo(dT) primers of 10, 16 or 35 bases were utilised.
First, the ability of the GSTRfa1 (182-421) protein to bind ssDNA in our system 
had to be verified. This was achieved by gel-shift assays comparing the mobility 
retardation of radiolabelled oligo(dT) oligonucleotides upon incubation with
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different concentrations of GSTRfa1 (182-421). GST was used as a negative 
control, and the full RPA complex was used as a positive control. Approximately 
0.5 pmol of radiolabelled 16mer or 35mer oligo(dT) primers were incubated with 
the proteins in GST-PD Binding buffer on ice for 20 min, subjected to native gel 
electrophoresis at 4°C and analysed by Western blot. As shown in Figure 6.1, 
even though GSTRfa1 (182-421) had higher affinity for the longer 35mer 
oligo(dT) than for the 16mer oligo(dT), increasing levels of this protein resulted 
in enhancement of complex formation for both of the tested oligonucleotides. In 
contrast, GST did not bind either of them while RPA was able to efficiently bind 
to the 35mer oligo(dT) but not to the shorter 16mer oligo(dT).
Subsequently, the effect of ssDNA on the interaction between HlsVSVRad18 and 
GSTRfa1 (182-421) was assessed. Oligo(dT) primers of 10, 16 or 35 bases were 
pre-incubated with GSTRfa1 (182-421) at an ssDNA:Rfa1 ratio of 1:1 or 5:1. 
ssDNA-bound GSTRfa1 (182-421) was immobilized on glutathione beads and 
used in pull-down experiments with HlsVSVRad18-Rad6. As shown in Figure 6.2, 
ssDNA pre-bound to GSTRfa1 (182-421) had a stimulatory effect on the retention 
of HlsVSVRad18, suggesting that the E3 has higher affinity for the ssDNA-bound 
conformation of Rfa1 than for the DNA-free form of Rfa1.
Since the GSTRfa2 protein was also found to be sufficient for direct interaction 
with HlsVSVRad18 (Figure 5.5), it might be important to examine the effect of 
ssDNA on the interaction between HlsVSVRad18 and GSTRfa2. An intrinsic but low 
affinity for ssDNA was demonstrated for yeast Rfa2 (Sibenaller et al., 1998). In 
order to test the affinity of GSTRfa2 for ssDNA in our system, gel-shift experiment 
was carried out. As shown in Figure 6.3, GSTRfa2 was found to have a very low 
affinity for ssDNA compared to GSTRfa1 (182-421). Therefore, in the context of 
the full RPA complex, any effect that the ssDNA may have on the interactions 
between Rfa2 and Rad18 would likely be masked by the Rfa1 subunit. For this 
reason, the effect of ssDNA on the interaction between Rad 18 and GSTRfa2 was 
not pursued. However, it may be worthwhile to investigate this effect in the 
future, as the binding of Rad 18 to Rfa2 could result in a significant 
conformational change, and in turn affect Rad18’s association with the ssDNA. 
Additionally, ssDNA might have a significant effect on the interaction between 
this subunit of RPA and Rad18.
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I------------------------------ 1 I------------------------------1 I-------1 I-------1
GSTR ,a1 GSTRfa1
GST (182-421) GST (182-421) RPA
I 1 I-------------1 I---- 1 I-------------1 I----------1
pmol: 5 0.05 0.5 5 5 0.05 0.5 5 0.5 0.5
Figure 6.1 -  GSTRfa1 (182-421) binds to short oligos with various affinities
Approximately 0 .5  pmol of radiolabelled 16mer or 35mer oligo(dT) were incubated in 
G ST-PD Binding buffer with GST, GSTRfa1 ( 1 8 2 -4 2 1 ) or RpA as in d ite d ,  for 20 min 
on ice. The samples were subjected to native gel electrophoresis at 4°C, the gel was 
dried and 32P-labelled DNA was detected by autoradiography.
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F ig u re  6 .2  -  s s D N A  s t im u la te s  th e  in te ra c tio n  b e tw e e n  GSTR fa1 an d
HisVSVRad18
Approximately 0.5 nmol of G S T  or GSTRfa1 (182-421) were pre-incubated with oligo-dT 
of different lengths (10, 16 and 35 bases; oligo no. 1045, 1092 and 1094, respectively) 
at either ssDNA:Rfa1 ratio of 1:1 or 5:1 followed by incubation with glutathione 
sepharose beads with G ST-PD  Binding buffer. Subsequently, the beads were washed 
once with 500 [iL G ST-PD  Binding buffer containing 100 jig/mL BSA and incubated 
with 10 pmol of the HlsVSVRad18-Rad6 complex in the same buffer at 4°C for 1 h. Then, 
the beads were washed 3 times with G ST-PD Binding buffer containing BSA and twice 
more with the same buffer without BSA. After elution, the samples were subjected to 
SDS-PAG E followed by Coomassie staining or Western blotting. Rad 18 was detected 
with anti-Rad18 antibody (polyclonal mouse 4 serum).
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GSTRfa1
GST (182-421) GSTRfa2
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pmol: "  5 0.05 0.5 5 0.05 0.5 5 50 500
Short exposure
Long exposure
Figure 6.3 -  GSTRfa2 has lower affinity for ssDNA than GSTRfa1 (182-421)
Approximately 0.5 pmol of radiolabelled 35m er oligo(dT) was incubated in GST-PD  
Binding buffer with GST, GSTRfa1 (182-421) or GS Rfa2, as indicated, for 30 min at 
30°C. The samples were subjected to native gel electrophoresis at room temperature, 
the gel was dried and 32P-labelled DNA was detected by autoradiography. Note that the 
short exposure corresponds to 4 h whereas the long exposure corresponds to 48 h.
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6.2.2 Salt Concentration Defines Two Modes of Interaction
The results presented in Figure 6.2 led to the hypothesis that Rad18 could be 
recruited to RPA-coated ssDNA by means of their interaction. This model could 
also provide an explanation to the observation made in Chapter 4 regarding the 
inability of Rad 18 to bind to ssDNA by itself at an ionic strength that resembles 
physiological conditions.
In order to gain additional insights regarding the interactions between Rad18, 
RPA and ssDNA, in vitro experiments were carried out.
6.2.2.1 Interactions of Rad18 with ssDNA and RPA at High Salt 
Concentrations
In order to test how RPA affected the association of Rad 18 with ssDNA under 
conditions in which Rad18’s binding to the ssDNA by itself was not observed 
(Figure 4.2), pull-down experiments with an immobilized oligonucleotide were 
performed. Either yeast RPA or E. coli SSB were pre-incubated at increasing 
concentrations with ssDNA in a binding buffer containing 250 mM NaCI (PD 
High-Salt Binding buffer). After a brief wash, H,sVSVRad18-Rad6 was added and 
incubated for 1 h at 4°C. Following high-salt washing steps and elution, the 
retention of HlsVSVRad18 and RPA on ssDNA was examined by Western blot 
analysis. As shown in Figure 6.4, in the absence of RPA, H,sVSVRad18 binding to 
the ssDNA could not be detected. In contrast, RPA binding to the ssDNA was 
independent of the presence of HlsVSVRad18, and increasing RPA levels in the 
input resulted in increasing levels of ssDNA-bound RPA. Consistent with the 
interaction described in Chapter 5, RPA recruited H,sVSVRad18 to the ssDNA, as 
increasing levels of ssDNA-bound RPA correlated with an enrichment of 
H|sVSVRad18 on the ssDNA. Importantly, this enrichment was not observed when 
SSB was used instead of RPA, suggesting a specific contribution of RPA to 
Rad18’s association with ssDNA under these conditions.
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6.2.2.2 Interactions of Rad18 with ssDNA and RPA at Low Salt 
Concentrations
In order to test how RPA affected Rad18 binding to ssDNA under conditions 
that were previously shown to allow the interaction between Rad 18 and ssDNA 
(Figure 4.2), the experiment described in paragraph 6.2.2.1 was repeated with 
the only difference that during the incubation of the proteins with the ssDNA a 
binding buffer without NaCI was used (PD Low-Salt Binding buffer). As shown in 
Figure 6.5, under these experimental conditions, a significant level of 
H,svsvRad18 was retained on the ssDNA in the absence of RPA. Similar to 
Figure 6.4, elevated levels of RPA in the input resulted in elevated levels of 
ssDNA-bound RPA.
Surprisingly, in contrast to the recruitment behaviour observed at high salt 
conditions, increasing levels of RPA on the ssDNA now reduced the levels of 
ssDNA-bound H,sVSVRad18. However, comparable amounts of SSB competed 
much more effectively with HlsVSVRad18 than RPA for ssDNA-binding. This 
indicates that, under the tested conditions, both RPA and HlsVSVRad18 probably 
share the space on the oligonucleotide (75 nt long), whereas increasing 
amounts of ssDNA-bound SSB prevent HlsVSVRad18 from binding to the ssDNA.
6.2.2.3 Interactions of Rad18 with ssDNA and RPA under a 
Range of Salt Concentrations
The results in Figure 6.4 and Figure 6.5, suggest two different modes of 
interaction between Rad18, RPA and ssDNA, depending on the ionic strength 
of the binding buffer. In order to assess the range of salt concentrations that 
corresponded to each interaction mode, the experiment described in paragraph
6.2.2.1 was performed in PD Low-Salt Binding buffer supplemented with 
different NaCI concentrations. As shown in Figure 6.6, under salt concentrations 
equivalent to or above 100 mM NaCI, RPA can efficiently recruit HlsVSVRad18 to 
the ssDNA. However, under salt concentrations equivalent to or below 50 mM 
NaCI, RPA and HlsVSVRad18 compete for ssDNA binding. Nevertheless, even in 
the latter experimental conditions, both proteins seem to be able to occupy the 
same stretch of ssDNA.
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High salt binding (15 mM KCI + 250 mM NaCI):
input bound
s s D N A    + +  + + +
HisVSVRad18 + - +  -  + -  + + +
RPA -  + -  + -  +
SSB
anti-Rad18
+ + + 
+ + +
anti-Rfal
Figure 6.4 -  RPA can recruit Rad 18 to ssDNA in vitro
A 75mer oligonucleotide of mixed sequence (no. 870; -  5 pmol), immobilized on 
streptavidin beads, was incubated with RPA or SSB at increasing amounts (2.4, 8 or 
24 pmol) at 4°C  for 30 min in PD High-Salt Binding buffer. After a brief wash with the 
same buffer, the HlsVSVRad18-Rad6 complex (5 pmol) was added for 1 h incubation at 
4°C. The beads were washed 3 times with PD High-Salt Binding buffer and twice with 
the same buffer with no BSA. After elution, the samples were subjected to SDS-PAG E  
followed by W estern blotting. Rad 18 was detected with anti-Rad18 antibody (polyclonal 
DH1 rabbit serum - see 2 .11.1 .2 ) and Rfa1 was detected with anti-Rfal antibody. Note 
that for the RPA blot, equal fractions of input and bound material were loaded. For the 
Rad 18 blot, 1% of the input and 35%  of the bound material were loaded.
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Low salt binding (15 mM KCI):
input bound
ssDNA
HisVSVRad18
RPA
S S B
I ” 11
— +  — +  
+  -  +  -
+  +  
-  +  
+  -
i
+  +  +  +  +  +
+  +  +  +  +  +
anti-Rad18 - -
anti-Rfal •
Figure 6.5 -  Low salt concentration results in competition between Rad18 
and RPA for binding to ssDNA
A 75m er oligonucleotide of mixed sequence (no. 870; ~ 5 pmol), immobilized on 
streptavidin beads, was incubated with RPA or SSB at increasing amounts (2.4, 8 or 
24 pmol) at 4°C for 30 min in PD Low-Salt Binding buffer. After a brief wash, the 
HisvsvRa d«| 8-R a d6 complex (5 pmol) was added for 1 h incubation with the same buffer 
at 4°C. The beads were washed 3 times with PD High-Salt Binding buffer and twice 
with the same buffer with no BSA. After elution, the samples were subjected to SDS- 
PAGE followed by Western blotting. Rad18 was detected with anti-Rad18 antibody 
(polyclonal DH1 rabbit serum - see 2.11.1.2) and Rfa1 was detected with anti-Rfal 
antibody. Note that for the RPA blot, equal fractions of input and bound material were 
loaded. For the Rad18 blot, 1% of the input and 35% of the bound material were 
loaded.
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Next, I tested whether the competition observed under conditions of low ionic 
strength (Figure 6.5) was dependent on the order in which the proteins bound to 
the ssDNA. Therefore, a similar experiment to that shown in Figure 6.5 was 
carried out, but the order of addition of the proteins was reversed. At first, the 
H'sVsvRad 18-Rad6 complex was incubated with ssDNA in binding buffer without 
NaCI at 4°C for 1 h. After a brief wash, increasing levels of either RPA or SSB 
were added and allowed to incubate for additional 30 min at 4°C. The beads 
were washed with a buffer containing 250 mM NaCI. After elution, the retention 
of H,sVSVRad18 and RPA on ssDNA was analysed by Western blot as before. As 
shown in Figure 6.7, both RPA and SSB were able to displace HlsVSVRad18 from 
the ssDNA. However, SSB seemed somewhat more efficient than RPA, as 
already at the lowest amount used (0.05 pmol), SSB was able to significantly 
reduce HlsVSVRad18 binding to ssDNA whereas, at that same amount, RPA did 
not seem to have an affect on the ssDNA-bound HlsVSVRad18 levels.
6.3 Discussion
6.3.1 Ionic Strength Modulates the Interactions between 
Rad 18, RPA and ssDNA
6.3.1.1 ssDNA-Binding Properties of RPA and SSB
As mentioned in paragraph 1.3.2.4, alternative modes of RPA binding to ssDNA 
are believed to rise from differences in the number of its OB folds that contact 
the DNA (Philipova et al., 1996) (see also Figure 1.3). Kumaran et al. (2006) 
found that the occluded site size required for yeast RPA binding was affected 
by salt concentration. At NaCI concentrations equivalent to or below 100 mM, 
the apparent occluded site was 1 8 - 2 0  nucleotides, at NaCI concentrations of 
200 to 400 mM the length of this site increased to 21 -  23 nucleotides, and the 
maximal occluded site was 26 -  28 nucleotides in NaCI concentrations above 
500 mM. Accordingly, in Figure 6.1, RPA was not able to bind to the short 
16mer oligo(dT), but bound efficiently to the longer 35mer oligo(dT).
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Figure 6.6 -  Interactions of Rad18 with RPA and ssDNA under a range of salt concentrations
A 75mer oligonucleotide of mixed sequence (no. 870; ~ 5 pmol), immobilized on streptavidin beads, was incubated with RPA or SSB at 
increasing amounts (2.4, 8 or 24 pmol) at 4°C for 30 min in PD Low-Salt Binding buffer supplemented with different NaCI concentrations (0, 
50, 100, 150 and 250 mM). After a brief wash, the HlsVSVRad18-Rad6 complex (5 pmol) was added for 1 h incubation at 4°C with the same 
buffer, keeping the ionic strength constant. The beads were then washed 3 times with PD High-Salt Binding buffer and twice with the same 
buffer with no BSA. After elution, the samples were subjected to SDS-PAGE followed by Western blotting. Rad 18 was detected with anti- 
Radi 8 antibody (polyclonal DH1 rabbit serum -  see 2.11.1.2) and Rfa1 was detected with anti-Rfal antibody. Note that for the RPA blot, 
equal fractions of input and bound material were loaded. For the Rad 18 blot, 1% of the input and 35% of the bound material were loaded.
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Figure 6.7 -  RPA and SSB have higher affinity for ssDNA than Rad18
A 75mer oligonucleotide of mixed sequence (no. 870; -  5 pmol), immobilized on 
streptavidin beads, was incubated with the H®vsvRad18-Rad6 complex (5 pmol) at 4°C for 
1 h in PD Low-Salt Binding buffer. After a brief wash, RPA or SSB were added at 
increasing amounts (0.05, 0.5, 5 or 25 pmol) and the samples were allowed to incubate 
at 4°C for additional 30 min in the same buffer. The beads were washed 3 times with PD 
High-Salt Binding buffer and twice with the same buffer with no BSA. Note that in lane 5, 
the beads were subjected to the washing steps immediately after the incubation of the 
HisVSVRad18-Rad6 complex with the ssDNA. In contrast, in lane 6, after pre-incubating 
the HisVSVRad 18-Rad6 complex with the ssDNA, PD Low-Salt Binding buffer was added 
and the sample was allowed to incubate for 30 min, before the beads were washed. 
After elution, the samples were subjected to SDS-PAGE followed by Western blotting. 
Rad 18 was detected with anti-Rad18 antibody (polyclonal mouse 4 serum) and Rfa1 
was detected with anti-Rfal antibody. Note that for the RPA blot, equal fractions of input 
and bound material were loaded. For the Rad 18 blot, 1% of the input and 35% of the 
bound material were loaded.
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The binding cooperativity can be affected by salt concentrations as well. 
Kumaran et al. (2006) found two modes of ssDNA-binding for yeast RPA, with 
RPA.ssDNA ratio of 1:1 or 2:1. At low salt concentration, both binding modes 
were detected whereas high salt concentration favoured the 1:1 binding mode. 
Taken these findings together, the expected number of RPA molecules to bind 
to a 75mer was 3 for the 1:1 binding mode and 6 for the 2:1 binding mode. 
These estimations were used for the experimental set-up described in Figure 
6.4, Figure 6.5 and Figure 6.6. Correspondingly, 24 pmol of RPA in the input 
was sufficient for saturation of the ssDNA (~ 5 pmol) in all of the tested 
conditions.
As mentioned in paragraph 1.3.1, the E. coli SSB tetramer contains four OB- 
folds (one per subunit) and also has a complicated ssDNA-binding behaviour 
that depends on the solution conditions. It has two binding modes, one involving 
two subunits, with an occluded site size of 35 nucleotides and high binding 
cooperativity, and the other involving all four subunits, with an occluded site 
size of 65 nucleotides and low binding cooperativity (Lohman and Overman, 
1985; Lohman and Ferrari, 1994).
Although the details of DNA-binding vary between RPA and SSB, (Philipova et 
al., 1996) suggested that yeast RPA is more similar to bacterial SSB than 
thought previously. As Rad18 did not bind to the SSB-derivatised beads (see 
Figure 7.6 below) and considering the literature discussed above, SSB was 
chosen as a negative control in the studies elucidating the interaction between 
ssDNA, Rad 18 and RPA.
6.3.1.2 RPA Recruits Rad18 to ssDNA at High Ionic Strength
According to Figure 6.4, RPA can efficiently recruit HlsVSVRad18 to ssDNA under 
conditions that do not allow the E3 to bind ssDNA by itself. Since SSB was not 
able to afford this effect, the recruitment was considered to be specific for RPA. 
Furthermore, the latter suggests that the recruitment does not arise from non­
specific effects such as a change in the ssDNA conformation upon RPA or SSB 
binding. Rather, the specific recruitment of Rad18 to the ssDNA by RPA may be
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mediated by protein-protein interactions. Alternatively, through these 
interactions RPA may stabilise the binding of Rad18 to ssDNA.
Although changes to the buffer conditions pose effects that are rather artificial, 
the results presented in Figure 6.6 indicate that under a range of ‘physiological- 
like’ salt concentrations, RPA is clearly needed for the recruitment of 
H,sVSVRad18 to the ssDNA. Importantly, these results are consistent with in vivo 
evidence, recently obtained in the laboratory, suggesting that the association of 
Rad 18 with ssDNA correlates with that of RPA. Chromatin immunoprecipitation 
experiments from yeast cells, released from G1-arrest and treated with HU, 
revealed that Rad18 associates with replication forks near a replication origin 
(Davies et al., 2008, Figure 6A in Appendix) similar to PCNA and RPA (Papouli 
e ta /., 2005). Moreover, in rad52 yeast cells, both Rfa1 and Rad18 are enriched 
next to an HO endonuclease-induced DSB (Davies et al., 2008, Figure 6B and 
6D in Appendix). These cells, deficient in homologous recombination and 
Rad51 filament formation, allow a prolonged binding by RPA to the resected 
DSB ends (Wang and Haber, 2004). This result suggests that Rad18 and RPA 
interact with each other on chromatin. Moreover, it excludes that the association 
of Rad18 with the DNA is mediated by PCNA (Davies et al., 2008, Figure 6C in 
Appendix).
RPA is considered to be a modular protein that is able to interact with many 
proteins (Fanning et al., 2006). Recruitment of proteins to ssDNA by RPA was 
proposed to occur via different mechanisms. On the one hand, RPA can 
engage in cooperative ssDNA-binding with other proteins. On the other hand, 
RPA can “trade places” on the ssDNA in a stepwise manner with another 
protein (Fanning et al., 2006). The results presented in Figure 6.4 and in Figure 
6.6 support the notion that, at high ionic stress, Rad 18 and RPA could 
cooperatively bind to the ssDNA or that the binding of RPA would mediate the 
binding of Rad18. However, induced conformational changes of Rad18 upon 
RPA or ssDNA-binding have yet to be verified.
In the literature, there are additional reports for similar salt-sensitive behaviour
of proteins that is overcome by interaction with another protein. For example,
the catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs), which is
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a nuclear serine / threonine protein kinase, was found to bind dsDNA only at 
low NaCI concentration (10 mM) but not at higher salt concentrations (100 mM 
and 200 mM) (Hammarsten and Chu, 1998). However, in the presence of the 
non-specific DNA-end binding Ku protein, the interaction between DNA-PKcs 
and DNA was restored at high salt conditions, suggesting that Ku stabilises the 
binding of DNA-PKcs to DNA at physiological conditions (Hammarsten and 
Chu, 1998). Consequently, Smith and Jackson (1999) hypothesised that in vivo, 
Ku recruits DNA-PKcs to the DNA, facilitating the interaction between DNA-PK  
and DNA and thereby channelling the kinase activity to the appropriate 
substrates. Similarly, and in accordance with Davies et al. (2008), upon DNA 
damage, RPA might recruit Rad 18 to stalled replication forks, facilitating PCNA  
ubiquitylation.
Precedence for the involvement of RPA in recruitment of DNA repair factors to 
ssDNA was shown for the human ATRIP-ATR and the yeast Ddc2-Mec1 
complexes (Zou and Elledge, 2003; Zou et al., 2003). This recruitment is 
important for the activation of the replication checkpoint (see 1.5.1). Although 
the circumstances for Rad18 and Ddc2-Mec1 recruitment are similar with 
regard to the cell-cycle phase and to the type of DNA damage inducing the 
response (see 1.5.2), the activation of the RAD6 pathway and the replication 
checkpoint were found to be independent of each other (Davies etal., 2008).
Taken together, the results presented in Chapter 6 and in Davies et al. (2008) 
support the hypothesis that in vivo, yeast Rad 18 is recruited to RPA-coated 
ssDNA, and in the context of replication fork stalling, contributes to PCNA 
ubiquitylation. Thus, both Rad18 and RPA are important for the activation of the 
DNA damage tolerance pathway.
6.3.1.3 RPA Competes with Rad18 for ssDNA-Binding at Low 
Ionic Strength
Surprisingly, the results shown in Figure 6.5 and in Figure 6.6 suggest that the 
mode of interaction between ssDNA, Rad 18 and RPA strongly depends on the 
ionic strength of the binding buffer. This phenomenon could be explained by
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salt-dependent conformational changes of both proteins. As discussed above 
(6.3.1.1), RPA is known to have a complicated DNA-binding behaviour, which is 
affected by the buffer’s ionic strength (Fanning et al., 2006; Kumaran et al., 
2006). In addition, the results presented in Chapter 4 could be explained by 
salt-dependent conformational changes in Rad 18 that modulate its ssDNA- 
binding ability. Therefore, it is probable that both proteins undergo 
conformational changes in response to different salt concentrations, which in 
turn modulate their interaction in the presence of DNA.
Apparently, at low ionic strength, Rad18 exhibits a detectable ssDNA-binding 
affinity by itself (Figure 4.2, Figure 6.5 and Figure 6.6). However, it does not 
appear to engage in cooperative binding with RPA. Instead, the two proteins 
compete for the same stretch of ssDNA. Under the same experimental 
conditions, the minimal length of DNA required for stable Rad18 binding was 
between 25 and 35 nucleotides (Figure 4.6), whereas the reported occluded 
binding site for RPA was between 18 and 20 nucleotides. Accordingly, RPA and 
Rad 18 could share the space on the 75mer used in these experiments. 
However, since the reported occluded binding site for SSB was larger (65 
nucleotides under similar salt concentration), Rad 18 would not be able to 
occupy the space left after SSB binding.
SSB and RPA have very high affinities for ssDNA in the range of 10'9 -  10'1° M 
(Fanning et al., 2006). Although the ssDNA-binding affinity of yeast Rad 18 was 
never calculated, it can be assumed that it is significantly lower compared to 
that of RPA. Accordingly, at low ionic strength, both SSB and RPA compete 
with Rad 18 for ssDNA-binding (Figure 6.7). However, SSB seems to compete 
more efficiently, suggesting that even under these conditions, weak or 
temporary interactions could still exist between Rad18 and RPA. Alternatively, 
the size difference in the occluded ssDNA-binding site for RPA and SSB could 
account for their somewhat different competition behaviours with Rad 18.
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6.3.2 Varying Affinities of RPA, 6STRfa1 (182-421) and 
GSTRfa2 for ssDNA
In order to verify the ssDNA-binding abilities of the individual subunits of RPA in 
our system, gel-shift assays were carried out. According to Figure 6.1, GSTRfa1 
(182-421) was able to bind to both tested oligonucleotides, suggesting that the 
occluded site size for this construct can be shorter than 16 nucleotides. In 
addition, following incubation with the 35mer oligo(dT), there were four bands 
corresponding to four different ssDNA-GSTRfa1 (182-421) complexes. These 
results are consistent with an occluded site size of eight nucleotides (Pfuetzner 
et al., 1997), with protein:ssDNA ratio of 1:1, 2:1, 3:1 and 4:1. As expected, 
GSTRfa1 (182-421) exhibited significantly lower affinity for the shorter 
oligonucleotide than for the longer one (Fanning etal., 2006).
When comparing the affinities of GSTRfa1 (182-421) and RPA for the 35mer 
oligo(dT), an apparent 10-fold reduction was observed for the Rfa1 DNA- 
binding domain. This is in agreement with Pfuetzner et al. (1997), suggesting 
that the GST tag does not significantly alter the ssDNA-binding properties of this 
domain. Consequently, GSTRfa1 (182-421) was further used to study how 
ssDNA effects its interaction with Rad18.
As shown in Figure 6.3 (longer exposure), GSTRfa2 was able to bind to the 
35mer oligo(dT) at an apparent affinity that was less than 10000-fold compared 
to that of GSTRfa1 (182-421). According to Bastin-Shanower and Brill (2001), 
only a 100-fold reduction was observed between yeast Rfa2 and the DNA- 
binding domain of yeast Rfa1. Perhaps the GST tag fused to the Rfa2 subunit is 
responsible for the discrepancy between the results presented in Figure 6.3 and 
the published literature. Alternatively, differences in the experimental conditions, 
including the oligonucleotide length, the temperature or the buffer composition 
may account for this discrepancy. Due to the very low affinity observed for the 
GSTRfa2 construct for ssDNA in our system, studies regarding the effects of 
ssDNA on the interaction between Rad18 and GSTRfa2 were not pursued. 
Nonetheless, in order to gain a complete understanding of the network of 
interactions between Rad 18, RPA and ssDNA, this should be an important 
aspect to explore in the future.
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6.3.3 ssDNA Stimulates the Interaction between Rad18 and 
Rfa1 DNA-Binding Domain
Bochkareva et al. (2001) suggested that OB folds might participate in protein- 
protein interactions. Accordingly, GSTRfa1 (182-421) was found to be sufficient 
for R ad18’s binding in vitro (Figure 5.4). As an OB domain can, in principle, bind 
to several types of molecules, it may have regulatory roles (Bochkareva et al., 
2001). The results presented in Figure 6.2 are in accordance with this notion. 
Pre-incubation of GSTRfa1 (182-421) with short oligonucleotides resulted in 
significant stimulation of H,sVSVRad18 binding, suggesting that ssDNA-bound 
GSTRfa1 (182-421) is a better binding partner for Rad18 than its ssDNA-free 
form.
According to Bochkareva et al. (2001), RPA undergoes a dramatic 
conformational change as a consequence of binding to ssDNA. The authors 
suggested that this conformational change could play a regulatory role for RPA- 
protein interaction via allosteric effects. For example, it could favour interactions 
with proteins that have higher affinity for DNA-bound RPA and disfavour 
interactions with proteins associating with DNA-free RPA. The results presented 
in Figure 6.2 indicate that conformational changes resulting from GSTRfa1 (182- 
421) binding to ssDNA favour the interactions between GSTRfa1 (182-421) and 
Hisvsvpg^g Furthermore, these results exclude a possibility of competition 
between ssDNA and Rad18 for GSTRfa1 (182-421) binding under these 
experimental conditions.
The oligonucleotides used in Figure 6.2 were too short to allow the binding of 
both proteins to the ssDNA. Although obtained from this simplified system, the 
results presented in Figure 6.2 can be applied to better understanding of 
principal characteristics of the interaction mechanism involving ssDNA, Rad 18 
and RPA. Consequently, this interaction might not require the DNA-binding 
ability of Rad18. However, further evidence has to be obtained to support this 
possibility (see Chapter 7 below).
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7 Results V: Contribution of the SAP Domain to 
Rad18 Interactions and Activity
7.1 Introduction
The results presented in previous chapters (Chapters 4-6) as well as in Davies 
et al. (2008) suggest that Rad 18 interacts physically with RPA, and that via their 
interaction Rad18 might be recruited to ssDNA under physiological conditions. 
However, these results do not address whether the interactions between 
Rad 18, RPA and ssDNA are mediated solely by means of protein-protein 
interactions or whether the interaction of Rad18 with ssDNA is also required. 
Figure 7.1 below illustrates two possible models for the interactions between 
Rad18, RPA and ssDNA. Figure 7.1 A represents a direct interaction between 
the Rad18-Rad6 complex and RPA, where the latter, in turn, physically interacts 
also with ssDNA. In this model, Rad18 does not contact the ssDNA directly. The 
stimulatory effect that ssDNA had on the interactions between Rad 18 and 
gstRPA (182-421) (Figure 6.2) might offer an explanation of how the interaction 
of Rad 18 with the ssDNA-bound RPA is favoured over the DNA-free form of 
RPA. Thus, in vivo, Rad 18 would be recruited to chromatin-associated RPA 
with higher affinity than to the soluble RPA pool. Figure 7.1 B represents an 
alternative model in which both RPA and Rad18 contact each other and the 
ssDNA simultaneously. In this scenario, the association of Rad18 with ssDNA 
could be stabilised by RPA under physiological conditions.
In order to test these two possible models, it was attempted to abolish Rad18’s 
intrinsic ability to bind to ssDNA. If a mutant of Rad 18 deficient in ssDNA- 
binding could still be recruited to the ssDNA by RPA, then the model in Figure
7.1 A would provide a better explanation for the interactions within the complex. 
However, if the result were the opposite, and assuming that the DNA- 
independent interaction between this Rad 18 mutant and RPA was unchanged, 
then the model in Figure 7.1B would best explain the interactions within the 
complex.
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Although in the literature there were several suggestions for putative DNA- 
binding domains in yeast Rad 18 (Bailly et al., 1997b), until now there is no 
formal evidence to confirm their role in DNA-binding. In principle, both the ZnF 
and the SAP domain could participate in DNA-protein interactions, although yet 
unidentified domains could contribute as well. Indeed, both domains were 
suggested to be involved in the formation of human Rad 18 foci in response to 
DNA damage (Nakajima et al., 2006). However, the SAP domain was 
suggested to contribute to the localisation of Rad 18 to stalled replication forks 
along with Polri, whereas the ZnF was found to be important for the formation of 
replication-independent damage-induced foci (Nakajima etal., 2006).
Recently, in Notenboom et al. (2007), the different domains of human Rad 18 
were mapped and the SAP domain was found to be sufficient for both ssDNA 
and dsDNA-binding in vitro. In addition, the ZnF domain was not able to bind to 
DNA by itself, but instead was shown to bind to ubiquitin, indicating its possible 
role as an ubiquitin-binding domain (of type UBZ).
Although a discrepancy exists between these two publications regarding the 
role of hRad18’s ZnF, both of them agree on the DNA-binding role of the SAP 
domain. Furthermore, important residues for ssDNA-binding that were identified 
within the SAP domain of hRad18 by Notenboom et al. (2007) are conserved in 
yeast, as shown by sequence alignment in Figure 7.1C. Therefore, the SAP 
domain was chosen as the best candidate to contribute to the ssDNA-binding 
activity of yeast Rad 18.
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F ig u re  7.1 -  P o s s ib le  m e c h a n is m s  fo r  th e  in te ra c tio n s  b e tw e e n  R a d 1 8 , R P A  
an d  s s D N A
A. Protein-protein interactions between the Rad18-Rad6 complex and RPA are sufficient 
for mediating the interaction with ssDNA.
B. Protein-protein interactions between the Rad18-Rad6 complex and RPA, but also direct 
interaction between Rad 18 and ssDNA are required for the stable association of the 
complex.
C. Sequence alignment of human and yeast Rad18’s SAP domains. Important ssDNA- 
binding residues in human SAP domain according to Notenboom et al. (2007) are marked 
with red lines. Three residues in yeast SAP domain that were mutated to alanines for this 
thesis are marked with blue triangles (G299, R301 and M304).
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7.2 Results
7.2.1 rad18 (SAPA) and rad18 (SAP*) Alleles Fail to 
Complement the Damage Sensitivity of the rad18 
Deletion Strain
In order to establish the importance of the SAP domain for the function of 
Rad 18, two rad18 mutant alleles, one lacking the SAP domain -  rad18 (SAPA) 
and another harbouring three point mutations in conserved residues (Figure 
7.1C) -  rad18 (SAP*), were assayed for their ability to complement the DNA 
damage sensitivity of the rad 18 deletion strain. A schematic representation of 
the mutant alleles used for the studies presented in this chapter can be seen in 
Figure 7.2A. As shown in Figure 7.2B, both mutant alleles did not complement 
the UV sensitivity of the rad18 deletion strain, and their sensitivities were 
identical to that of the rad18 strain harbouring an empty plasmid. As expected, 
the positive control strain, harbouring a W T copy of the RAD18 gene, was 
resistant to UV irradiation. Accordingly, in Figure 7.2C, both mutant alleles failed 
to complement the sensitivity of the rad18 deletion for two other DNA damaging 
agents, 4NQO and MMS. Their defect was equivalent to that of the rad18 
deletion strain. In contrast, the positive control strain, harbouring a W T copy of 
the RAD 18 gene, was resistant to the different treatments, as expected.
One possible explanation for the inability of the mutant alleles to complement 
the deletion phenotype could be that the mutant proteins are unstable or are not 
produced. Figure 7.2D shows a comparison of Rad 18 levels in total cell extracts 
derived from yeast strains used in Figure 7.2B and Figure 7.2C. Noticeably, the 
Rad18 levels in the W T  yeast strain, used as a positive control, are higher than 
those of a rad18  deletion strain complemented with a WT copy of the RAD18 
gene. However, the levels of the latter are similar to those of the Rad18 (SAP*) 
mutant. Unfortunately, the Rad18 (SAPA) could not be detected in this Western 
blot, as it was masked by one of the non-specific bands recognised by the 
antibody. Nevertheless, an immunoprecipitation experiment, performed with 
those strains, revealed that the levels of the Rad 18 (SAPA) and the Rad 18
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(SAP*) proteins were somewhat reduced in comparison to the W T protein levels 
(Davies eta l., 2008, Figure 7D in Appendix).
To exclude that this reduction in the protein levels could account for the DNA 
damage sensitivity observed for the rad18 (SAPA) and the rad18 (SAP*) 
mutants, the mutant alleles were over-expressed using the inducible GAL1 
promoter. As shown in Figure 7.3A, after induction of RAD18 over-expression 
with galactose, the levels of the mutant proteins were comparable to that of the 
over-expressed Rad 18 (WT) protein in total cell extracts. As expected, 
expression of the mutant alleles in a glucose-containing medium was 
repressed. As a positive control, a W T  yeast strain, transformed with the RAD 18 
gene under the GAL1 promoter, was used. Thus, in this strain RAD18 was 
expressed also in the glucose-containing medium. However, upon induction 
with galactose, there was a significant elevation in the protein levels.
Subsequently to ensuring equivalent protein levels (Figure 7.3A), these strains 
were analysed with respect to their DNA damage sensitivities by spot assays as 
before. As shown in Figure 7.3B, even when the mutant alleles were over­
expressed, the DNA damage sensitivity to 4NQO or MMS was not rescued. As 
expected, the WT  strain, transformed with a W T copy of the RAD18 gene, was 
resistant to both tested drugs, on either the glucose- or the galactose-containing 
plates. Although the RAD18 expression was significantly enhanced as a result 
of the induction with galactose, there was no change in the resistance of this 
strain. This suggests that a small amount of the Rad 18 protein is sufficient for 
overcoming the DNA damage-induced sensitivity but also that its over­
expression does not have a negative effect. In addition, the results suggest that 
the rad18 deletion strain has a slight growth defect in comparison to the W T  
strain, which cannot be rescued by either one of the mutant alleles (Figure 7.3B 
-  control plates).
Taken together, these results suggest that the SAP domain is essential for 
Rad18’s function in vivo.
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Figure 7.2 -  rad18 (SAPA) and rad18 (SAPk) alleles cannot complement 
rad18 sensitivity to DNA damage
A. A schematic representation of two Rad 18 mutant proteins: the SAP* construct 
harbours three amino acid substitutions (G299A/R301A/M304A), whereas in the SAPA 
construct the entire SAP domain, amino acids 279 to 312, is deleted.
B. A UV sensitivity assay was performed with rad18 strain complemented with RAD18 
WT, empty plasmid, SAPA or SA P* constructs.
C. Spot assays for 4NQ O  and MMS sensitivity were performed on rad18 deletion 
strain, complemented by the indicated RAD18  constructs as in B.
D. Western blot analysis of total cell extracts derived from yeast strains used in B and 
in C. The W T  strain was included as a positive control for Rad 18 protein levels. Rad 18 
was detected with anti-Rad18 antibody (DH1 rabbit polyclonal serum -  see 2.11.1.2). 
Note that a non-specific band, recognised by the antibody, is masking the signal for 
Rad 18 (SAPA). PGK was detected by anti-PGK antibody as a loading control.
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Figure 7.3 -  Over-expression of RAD18 mutant alleles does not rescue 
rad18 sensitivity to DNA damage
A. Western blot analysis of total cell extracts derived from yeast strains grown in 
medium containing either glucose (Glu) or galactose (Gal). The rad18 deletion strain 
was complemented with an empty plasmid or with SAPA or SAP * constructs under 
control of the GAL1 promoter. The W T  strain transformed with the GAL-RAD18 
construct was used as a positive control. Rad 18 was detected with anti-Rad18 
antibody (DH1 rabbit polyclonal serum -  see 2.11.1.2) and PGK was detected by anti- 
PGK antibody as a loading control.
B. Spot assays for 4NQO and MMS sensitivity were performed on the rad18 deletion 
strain, complemented by the indicated RAD18  constructs as in A. The W T  strain 
transformed with GAL-RAD18 construct was used as a positive control. Cells were 
grown on plates containing either glucose (Glu) or galactose (Gal) with the respective 
drugs, as indicated.
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7.2.2 Purification of the HisVSVRad18 (SAPA)-Rad6 Complex
In order to dissect the role of the SAP domain in Rad18’s function, in vitro 
experiments were carried out. Therefore, the HlsVSVRad18 (SAPA)-Rad6 
complex was purified by the same method as described for the H,sVSVRad18- 
Rad6 complex. As expected, HlsVSVRad18 (SAPA) protein ran slightly lower on 
SDS gels than H,sVSVRad18 (WT) due to the absence of the SAP domain, which 
reduces its molecular weight by approximately 4 kDa (Figure 7.4). Both protein 
preparations seemed to contain comparable amounts of Rad6, suggesting that 
the deletion of the SAP domain did not affect the interaction between Rad 18 
and Rad6, as expected (Bailly e ta l ., 1997b).
7.2.3 The SAP Domain is Dispensable for ssDNA-Binding
According to Chapter 4, Rad 18 exhibits binding to ssDNA under conditions of 
low ionic strength, but at high ionic strength, this activity is no longer detectable. 
In order to determine whether Rad18’s ssDNA-binding activity originates from 
its SAP domain, the ability of HlsVSVRad18 (SAPA) to bind ssDNA was analysed. 
Similar to Figure 4.2, pull-down experiments with immobilized oligonucleotide 
were carried out to compare the binding of HlsVSVRad18 (WT) and HlsVSVRad18 
(SAPA) to ssDNA at low (15 mM KCI) and high (15 mM KCI + 150 mM NaCI) 
salt concentrations.
As shown in Figure 7.5, at low salt concentration, both proteins were retained 
on the ssDNA. This surprising result suggests that HlsVSVRad18 (SAPA) still 
contains an intrinsic ability to bind to ssDNA. When comparing the Western blot 
signal of the input samples, it is apparent that more HlsVSVRad18 (SAPA) was 
used than W T protein in this experiment. Hence, it is difficult to assess if there is 
a difference between the affinities of the WT and the mutant protein for ssDNA. 
As expected, neither of the proteins seemed to be able to bind to the ssDNA at 
high salt concentration.
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Figure 7.4 -  Purified HlsVSVRad18 (SAPA)-Rad6 complex
Comparison of protein preparations from baculovirus-infected Sf9 insect cells. 
HisvsvRacji 8-R ad6 and HtsVSVRad18 (SAPA)-Rad6, approximately 0.5 ng and 1 ng, 
respectively, were loaded and analysed by Coomassie staining.
NaCI 0 mM 150 mM
input bound
ssDNA -  - -  + + -  + + - +  + -  + + 
HisVSVpad-js + -  □ -  -  -  □ -  -  -
HisVSVRad18 (SAPA) ~ + ~ -  -  □
anti-Rad18
Figure 7.5 -  HisVSVRad18 (SAPA) can still bind to ssDNA at low ionic 
strength
Approximately 5 and 10 pmol of HisVSVRad18-Rad6 and HisVSVRad18 (SAPA)-Rad6 
complexes were incubated with a 75mer of mixed sequence (no. 870; -  5 pmol) at 4°C  
for 1 hour in PD Low-Salt Binding buffer supplemented with different NaCI 
concentrations (0 and 150 mM NaCI). Then, the beads were washed 3 times with PD 
High-Salt Binding buffer and twice more with the same buffer with no BSA. After 
elution, the samples were subjected to SDS-PAGE followed by Western blotting. 
Rad 18 was detected with anti-Rad18 antibody (polyclonal mouse 4 serum).
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7.2.4 The Importance of the SAP Domain for Rad18’s 
Interactions with RPA
7.2.4.1 Rad 18 (SAPA)-RPA Interaction
In order to establish whether the SAP domain played a role in the direct 
interactions between Rad18 and RPA described in Chapter 5, pull-down 
experiments with SSB- or RPA-derivatised beads were performed. The 
retention of the HlsVSVRad18-Rad6 or the H,sVSVRad18 (SAPA)-Rad6 complexes 
was analysed by Western blot. In addition, a mock purification derived from 
RAD6 baculovirus-infected insect cells was included as a negative control. As 
described previously for Figure 5.2, a non-specific endonuclease was present 
during the incubation of the proteins to exclude mediation of DNA in the 
interactions. As shown in Figure 7.6A, the amount of H,sVSVRad18 (SAPA) that 
was able to bind to the RPA-derivatised beads was significantly reduced 
compared to HlsVSVRad18, suggesting a possible role for the SAP domain in the 
protein-protein interactions between Rad 18 and RPA.
7.2.4.2 Rad 18 (SAPA)-Rfal DNA-Binding Domain Interaction
In order to test the interaction between H,sVSVRad18 (SAPA) and the DNA- 
binding domain of Rfa1, either GST or GSTRfa1 (182-421) were immobilized on 
glutathione sepharose beads and incubated with either HlsVSVRad18-Rad6 or 
Hisvsvpg^g (SAPA)-Rad6. As shown in Figure 7.6B, both W T and mutant 
proteins bound to GSTRfa1 (182-421) at comparable amounts, suggesting that 
the deletion of the SAP domain does not significantly alter the binding 
properties of Rad18 to the DNA-binding domain of Rfa1. Furthermore, this 
conclusion is in agreement with Figure 7.8A, showing that both rad18 (SAPA) 
and rad18 (SAP*) constructs retained the ability to interact with different 
constructs of RFA1 in the two-hybrid system with a similar pattern to that of 
RAD18 (W T) (see middle panel (-HLW)). In the same experiment, the rad18 (1- 
192) construct, used as positive control, gave the strongest interaction signals 
(see right panel (-AHLW)), as expected, and its interaction pattern was 
consistent with previously published data for the rad18 (1-248) construct 
(Davies eta l., 2008, Figure 5E).
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Figure 7.6 -  HlsVSVRad18 (SAPA) can still bind to Rfa1 via its DNA-binding 
domain but not to the RPA complex
A. A mock purification, HisVSVRad18-Rad6 or HisVSVRad18 (SAPA)-Rad6 (~ 5 pmol) were 
incubated in Coupled-PD Binding buffer, supplemented with 2.5 u benzonase, at 4°C  
for 1 h with either SSB- or RPA-derivatised beads. The beads were washed 5 times 
with Coupled-PD Washing buffer. After elution, the samples were subjected to SDS- 
PAGE followed by Western blotting. Rad18 was detected with anti-Rad18 antibody 
(polyclonal mouse 4 serum). 5% of the input and 35% of the bound material were 
loaded.
B. Approximately 0.5 nmol of GST or GSTRfa1 (182-421) were pre-immobilized on 
glutathione sepharose in G ST-PD  Binding buffer for 1 h at 4°C. After a brief wash with 
G ST-PD  Binding buffer, HisVSVRad18-Rad6 or HisVSVRad18 (SAPA)-Rad6 (~ 10 pmol) 
were added in the same buffer containing 100 ^g/mL BSA and incubated at 4°C for 1.5 
h. Then, the beads were washed 3 times with 500 .^L of GST-PD Binding buffer 
containing BSA and twice more with the same buffer without BSA. After elution, the 
samples were subjected to SDS-PAG E followed by Coomassie staining or Western 
blotting. Rad18 was detected with anti-Rad18 antibody (polyclonal mouse 4 serum) 
and Rad6 was detected with anti-Rad6 antibody. Note that for the Rad 18 and the Rad6 
blots 1% input and 35% of the bound material were loaded. For the Coomassie 
staining, equal fractions of input and bound material were loaded.
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7.2.5 Hi5VSVRad 18 (SAPA) is Recruited to ssDNA by RPA
The results presented above suggest that although the SAP domain seems to 
contribute to Rad18’s interactions with the full RPA complex, deletion of this 
domain does not disrupt the interaction of Rad 18 with the DNA-binding domain 
of Rfa1. Therefore, it was important to determine if, under conditions of high 
ionic strength, HlsVSVRad18 (SAPA) was still recruited to ssDNA by RPA. Similar 
to the experiment presented in Figure 6.4, RPA was pre-incubated at increasing 
levels with ssDNA in PD High-Salt Binding buffer, consisting of 250 mM NaCI. 
After a brief wash, H,sVSVRad18-Rad6 or HlsVSVRad18 (SAPA)-Rad6 were added 
for 1 h at 4°C. The beads were washed with PD High-Salt Binding buffer, eluted 
and examined for the retention of H,sVSVRad18 and RPA on ssDNA by Western 
blot analysis. According to Figure 7.7, both HlsVSVRad18 W T and H,sVSVRad18 
(SAPA) were recruited to the ssDNA by RPA, as increasing levels of RPA 
resulted in enhanced retention of both proteins.
7.2.6 The SAP Domain Contributes to the Interaction 
between Rad 18 and PCNA
In addition to its putative role in DNA-binding or in the interactions between 
Rad 18 and RPA, the SAP domain of Rad 18 could be involved in other protein- 
protein interactions, which are essential for Rad18’s function. I decided to test 
two of these interactions, the self-association of Rad 18 and the interaction of 
the E3 with its substrate, PCNA, by two-hybrid approach. Consequently, rad18 
(SAPA), rad18 (SAP*), a rad18 (1-192) truncation and RAD18 (WT) constructs 
were analysed with respect to their interactions with different constructs of 
RAD18 and POL30.
As shown in Figure 7.8B -  middle panel (-HLW), the dimerisation of Rad18 was 
preserved even for the mutant alleles, indicating that the SAP domain is not 
required for Rad18’s interactions with itself. These results are in agreement with 
Ulrich and Jentsch (2000) that implicated the N-terminus of Rad 18, which lacks 
the SAP domain, in its self-association. As expected, rad18 (1-192) showed the 
strongest signals for the interaction with itself (see right panel (-AHLW) and 
Helle Ulrich -  unpublished results).
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In addition, POL30 showed fairly weak but detectable signals for the interaction 
with itself, consistent with the fact that PCNA forms a trimer in vivo (see middle 
panel (-HLW)). Interestingly, the interaction of both rad18 mutant alleles with 
POL30  seemed to be significantly reduced compared to the RAD18 (WT) and 
the rad18 (1-192) constructs (see middle panel (-HLW)). This result could imply 
that the SAP domain plays a regulatory role in Rad18’s interaction with its 
substrate, PCNA.
7.2.7 The Catalytic Activity of the H,#vsvRad18 (SAPA)-Rad6 
Complex
Lack of interaction between Rad18 (SAPA) and PCNA might affect Rad18’s 
catalytic activity. In order to test this, in vitro PCNA ubiquitylation assays with 
HlsVSVRad18-Rad6 and HlsVSVRad18 (SAPA)-Rad6 were carried out. Based on 
the procedure described in paragraph 2.14.1, increasing amounts of a mock 
purification, HlsVSVRad18-Rad6 or h,sVSVRad18 (SAPA)-Rad6 were added to a 
reaction mixture containing E1, ubiquitin, H,SPCNA and ATP. After incubation of 
2 h at 30°C, the samples were analysed by Western blot.
As shown in Figure 7.9 (upper panel), the auto-ubiquitylation activities of W T  
and mutant proteins were comparable, suggesting that the SAP domain is 
dispensable for the ubiquitin ligase activity per se. However, PCNA modification 
was significantly reduced in the reaction with the H,sVSVRad18 (SAPA)-Rad6 
complex compared to that of the hlsVSVRad18-Rad6 complex (Figure 7.9 -  lower 
panels). This result is consistent with the contribution of the SAP domain to the 
interaction between Rad18 and PCNA, suggested from Figure 7.8.
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High salt binding (15 mM KCI + 150 mM NaCI): 
input bound
i---------------------n-----------------------------------------------------------
ssDNA — — — + + + +  + + + + +
HsvsvRadi 8 
HlsVSVRad18
RPA + -  -  + -  -
anti-Rad18
anti-Rfal
1 H I
—  mm
*
♦ mm mm —  -
Figure 7.7 - HlsVSVRad18 (SAPA) is recruited to ssDNA by RPA
A 75mer oligonucleotide of mixed sequence (no. 870; -  5 pmol), immobilized on 
streptavidin beads, was incubated with RPA at increasing amounts (2.4, 8 or 24 pmol) 
at 4°C for 30 min in PD High-Salt Binding buffer. After a brief wash with the same 
buffer, The HisVSVRad18-Rad6 and the HisVSVRad18 (SAPA)-Rad6 complexes (10 pmol 
each) were added at 4°C  for 1 h incubation. The beads were washed 3 times in PD 
High-Salt Binding buffer and twice with the same buffer with no BSA. After elution, the 
samples were subjected to SDS-PAG E followed by Western blotting. Rad18 was 
detected with anti-Rad18 antibody (polyclonal DH1 rabbit serum - see 2.11.1.2) and 
Rfa1 was detected with anti-R fal antibody. Note that for the RPA blot, equal fractions 
of input and bound material were loaded. For the Rad 18 blot, 1% of the input and 35%  
of the bound material were loaded.
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Figure 7.8 -  Protein-protein interactions between Rad18 SAP mutant 
proteins, Rfa1 and PCNA
A. The open reading frames of RFA1 and its truncations were expressed as fusions to 
the Gal4 DNA-binding domain (BD), whereas the open reading frames of the RAD18  
constructs were expressed as fusions to the Gal4 activation domain (AD). The 
presence of the constructs was confirmed by growth on selective medium lacking 
leucine and tryptophane (-LW ). Positive interactions were scored by growth on plates 
lacking histidine (-HLW ) and stronger interactions on plates lacking histidine and 
adenine (-AHLW ) in addition to leucine and tryptophane.
B. The open reading frames of RAD18  and POL30  constructs were expressed as 
fusions to the Gal4 activation (AD) and DNA-binding domains (BD). The experiment 
was performed as in A.
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Figure 7.9 -  The HlsVSVRad18 (SAPA)-Rad6 complex retains its E3 ligase 
activity but cannot ubiquitylate PCNA
Either buffer or increasing amounts of mock purification, H,sVSVRad18-Rad6 or 
H,sVSVRad18 (SAPA)-Rad6 (2.4, 8 or 24 pmol) were added to a reaction mix containing 
112.5 nM yeast E1, 65 pM ubiquitin and 3 pM H|SPCNA. The proteins were incubated in 
Ubiquitylation buffer at 30°C for 2 h. Then, the reaction was stopped, the samples were 
subjected to SD S-PA G E and analysed by Western blotting. Rad18 was detected by 
anti-VSV antibody and PCNA was detected by anti-PCNA antibody (polyclonal).
HisVSVRad18-Un
J_HisvsvRaH1ft
- H,sVSVNad18(SAPA)
— PCNA-U.,
— PCNA
— PCNA-U.,
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- 2 0 8 -
7.3 Discussion
Chapter Seven: Results V
7.3.1 Comparison between the hRad18 and the yRad18 SAP 
Domains
The SAP domain is a 35 amino acid domain, predicted to have a helix- 
extended loop-helix structure, and is believed to be involved in DNA-binding 
(Aravind and Koonin, 2000). According to the alignment shown in Figure 7.1C, 
11 out of 35 residues are identical between the human and the yeast Rad 18 
SAP domains, additional 14 amino acids have the same charge and 5 more are 
polar residues. Thus, with respect to homology between the SAP domains of 
the two species, there is a 31% identity and 86% similarity.
Consequently, and in line with the published data regarding the role of human 
SAP domain in DNA-binding (Notenboom et al., 2007; Nakajima et al., 2006), 
yeast Rad18’s SAP domain was chosen as the domain most likely to contribute 
to Rad18 ssDNA-binding ability. Notenboom et al. (2007) identified a few 
residues in hRad18, which are important for hRad18’s binding to ssDNA, 
located in the predicted loop region of its SAP domain. Therefore, two of these 
conserved residues were mutated to alanine (G279 and R301). In addition, a 
third residue (M 304) was mutated based on the consensus sequence of the 
SAP domain among different proteins (see Figure 1.2). In parallel, the entire 
domain (amino acids 279 -  312) was deleted (Figure 7.2k).
7.3.2 The SAP Domain is Essential for Rad18’s Activity In 
vivo
According to Figure 7.2, neither the rad18 (SAPA) nor the rad18 (SAP*) allele 
rescued the sensitivity of a rad18 deletion strain to UV irradiation (B) or to other 
DNA damaging agents, 4NQO and MMS (C). According to Davies et al. (2008) 
the levels of the mutant proteins seemed to be somewhat reduced in 
comparison to that of the W T protein. To exclude that the difference in the 
protein levels was responsible for the DNA damage sensitivity of the SAP 
mutant strains, the W T  and the mutant rad 18 alleles were over-expressed 
under control of the GAL1 promoter. Indeed, as shown in Figure 7.3, both
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mutant alleles failed to complement the sensitivity of the rad18 deletion strain to 
MMS or 4NQO, even though the protein levels were significantly enhanced 
upon induction with galactose. Consequently, I can conclude that the SAP 
domain of Rad 18 is required for protection from DNA damage in vivo. This 
conclusion is in accordance with Davies et al. (2008), in which PCNA 
ubiquitylation in response to MMS treatment was shown to be impaired in both 
rad18 (SAPA) and rad18 (SAP*) mutants.
7.3.3 Dissecting the Role of the SAP Domain In vitro
7.3.3.1 ssDNA-Rad18 (SAPA) Interactions
Notenboom et al. (2007) found that the SAP domain of hRad18 was sufficient to 
bind to ssDNA in vitro, and that it bound to a 40mer oligo(dT) with an apparent 
affinity of 1.1 pM. However, since they did not analyse the DNA-binding of the 
SAP domain mutant in the context of the full-length protein, it is not clear from 
their results if the SAP domain is the only domain necessary for hRad18 
interactions with DNA. A recent publication by Tsuji et al. (2008) complemented 
these findings by showing that the SAP domain of hRad18 was crucial for its 
DNA-binding activity, as a deletion of this domain impaired the efficient binding 
of hRad18 to ssDNA as well as to forked-DNA structures. Taken together, the 
evidence presented in these two publications indicates that the SAP domain of 
human Rad 18 is both necessary and sufficient for its ability to bind to DNA in 
vitro.
According to Figure 7.5, yeast H,sVSVRad18 (SAPA) still retains the ability to bind 
to ssDNA at low ionic strength in vitro. Moreover, preliminary experiments with 
different DNA structures suggest that HlsVSVRad18 (SAPA) binds to DNA with 
similar structural preferences to that of the W T protein (data not shown). Due to 
the homology between the SAP domains of the human and the yeast Rad 18 
protein, discussed in paragraph 7.3.1, these results were unexpected. 
Nevertheless, since the experimental method was not quantitative as discussed 
in 4.3.1, I cannot exclude that the deletion of the SAP domain resulted in a 
reduction of Rad18’s affinity for ssDNA. But even if the SAP domain of yeast 
Rad 18 could potentially contribute to its interactions with ssDNA, the results
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presented in Figure 7.5 indicate that, most likely, there are additional domains 
involved in the ssDNA-binding activity of yeast Rad 18.
The ZnF of Rad 18 was suggested as a putative DNA-binding domain (Bailly et 
at., 1997b). According to Nakajima et al. (2006), the ZnF of human Rad18 was 
important for its localisation to replication-independent damage-induced foci in 
vivo. In contrast, Notenboom et al. (2007) could not detect binding of the human 
GST-ZnF construct to ssDNA or to dsDNA but rather suggested a role in 
ubiquitin binding. Consistent with this notion, an MBP-fused construct of ZnF 
from human Rad18 was shown to bind to K48-linked-poly-ubiquitin chains in 
vitro (Bish and Myers, 2007). Thus, further analysis is required to determine if 
the SAP domain of yeast Rad 18 is at all involved in DNA-binding and if the ZnF 
or alternative yet unidentified domains are important for this activity.
7.3.3.2 Rad 18 (SAPA)-RPA Interactions
The H,sVSVRad18 (SAPA) protein binds to the DNA-binding domain of Rfa1 with 
a similar affinity to that of the W T protein (Figure 7.6B). This in vitro result was 
expected, as it is in agreement with the two-hybrid results in Davies et al. (2008) 
demonstrating that the SAP domain is dispensable for Rad18’s interaction with 
Rfa1. In addition, it is consistent with the two-hybrid results presented in Figure 
7.8A.
However, as shown in Figure 7.6A, the ability of the HlsVSVRad18 (SAPA) protein 
to bind to the RPA complex is significantly reduced compared to the WT  
protein. In principle, it is possible that the deficiency of this Rad18 mutant to 
bind to RPA originates from a defect in binding to Rfa2. However, this possibility 
is unlikely, since a rad18 (1-192) construct, which completely lacks the SAP 
domain, was sufficient for Rfa2 binding (Davies et al., 2008, Figure 5D in 
Appendix). An alternative explanation could be that the SAP domain of Rad 18 
mediates its interaction with the full RPA complex via a surface that is formed 
between two or three RPA subunits. Thus, the absence of the SAP domain only 
affects the interaction of Rad 18 with the full RPA complex, but not with its 
individual subunits. In another scenario, the absence of the SAP domain may
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have an indirect effect causing a conformational change in the Rad18 protein, 
which in turn results in the inhibition of its interaction with the RPA complex.
7.3.3.3 ssDNA-Rad18 (SAPA)-RPA Interactions
Although Figure 7.6 presents conflicting results regarding the importance of the 
SAP domain in the interaction between Rad18 and RPA, Figure 7.5 suggests 
that this domain is not essential for the interaction between Rad 18 and ssDNA. 
As shown in Figure 7.7, HlsVSVRad18 (SAPA) can be recruited to ssDNA by RPA 
at high salt concentrations, similar to the W T protein. This result is consistent 
with the notion that H,sVSVRad18 (SAPA) can still bind to the DNA-binding 
domain of Rfa1 but contradicts the reduced binding observed for H,sVSVRad18 
(SAPA) and RPA in the absence of DNA. A possible explanation to solve this 
discrepancy is that Rad 18 could have higher affinity for ssDNA-bound RPA, and 
that this enhanced affinity would compensate for the effect observed in Figure 
7.6A. This hypothesis is supported by the stimulation of the interactions 
between HlsVSVRad18 and GSTRfa1 (182-421) in the presence of short 
oligonucleotides (Figure 6.2).
Unfortunately, due to the remaining ssDNA-binding ability of HlsVSVRad18 
(SAPA), I was not able to determine whether the association between Rad 18 
and ssDNA is essential for its recruitment to the DNA by RPA, as was initially 
planned.
7.3.3.4 Rad18 (SAPA)-PCNA Interactions
As shown in Figure 7.8, the interactions of the rad18 (SAPA) and the rad18 
(SAP*) constructs with the RFA1 and the RAD18 constructs in the two-hybrid 
assay seemed unaffected, but the interaction with the POL30 construct was 
significantly reduced compared to that of the WT Rad18 protein. This was rather 
a surprise, as the N-terminus of RAD18 (1-192), lacking the SAP domain, was 
sufficient for the interaction with POL30. Accordingly, the SAP domain might 
have a regulatory effect specific for PCNA binding. For example, the mutation 
or the deletion of this domain could result in conformational changes that do not
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affect Rad18’s interactions with Rfa1 or with itself, but cause an alteration in 
Rad18’s interactions with PCNA.
7.3.3.5 The Catalytic Activity of Rad18 (SAPA)
As shown in Figure 7.9 (upper panel -  anti-VSV antibody blot), HlsVSVRad18 
(SAPA) is proficient in its auto-ubiquitylation at similar levels to those observed 
for the W T protein. As the auto-ubiquitylation activity is often regarded as a 
hallmark for the catalytic activity of E3 enzymes, this result indicates that the 
ubiquitin ligase activity per se is not impaired in the mutant. Furthermore, the 
interaction with Rad6, the E2 ubiquitin-conjugating partner of Rad18, seems to 
be intact (Figure 7.4). The latter supports the notion that mechanistically, the 
ubiquitin conjugation ability of HlsVSVRad18 (SAPA)-Rad6 complex is comparable 
to that of H,sVSVRad18-Rad6 complex.
The fact that the SAP domain is not important for Rad18’s auto-ubiquitylation is 
consistent with additional observations for other E3s containing SAP domains. 
For example, the SAP domain of the E3 SUMO ligase, Siz1, was found to be 
dispensable for Cdc3 sumoylation in vitro (Takahashi and Kikuchi, 2005). In 
addition, recently obtained results in the Ulrich laboratory indicate that the SAP 
domain of Siz1 is involved in dsDNA-binding and is not absolutely required for 
PCNA sumoylation (Parker e ta l., in revision).
Nevertheless, according to Figure 7.9 (lower panels -  anti-PCNA antibody 
blots), it appears that the H,sVSVRad18 (SAPA)-Rad6 complex is significantly 
impaired in PCNA ubiquitylation as compared to the HlsVSVRad18-Rad6 
complex. Although the experimental conditions used here represent only basal 
levels of PCNA modification by the Rad18-Rad6 complex (Garg and Burgers, 
2005; Haracska eta l., 2006; Davies etal., 2008), they could, in principle, reflect 
a real effect. In the future, it will be important to study the affects of the SAP 
domain on the catalytic activity of Rad18 in a system that allows the loading of 
PCNA on the DNA prior to ubiquitylation.
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Consistently, yeast rad18 SAP mutants were found to be deficient in MMS- 
induced PCNA ubiquitylation (Davies et al., 2008, Figure 7D in Appendix). A 
possible explanation for this result as well as for the result obtained in Figure 
7.9 could be that a deletion of the SAP domain induces a conformational 
change in Rad18. This change, in turn, reduces Rad18’s ability to bind to PCNA 
(see Figure 7.8B), and consequently reduces Rad18’s ability to efficiently 
modify the clamp.
Recently published data by Tsuji et al. (2008) suggested a role for the SAP 
domain of human Rad18 in PCNA ubiquitylation in vivo. However, they did not 
address the possibility that this effect is caused by a direct reduction of PCNA -  
hRad 18 interactions. Instead, they focus on the possibility that mutations in the 
SAP domain of the E3 impair its DNA-binding ability, consequently leading to 
the deficiency in PCNA modification. In theory, both possibilities may contribute 
together to the disruption of hRad18’s catalytic activity.
To summarise the results presented in this chapter, I have provided compelling 
evidence, both in vivo and in vitro, for the essential role of the SAP domain of 
yeast Rad 18 in the DNA damage tolerance pathway.
7.3.3.6 Additional Putative Roles of the SAP Domain
As the SAP domain seems to be essential for yeast Rad18 function in vivo, it is 
tempting to speculate on possible additional roles for it, taking into account the 
literature regarding the role of this domain in other proteins.
7.3.3.6.1 Regulation of Localisation by the SAP Domain
The N-terminal SAP domain of the E3 SUMO ligase, Siz1, seems to play a role 
in its localisation to the nucleus throughout the cell cycle (Takahashi and 
Kikuchi, 2005; Reindle et al., 2006). Furthermore, SizTs SAP domain consists 
of an acceptor site for auto-sumoylation of the E3 in vitro, and Takahashi and 
Kikuchi (2005) postulated that this auto-modification facilitates the dissociation 
of Siz1 from chromatin, and in turn affects its cellular localisation. However, no 
formal evidence was provided for this, and the SAP domain could either
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contribute to the nuclear import or to nuclear retention of Siz1 (Reindle et al., 
2006). Furthermore, an overlap of the SAP domain with the nuclear localisation 
signal was not excluded.
As H,sVSVRad18 (SAPA) and HlsVSVRad18 auto-ubiquitylate with similar levels, it 
is unlikely that Rad18’s SAP domain harbours a site for its auto-modification. In 
addition, Rad6-mediated auto-ubiquitylation was suggested to regulate 
hRad18’s localisation and protein levels (Miyase et al., 2005). This required the 
self-association of hRad18, independent of the SAP domain. Consistent with 
Ulrich and Jentsch (2000) and with the results obtained by two-hybrid analysis 
(Figure 7.8B), the SAP domain of yeast Rad 18 is not involved in its self­
association. Thus, the localisation of either hRad18 or yRad18 proteins is 
unlikely to be mediated by their SAP domain.
7.3.3.6.2 Regulation of Substrate Selectivity
A SAP deletion mutant of Siz1 failed to sumolyate a few of its known targets, 
but was proficient in sumoylation of others (Reindle et al., 2006). Consequently, 
the authors suggested a role of the SAP domain in substrate selectivity, 
influenced either by protein-protein interactions or by DNA-protein interactions. 
Parker et al. (in revision) suggested an attractive mechanism for the regulation 
of PCNA sumoylation by Siz1, in which the association of the clamp with the 
DNA leads to its modification. But in this specific case, even though the SAP 
domain of Siz1 is required for dsDNA-binding, it was found to be dispensable 
for PCNA sumoylation.
In contrast, PIAS1, a member of the PIAS family, requires its SAP domain for 
two important functions. On one hand, the SAP domain mediates PIAS1 binding 
to AT-rich DNA. On the other hand, this domain is specifically involved in PIAS1 
binding to its sumoylation substrate, p53 (Okubo et al., 2004). In their study, 
Notenboom et al. (2007) suggested that the manner in which hRad18 and 
PIAS1 bind to DNA is conserved. Accordingly, it is plausible that hRad18’s SAP 
domain plays a dual role in Rad 18 function, mediating both DNA-binding and 
PCNA recognition.
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The function of yet another E3 SUMO ligase protein, PIASxa, is regulated via 
its SAP domain, independently of the protein’s sumoylation activity. This protein 
was shown to employ a co-repression activity towards a transcription factor of 
the EST family, Fli1. This repression, which involves the re-localisation of the 
latter to nuclear bodies, was dependent on the proteins’ physical interactions 
via the EST domain of Fli1 and the SAP domain of PIASxa (van den Akker et 
al., 2005).
In agreement with Figure 7.8B and with Figure 7.9, the deletion or the mutation 
of the SAP domain of yeast Rad 18 result in the disruption of its interaction with 
PCNA. However, this effect may not be direct. The deletion or the mutation of 
the SAP domain might confer conformational changes to Rad18, and alter its 
interactions with the clamp or with other proteins.
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8 Discussion and Outlook
The purpose of this thesis was to gain insights into the biochemical functions of 
the Rad 18 protein from S. cerevisiae and to broaden our understanding 
regarding its role mediating the DNA damage tolerance pathway. The 
characterisation of the DNA-binding activity of the recombinant yeast Rad18- 
Rad6 complex in this work led to the finding that Rad 18 is able to bind to other 
DNA structures, in addition to its reported ability to bind to ssDNA. This in vitro 
activity was recapitulated for human Rad18 in a recent publication (Tsuji et al., 
2008). Furthermore, this work shows that the intrinsic DNA-binding ability of 
yeast Rad 18 is dependent on the ionic strength of the buffer, in agreement with 
Bailly et al. (1997a). Interestingly, the binding of yRad18 to ssDNA at low ionic 
strength confers a stable association of the E3 ligase with the DNA for 
subsequent high ionic strength conditions. This novel observation suggests a 
complex salt-dependent behaviour of yRad18, which probably involves several 
conformations of this protein. Importantly, this work demonstrates that yRad18 
is unable to bind to ssDNA under physiological-like conditions and argues 
against the widespread speculation that Rad 18 recognises ssDNA in vivo by 
itself. Moreover, this work provides compelling evidence for the physical 
interaction between the yeast Rad18-Rad6 complex and RPA and for the 
stimulation of their association by ssDNA. Strikingly, at physiological-like ionic 
strength, RPA recruits the Rad18-Rad6 complex to ssDNA. This finding, 
supported by additional data obtained in the Ulrich lab by my colleagues and 
published in Davies et al. (2008), suggests that RPA-coated ssDNA recruits 
Rad18 to sites of DNA damage, thus providing the up-stream signal for the 
activation of the DNA damage tolerance pathway and for PCNA ubiquitylation. 
Finally, this work shows that the SAP domain of yRad18 is essential for its in 
vivo function. Furthermore, the gathered evidence suggests that mutation or 
deletion of this domain impairs the interaction of Rad 18 with its substrate, 
PCNA, and thereby prevents the ubiquitylation of the clamp. These findings are 
consistent with the observations made in vivo (Davies etal., 2008).
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8.1 The Catalytic Activity of Rad18
The recombinant yeast HlsVSVRad18-Rad6 complex was partially purified from 
baculovirus-infected insect cells. Its catalytic activity was verified with regard to 
the auto-ubiquitylation of Rad18, a self-modification activity characteristic for 
many E3 ligases (Lorick et al., 1999). Furthermore, its ability to mono- 
ubiquitylate PCNA in vitro was confirmed. Although PCNA mono-ubiquitylation 
reaction was performed under conditions, which allowed only basal levels of 
modification (Garg and Burgers, 2005), the specificity for lysine 164 was 
demonstrated. Taken together, the results presented in Chapter 3 suggest that 
the purified complex is functional and folded properly.
The purification method, which involved the fractionation of the insect cells to 
cytoplasm and nuclei, revealed interesting differences between the cytoplasm- 
derived HlsVSVRad18-Rad6 complex and the nuclei-derived one. The former was 
post-translationally modified, whereas the latter was not (Figure 3.4A). 
Furthermore, the former had enhanced E3 ligase activity for itself and for PCNA 
(Figure 3.5 and data not shown). The results presented in Figure 3.5 show that 
the cytoplasm-derived yeast H,sVSVRad18-Rad6 is mono-ubiquitylated in the 
insect cells. This finding recapitulates the observations made for the 
mammalian Rad 18 by Miyase et al. (2005).
Indication that yRad18 mono-ubiquitylation is a physiologically relevant 
modification and not an artefact of the expression system was obtained by pull­
down experiments from yeast cells over-expressing Hlsubiquitin. Several lines of 
evidence argue in favour of the hypothesis that the role of Rad18’s modification 
in yeast may be different than that reported for the mammalian Rad 18. First, 
Miyase et al. (2005) concluded that the mono-ubiquitylated form of mammalian 
Rad 18 protein, which was predominantly found in the cytoplasm, reflects a 
regulatory mechanism and that Rad6-dependent poly-ubiquitylation of Rad 18 
led to its subsequent degradation. In yeast cells, although Rad6 seems to 
contribute somewhat to Rad18 ubiquitylation, it may not be the only E2 enzyme 
involved in this modification. This result is in contrast to the observations made 
by Miyase et al. (2005) for mammalian Rad18. Furthermore, the levels of the
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yeast Rad 18 protein in the yeast strains over-expressing H,subiquitin were not 
reduced in comparison to those with normal ubiquitin levels, suggesting that this 
modification does not lead to the degradation of yRad18. Second, Notenboom 
et al. (2007) have identified four different mono-ubiquitylation sites in murine 
Rad18 by mass spectrometry. Even though these sites are conserved in human 
Rad 18, they are not conserved in yeast. Hence, the function of this modification 
may not be conserved either.
In order to determine the role of Rad18 ubiquitylation in yeast, a further 
characterisation of this modification is required. First, it is important to study the 
timing of this modification and the localisation of modified Rad18. Preliminary 
data suggests that this modification is constitutive and does not require 
induction by specific conditions, such as DNA damage. Although Rad 18 protein 
levels do not seem to significantly fluctuate during the cell cycle (unpublished 
data -  Davies and Ulrich), it is predominantly active during S phase (Davies et 
al., 2008). It would be important to establish whether the levels of the 
modification changed instead. Second, identification of the ubiquitylation sites 
on yRad18 could provide essential tools for mutational analysis, potentially 
leading to the elucidation of a physiological role for this modification. Third, 
determining which type of poly-ubiquitin chains are conjugated to Rad 18 can 
provide important clues regarding the consequences of this modification.
Perhaps Rad 18 ubiquitylation results from non-specific ubiquitin ligase activity 
of its catalytic domain. Alternatively, it may serve as a regulatory mechanism for 
its function. As E3 ligases provide the specificity to the ubiquitylation process, 
their regulation can determine when and where their substrates are modified 
(Pickart, 2001). In the literature, there are examples for different covalent 
modifications of E3s that contribute to their function, such as sumoylation and 
phosphorylation (Pickart, 2001). In some cases, mono-ubiquitylation of the E3 is 
required prior to the conjugation of the substrate. This coupled-mono- 
ubiquitylation mechanism was suggested for substrates that contain ubiquitin- 
binding domains, but may also apply to substrates that do not contain them 
(Woelk et al., 2006). As previously mentioned, mono-ubiquitylated Rad18, 
derived from the cytoplasm of insect cells, was more efficient than unmodified
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Rad18, derived from the nuclei, with regard to both auto-ubiquitylation and 
mono-ubiquitylation of PCNA. This can be explained either by direct or indirect 
effects of the conjugated ubiquitin on Rad18. A direct effect would be a 
mechanistic pre-requisite for subsequent PCNA ubiquitylation. The conjugation 
of the first ubiquitin on Rad 18 might be an intermediate rate-limiting step prior to 
the modification of the clamp. An indirect effect would be inducing a 
conformational change that enhances the association of Rad 18 with PCNA or 
makes it a better E3 ligase by positioning the players involved in the correct 
conformation for the catalytic activity. Although these speculations are exciting, 
I cannot exclude that the results presented in Figure 3.5 are dependent on the 
expression system used or on the protein preparation, as discussed before in 
paragraph 3.2.5.3.
Nevertheless, it is clear that a restriction of Rad 18 activity is essential for the 
cell, as the DNA tolerance pathway should act only when needed (Ulrich, 2005). 
Davies et al. (2008) provided evidence that this is achieved by maintenance of 
low levels of the yRad18 protein, as over-expression of Rad18 relaxes the 
requirement for PCNA ubiquitylation. The results presented in this thesis and in 
Davies et al. (2008) implicate RPA in the recruitment of Rad18 to the sites of 
DNA damage, thus providing another level of regulation on its activity.
8.2 Interactions between Rad18 and DNA
The results presented in Chapter 4 of this thesis demonstrate that the yeast 
Rad 18 protein harbours an intrinsic DNA-binding ability. This activity is highly 
sensitive to salt concentrations (Figure 4.1 and Figure 4.2), in agreement with 
Bailly et al. (1997a). In addition, the results presented in Figure 4.5 suggest that 
Rad 18 binding to ssDNA is affected by different anions in correlation with the 
Hofmeister series (Griep and McHenry, 1989). Taken together, the evidence in 
Chapter 4 indicate that the interaction between Rad 18 and ssDNA is mediated 
by a network of hydrogen and electrostatic bonds that are sensitive to the ionic 
strength of the buffer.
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The results presented in Figure 4.7 are consistent with the notion that Rad18 
binds to ssDNA preferentially over dsDNA (Bailly et al., 1997a; Notenboom et 
al., 2007). However, in both ionic strength conditions that were tested, Rad18 
was able to bind to other DNA structures with ssDNA regions but also to 
dsFork-DNA, containing no unpaired bases. According to Figure 4.6, Rad 18 
binds better to longer ssDNA oligonucleotides than to shorter ones. These 
results are consistent with Tsuji et al. (2008) regarding the structural binding 
preference of human Rad 18. Furthermore, these results may suggest that in 
vivo, Rad 18 binds to replication intermediates or to stalled replication forks.
The result in Figure 4.3 indicates that the Rad6 protein is not able to bind to 
ssDNA by itself, but can be brought to the ssDNA via its interaction with Rad 18. 
This observation supports earlier findings by Bailly et al. (1994).
The experimental method that was used to study the interaction between 
Rad 18 and DNA revealed a complex behaviour, which is dependent on the salt 
concentration in the buffer. As mentioned earlier, Rad 18 readily binds to ssDNA 
at low salt concentrations. However, if the incubation of this protein and the 
ssDNA occurs at high salt concentrations instead, then a reduced or no binding 
is observed. Interestingly, if the binding partners are incubated at low salt 
concentrations first, but then exposed to high salt washes, then their 
association seems to become salt-resistant. This is a slow effect, as shown in 
Figure 4.4. A hypothesis that could explain these observations would be that at 
low salt concentrations, Rad 18 binds to the ssDNA with low affinity. Following 
this binding, a slow conformational change occurs, possibly involving the 
Rad18-Rad6 complex, the ssDNA or both. As a consequence, the Rad 18 
protein associates with the ssDNA in a high affinity mode, which is stable to 
high salt washes. However, if the Rad18-Rad6 complex is incubated at high salt 
concentrations in its DNA-free form, it may have a different conformation that 
prevents it from binding to the ssDNA in the first place. Additional experiments 
involving different incubation periods and washes with different salt 
concentrations may shed additional light on the timing and the mechanism of 
these conformational changes.
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As the binding of the Rad18-Rad6 complex to the ssDNA was not detected 
under physiological-like ionic strength conditions (Figure 4.2), these results 
question the ability of yeast Rad18 to bind to ssDNA by itself in vivo. This 
behaviour of yeast Rad 18 may be different than that reported for the human 
Rad 18 protein (Notenboom et al., 2007; Tsuji et al., 2008). Consistently, the 
domain responsible for the intrinsic ssDNA-binding ability of Rad18 may not be 
conserved among species (see Chapter 7).
8.3 Interactions between Rad18 and RPA
The results presented in Chapter 5, together with additional evidence published 
in Davies et al. (2008) indicate that the Rad18-Rad6 complex and RPA interact 
physically with each other. This interaction probably occurs via direct contacts 
of the E3 with two subunits of the RPA complex, Rfa2 and the DNA-binding 
domain of Rfa1 (Figure 5.4 and Figure 5.5). The N-terminal region of Rad 18 
(amino acids 1-192), including a functional RING domain, was shown to be 
sufficient for the interaction with both RPA subunits (Davies et al., 2008, Figure 
5D and 5E in Appendix). Furthermore, Rad6 appears to contribute to the direct 
interaction with RPA (Figure 5.3). These interactions proved to be specific, as 
under the same reaction conditions, PCNA did not bind to RPA (Figure 5.3).
RPA is a modular protein that often makes more than one contact with its
binding partners (Ball et al., 2007). The interactions of RPA with other proteins
predominantly involve Rfa1, Rfa2 or both (Wold, 1997). For instance, XPA was
reported to bind both Rfa1 and Rfa2 (Matsuda e ta l., 1995). Similarly, Rad51
and Rad52 bind to RPA via these two subunits (Jackson et al., 2002; Stauffer
and Chazin, 2004). Furthermore, the ssDNA-binding site of human RPA70 is
directly involved in the interactions with human XPA, Rad52 or Rad51 (Jackson
et al., 2002; Daughdrill et al., 2003; Stauffer and Chazin, 2004). Therefore, the
molecular mechanism by which RPA interacts with Rad 18 may correspond to
the way it interacts with other proteins. The interactions of RPA with various
binding partners via the same subunits and domains may play an important
regulatory role. For example, a particular DNA repair pathway may be preferred
at a particular time by competition between binding partners of RPA from
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different repair pathways. Alternatively, the interactions of RPA with proteins 
from the same DNA repair pathway may be regulated in a sequential mode by a 
‘hand-off mechanism (Fanning et al., 2006); (see also 1.3.2.5).
Apparently, the N-terminal part of yRad18, which contributes to most of its 
interactions with its known binding partners (unpublished data and Ulrich and 
Jentsch, 2000), is also responsible for its interactions with RPA (Davies et al., 
2008). A closer look into the two-hybrid results presented in Davies et al. (2008) 
suggests complex interaction behaviour of Rad18 toward RPA. First, the rad18 
(83-248) construct is sufficient for the interaction with Rfa2, but is deficient in 
Rfa1 binding, suggesting that the two RPA subunits bind to different regions 
within the N-terminal part of Rad18. Second, the C-terminus of Rad18 seems to 
play an inhibitory role for Rad18’s binding to both RPA subunits, as C-terminal 
truncations of Rad18 give enhanced interaction signals compared to the full- 
length protein. Since the C-terminus of Rad 18 contains an acidic region (Bailly 
et al., 1997b), it may participate in binding to RPA in the absence of ssDNA, 
mimicking its charge. This binding mechanism was suggested for the Rad51 
protein (Stauffer and Chazin, 2004). However, in the presence of ssDNA and as 
a result of ssDNA-induced conformational changes, this region would be 
displaced from RPA allowing the N-terminal region of Rad18 to cooperatively 
bind to RPA and to ssDNA with higher affinities. This speculative mechanism 
can be tested by competition experiments with the C-terminal or the N-terminal 
truncation constructs of Rad18 for binding to RPA, ssDNA or both.
8.4 Interactions between Rad18. RPA and ssDNA
The results presented in Chapter 6 indicate that RPA can associate with the 
Rad18-Rad6 complex on ssDNA in vitro. This conclusion is consistent with the 
in vivo observations made by Davies et al. (2008) and is supported mainly by 
two important findings obtained in this thesis. The first finding is that the 
interaction between the DNA-binding domain of Rfa1 and the HlsVSVRad18-Rad6 
complex is stimulated by ssDNA (Figure 6.2). Upon binding to ssDNA, the DNA- 
binding domain of Rfa1 was reported to undergo significant conformational 
changes, resulting in different accessibilities of side-chain residues within that
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region (Bochkareva et al., 2001). Thus, additional or alternative residues of 
Rfa1 may contact the Rad18-Rad6 complex and enhance the formation and the 
stability of the quaternary ssDNA-RPA-Rad18-Rad6 complex. Therefore, the 
DNA-binding domain of Rfa1 may be considered a better binding partner for the 
Rad18-Rad6 complex in the presence of ssDNA. Hence, in vivo ssDNA-bound 
RPA may be preferred over ssDNA-free RPA by the Rad18-Rad6 complex 
through Rfa1, providing a regulatory mechanism for directing it to ssDNA-bound 
RPA (see Figure 8.1 A). Interestingly, short oligonucleotides, to which the 
Rad18-Rad6 complex was not able to bind, promote its association with RPA in 
a similar manner to longer oligonucleotides. This suggests that under the tested 
conditions, the direct contact between ssDNA and the Rad18-Rad6 complex is 
not necessary for the association of the quaternary complex. However, 
additional studies are needed to dissect the network of interactions within this 
complex (see Chapter 7). As mentioned in paragraph 6.2.1.1, it would be 
interesting to determine the effects of ssDNA on the interaction between Rfa2 
and Rad18-Rad6.
The second and most important finding in this thesis is that under physiological- 
like salt concentrations, RPA recruits the H,sVSVRad18-Rad6 complex to ssDNA 
(Figure 6.4 and Figure 6.5). This behaviour was specific for RPA, as bacterial 
SSB failed to recruit the Rad18-Rad6 complex under the same conditions. 
Thus, under conditions in which the binding of the Rad18-Rad6 complex to 
ssDNA cannot be detected (Figure 4.2), RPA enables the binding of this 
complex to ssDNA (Figure 6.4 and Figure 6.5). Figure 8.1C illustrates how 
increasing amounts of RPA, pre-bound on ssDNA, enhance the binding of the 
Rad18-Rad6 complex to ssDNA. A similar recruitment effect was observed for 
the Mec1-Ddc2 complex or for the Rad17 protein (Zou and Elledge, 2003; Zou 
et al., 2003). The recruitment of the Rad18-Rad6 complex to ssDNA by RPA 
may be mediated solely by protein-protein interactions (Figure 7.1 A). 
Alternatively, RPA may stabilise the interactions between the Rad18-Rad6 
complex and the ssDNA (Figure 7.1B). Examples for both mechanisms can be 
found in the literature. For instance, the interaction between Rad52 and RPA 
stimulates their interactions with ssDNA (Jackson et al., 2002). Using a Rad52 
mutant lacking the ability to bind to ssDNA, the authors found that the enhanced
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binding of the RPA-Rad52 complex to ssDNA is mediated through the protein- 
protein interactions between Rad52 and the Rfa2 subunit. An example for the 
second mechanism was reported for RPA and XPA. Their complex was 
reported to have an enhanced recognition of damaged DNA in comparison to 
the individual proteins (He et al., 1995). This effect was interpreted as the 
stabilisation of XPA binding to DNA lesions by RPA (Wang eta!., 2000). As the 
RAD6 and the NER pathways are likely to deal with similar lesions on the DNA 
but at different timing (see 1.4.2) it would be interesting to test the behaviour of 
RPA and the Rad18-Rad6 complex on damaged DNA as well.
According to Davies et al. (2008) RPA specifically contributes to PCNA 
ubiquitylation but not to PCNA sumoylation, as depletion of the Rfa1 subunits 
abolishes only the former modification in response to DNA damage. In addition, 
the association of the Rad 18 protein with chromatin correlates with that of RPA. 
Taken together, the results presented in this thesis and in Davies et al. (2008) 
argue in favour of a model in which RPA plays an important role in the initiation 
of the DNA damage tolerance pathway. As a result of DNA lesions, which cause 
the uncoupling of the helicase movement from that of the replicative DNA 
polymerases, ssDNA regions are exposed in the vicinity of stalled replication 
forks (Byun et al., 2005); (see Figure 8.2A). These ssDNA stretches are 
covered by RPA (Figure 8.2B) and serve as a signal to recruit the Mec1-Ddc2 
complex and activate the replication checkpoint response (Zou and Elledge, 
2003; Zou et al., 2003). In a parallel but independent manner (Davies et al., 
2008), the Rad18-Rad6 complex is recruited to stalled replication forks (Figure 
8.2C). Consequently, PCNA is modified (Figure 8.2D) and activates the DNA 
damage tolerance pathway (Figure 8.2E). The mono-ubiquitylation of PCNA 
appears to be a rate-limiting step for subsequent poly-ubiquitylation by Rad5 
and the Mms2-Ubc13 hetero-dimer (Parker and Ulrich -  unpublished results). 
Therefore, it is still not clear how the choice is made between the error-free and 
the error-prone branches of the DNA damage tolerance pathway.
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Figure 8.1 -  The interactions between Rad18-Rad6, RPA and DNA
A. The Rad18-Rad6 complex interacts with RPA. The interactions are mediated by a 
direct contact between the E3 and two of the RPA subunits, Rfa2 and the DNA binding 
domain of Rfa1. Rad6 seems to contribute as well to the physical interaction with RPA. 
Rad18-Rad6 can interact with either DNA-free RPA or DNA-bound RPA. The latter is 
hypothesised to be preferred over the former, as the binding of Rad18-Rad6 and the 
DNA binding domain of Rfa1 is stimulated in the presence of oligonucleotides.
B. At low salt concentrations, the Rad18-Rad6 complex can bind to ssDNA on its own, 
via direct interactions between Rad18 and the DNA (1). When low amounts of RPA are 
pre-bound to ssDNA, both proteins can share the space on the DNA (2). However, 
increasing levels of RPA compete with the E3 for the binding to ssDNA (3).
C. At physiological-like or high salt concentrations, the Rad18-Rad6 complex cannot 
bind to ssDNA on its own (1). Increasing amounts of RPA, pre-bound to ssDNA, 
enhance the binding of the E3 on the ssDNA (2 + 3), suggesting that in vivo, Rad 18- 
Rad6 may be recruited to stalled replication forks by RPA.
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Figure 8.2- Model for the activation of the DNA damage tolerance pathway 
through Rad18-Rad6 recruitment by RPA
As a result of DNA lesions, which cause the uncoupling of the helicase movement from 
that of the replicative DNA polymerases, ssDNA regions are exposed in the vicinity of 
stalled replication forks (A). RPA quickly binds to these ssDNA stretches (B) and 
recruits the Rad18-Rad6 complex (C). Consequently, PCNA is mono-ubiquitylated (D) 
and the DNA damage tolerance pathways are activated (E). The replicative DNA 
polymerase can be replaced by TLS polymerases that may be recruited to the 
replication fork by mono-ubiquitylated PCNA, activating translesion synthesis (TLS) for 
lesion bypass (E -  left panel). Alternatively, Rad 18 may recruit the Rad5-Ubc13-Mms2 
complex to the stalled fork. Hence, PCNA can be poly-ubiquitylated leading to the 
activation of the damage avoidance (DA) pathway (E -  right panel).
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Interestingly, the ability of RPA to recruit Rad18-Rad6 to ssDNA depends on 
the ionic strength of the buffer. As illustrated in Figure 8.1 B, at low salt 
concentrations, the complex can bind to ssDNA by itself. When low levels of 
RPA are pre-bound to ssDNA, both proteins can share the space on the DNA. 
However, increasing amounts of RPA can compete with the E3 for the binding 
to ssDNA, resulting in reduced retention of the Rad18-Rad6 complex on DNA.
As shown in Figure 5.3, Rad6 can bind directly to RPA by itself or when it is 
associated in a complex with Rad18. In contrast, Rad6 was not able to bind to 
ssDNA on its own, but was brought to the ssDNA by Rad18 (Figure 4.3). An 
important question that should be addressed in the future is whether Rad6 can 
be recruited to the ssDNA via its interaction with RPA, in the absence of Rad 18. 
As discussed in paragraph 5.3, this may have implications for other processes 
in the cell mediated by Rad6, which are independent of Rad 18.
8.5 The Role of the SAP Domain
The results presented in Chapter 7 led to the conclusion that the SAP domain of 
yeast Rad 18 is essential for its activity in the DNA damage tolerance pathway. 
As mentioned before, the evidence in the literature suggests that the SAP 
domain of mammalian Rad 18 is sufficient and necessary for its interactions with 
DNA (Notenboom et al., 2007; Tsuji et al., 2008). However, Figure 7.5 and 
Figure 7.7 support the hypothesis that the SAP domain of yeast Rad 18 is 
dispensable for its interactions with ssDNA. Thus, it is most likely that the SAP 
domain mediates another function of yRad18, which is essential for its DNA 
damage protection activity.
Figure 7.8B and Figure 7.9 support the hypothesis that a mutation or a deletion 
of this domain in the context of the full-length Rad18 protein impairs its 
interaction with PCNA, and thereby disrupts its catalytic activity towards the 
clamp. These results are in agreement with Davies et al. (2008). Consistently, 
Tsuji et al. (2008) showed that mutations in the SAP domain of human Rad 18 
failed to support PCNA mono-ubiquitylation in vivo and in vitro. Most proteins 
that interact with PCNA contain the PIP motif (Moldovan et al., 2007) but this
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domain is missing from Rad 18. Notenboom et al. (2007) found by gel filtration 
analysis that the N-terminal part of Rad 18 (aa 16-366) was sufficient for PCNA 
binding. This region contains the RING, the ZnF and the SAP domains. 
Notenboom et al. (2007) were not able to localise the binding of PCNA to any of 
these domains, suggesting that the interactions with PCNA are mediated 
through more than one of these domains or that a yet unidentified domain for 
PCNA binding exists in this region. Their results are consistent with Figure 7.8B 
in which an N-terminal construct of yRad18 that lacks the SAP and the ZnF 
domains is sufficient for PCNA binding. Taken together, the evidence for both 
yeast and human Rad 18 supports the hypothesis that the SAP domain does not 
interact directly with PCNA. Nevertheless, a mutation or a deletion of the SAP in 
the context of the full-length protein might alter its structure in the vicinity of the 
residues mediating the interaction between the clamp and the E3 and therefore 
disrupt their association. Possibly, this structure-function relationship of the SAP 
domain can also account for the impaired interactions between Rad 18 (SAPA) 
and RPA, observed in Figure 7.6A. However, in order to confirm the results 
obtained by the two-hybrid analysis (Figure 7.8B), additional experiments have 
to be performed. Co-immunoprecipitation assays with both PCNA and Rad18 
from rad18 SAP  mutants should be used as an alternative method to show 
whether Rad18’s SAP domain is important for their interaction in vivo. 
Furthermore, in vitro interaction assays with purified proteins could determine if 
a mutation or a deletion of the SAP domain results in impairment of Rad18’s 
binding to PCNA. Moreover, testing if the SAP domain is sufficient for direct 
interaction with PCNA would be equally important. However, the latter is 
unlikely, as a rad18 (1-192) truncation that lacks the SAP domain interacted 
with PCNA in the two-hybrid system (Figure 7.8B and Helle Ulrich -unpublished 
results).
Apart from RPA, the novel interactor of Rad18 presented in this thesis, there 
are additional known binding partners of yeast Rad18, such as Rad5 (Ulrich 
and Jentsch, 2000) and Ubc9 (Hoege etal., 2002). Thus, it would be interesting 
to test if a deletion or a mutation in Rad18’s SAP domain could affect its 
interactions with those proteins. This should address whether the SAP domain
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regulates Rad18-PCNA interactions specifically, or if its importance extends to 
additional protein-protein interactions of Rad18.
Taken these results together, the Rad 18 (SAPA)-Rad6 complex may still be 
recruited to ssDNA stretches at stalled replication forks by RPA (Figure 7.7). 
Although it then may be in the vicinity of PCNA, Figure 7.8B supports the 
hypothesis that its interaction with the clamp is compromised. Consistently, and 
in agreement with Figure 7.9, this mutant may no longer be able to mono- 
ubiquitylated PCNA at stalled replication forks. Thus, this mutant is deficient in 
the activation of DNA damage tolerance either via the error-prone or the error- 
free sub-pathways. Both Figure 7.2 and Figure 7.3 support this conclusion as 
well as Davies et al. (2008).
8.6 Outlook
The results presented in this thesis and in Davies et al. (2008) suggest that the 
up-stream signals that activate the DNA damage tolerance pathway involve the 
recruitment of the Rad18-Rad6 complex to stalled replication forks by RPA. 
Hence, in response to replication fork stalling and as a consequence of the 
exposure of ssDNA regions bound by RPA, PCNA mono-ubiquitylation is 
facilitated.
The Ulrich lab is very interested in the molecular mechanisms involved in PCNA 
ubiquitylation. Therefore, it would be important to understand the significance of 
the results presented in this thesis in the context of the reconstituted PCNA 
ubiquitylation reaction when the clamp is loaded onto DNA. Recently, my 
colleague was able to establish the system for the reconstitution of DNA- 
dependent mono- and poly-ubiquitylation of PCNA In vitro (Parker and Ulrich -  
unpublished results). When different salt concentrations were applied to the 
reaction for PCNA mono-ubiquitylation, high salt concentrations resulted in 
lower modification efficiency compared to low salt concentrations. This result is 
consistent with the notion that high salt concentrations disrupt the interactions 
between Rad 18 and ssDNA, and thereby reduce the catalytic activity of the E3
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towards the clamp. However, the effects of the salt concentration on PCNA 
loading cannot be excluded.
The recruitment of the Rad18-Rad6 complex to ssDNA by RPA may have 
stimulatory effects on the ubiquitylation of PCNA. Alternatively, it may only 
enable the E2-E3 complex to localise to sites of stalled replication forks at the 
right time. In the latter case, the interaction of RPA with the Rad18-Rad6 
complex would be separate from its catalytic activity. Analogously, although the 
ATRIP-ATR complex is recruited to ssDNA by RPA, the addition of either RPA 
or ssDNA-bound RPA failed to stimulate its kinase activity (Ball etal., 2007).
Preliminary experiments to test the effect of RPA on PCNA modification at high 
salt concentrations were performed with PCNA loaded onto a circular viron 
ssDNA annealed with several oligonucleotides. Interestingly, PCNA mono- 
ubiquitylation levels were abolished in the absence of RPA and restored in its 
presence (Parker and Ulrich -  unpublished results). However, this effect turned 
out to be independent of RPA as it was reproduced when bacterial SSB was 
used instead. Thus, it appears that at high salt concentrations, the loading of 
PCNA on the DNA may be compromised, and either RPA or SSB can rescue 
the binding of the clamp to DNA. However, additional experiments with PCNA 
loaded onto different DNA structures might reveal an RPA-dependent 
stimulation of the ubiquitylation reaction.
Additional factors could affect the reconstituted PCNA ubiquitylation reaction 
that should be taken into consideration. RPA and RFC, the clamp loader, are 
known to interact with each other (Yuzhakov et al., 1999). Through their 
association, the loading of PCNA onto an ssDNA-dsDNA junction is facilitated 
and stabilised. Furthermore, one of the subunits of the human RFC complex, 
Rfc2, was shown to be ubiquitylated by hRad18 in response to DNA damage 
(Tomida et al., 2008). Interestingly, hRPA was reported to have an inhibitory 
effect on this modification. Future studies should reveal the interplay between 
the modifications of the clamp and the clamp loader and additional aspects of 
the regulation of Rad 18 activity by RPA.
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Table 10-1
Appendix
No.
oHU
Name Sequence Length
(nt)
Features and Use
55 RAD6 up CCGG AT CCT GC AGTC AGTC TGCTTCGTCGTC 31
Antisense
Amplification of ORF
57 RAD18 up CCGG ATCCT GC AGTTAATT GTTACCGGGTGG 31
Antisense
Amplification of ORF
72
Rad 18 promoter up GACCTGCAGGATCCGAGTA
GTAAAAATGGCCTTTTC 36
Antisense 
Amplification of 
promoter
73
RAD 18 promoter 
down
CCGAATTCCTCACCGAAAA
CTAATTATTC 29
Antisense 
Amplification of 
promoter
168
RAD18 C48S down C ATTTT C AAGCTT GT GT ATT 
AG AAC AC ATTT G AAT 35
Sense
Mutagenesis of ORF 
C48S (RING finger)
169
RAD18 C48S up AATACACAAGCTTGAAAATG
TATGGCCACAAG 32
Antisense
Mutagenesis of ORF 
C48S (RING finger)
170
RAD 18 GAA down GGGGCAGCGAGCTCATATA
GGAAATTACTTGAA
33
Sense
Mutagenesis of ORF 
G365A/K366A/S367 
A (ATPase)
171
RAD18GAA up T G AGCT CGCT GCCCC ATT A 
CTCTTCATTATC
31
Antisense
Mutagenesis of ORF 
G365A/K366A/S367 
A (ATPase)
179
RAD 18- 
AA(110/111) down
GT CCCTG AG AAT GcGGc AGT 
ACCAGGTCCTG 31
Sense
Mutagenesis of ORF 
E110/111A
180
RAD 18- 
AA(110/111) up
CAGGACCTGGTACTgCCgCA
TTCTCAGGGAC 31
Antisense
Mutagenesis of ORF 
E110/111A
181
RAD18-AAA(136- 
138) down
GT GTAAATGCCGCT GcT GcT 
GcCTTGCAAATTGTTGCAAC 40
Sense
Mutagenesis of ORF 
D136/137/138A
182
RAD 18-AAA( 136- 
138)up
GTT GC AAC AATTT GC AAGgC 
AgCAgCAGCGGCATTTACAC 40
Antisense
Mutagenesis of ORF 
D136/137/138A
183
RAD 18- 
AA(151/152) down
GCAACAAGTGAAAGAAAAC 
TT GCCgcAgcAT CC AT G ACT G 
ATATATTACC 50
Sense
Mutagenesis of ORF 
K151A/R152A
184
RAD 18- 
AA(151/152) up
GGTAATATATCAGTCATGGA
TgcTgcGGCAAGTTTTCTTTC
ACTTGTTGC 50
Antisense
Mutagenesis of ORF 
K151A/R152A
185
RAD18-AAA(178- 
180)down
GTT C AGAAGT G AACGT AT Cg 
cGgcAgc AT C AAAGCC AAATG 
AAC AAAT GGCC C 53
Sense
Mutagenesis of ORF 
K178/179/180A
186
RAD 18-AAA( 178- 
ISO) up
GGGCCATTTGTTCATTTGGC 
TTT GAT gcT gcCgcG ATACGT 
TCACTTCTGAAC 53
Antisense
Mutagenesis of ORF 
K178/179/180A
187
RAD18-S(190)
down
GAACAAATGGCCCAGaGCC 
CC AT AT GT C AAC 31
Sense
Mutagenesis of ORF 
C190S (Zinc finger)
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188
RAD18-S(190) up GTTGACATATGGGGCtCTGG
GCCATTTGTTC 31
Antisense
Mutagenesis of ORF 
C190S (Zinc finger)
189
RAD 18- 
AA(208/209) down
CCTT G AAAAAAC AC ATTT GG 
cTGcATGCCTAACTTTACAAT 
CAC 44
Sense
Mutagenesis of ORF 
D208A/E209A
190
RAD 18- 
AA(208/209) up
GT GATT GT AAAGTT AGGC AT 
gCAgCCAAATGTGTTTTTTCA 
AGG 44
Antisense
Mutagenesis of ORF 
D208A/E209A
536 RAD18 down (pET) ACTAGGATCCGC ACC AAAT AACCACTGCAAG 31
Sense
Amplification of ORF
537 RAD18 up (pET) GTGTGGTACCTTAATTGTTACCGGGTGGGT 30
Antisense
Amplification of ORF
538 RAD6 down (pET) ACTAGG AT CC AAT GT CC AC A CCAGCTAGAAG 31
Sense
Amplification of ORF
539 RAD6 up (pET) GTGTGGTACCTCAGTCTGCTTCGTCGTCG 29
Antisense
Amplification of ORF
543
PhoA linker I GGTATCTAG AG GTT GAG GT 
GATTCCATGGATCCATTCTG 
CAGCTAGAGGTTGAGGTGA 
I I I IATGG 66
Linker for pUC- 
PhoA-Duet
544
PhoA linker II TGCCAAGCTTACTCGAGGG 
TACC AT GC ATT G GG AG AT CT 
GCC AT AAAAT C ACCTC AACC 
TCT 62
Linker for pUC- 
PhoA-Duet
545
PhoA seq CG AG ACTT ATAGT C GCTTT G 
TT 22
Sense
Amplification of 
promoter
724 pFastBacHTc down AGC AT C AAG AT CT C ATGTCG TACTACCATCA 31
Sense
Sequencing
794
[Phi]X-174-1 ATTTT CT C ATTTT CCGC C AG 
CAGTCCAC 28
Antisense 
[Phi]X-174 ssDNA 
DNA-binding assays
795
[Phi]X-174-2 TCAACAGGAGCAGGAAAGC
GAGGGTATC 28
Antisense 
[Phi]X-174 ssDNA 
DNA-binding assays
796
[Phi]X-174-3 C ACG AC GC AATGG AG AAAG 
ACGGAGAGC 28
Antisense 
[Phi]X-174 ssDNA 
DNA-binding assays
797
[Phi]X-174-4 GCCCAGAGATTAGAGCGCA
TGACAAGTA 28
Antisense 
[PhiJX-174 ssDNA 
DNA-binding assays
798
[Phi]X-174-5 GCTT CGGCGTTAT AACCTC A 
CACTCAATCI I I I 33
Antisense 
[Phi]X-174 ssDNA 
DNA-binding assays
799
[Phi]X-174-6 CGCC AGC AATAGC ACC AAA 
CATAAATCACCTCACT 35
Antisense 
[Phi]X-174 ssDNA 
DNA-binding assays
800
[Phi]X-174-7 TCAAATCCGGCGTCAACCA
TACCAGCAGAG 30
Antisense 
[Phi]X-174 ssDNA 
DNA-binding assays
801
[Phi]X-174-8 G AAAAAT AT C AACC AC ACC A 
GAAGCAGCATCAGT 34
Antisense 
[Phi]X-174 ssDNA 
DNA-binding assays
802
[Phi]X-174-9 CGAACTCAACGCCCTGCAT
ACGAAAAGA 28
Antisense 
[Phi]X-174 ssDNA 
DNA-binding assays
803 [Phi]X-174-10 CGTGAAAAAGCGTCCTGCG
TGTAGCGAACT
30 Antisense 
[Phi]X-174 ssDNA 
DNA-binding assays
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834 ssDNA-bio TTGTAAAACGACGGCCAGT 
G AATT CATC AT C AATAATAT 
ACCTTAI I I IGGCAGGCGG 
T GTTAATACT G ACCGCC [Bio 
TEG-Q]
75 3’-biotinylated 
DNA-binding assays
835 dsDNA GGCGGTCAGTATTAACACC 
GCCTGCC AAAAT AAGGT AT A 
TT ATT GAT GAT G AATT C ACT 
GGCCGTCGI I I IACAA
75 Reverse complement 
to OHU834 
DNA-binding assays
844 XOIc GGGTGAACCTGCAGGTGGG 
CAAAGATGTCCTAGCAAGG 
C ACT GGTAG AATTCGGC AG 
CGTC
61 Reverse complement 
to XOI (OHU1055) 
DNA-binding assays 
(Table 2-9)
847 X04 ATCG ATAGTCGG AT CCTCT A 
GAC AGCTCC AT GT AGC AAG 
GCACTGGTAGAATTCGGCA 
GCGT
62 Splayed arm with 
XOI (OHU1055) 
DNA-binding assays 
(Table 2-9)
848 X02.1/2 TGGGTGAACCTGCAGGTGG
GCAAAGATGTCC
31 DNA-binding assays 
(Table 2-9)
849 X03.1/2 CAT GG AGCT GTCTAG AGG A 
TCCGACTATCGA
31 DNA-binding assays 
(Table 2-9)
870 ssDNA-bio II AT GG ATTAG AT AG ACG AAGT
TGTCAAGAGCTCTGCTGCT
GGTAACACCGTATGCTAGT
ACACTGCGTTTATGTAT[BioT
EG-Q]
75 3’-biotinylated 
DNA-binding assays 
(Weak secondary 
structure; Sequence 
based on PGK1)
871 dsDNA II AT AC AT AAACGC AGT GT ACT 
AGCATACGGTGTTACCAGC 
AGCAGAGCTCTTGACAACTT 
CGTCTATCTAATCCAT
75 Reverse complement 
to OHU870 
DNA-binding assays
881 RAD18 SAPA up CCAAAGCATAAAATTGATCT
TCGGCAATCT
30 Antisense
Mutagenesis of ORF 
(279-312)A 
(SAP domain)
882 RAD18 SAPA down G AAG AT CAATTTT AT GCTTT 
GG AATTCT AATTTTT G
36 Sense
Mutagenesis of ORF 
(279-312)A 
(SAP domain)
883 RAD18 SAP* up CgcGTTTTGCgcAGTAgCATT
AGTTGACAGTCCCAAC
37 Antisense
Mutagenesis of ORF 
G299A/R301A/M304 
A
(SAP domain)
884 RAD 18 SAP* down GcTACTgcGCAAAACgcGATT 
AAAAG AT AC AAT C ACT AC
39 Sense
Mutagenesis of ORF 
G299A/R301A/M304 
A
(SAP domain)
885 pFastBacHTc down 
new
AGC AT C AAG AT CT CAT GT CG 
TACTACCATCACCA
34 Sense
Amplification of tag
886 RAD6 C88S up AATATCCAAAgAAATTTCAC 
CATTT GCAT AG AC
33 Antisense
Mutagenesis of ORF 
C88S
887 RAD6 C88S down TGGTGAAATTTcTTTGGATA 
TTTT GC AG AAC AG
33 Sense
Mutagenesis of ORF 
C88S
906 ssDNA-bio III CGCCAGC AAT AGC ACC AAA
CATAAATCACCTCACT[BioTE
G-Q]
35 3-biotinylated 
Identical to OHU799 
DNA-binding assays
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907 dsDNA III AGT GAG GT G ATTTAT GTTTG 
GTGCTATTGCTGGCG
35 Reverse complement 
to OHU906 
DNA-binding assays
1045 dT 10mer TI I I I I I I I I 10 DNA-binding assays
1055 XOI [BiodT]ACGCTGCCGAATTCT
ACCAGTGCCTTGCTAGGAC
ATCTTTGCCCACCTGCAGG
TTCACCC
61 5’-biotinylated 
DNA-binding assays 
(Table 2-9)
1092 dT 16mer II  I I I I I IITTTTTTT 16 DNA-binding assays
1093 dT 25mer TTT TT1111ITTTTTTTI1 1 1 1 
TTT
25 DNA-binding assays
1094 dT 35mer TTTTTTITl1TTTTTTT11111 35 DNA-binding assays
1095 dT 75mer TTTi l l  111ITTTTTTTI1111 75 DNA-binding assays
TTTTTTTTTTTTTTTTT1IT 1T 
TTTTTTTTT
1177 36mer-5’ biotin [BiodT]ACGCTGCCGAATTCT
ACCAGTG
CCTT GCT AGGAC A
36 5’-biotinylated 
Based on XOI 
3-Flap of 5 
nucleotides with 
OHU847 & OHU849 
DNA-binding assays
1178 46mer-5’ biotin [BiodT]ACGCTGCCGAATTCT
ACCAGTGCCTTGCTAGGAC
ATCTTTGCCCA
46 5’-biotinylated 
Based on X01 
3’-Flap of 15 
nucleotides with 
OHU847 & OHU849 
DNA-binding assays
1179 76mer-5’ biotin [BiodT]ACGCTGCCGAATTCT 
ACCAGTGCCTTGCTAGGAC 
ATCTTTGCCCACCTGCAGG 
TTCACCC 1 1 TTT TTTTTTTTT 
T
76 5-biotinylated 
Based on XOI 
3’-Flap of 45 
nucleotides with 
OHU847 & OHU849 
DNA-binding assays
1180 dT 60mer 3’ biotin 1111111111111 h i t  11111 60 3’-biotinylated 
DNA-binding assays11 ITT 11111111ITTT1111T
1 1 1 1 1 1 1 II  1 i 1 1 1 1 1 [bio 1 bu
-Q]
1181 dT 45mer 3’ biotin 1 1 1 1 1 II  n  1 II  I TTTTI 1 ITT 45 3’-biotinylated 
DNA-binding assays1111111111111TTTT11! IT 
T[BioTEG-Q]
1182 dT 35mer 3’ biotin 1 1 1 1 1 11T l 1111ITTT11 I I I 35 3’-biotinylated 
DNA-binding assays1 1 1 ITTT l l l 1 1 r[bioTbG-u]
1183 dT 25mer 3’ biotin ITTTTTIIITTTTTTTTTTTTT 
TTTrBioTEG-Q]
25 3-biotinylated 
DNA-binding assays
1184 dT 15mer 3’ biotin I 1 TTT 1 TTTTTTTTT[BioTEG- 
Q]
15 3-biotinylated 
DNA-binding assays
- M13 reverse CAGGAAACAGCTATGAC 17 Sequencing
Table 10-1: The sequences of all the oligonucleotides that were used.
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SUMMARY
Replicative DNA damage bypass, mediated by the 
ubiquitylation of the sliding clamp protein PCNA, 
facilitates the survival of a cell in the presence of 
genotoxic agents, but it can also promote genomic in­
stability by damage-induced mutagenesis. We show 
here that PCNA ubiquitylation in budding yeast is ac­
tivated independently of the replication-dependent S 
phase checkpoint but by similar conditions involving 
the accumulation of single-stranded DNA at stalled 
replication intermediates. The ssDNA-binding repli­
cation protein A (RPA), an essential complex involved 
in most DNA transactions, is required for damage- 
induced PCNA ubiquitylation. We found that RPA di­
rectly interacts with the ubiquitin ligase responsible 
for the modification of PCNA, Radi 8, both in yeast 
and in mammalian cells. Association of the ligase 
with chromatin is detected where RPA is most abun­
dant, and purified RPA can recruit Radi 8 to ssDNA 
in vitro. Our results therefore implicate the RPA 
complex in the activation of DNA damage tolerance.
INTRODUCTION
DNA damage tolerance enables a cell to resolve replication prob­
lems such as damage-induced fork stalling (Lawrence, 1994; 
Lehmann, 2002; Ulrich. 2005). Replicative bypass of DNA lesions 
occurs via translesion synthesis (TLS) by specialized damage- 
tolerant DNA polymerases or by an error-free damage avoidance 
pathway that makes use of the information of the newly synthe­
sized sister chromatid (Lawrence, 1994). Both pathways are ac­
tivated by posttranslational modification of the replicative sliding 
clamp, proliferating cell nuclear antigen (PCNA) (Hoege et al., 
2002; Kannouche et al., 2004; Stetter and Ulrich, 2003; Watanabe 
et al., 2004). In response to DNA damage, monoubiquitylation of 
PCNA at a conserved lysine, K164, activates the damage-toler­
ant polymerases for TLS, whereas polyubiquitylation is required 
for error-free damage avoidance. Independent of DNA damage, 
budding yeast PCNA is also modified during S phase by the ubiq- 
uitin-like protein SUMO (Papouli et al., 2005; Pfander et al., 2005). 
PCNA monoubiquitylation involves the ubiquitin-conjugating 
enzyme (E2) Rad6  and its cognate ubiquitin ligase (E3), Rad18. 
A second E2-E3 pair, the heterodimeric E2 Ubc13-Mms2 with
the E3 Rad5, is responsible for polyubiquitylation. Although it 
promotes resistance to genotoxic agents, TLS is a potentially mu­
tagenic process that endangers the cell’s genomic stability. At 
the same time, failure to reactivate stalled replication forks may 
lead to genome instability by inducing DNA double-strand breaks 
(DSBs) and gross chromosomal aberrations (Branzei and Foiani,
2005). Stringent control over DNA damage bypass is therefore 
essential, but the upstream signals that activate PCNA modifica­
tion in vivo are not well defined.
One of the important regulatory mechanisms responsible for 
the sensing of DNA damage and replication stress is the replica­
tion-dependent S phase checkpoint, a surveillance system that 
inhibits the firing of late-replication origins, prevents cell-cycle 
progression to mitosis, and is important for the stabilization of 
stalled replication forks (Branzei and Foiani, 2005; Nyberg et al., 
2002). The ATR-ATRIP kinase complex and the PCNA-like 9-1-1 
checkpoint clamp, responsible for initiating the checkpoint sig­
naling cascade during S phase, are activated by replication fork 
stalling. Their recruitment to stretches of single-stranded (ss)DNA 
is mediated by interactions of ATRIP and the 9-1-1-specific 
clamp loader with the ssDNA-binding RPA complex (Zou and 
Elledge, 2003; Zou et al., 2003).
Our analysis of the mechanisms that control the activity of the 
RAD6 pathway in budding yeast now reveals striking parallels to 
the replication checkpoint response: although the two systems 
operate independently, they are activated in a similar fashion 
by stalled replication intermediates that involve an accumulation 
of ssDNA. We show that yeast and human Radi 8 , like ATRIP and 
the 9-1-1 clamp loader, directly interact with the RPA complex. 
In vivo, the abundance of Rad18 on DNA mirrors that of RPA 
even in the absence of its physiological target, PCNA, and deple­
tion of RPA prevents damage-induced PCNA ubiquitylation in S 
phase. In vitro, the RPA complex can recruit the ubiquitin ligase 
to ssDNA. These results suggest an effective activation mecha­
nism for ubiquitin-dependent damage bypass.
RESULTS 
Replication Forks Are Required for PCNA Ubiquitylation
In order to characterize the conditions required for PCNA ubiqui­
tylation in S. cerevisiae, we examined possible contributions of 
the DNA damage checkpoint and cell-cycle regulation. We found 
that, in budding yeast, as in X. laevis egg extracts and in S. pombe 
(Chang et al., 2006; Frampton et al., 2006), ubiquitin-dependent 
DNA damage tolerance and checkpoint signaling operate inde­
pendently (see Figure S1 available online). Given the importance
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Figure 1. Effects of the Cell Cycle and 
RAD18 Overexpression on PCNA Ubiquity­
lation
(A) Cell-cycle dependence of PCNA modification. 
Cells arrested in G1, S, and G2 phase were treated 
with 0.02% MMS for 90 min where indicated, and 
modifications of ^ “PCNA, isolated under denatur­
ing conditions, were detected by western blot. 
DNA contents were monitored by flow cytometry 
(FACS). Asynchronous cells (AS) were processed 
in parallel.
(B) Effects of RAD18 overexpression on PCNA 
modification throughout the cell cycle. Cells were 
treated and analyzed as in (A). Note that, in this 
panel, monoubiquityiated PCNA is abundant 
enough to be detected by the anti-ubiquitin anti­
body, which recognizes this form very poorly 
(Hoege et al., 2002). Rad18 was detected in total 
cell extracts.
of ubiquitylated PCNA for replicative lesion bypass, the modifica­
tion is expected to be most relevant during S phase. In fact, con­
sistent with our previous findings (Papouli et al., 2005) and with 
the situation in mammalian cells (Kannouche et al., 2004), arrest 
in S phase with hydroxyurea (HU), which causes replication fork 
stalling by nucleotide depletion without directly damaging DNA, 
is sufficient to trigger PCNA modification (Figure 1 A). In contrast, 
ubiquitylated PCNA was not detected in G1 - or G2-arrested cells 
even after treatment with DNA-damaging agents. This indicates 
that, even in asynchronous populations, all detectable PCNA 
ubiquitylation arises from S phase cells.
The absence of ubiquitylated PCNA outside of S phase could 
be due to the lack of replication forks. Alternatively, the physio­
logical state of the cell, defined by the activities of cyclin-depen- 
dent kinases, could control PCNA modification. In order to 
directly examine the need for DNA replication, we made use of 
a temperature-sensitive mutant of an essential kinase gene 
responsible for DNA replication initiation, cdc7** (Figure 2) (Hart­
well, 1973). At the permissive temperature, c d c 7 cells undergo 
regular cycles of DNA replication and cell division, whereas upon 
release from G1 arrest at the restrictive temperature, the mutant 
enters the cell cycle without initiating DNA replication (Figure 2B). 
Degradation of the CDK inhibitor Sic1 at the beginning of S 
phase and later on the accumulation of the mitotic cyclin Clb2 
proceeds normally in cdc7te cells (Figure 2C), indicating that 
the physiological state under these conditions resembles a pas­
sage through the cell cycle. Following the scheme outlined in 
Figure 2A, we asked whether DNA damage would trigger 
PCNA modification in the mutant. We found that WT cells under­
went PCNA ubiquitylation normally at 24°C and 37°C, but in 
cdcT* the modification was visible only at the permissive tem­
perature (Figure 2D). In order to exclude the possibility that the 
kinase activity of Cdc7 itself was needed for the modification, 
we examined a strain in which the requirement for CDC7 is 
bypassed by a mutation in MCM5, encoding a subunit of the rep­
licative helicase (Hardy et al., 1997). In the context of this allele, 
bob1, deletion of CDC7 did not abolish PCNA ubiquitylation, im­
plying that the Cdc7 kinase itself is dispensable for modification 
of the clamp (Figure 2E). This suggests that PCNA needs to be 
engaged in replication for efficient ubiquitylation in vivo.
Not All Types of DNA Damage Induce PCNA 
Ubiquitylation
We next asked what types of lesions would induce PCNA mod­
ification during DNA replication. In addition to UV radiation and 
methyl methane sulfonate (MMS), which induce ubiquitylation 
in all species examined so far, agents that cause bulky adducts 
such as 4-nitroquinoline oxide (NQO) and also the oxidizing 
agent hydrogen peroxide (H2O2) were found to be active 
(Figure 3A). As observed in S. pombe (Frampton et al., 2006), 
PCNA was also ubiquitylated after treatment with ionizing radia­
tion (IR) (Figure 3A), despite our previous finding that PCNA ubiq­
uitylation site mutants are not particularly sensitive to IR, and 
DSBs induced by an endonuclease do not cause PCNA modifi­
cation (Chen et al., 2005). Moreover, mammalian cells do not 
ubiquitylate PCNA after IR treatment (Kannouche et al., 2004). 
A possible explanation for the IR-induced modification of S. cer­
evisiae and S. pombe PCNA may therefore be base damage 
associated with the high doses of radiation used in the yeast 
system rather than DSBs per se.
To further explore this hypothesis, we analyzed the response 
to chemicals that cause DSBs by different mechanisms. Bleo­
mycin, which acts independently of the cell-cycle phase, did 
not trigger PCNA modification (Figure 3A), although it affected 
viability (Figure 3B). Camptothecin (CPT), a topoisomerase I inhib­
itor, induces covalent adducts of the enzyme to DNA, which are 
converted to DSBs in S phase through collisions with replication 
forks (Liu et al., 2000). Despite its S phase-specific action, CPT 
treatment did not result in PCNA ubiquitylation (Figure 3A). In or­
der to exclude the possibility that the drug had simply no effect at 
the concentrations used in this experiment, we examined PCNA 
modifications in a rad52 mutant, which is highly sensitive to CPT 
(Figure 3C). Again, we did not observe PCNA ubiquitylation in re­
sponse to CPT in rad52, whereas its reaction to MMS was com­
parable to that of WT cells (Figure 3D). Likewise, CPT induces 
PCNA modifications very modestly in S. pombe when com­
pared to HU or UV (Frampton et al., 2006), and the drug is also 
a poor inducer of the replication checkpoint in budding yeast 
(Redon et al., 2003) (Figure 3E).
Replication fork stalling by treatment with HU or adduct-form- 
ing agents like MMS results in an inhibition of DNA polymerases
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Figure 2. Active Replication Forks Are Required for PCNA Ubiquitylation
(A) Experimental strategy to prevent the formation of replication forks in the cd c 7° mutant.
(B) FACS profiles of WT and cdc7* cells subjected to the treatment outlined in (A).
(C) Progression through the cell cycle in WT and cdc7*“ cells as monitored by Clb2 and Sic1 levels. Note that at 37°C WT cells have completed mitosis and 
re-entered G1 phase at 80 min, whereas cdc7a  mutants accumulate in G2/M with abnormally high Clb2 and low Sic1 levels. The asterisk indicates a band cross­
reactive to the Sic1 antibody. Detection of phosphoglycerate kinase (PGK) served as a loading control.
(D) Damage-induced PCNA ubiquitylation in WT and cdc7** cells after treatment as outlined in (A). S phase samples in cdc7° cells and in W T at 24°C were taken 
40 min after release, whereas the S phase sample in the WT at 37°C was taken after 25 min due to the faster cell-cycle progression at this temperature (see [B] 
and (CD-
(E) CDC7 is dispensable for PCNA ubiquitylation. Damage-induced PCNA modification was examined in asynchronous cultures of isogenic WT, bob1, and bob 1 
cdc7A cells.
and an accumulation of ssDNA due to the continuing movement 
of the replicative helicase (Branzei and Foiani, 2005). In contrast, 
collision of the replication machinery with CPT-induced topoisom- 
erase adducts and DSB formation is expected to affect the 
entire replicon and should therefore not initially involve an accu­
mulation of ssDNA. In support of this model, radioactive labeling 
of nondenatured total DNA by random priming was significantly 
enhanced after MMS or HU, but not after CPT treatment (Fig­
ure 3F). This even applied to the checkpoint-defective rad53 
mutant, which is known to accumulate ssDNA in response to 
replication stress (Sogo et al., 2002). In rad52 cells, the difference 
was less pronounced, but we cannot rule out a replication-inde­
pendent effect of the mutation—for example, on formation or 
resection of DSBs—that would have no consequences for 
PCNA modification. Thus, PCNA ubiquitylation correlates well 
with elevated levels of ssDNA during replication.
Overexpression of RAD 18 Relaxes the Conditions 
for PCNA Modification
Given that the ubiquitin ligases, Rad 18 and Rad5, are ssDNA- 
binding proteins, they might directly recognize a blocked fork 
by associating with the stretches of ssDNA adjacent to the stalled 
polymerase-PCNA complex. If these enzymes are limiting factors 
in transmitting the signal for modification, changes in their abun­
dance should affect the extent of modification. We therefore 
analyzed the consequences of overexpressing RAD18, encoding 
the E3 responsible for PCNA monoubiquitylation. Figure 1B 
shows that overexpression of RAD18 caused significantly in­
creased levels of ubiquitylated PCNA. In asynchronous popula­
tions, RAD18 overexpression resulted in constitutive modifica­
tion of PCNA even in undamaged cells, suggesting that fork 
stalling was no longer required. Likewise, the modification was 
no longer restricted to S phase, as ubiquitylated PCNA now
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Damage on PCNA Ubiquitylation
(A) PCNA ubiquitylation after treatment with HU, 
MMS, NQO, H202, UV, IR, Bleomycin (Bleo), and 
CPT at the indicated doses. Modified forms of 
PCNA were detected as described in the legend 
to Figure 1.
(B) Sensitivities of WT cells to Bleomycin as mon­
itored by spot assays.
(C) Sensitivities of WT and rad52 cells to CPT.
(D) PCNA ubiquitylation in WT versus rad52 cells. 
Treatment with damaging agents (50 ng/ml CPT, 
0.02% MMS) and detection of the modifications 
was performed as above.
(E) Induction of the DNA damage checkpoint after 
treatment with selected DNA-damaging agents. 
Rad53 phosphorylation, monitored by western 
blot analysis, was used as an indicator of check­
point activation.
(F) Quantification of ssDNA after treatment with 
MMS, HU, or CPT by radioactive random-primed 
labeling of nondenatured genomic DNA. The 
graph shows the average labeling efficiencies 
with standard deviations (in cpm) from triplicate 
experiments, corrected for the amount of template 
DNA as determined by real-time PCR.
control CPT 
(50 pg/ml)
WT
rad52
damage:
anti-Rad53
-  HU MMS CPT - HU CPT - HU CPT
rad52 rad53
appeared in G1 - and G2-arrested cells. Outside of S phase, how­
ever, DNA damage was still a prerequisite for the reaction. Taken 
together, elevated levels of Radi 8  afforded PCNA ubiquitylation 
whenever the clamp was detectable in association with chroma­
tin (Figure S2), strongly suggesting that the modification takes 
place on DNA. Consistent with this notion, loading of PCNA 
onto DNA was shown to be required for efficient modification 
in vitro (Garg and Burgers, 2005).
RPA Is Required for Ubiquitylation of PCNA
Our findings suggest that PCNA ubiquitylation is induced by the 
recruitment of Radi 8  to regions of ssDNA exposed by the un­
coupling of helicase movement from DNA synthesis, analogous 
to the way in which stalled forks are believed to activate the rep­
lication checkpoint (Branzei and Foiani, 2005). Considering that 
the factor responsible for recruitment of the ATR kinase complex
and the 9-1-1 clamp loader is not naked 
R a d5 3  ssDNA but rather ssDNA coated by the
ssDNA-binding RPA complex (Zou and 
Elledge, 2003; Zou et al., 2003), we exam­
ined a possible contribution of RPA to 
PCNA ubiquitylation.
The rfa1-t11 mutant (K45E), defective in 
homologous recombination and recruit­
ment of checkpoint factors (Umezu 
et al., 1998; Zou and Elledge, 2003; Zou 
et al., 2003), was competent in damage- 
induced PCNA ubiquitylation (Figure 4A). 
Likewise, a temperature-sensitive mu­
tant, rfa1-t33 (S373P), which is unable to 
mediate DNA replication at the restrictive 
temperature (Umezu et al., 1998), ubiqui­
tylated PCNA normally. This indicates that the replicative function 
of RPA is not required for PCNA modification. However, even at 
the restrictive temperature, the mutant protein was found in asso­
ciation with DNA (Figure 4B), which leaves the possibility that it 
was still able to promote the recruitment or activation of Radi 8 . 
A panel of rfa2 and rfa3 mutants defective in various aspects of 
DNA replication and repair (Maniar et al., 1997) had relatively 
minor effects on PCNA ubiquitylation (Figure S3). We therefore 
examined the consequences of depleting Rfa1 by means of 
a heat-inducible degradation signal (Dohmen et al., 1994). Fol­
lowing the procedure outlined in Figure 4C, we induced degrada­
tion of the Rfa1,d protein in G1-arrested cells. The rfa 1-td mutant 
engaged in DNA replication (Figure 4D) with less than 5% of the 
Rfa1td protein remaining, but damage-induced PCNA ubiquityla­
tion was almost completely abolished (Figure 4E). In contrast, S 
phase-associated sumoylation of PCNA, which likewise depends
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Figure 4. RPA Is Required for PCNA Ubiquitylation
(A) PCNA is ubiquitylated normally in the rfa 1-t 11 and rfa1-t33 mutants. MMS-induced PCNA ubiquitylation was detected as described in the legend to Figure 1 in 
WT(RFA1) and two rfal mutants.
(B) DNA association of the mutant protein encoded by rfa1-t33 is indistinguishable from the WT protein at 25°C and 37°C. Whole-cell extracts (W) were fraction­
ated by centrifugation into soluble (S) and chromatin-associated (C) material. Proteins were detected by western blot. The distributions of the chromatin-asso­
ciated 0rc6 protein and soluble PGK served as controls for the quality of fractionation.
(C) Experimental strategy to deplete Rfal“ from yeast cells. In ther/al-fd strain, the construct encoding the heat-labile Rfa1,d protein is controlled by a doxycy- 
cline (Dox)-repressible promoter, and UBR1, encoding the E3 responsible for degradation of Rfal"1, is induced by galactose (Gal). Rfa1w remains stable at 25°C 
in raffinose (Raf) medium. Temperature effects were excluded by returning the cells to 25°C without allowing resynthesis of Rfa1,d before releasing them into 
S phase.
(D) DNA replication proceeds after depletion of the Rfal,d protein. FACS samples were taken before and 50 min after release from G1 arrest following the scheme 
shown in (C).
(E) Loss of damage-induced PCNA ubiquitylation after depletion of the Rfa1w protein. H“PCNA and its modified forms were detected as in Figure 1. Rfal was 
detected in total cell extracts.
(F) Chromatin association of PCNA in RFA1 and rfa1-td. Chromatin-binding assays were performed as described in (B). Note that the Rfa1,d protein remaining 
after depletion is entirely associated with chromatin. The degron tag is partially cleaved from the protein during extract preparation.
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Figure 5. Interaction of Rad 18 with the RPA Complex
(A) Protein-protein interactions between Radi8, Rad5, and the RPA subunits Rfal, Rfa2, and Rfa3 in the yeast two-hybrid system. The open reading frames were 
expressed as fusions to the Gal4 activation (AD) and DNA-binding domains (BD), and the presence of the constructs was confirmed by growth on selective 
medium (-LW). Positive interactions were scored by growth on plates lacking histidine (-HLW) and stronger interactions on plates lacking histidine and adenine 
(-AHLW). Interactions between Rad 18 and Rad5 (Ulrich and Jentsch, 2000) and between the individual RPA subunits are shown as internal controls.
(B) Coomassie-stained gel of recombinant Hi9VSVFtad18 isolated in complex with untagged Rad6 from baculovirus-infected insect cells.
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on DNA replication (our unpublished results), was not impaired 
(Figure 4E), implying that the lack of ubiquitylation is not due to 
a general failure to modify PCNA. In addition, comparable 
amounts of PCNA were chromatin-associated in WT  and rfa l- 
td (Figure 4F), suggesting that replication forks remain largely in­
tact when Rfal levels are seriously reduced. These findings indi­
cate that RPA is required for damage-dependent ubiquitylation of 
PCNA during S phase, independent of its function in DNA replica­
tion, recombination, and the recruitment of checkpoint factors.
Rad18 Interacts with the RPA Complex
We asked whether RPA contributes directly to the recruitment of 
the ubiquitylation machinery to stalled replication intermediates 
by examining possible interactions between Rad18, Rad5, and 
the RPA subunits. In the two-hybrid system, we observed an in­
teraction of Rad18, but not of Rad5, with the subunits Rfal and 
Rfa2 in addition to mutual interactions among the three RPA 
subunits (Figure 5A). In order to exclude indirect effects, we ex­
amined the interaction of recombinant yeast Rad6-Rad18 com­
plex (Figure 5B) with RPA immobilized on Sepharose beads. 
Purified HlsVSVRad18 was retained on the beads in the presence 
of a nuclease, indicating that the interaction was direct and not 
mediated by DNA or other cellular factors (Figure 5C).
Analysis of truncations and mutations of Rad 18 in the two-hy­
brid system revealed that an N-terminal portion of Radi 8 , includ­
ing the RING domain, is sufficient for interaction, whereas the 
central Zinc finger and a DNA-binding SAP domain (Notenboom 
et al., 2007) are irrelevant (Figure 5D). Within R fa l, we mapped 
the interaction site to the central region spanning amino acids 
167-452 (Figure 5E), which comprises the primary ssDNA-bind- 
ing motifs of RPA. This interaction, as well as the association 
between Rad18 and Rfa2, was confirmed in vitro using recombi­
nant constructs GSTRfa1 (182-421), ^ R fa Z , and HisVSVRad18 
(Figure 5F). Thus, both subunits, Rfal and Rfa2, contribute inde­
pendently to the interaction with the E3.
Coimmunoprecipitations from strains bearing epitope-tagged 
RAD18^ha and RFA19myc in their native contexts confirmed the 
association of Rad18 with RPA in vivo (Figure 5G). The interac­
tion did not vary measurably between damaged and undamaged 
cells (data not shown). Considering the conservation of PCNA 
modification in eukaryotes, we asked whether interaction of 
Rad18 with RPA was detectable in human cells. Upon transfec­
tion with an expression construct for FI_AG-tagged human
Rad18, isolation of FLAGhRad18 indeed resulted in copurification 
of endogenous hRPA both from the cytoplasmic and the chro­
matin-associated fraction (Figure 5H). Addition of nuclease did 
not abolish the interactions in yeast or mammalian extracts 
(data not shown), indicating that they are primarily mediated by 
protein-protein contacts. These observations raised the ques­
tion of whether Rad18 is recruited to ssDNA by means of its 
interaction with RPA.
Association of Rad18 with ssDNA Correlates  
with that of RPA Even in the Absence of PCNA
Chromatin immunoprecipitations (ChlPs) from yeast cells bear­
ing a RAD18^myc allele provided evidence for association of 
Rad18 with chromatin in vivo. In HU-treated cells, Rad189myc, 
like RPA and PCNA (Papouli et al., 2005), was detectable at rep­
lication forks in the vicinity of a replication origin (Figure 6 A). In 
order to exclude the possibility that the presence of Rad18 at 
this site was merely due to its interaction with PCNA, we analyzed 
the chromatin association of Radi 8  at stretches of ssDNA that re­
sult from the resection of a DSB induced by the HO endonuclease 
(Lee et al., 1998). In this context, RPA initially associates with se­
quences adjacent to the break but is displaced by the recombino- 
genic Rad51 filament in a Rad52-dependent manner (Wang and 
Haber, 2004) (Figure 6 B). Although PCNA is easily detectable at 
replication forks by ChIP (Papouli et al., 2005), the protein was 
absent from the DSB (Figure 6 C). We had previously failed to ob­
serve significant Rad189rnyc association by ChIP using multiplex 
PCR (Chen et al., 2005); however, with a more sensitive real-time 
PCR method, we were able to detect a 2-fold enrichment after 
induction of the HO endonuclease (Figure 6 D). This small but re­
producible signal is likely to be significant, as it was abolished in 
an m rel 1 mutant, in which ssDNA forms more slowly (Lee et al., 
1998) (Figure S4). Importantly, inhibition of Rad51 filament forma­
tion by deletion of RAD52 resulted in strongly enhanced associ­
ation of RadlS9™70 (Figure 6 D), consistent with elevated RPA 
levels on the ssDNA in this mutant (Wang and Haber, 2004) 
(Figure 6 B). Thus, the amount of Rad18 on ssDNA correlates 
with that of RPA even where PCNA is not present.
RPA Can Recruit Rad 18 to ssDNA In Vitro
To gain insight into how RPA might associate with Rad18 on 
ssDNA, we examined the effect of RPA on the DNA binding of 
H ® v sv R a d 1 8  tQ  g n  jm m o b j| jz e c | 7 5  nt oligonucleotide in vitro. At
(C) Interaction between purified recombinant RPA, covalently coupled to Sepharose, and HlsVSVRad18. HI,vsvRad18 retained on the RPA beads was eluted 
in Laemmli buffer and detected by western blotting. BSA-coupled beads served as negative control.
(D) Two-hybrid analysis of the Rad18 domains interacting with Rfal and Rfa2. The scheme on the right indicates the RING domain, a Zinc finger (ZF), a SAP 
domain, and the region relevant for interaction with Rad6. Positions C48 and C190 are indicated by asterisks in the respective mutants.
(E) Two-hybrid analysis of the Rfal domains interacting with Radi 8. The scheme on the right indicates the regions relevant for ssDNA binding and holocomplex 
formation as well as a Zinc finger domain. The position of the rfa1-t11 mutation (Umezu et al., 1998) is indicated by an asterisk.
(F) Interaction of Radi 8 with the ssDNA-binding domain of Ftfal and with Rfa2 in vitro. Purified recombinant ^ R fal (182-421) or Rfa2, immobilized on glutathione 
Sepharose, was incubated with H*vsvRad18. Bound material was eluted and analyzed by western blot to detect Rad18 (upper panel) or by Coomassie staining to 
detect the GST constructs (lower panel).
(G) In vivo interaction of Rad 18 with RPA was analyzed by coimmunoprecipitation of yeast RadlS6”* and Rfa19rnyo by using the indicated antibodies. Strains 
expressing untagged RAD 18 or RFA1 served as negative controls for precipitation of Rad 18®  ^and Rfa19myc, respectively. In the anti-Rfal precipitation, 
antibody was omitted as a negative control. Bands of higher molecular weight in anti-HA precipitates represent ubiquitylated Radis6”''.
(H) Interaction between hRad18 and hRPA in cultured human cells. Immunoprecipitations (anti-FLAG) were performed from extracts derived from HEK293T cells 
transiently transfected with an expression construct for FLAQhRad18. Cells transfected with the empty vector served as negative control. Extracts were partitioned 
into detergent-soluble (S) and -insoluble (I) material. Note that FLAQhRad18 is monoubiquitylated in the soluble fraction, which includes the cytoplasmic material, 
but not in the chromatin-associated fraction.
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Figure 6. In Vivo Association of Rad18 with ssDNA
(A) Association of Radi 8*™ ^ with a replication fork in HU-treated cells detected by ChIP after release from G1 arrest. Radi 89myc was precipitated (anti-myc) from 
formaldehyde-crosslinked cells at the indicated times, and associated DNA was quantified by real-time PCNA using primers specific for an early-firing origin, 
ARS607 (black); a sequence 4 kbp removed from ARS607 (gray); and a late-firing origin, ARS501 (white). AS, asynchronous cells. Error bars in all panels represent 
combined standard deviations from three independent amplifications.
(B) Rfa1Smyc is detectable by ChIP at sequences adjacent to an HO-induced DSB. Enrichment of sequences adjacent to the HO site (MAT) relative to those at an 
unrelated locus (ACT1) in immunoprecipitates (anti-myc) from crosslinked cells was followed over the indicated time using real-time PCR as in (A). ChIP assays 
were performed in WT (black) and rad52 mutants (white).
(C) PCNA (Pol309myc) is not detectable by ChIP at the site of an HO-induced DSB in W T (black) or rad52 (white) cells.
(D) Association of Rad189myc next to a DSB, analyzed as above in W T (black) and rad52 (white) cells.
250 mM sodium chloride, binding of HlsVSVRad18 by itself was 
undetectable, but increasing levels of RPA afforded a robust 
and RPA-specific enrichment of the E3 in the bound material, 
indicating that RPA recruits HisVSVRad18 to ssDNA (Figure 7A). 
Similar results were obtained at 150 mM NaCI (data not shown). 
Surprisingly, under low-salt conditions, HisVSVRad18 alone asso­
ciated with the oligonucleotide, and RPA now caused a reduction 
in the amount of bound HlsVSVRad18 (Figure 7B). However, com­
parable quantities of the bacterial ssDNA-binding protein, SSB, 
competed much more effectively with HisVSVRad18 than RPA, 
indicating that, even at low ionic strength, RPA and the E3 can 
occupy a common stretch of DNA.
In order to assess in a simplified system whether RPA can 
simultaneously interact with ssDNA and Rad18, we examined 
the interaction of the E3 with ^ R f a l  (182-421) in the presence 
of short oligonucleotides with no measurable affinity for Rad18 
(data not shown) and varying affinities for Rfal (Fanning et al., 
2006) (Figure S5). We found that ssDNA prebound to Rfal en­
hanced retention of Rad18, suggesting that Rfal in its DNA- 
bound conformation interacts with Rad18 better than free in so­
lution (Figure 7C). An interaction of RPA with Radi 8  not involving 
DNA binding of Rad18 itself thus appears possible. Yet, the 
Rad18 SAP domain, responsible for DNA binding of the human 
protein (Notenboom et al., 2007), was previously shown to be 
involved in the assembly of the E3 at replication foci (Nakajima 
et al., 2006). Inactivation of this domain in yeast Radi 8  abolished 
its function in vivo, as judged by PCNA modification and DNA 
damage sensitivity (Figures 7C and 7D), despite the ability of 
the mutants to autoubiquitylate in vitro (data not shown). Hence, 
DNA binding by Rad18 itself also appears to be important for 
its activity toward PCNA.
DISCUSSION
RPA has been implicated in virtually all eukaryotic DNA transac­
tions (Fanning et al., 2006; Zou et al., 2006). Its stabilizing effect
on ssDNA is essential for replication, recombination, and nucle­
otide excision repair, but the complex engages in DNA metabo­
lism even more directly by means of protein-protein interactions, 
for example with DNA polymerase a/primase or the recombina­
tion protein Rad52. During S phase, RPA-coated ssDNA signals 
replication stress by recruiting the PCNA-like 9-1-1 clamp and 
the ATR/ATRIP checkpoint kinase complex to sites where poly­
merase stalling has resulted in exposure of extended stretches 
of ssDNA (Zou and Elledge, 2003; Zou et al., 2003). Our findings 
now point to an even more general role of RPA in dealing with 
replication problems that appears to be conserved from yeast 
to mammals.
RPA Contributes Independently to Damage 
Signaling and Damage Bypass
Loss of PCNA ubiquitylation upon depletion of Rfal implicates 
RPA in the activation of the RAD6 pathway, suggesting that 
the complex is responsible not only for the sensing of damaged 
DNA and the stabilization of stalled forks but also for initiating the 
steps necessary to overcome the damage that caused the ar­
rest. Our results indicate that the requirements of RPA for repli­
cation and recombination are genetically and physically separa­
ble from its role in DNA damage bypass.
Identification of RPA-covered ssDNA as an upstream signal 
for the RAD6 pathway explains a large body of circumstantial 
evidence defining the conditions that induce PCNA ubiquityla­
tion. Although experiments with synchronized cells suggest 
that DNA damage causes PCNA ubiquitylation primarily during 
S phase, the cell-cycle stage itself is irrelevant for the modifica­
tion: on one hand, a replication initiation defect abolishes PCNA 
ubiquitylation under conditions that physiologically resemble S 
phase. On the other hand, the reaction can be triggered in G1 
by stalled replication intermediates resulting from the processing 
of DNA interstrand crosslinks (Sarkar et al., 2006). Hence, stalled 
replication intermediates appear to be both necessary and 
sufficient for activation of PCNA ubiquitylation.
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Figure 7. Effects of DNA on the Interaction between R ad18 and RPA
(A) Recruitment of H,,vsvRad18 to RPA-coated ssDNA under high-salt conditions. A 75 nt 5'-biotiny1ated oligonucleotide was immobilized on streptavidin agarose 
and preincubated with increasing amounts of purified yeast RPA and retention of HlsVSVRad18 was analyzed by western blotting. RPA and H"vsvRad18 were 
allowed to bind in a buffer containing 15 mM KCI and 250 mM NaCI.
(B) DNA binding of Hi*vsvRad18 under low-salt conditions. The experiment was performed exactly as in (A), except that the proteins were allowed to bind to the 
ssDNA at 15 mM KCI.
(C) Preincubation of short oligonucleotides with QSTRfa1(182-421)at a ratioof 1:1 or 5:1 enhances interaction with Rad18. Pull-down assays were performed as 
described in the legend to Figure 5F.
(D) Deletion (A) or mutation (*) of the Radi 8 SAP domain impairs PCNA ubiquitylation in vivo. The rad 18 deletion mutant was complemented by the indicated 
alleles, and PCNA modifications were analyzed as in Figure 1. Presence of the mutant proteins was verified by immunoprecipitation and western blot (lower 
panel).
(E) The Rad 18 SAP domain is required for protection from DNA damage in vivo. Spot assays for NQO and MMS sensitivity were performed on a rad 18 deletion 
mutant complemented by the indicated RAD18 constructs.
A need for ssDNA at the sites of stalled replication intermedi­
ates is implied by our inability to detect PCNA modification in re­
sponse to DSB-inducing agents that do not cause base damage. 
Even CPT, which induces strand breaks in a replication-depen­
dent manner and stalls replication forks, did not result in PCNA 
ubiquitylation, consistent with our finding that this drug does 
not cause accumulation of ssDNA. By similar reasoning, uncou­
pling between polymerase and helicase has been suggested to 
activate damage bypass in X. laevis egg extracts (Chang et al„ 
2006).
Elevated levels of Radi 8  can overcome the requirement for fork 
stalling and promote ubiquitylation of PCNA whenever the clamp 
is associated with DNA (Figure 1B). This suggests that the E3 is 
rate limiting for the reaction, and higher concentrations will drive 
ubiquitylation at shorter or more transient stretches of ssDNA dur­
ing undisturbed replication. Constitutive modification of PCNA, 
as observed in S. pombe and in X. laevis egg extracts (Frampton 
et al.. 2006; Leach and Michael, 2005), might therefore be caused 
by a higher expression level or a lower activation threshold of 
Rad18 in these systems. A higher incidence of spontaneous 
fork stalling or intrinsic damage might have the same effect.
Finally, a placement of RPA-covered ssDNA upstream of 
PCNA ubiquitylation explains the similarities between the signals 
for modification of the clamp and those that elicit the replication- 
dependent S phase checkpoint (Branzei and Foiani, 2005). Given 
that the domains required for the recruitment of the checkpoint 
factors and for interaction with Rad18 are distinct, the two path­
ways—damage sensing and damage bypass—appear to origi­
nate independently from a common structure. Intriguingly, a 
reduction in PCNA ubiquitylation has been reported in mamma­
lian cells upon siRNA-mediated downregulation of ATR (Bi et al.,
2006). Hence, while damage tolerance is clearly independent of 
checkpoint function in S. cerevisiae (Figure S1), S. pombe, and 
X. laevis (Chang et al., 2006; Frampton et al., 2006), an indirect 
contribution of the kinase in the mammalian system remains 
possible.
Interactions of RPA and Rad 18 on ssDNA
RPA is well known for a complicated DNA-binding behavior that 
involves several distinct binding modes and varies considerably 
with ionic strength (Fanning et al., 2006). Interactions with other 
cellular factors may involve either one or multiple of its subunits,
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and these interactions often induce conformational changes of 
RPA. Recruitment of other proteins by RPA can involve cooper­
ative binding but also a “trading of places” whereby a replication 
or repair factor would replace the RPA domains in a stepwise 
manner (Fanning et al., 2006). Our in vitro experiments reveal 
that both protein-protein and protein-DNA interactions are likely 
to contribute to the recruitment of Radi 8  to ssDNA. In particular, 
we found that the affinity of Rad18 for ssDNA and RPA strongly 
depends on ionic strength. While modulation of the reaction 
buffer imposes rather artificial conditions on the RPA-Rad18- 
ssDNA interaction, our experiments have nevertheless revealed 
two patterns that might explain in principle how the two proteins 
can interact on DNA: at low ionic strength, Rad18 exhibits de­
tectable affinity for ssDNA by itself but does not engage in coop­
erative interactions with RPA. In physiological salt conditions, 
however, RPA is clearly necessary for recruitment of Rad 18 to 
ssDNA, and interaction of Rad 18 with the DNA-binding domain 
of Rfa1 is enhanced when the latter is bound to ssDNA (Figure 7). 
Whether the association in vivo relies solely on protein-protein 
interactions or whether RPA and Rad18 bind cooperatively to 
the DNA needs to be determined. A change between the two 
interaction modes during recruitment of Rad 18 would explain 
the requirement of both RPA and the Rad 18 SAP domain for 
PCNA ubiquitylation. However, the SAP domain may also have 
other functions in addition to DNA binding.
Implications of the Rad18-RPA Interaction  
for Rad 18 Function
The physical interactions between RPA and Rad18, detectable 
in yeast and mammalian cells, suggest that RPA recruits Rad18 
to ssDNA by direct association. In the context of a stalled 
replication fork, it is likely that additional cellular factors will 
also influence the behavior of Rad18. For example, interaction 
of the E3 with its target, PCNA, might affect its DNA-binding 
properties. Alternatively, Rad18 might undergo a conformational 
change upon DNA binding that would in turn modulate its inter­
actions with PCNA, RPA, or Rad5. Notably, C-terminal trunca­
tions of Rad18 excluding the DNA-binding SAP domain consis­
tently exhibit stronger interaction signals than the full-length 
protein in two-hybrid assays (Figure 5D) (Ulrich and Jentsch,
2000), possibly indicating an inhibitory function of the C-termi­
nal domain that might be relieved by DNA binding. Further 
biochemical studies and isolation of selectively interaction- 
deficient mutants of both Rad18 and RPA will be necessary 
to define the molecular mechanism by which RPA targets 
Rad18 to its sites of action. However, the presence of Rad18 
at ssDNA in vivo correlates with that of RPA even in the 
absence of its ubiquitylation target, PCNA. Association of the 
E3 with HO-induced DSBs might therefore suggest additional, 
PCNA-independent functions. Consistent with this notion, 
yeast rad18, but not ubiquitylation-deficient PCNA mutants, 
are highly sensitive to IR (Chen et al., 2005; Friedl et al.,
2 0 0 1 ), and the phenotypes of vertebrate rad18~'~ cells have 
implicated the E3 in the repair of DNA-strand breaks and re­
combination (Shiomi et al., 2007; Szuts et al., 2006). However, 
the relevant ubiquitylation targets as well as possible contribu­
tions of the RPA complex to these alternative functions remain 
to be identified.
EXPERIMENTAL PROCEDURES 
Yeast Strains and Plasmids
Standard procedures were followed for the cultivation of yeast. Mutants in 
rad18, rad53, and rad52 as well as POL30 and RADIE?"* have been de­
scribed previously (Steiter and Ulrich, 2003; Ulrich and Jentsch, 2000), and 
other epitope-marked alleles were created in the same background. The ccte7“ 
allele was transferred into POL30 by cloning of the open reading frame with 
flanking regions into a URA3 plasmid, integration into the CDC7 locus, selection 
for loss of the marker, and screening for temperature-sensitive growth. Mutants 
bob7, bob1 cdc7A, and an isogenic W T (Hardy et al., 1997) were modified by 
introduction of POL30. ChIP experiments at HO-induced DSBs were per­
formed in the background of JKM179 (Lee et al., 1998). The rfa1-t11 strain 
was generated in n^POLSO by direct replacement of the WT allele with 
a l/flA3-marked construct. Experiments involving rfa1-t33 were performed in 
the S288c background by introduction of m POL30 into isogenic RFA1 and 
rfa1-t33 strains (Umezu et al., 1998). The rfa1-td strain carries the degron allele 
(Dohmen et al., 1994) under control of a dual tetracycline-repressible promoter 
system (Belli et al., 1998). Both rfa1-td and its isogenic WT carry an integrative 
plasmid expressing mycUBR1 under control of the GAL1 promoter and the 
Hi3POL30 allele in addition to endogenous POL30. Overexpression of RAD 18 
was accomplished using an integrative vector with the GAL1 promoter. For 
complementation of rad18 with WT, SAP A (amino acids 279-312), or SAP' 
(G299A, R301A, M304A), we used integrative vectors carrying the respective 
alleles under control of the RAD18 promoter. Strains with a barl deletion 
were used for experiments involving G1 synchronization, except for those 
used in Figure 4. Details of strains and plasmids are available on request.
Antibodies
Rabbit polyclonal antibodies were obtained from S. Brill (Rfa1), J. Diffley (Sic1, 
Rad53, Orc6), or S. West (hRPA); purchased from Santa Cruz Biotechnology 
(Clb2, myc, HA) or Abeam (hRad18); or generated for our lab (PCNA Rad18); 
monoclonals were from Molecular Probes (PGK), Sigma (FLAG), Cell Signaling 
Technology (ubiquitin, P4D1) or Cancer Research UK (myc, 9E10; HA 12CA5).
Detection of PCNA Modifications
Strains bearing the POL30 allele were subjected to the desired treatment 
and processed for isolation of Hi8PCNA by Ni-NTA pull-downs under denatur­
ing conditions followed by detection of PCNA and ubiquitin as described 
previously (Hoege et al., 2002; Steiter and Ulrich. 2003). Responses to DNA 
damage were analyzed by treatment with HU, MMS, NQO, Bleo, CPT, or 
H202 in liquid YPD medium for 90 min. For UV irradiation, exponentially grow­
ing cultures were plated onto solid YPD medium, irradiated at 254 nm (UV Stra- 
talinker 2400, Stratagene), resuspended in fresh medium, and incubated for 
40 min prior to analysis. Treatment with IR was performed with a 137Cs y source 
in liquid YPD. Cell-cycle arrests in G1, S, and G2 were achieved by treatment 
with a factor (10 ng/ml), HU (100 mM), or nocodazole (15 pg/ml), respectively, 
and monitored by propidium iodide staining and flow cytometry.
Induction of Rfa1,d Degradation
Cells were pregrown in raffinose medium at 25°C and blocked in G1 with 5 ng/ml 
a factor for 3 hr. After exchange into galactose medium with 100 ng/ml dox- 
ycydin and a factor and incubation for 1 hr, the temperature was raised to 
37°C, and incubation was continued for 2 hr. After returning the cultures to 
25°C and addition of more a factor (2 ng/ml), cells were incubated for another 
2 hr before being released into S phase by washing in galactose/doxycyclin 
medium. Control cultures were blocked in G1 and kept in raffinose medium 
at 25°C for 3 hr before release in raffinose medium. Damage was induced after 
release by addition of 0.02% MMS for 90 min.
Analysis of DNA Damage Sensitivities and Checkpoint Activation
Sensitivities to Bleo, CPT, NQO, and MMS were analyzed by spot assays on 
YPD plates containing the indicated concentrations of damaging agents as 
described previously (Steiter and Ulrich, 2003). Strains were spotted onto 
the plates in 10-fold serial dilutions. Phosphorylation of Rad53 was followed 
by preparation of total cell extracts under denaturing conditions and western 
blotting.
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Analysis of Protein-Protein Interactions in the Two-Hybrid System
Protein-protein interactions were monitored in the reporter strain PJ69-4A as 
described previously (Ulrich and Jentsch, 2000) by using constructs based 
on fusions to the GaW activation and DNA-binding domains. Constructs for 
full-length RAD 18 and RADS have been described (Ulrich and Jentsch, 
2000). Mutations C48S and C190S were introduced by PCR. The RFA1, 
RFA2, and RFA3 open reading frames were amplified by PCR from genomic 
DNA. Truncations were generated using appropriate internal restriction sites.
Immunoprecipitations in Yeast
Total cell extracts were prepared from yeast strains expressing RFA19mye and/ 
or R A D 1 8 by lysis with zirconium/silica beads in 50 mM Tris-HCI (pH 7.5), 
250 mM KCI, 20% glycerol, 1 % NP40,2 mM DTT, and protease inhibitors. Im­
munoprecipitations were performed from ~6 x 10® cells (~4 mg total protein) 
by incubation with 3-5 ng antibody for 2 hr, addition of 20 (ii Protein G agarose 
(Roche), and further incubation for 1 hr followed by washing five times with 
lysis buffer and once with the same buffer containing no detergent.
Immunoprecipitations in Mammalian Cell Culture
HEK293T cells were transiently transfected with a construct encoding FLAG- 
tagged human Radi 8 (Mulder et al., 2002). After 3 days, cell extracts were pre­
pared from one 90 mm plate per immunoprecipitation in 50 mM Tris-HCI (pH 
7.5), 25 mM NaCI, 1.05 mM sucrose, 3 mM MgCI2, 1 mM EGTA, 0.5% NP40, 
and protease inhibitors. Soluble material was recovered by centrifugation at 
2000 rpm for 5 mm. The pellet was washed twice with lysis buffer and extracted 
with 50 mM Tris-HCI (pH 7.5), 125 mM NaCI, 1 mM EDTA, 0.5% NP40, and pro­
tease inhibitors for 30 min on ice to yield the detergent-insoluble chromatin 
fraction. Both extracts were centrifuged at 13,000 rpm for 15 min, and the 
lysates were precleared with Protein G agarose for 1 hr. Immunoprecipitations 
were performed with 20 nl anti-FLAG agarose (Sigma) for 3 hr. The beads were 
washed four times with 50 mM Tris-HCI (pH 7.5), 200 mM NaCI, 1 % NP40, and 
protease inhibitors and twice with the same buffer without NP40.
Chromatin Immunoprecipitations
ChIP assays at replication forks were performed as described previously 
(PapouM et al., 2005). A full description of the assay conditions for ChIP at 
HO-induced DSBs (Chen et al., 2005) is available in the Supplemental Data.
Chromatin-Binding Assays
Fractionation of total cell extracts prepared by spheroplast lysis into soluble 
and chromatin-bound fractions was achieved by centrifugation through a 
sucrose cushion essentially as described (Liang and Stillman, 1997).
Quantification of ssDNA
After the desired treatment of exponential cultures, genomic DNA was isolated 
from ~5 x 107 cells with the DNeasy Blood & Tissue Kit (QIAGEN) according to 
the manufacturer’s instructions. Klenow enzyme (0.5 U) with 0.5 nl hexanu- 
cleotide mix (Roche), 7.5 nCi “ P-dCTP, and 5 mM each of cold dATP, 
dGTP, and cfTTP were used in 5 nl random-primed labeling reactions on 100 ng 
of nondenatured DNA for 16 hr at room temperature (RT). Unincorporated 
nucleotides were removed by two steps of ammonium acetate precipitation. 
Aliquots of 2 nl spotted in duplicate on nitrocellulose were quantified by phos- 
phorimaging. A correction factor for the exact amount of input DNA was deter­
mined by real-time PCR quantification of the template with primers specific for 
the PAC2 gene (5'-AATAACGAATTGAGCTATGACACCAA-3' and 5'-AGCTT 
ACTCATATCGATTTCATACGACTT-3'). Standard deviations were calculated 
from triplicate measurements.
Protein Preparations
Bacterial SSB was from Pro mega. Yeast RPA was purified from E. coli as de­
scribed (Sibenaller et al., 1998). The expression constructs for QSTRfa1(181- 
422) and QSTRfa2 were generated in pGEX-4T-3 (GE Healthcare); the proteins 
were produced in E. coli and purified by affinity chromatography on glutathione 
Sepharose. Expression constructs for yeast H“vsvRad18 and untagged Rad6 
were generated in the vector pFastBAC (Invitrogen). The proteins were 
produced in Sf9 insect cells and purified as a complex from cytoplasmic ex­
tracts on Ni-NTA agarose. Thus, Rad6 was present in all experiments involving
HisVSVRad18. Protein concentrations were determined by comparison to a BSA 
standard.
Analysis of Protein-Protein Interactions In Vitro
Interaction of Hi,vsvRad18 with RPA in the absence of DNA was examined by 
covalent coupling of yeast RPA to activated CH Sepharose 4B (at 2.5 ng/ml) 
and monitoring retention of HlsVSVRad18 in 50 mM Tris-HCI (pH 7.5), 100 mM 
NaCI, 5 mM MgCI2, 0.05% Triton X-100, and 2.5 U benzonase (Novagen). 
Beads (20 n>) were incubated with ~2 pmol H“vsvRad18 for 2 hr at 4°C and 
washed five times with the same buffer containing 250 mM NaCI. BSA-deriv- 
atized beads served as negative control. Bound material was eluted with 
Laemmli buffer and analyzed by western blotting.
Interaction of Radi 8 with 6:37Rfa1 (182-421) or QSTRfa2 was assayed by im­
mobilizing 0.5 nmol fusion protein on glutathione Sepharose for 30 min at 4°C, 
followed by a brief wash in a buffer containing 50 mM Tris-HCI (pH 7.5), 50 mM 
NaCI, 1 mM EDTA, and 0.05% Triton X-100. Hi#vsvRad18 (10 pmol) was added 
in the same buffer containing 100 ng/ml BSA and incubated for 60 min at 4°C. 
Beads were washed five times in buffer without BSA, and bound material was 
eluted as above and analyzed by western blotting and Coomassie blue staining. 
Where indicated, GST or OSTRfa1 (182-421) was incubated with a 1 x or 5 x mo­
lar excess of oligo-dT (10,16, or 35 nt) for 45 min before binding to the beads.
Binding of HlsVSVRad18 to RPA-covered ssDNA was examined by immobiliz­
ing a 75 nt, 5'-biotinylated oligonucleotide of mixed sequence on streptavidin 
agarose (Pierce) in phosphate-buffered saline (PBS) with 1 mM EDTA for 1 hr at 
RT. After washing three times in PBS with 1 mM EDTA and three times in bind­
ing buffer (25 mM HEPES-NaOH [pH 7.5], 15 mM KCI, 1 mM EDTA, 0.05% Tri­
ton X-100, 0.5 mM DTT, 100 Mg/ml BSA, supplemented with 150 or 250 mM 
NaCI for high-salt conditions), 15 nl beads per reaction (~5 pmol of the oligo­
nucleotide) were incubated with increasing amounts of purified yeast RPA or 
bacterial SSB (2.4, 8, and 24 pmol) for 30 min at 4°C. Beads were washed 
once, and ~5 pmol HisVSVRad18 was added. Incubation was continued for 
1 hr at 4°C, and the beads were washed three times with high-salt binding 
buffer and twice with the same buffer containing no BSA. Bound material 
was eluted as above and detected by western blotting. For RPA blots, equal 
fractions of input and bound material were loaded. For Radi 8 blots, 1 % of 
the input and 35% of the bound material were loaded.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and five 
figures and can be found with this article online at httpV/www.molecule.org/ 
cgi/content/full/29/5/625/DC 1 /.
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